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Formation of new C–C bonds is a mainstay of modern molecule construction, 
however methods for the asymmetric construction of these scaffolds has been limited by 
the use of premetalated reagents or the use of catalytic methods that still require the use of 
stoichiometric metallic reductants. The Krische group’s approach to this bond formation 
utilizes the concepts of transfer hydrogen and carbonyl addition to form C–C bonds. These 
processes proceed through the in situ formation of a transient allylmetal species which then 
undergoes carbonyl addition. The research presented herein describes the development of 
several methods for the enantioselective construction of new C–C bonds, utilizing allenes 
to form nucleophilic allylmetal complexes that react with carbonyl electrophiles. 
Additionally, a method for the enantioselective construction of new C–N bonds is 
described, utilizing branched allylic acetates to form allylmetal complexes that react in an 
electrophilic manner with non-redox active primary and secondary amine nucleophiles. 
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Chapter 1:  Allene Pronucleophiles in Metal-Catalyzed Carbonyl 
Addition: Hydrometalative, Carbometalative, and Borometalative 
Processes 
1.1 INTRODUCTION  
Carbonyl addition reactions traditionally rely on preformed carbanion equivalents 
from Grignard and related organometallic reagents. These reagents, however, pose issues 
of safety and usability as many are moisture sensitive or require multi-step preparation and 
cryogenic conditions.1 In contrast, in situ formation of a nucleophilic allylmetal species 
from hydro-, carbo-, or borometalation of an allene, followed by combination with a 
carbonyl electrophile to form products of carbonyl addition, can circumvent these 
concerns.2-4 
The general mechanism for these transformations involves formation of a M–H, 
M–CR3, or M–BR species followed by respective hydro-, carbo-, or borometalation of the 
allene to yield an allylmetal species (Scheme 1.1). Typically, this metalation occurs on the 
least hindered face of the allene; however, ligand effects and substrate-metal interactions 
can occasionally favor a more hindered addition. These allylmetal species can then either 




react from their kinetic haptomers, or isomerize by way of σ–π–σ interconversion to more 
thermodynamically favored haptomers before undergoing carbonyl addition, commonly 
through a six-centered Zimmerman–Traxler-type5 transition structure. The product is then 
released and the M–H, M–CR3, or M–BR species regenerated. 
In this review, transition metal-catalyzed carbonyl additions utilizing allenes as 
pronucleophiles are discussed. Discussion is restricted to processes in which the catalytic 
mechanism proceeds via a hydro-, carbo-, or borometalation step to produce the reactive 
allylmetal intermediate. Transformations are catalogued by metalation process and then by 
metal catalyst. Metal-catalyzed couplings to carbon dioxide are not covered. 
1.2 HYDROMETALATIVE PROCESSES 
1.2.1 Ruthenium 
In 2008, Krische and co-workers6 identified ruthenium(II) complexes modified by a 
monodentate phosphine ligand catalyze the reductive coupling of 1,1-disubstituted allenes 
with paraformaldehyde and higher aldehydes (Scheme 1.2). Utilizing 2-propanol as the 
terminal reductant, homoallylic alcohol products could be isolated in good yields. Under 
similar reaction conditions the anti-aminoallylation of aldehydes can be achieved utilizing 
sulfonamido-allene as pronucleophile (Scheme 1.2).7 The catalytic mechanism of these 
transformations involves allene hydrometalation to form a nucleophilic allylruthenium 
species followed by aldehyde addition by way of a 6-centered transition structure. The 
resulting ruthenium alkoxide then undergoes alkoxide exchange with 2-propanol, releasing 
the coupling product and forming ruthenium isopropoxide. Following β-hydride 
elimination, acetone is released regenerating the metal-hydride. In this way, it is possible 
to exploit primary alcohols to serve dually as reductant and aldehyde proelectrophile. 
 3 
Scheme 1.2 Ruthenium(II)-Catalyzed Allene–Aldehyde Reductive Couplings Mediated 
by 2-Propanol or Hydrogen Autotransfer 
 
Utilizing the precatalyst HClRu(CO)(PPh3)3 and the bidentate ligand 1,1’-
bis(diisopropylphosphino)ferrocene (dippf) the highly anti-diastereoselective formation of 
vicinal anti-amino alcohols can be achieved using primary alcohols (Scheme 1.2).8 When 
this catalytic system is applied to the coupling of 1,1-disubsittued allenes and primary 
alcohols high levels of anti-diastereoselectivity can now be observed (Scheme 1.2).9 The 
high diastereoselectivity observed in these cases is attributed to a Curtin–Hammett scenario 
being operative; the (E)- allylruthenium isomer provides a lower energy carbonyl addition 
pathway, which leads to exclusive formation of the anti-diastereomer. The (Z)- and (E)-
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allylruthenium species rapidly interconvert at low concentrations, allowing the favored 
(E)-isomer to be replenished. 
Krische and co-workers10 also disclosed that ruthenium(II)-hydride complexes 
modified by the phosphine ligand bis(diphenylphosphino)methane (dppm) are effective 
catalysts for the 2-propanol-mediated reductive coupling of CF3-bearing allenes with 
paraformaldehyde to form CF3-bearing neopentyl alcohols in good yields (Scheme 1.3). 
While 2-propanol is the primary terminal reductant in this system, small quantities of 
formate esters were identified as minor reaction products, suggesting that 
paraformaldehyde is also acting as terminal reductant to some extent. Utilizing similar 
reaction conditions, fluorinated alcohols undergo reductive coupling with  1,1-disubstitued 
allenes to deliver homoallylic alcohols with moderate to high levels of anti-
diastereoselectivity (Scheme 1.3).11 This transformation is significant as many of the 
corresponding fluorinated aldehydes are not stable or commercially available. 
Scheme 1.3 Ruthenium(II)-Catalyzed Allene–Aldehyde Reductive Couplings with CF3-




Following their report of the first iridium-catalyzed allene–aldehyde reductive 
coupling under hydrogenation conditions utilizing hydrogen gas (not shown),12 Krische 
and co-workers reported related iridium-catalyzed allene–aldehyde reductive couplings 
mediated by 2-propanol and hydrogen autotransfer (Scheme 1.4).13 Using dimethylallene 
as pronucleophile and a variety of primary alcohols, products of reverse prenylation could 
be obtained in good yields. Under related transfer hydrogenation conditions, with 2-
propanol as terminal reductant, these same transformations give comparable yields. 
Methylallene and gaseous allene (not shown) could also be utilized, yielding products of 
carbonyl crotylation and allylation in moderate to good yields. 
Scheme 1.4 Iridium-Catalyzed Reverse Prenylation, Crotylation, and Allylation via 
Hydrogen Autotransfer and Transfer Hydrogenation 
 
In 2009, Krische and coworkers14, 15 reported an iridium(III)-catalyzed allene–
aldehyde reductive coupling mediated by 2-propanol (Scheme 1.5). Utilizing a 
cyclometalated π-allyliridium C,O-benzoate complex modified by (S)-SEGPHOS, Ir-I, 
aliphatic, α,β-unsaturated, and aromatic aldehydes could be coupled with dimethylallene 
to produce products of carbonyl tert-prenylation in good to excellent yields with high levels 
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of enantioselectivity. These same transformations could be carried out from the alcohol 
oxidation level, where the reactant alcohol acts dually as the carbonyl proelectrophile and 
the terminal reductant (Scheme 1.5). 
Scheme 1.5 Enantioselective Iridium(III)-Catalyzed Carbonyl tert-Prenylation from the 
Aldehyde or Alcohol Oxidation Level 
 
A related cyclometalated π-allyliridium C,O-benzoate complex modified by 1,1′-
bis(diphenylphosphino)ferrocene (dppf), Ir-II, catalyzes the allene–formaldehyde 
reductive coupling via methanol-mediated hydrogen autotransfer to form acyclic 
quaternary carbon centers (Scheme 1.6).16 A variety of 1,1-disubtituted allenes were used 
to form products of hydrohydroxymethylation in good yields. Kinetic studies identified 
methanol dehydrogenation, not the carbonyl addition step, to be turnover-limiting. 
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Scheme 1.6 Iridium(III)-Catalyzed Reductive Coupling of 1,1-Disubstituted Allenes with 
Methanol 
 
Attempts from Krische and co-workers to develop an enantioselective reductive 
coupling of allenes with methanol utilizing cyclometalated π-allyliridium C,O-benzoate 
catalysts failed to provide high levels of selectivity. However, utilizing an iridium catalyst 
modified by (R)-PhanePhos, CF3-allenes react with methanol to form neopentyl alcohols 
with CF3-bearing quaternary carbon stereocenters in good yields with high levels of regio- 
and enantioselectivity (Scheme 1.7).17 This iridium–PhanePhos catalyst system was further 
exploited in a highly regio-, anti-diastereo-, and enantioselective 2-propanol-mediated 
allene–fluoral reductive coupling to form CF3-substituted secondary alcohols that 
incorporate quaternary carbon-containing stereodiads (Scheme 1.7).18 Studies examining 
the effectiveness of the iridium–PhanePhos catalyst in these and related transformations19 
led to the identification of a chromatographically stable cyclometalated iridium(III) 
complex (Scheme 1.7), in which a four-member metallacycle is formed from oxidative 
addition to the ligand’s paraphane backbone. Crystallographic elucidation of this structure, 
along with DFT calculations, suggest the observed excellent control of selectivity stems 
from minimization of steric interactions with the paraphane ligand; the most favored 
transition state for all of the transformations is that in which the substituted σ-allyl and the 
CH2 moiety of the ligand are not in the same plane.
18 
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Scheme 1.7 Iridium–PhanePhos-catalyzed Reductive Couplings to Form Quaternary 
Carbon Stereocenters 
 
In 2019, Krische and co-workers20 further expanded upon the utility of the 
cyclometalated π-allyliridium C,O-benzoate catalysts, reporting the first catalytic 
enantioselective carbonyl (α-amino)allylations (Scheme 1.8). The cyclometalated π-
allyliridium C,O-benzoate catalyst modified by (R)-H8-BINAP, Ir-III, effectively 
catalyzes the reductive coupling of phthalimido-allene and primary alcohols to yield 1,2-
amino alcohols with high levels of regio-, anti-diastereo, and enantioselectivity. The use 
of alcohol coupling partners, which are typically commercially available, is significant as 
some corresponding aliphatic aldehydes can be relatively unstable and difficult to handle. 
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Scheme 1.8 Enantioselective Iridium(III)-Catalyzed Carbonyl (α-Amino)Allylation 
 
In an extension of their work in the area of allylation reactions, Krische and co-
workers21 reported the first enantioselective iridium(III)-catalyzed aldehyde allylation 
mediated by gaseous allene (Scheme 1.9). Utilizing the cyclometalated π-allyliridium C,O-
benzoate catalyst modified by (S)-Tol-BINAP, Ir-IV, and feedstock chemicals allene gas 
and 2-propanol, homoallylic alcohols were formed in good to excellent yields with high 
levels of enantioselectivity. The authors note an inversion of enantioselectivity was 
observed in these transformations in comparison to those conducted under identical 
conditions using allyl acetate as pronucleophile. Experimental and computational studies 
support this deviation stems from a difference in catalytic mechanism. Allyl acetate  




ionization occurs from a square planar iridium species while allene hydrometalation occurs 
from a pentacoordinate iridium hydride, resulting in the formation of diastereomeric 
iridium complexes and consequently lead to enantiomeric products. 
1.2.3 Copper 
In 2018, Buchwald and co-workers22 reported an enantioselective copper(I)-
catalyzed allene–ketone reductive coupling mediated by silane (Scheme 1.10). Utilizing a 
copper complex modified by JOSIPHOS-type ligand-I and a variety of methyl ketones 
homoallylic alcohols were synthesized with moderate to good levels of anti-diastereo- and 
enantioselectivity. The catalytic mechanism is hypothesized to involve formation of a 
nucleophilic allylcopper-(I) species from hydrometalation of the allene, followed by ketone 
addition to give a copper(I) alkoxide. Silane-mediated σ-bond metathesis produces the 
homoallylic silyl ether, which is hydrolyzed upon isolation, and regenerates the copper-(I) 
hydride. 
Scheme 1.10 Copper-Catalyzed Allene-Ketone Reductive Coupling Mediated by Silane. 
 
 In 2019, Buchwald and co-workers23 expanded their previous technology utilizing 
allene gas in an enantioselective copper-catalyzed ketone allylation mediated by silane 
(Scheme 1.11). Utilizing a copper catalyst and the chiral ligand (S,S)-QuinoxP*, a wide 
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variety of ketones undergo allylation with moderate to high levels of enantioselectivity. 
Racemic-BINAP can also be used to efficiently form the racemic allylation products with 
high yields. Additionally, under these conditions, more common industrially produced 
hydrocarbon mixtures of allene, methylacetylene, and propylene can be utilized as the 
source of allene gas with comparable yields to pure allene gas (not shown). 
Scheme 1.11 Copper-Catalyzed Allene Gas–Ketone Reductive Coupling Mediated by 
Silane 
 
In 2019, Sieber and co-workers reported the stereoselective copper(I)-catalyzed 
reductive couplings of ketones and a chiral allenamide mediated by silane for the formation 
of both linear24 and branched25 aminoallylation products (Scheme 1.12). Using a copper 
catalyst modified by either a phosphoramidite or NHC ligand, high levels of respective 
linear or branched selectivity and moderate to good levels of anti-diastereoselectivity could 
be achieved for a wide array of ketones. However, some loss of selectivity can be observed 
as the steric bias between RL and RS of the ketone is reduced. As with previous examples, 
the catalytic mechanism is postulated to involve hydrocupration of the allenamide to form 
a nucleophilic σ-allylcopper species, which can isomerize prior to ketone addition yielding 
the copper alkoxide. The authors suggest the origin of the observed regioselectivity lies in 
competition between the strength of coordination of the oxazolidinone ring to copper  
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Scheme 1.12 Copper-Catalyzed Stereoselective Ketone–Allenamide Reductive Coupling 
Mediated by Silane. 
 
versus the magnitude of A1,3-strain present in the initially formed σ-allylcopper species 
(Scheme 1.12). The poor electron-donating ability of the phosphoramidite ligand 
contributes to higher A1,3-strain in the linear allyl-copper species, as well as increases 
electrophilicity of the copper center, leading to a preference for the branched allylcopper 
species. Likewise, the bulky, strongly electron-donating NHC ligand disfavors 
coordination of the oxazolidinone. Furthermore, dipole-minimization can occur in this 
chair-like transition structure, leading to formation of the branched product (Scheme 1.12, 
bottom). 
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1.2 CARBOMETALATIVE PROCESSES 
1.2.1 Cobalt 
 In 2018, Komeyama and co-workers26 reported a diastereoselective 
cobalt/chromium-catalyzed three-component aryl iodide–allene–aldehyde coupling 
mediated by manganese and TMSCl (Scheme 1.13). Homoallylic alcohols could be formed 
with moderate to good levels of syn-diastereoselectivity from a variety of substituted aryl 
iodides, aryl and alkyl aldehydes, and alkyl monosubstituted allenes. The authors posulate 
a catalytic mechanism wherein oxidative addition of aryl iodide to a low-valent cobalt 
species preceeds carbometalation of the allene to yield an aryl-substituted allylcobalt 
species. A rapid transmetalation event then transfers the allyl moiety from cobalt to 
chromium with retention of alkene geometry. Carbonyl addition then occurs by way of a 
6-centered transition structure to give a chromium alkoxide which is cleaved by TMSCl to 
give the homoallylic silyl ether, which is cleaved upon workup. Notably, utilizing allenes 
with oxygen substituents at the allenyl position resulted in products with moderate to good 
levels of anti-diastereoselectivity. The origin of the observed inversion of 
diastereoselectivity when utilizing these allenyl ethers is believed to result from 
carbometalation occurring at the more substituted alkene due to hyperconjugative 
stabilization of the newly forming Co–C bond by the σ* orbital of the adjacent C–O bond 
(Scheme 1.13, right). The resulting branched cobalt species then isomerizes to the more 
thermodynamically stable (E)-allylcobalt species before stereoretentive transmetalation to 
chromium. This occurs in contrast to carbometalation of the unactivated allene terminus, 
which yields the kinetic (Z)-allylcobalt species and undergoes rapid transmetalation before 
isomerization can occur. 
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Scheme 1.13 Cobalt/Chromium-Catalyzed Aryl Iodide–Allene–Aldehyde Coupling 
Mediated by Manganese 
 
 
In 2019, Yang, Yoshikai, and co-workers27 described a cobalt-catalyzed 
cyclopropanol–allene coupling giving products of formal (3+2) cycloaddition with high 
levels of regio- and diastereoselectivity (Scheme 1.14). A variety of aryl and alkyl 
substituted cyclopropanols react with allenes to form monocyclic and fused polycyclic 3-
alkylidenecyclopentanols in moderate to good yields as single diastereomers. The catalytic 
mechanism involves base-assisted cyclopropanol ring opening to yield a cobalt 
homoenolate, followed by carbometalation of the allene to give an allylcobalt species. 
Intramolecular carbonyl addition then proceeds by way of a 6-centered transition structure 
in which steric interactions are minimized (Scheme 1.14, bottom). 
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Scheme 1.14 Cobalt-Catalyzed Formal (3+2) Cycloaddition of Cyclopropanol and Allene 
 
1.2.2 Palladium 
In 2000, Grigg and co-workers28 reported the palladium-catalyzed coupling of aryl 
aldehydes and ketones with allene gas (Scheme 1.15). Utilizing a non-phosphine palladium 
precatalyst, methylene-bearing cyclopentanols and cyclohexanols are formed in moderate 
to good yields. The authors suggest the precatalyst serves as a source of Pd(0) nanoparticle, 
which can then undergo oxidative addition with the carbonyl-containing aryl halide. 
Carbometalation to allene gas under base-mediated conditions with Cs2CO3 then results in 
the formation of an anionic allylpalladium species, which can combine with the carbonyl. 
While the terminal reductant in this system is not immediately apparent, the authors 
emphasize the necessity of dimethylformamide as solvent, suggesting formate impurities 
and decomposition products could be involved. 
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Scheme 1.15 Palladium-Catalyzed Nucleophilic Cyclization of 2-Haloaryl Aldehydes 
and Ketones with Allene Gas 
 
The β-pinene-derived π-allylpalladium(II) precatalyst, Pd-II, was reported by 
Malinakova and co-workers29 to catalyze a three-component arylboronic acid–allene–
aldehyde coupling (Scheme 1.16). 4-Methoxyphenyl boronic acid and 1,2-nonadiene 
reacted with a variety of aromatic, heteroaromatic, and alkyl aldehydes to give branched 
racemic homoallylic alcohols with varying levels of syn-diastereoselectivity. The catalytic 
mechanism is believed to proceed via a bis-π-allylpalladium(II) intermediate. The authors 
utilized this methodology as the initial step in a simple 3-step protocol for the 
diastereoselective synthesis of substituted tetrahydrofurans (not shown).30 A related 
coupling was also reported in which an ethyl allenoate, boronic acids, and aldehydes are 
coupled to form substituted α,β-unsaturated δ-hydroxy esters which cyclize to the 
corresponding δ-lactones in moderate to good yields.31 Again, carbopalladation results in 
a bis-π-allylpalladium species however the authors suggest isomerization to the metal-
enolate occurs and carbonyl addition then proceeds via an open transition state. 
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Scheme 1.16 Allylpalladium(II)-Catalyzed Boronic Acid–Allene–Aldehyde Couplings 
 
In 2008, Tsukamoto and co-workers32 reported the first enantioselective 
palladium(II)-catalyzed arylative cyclization of allenyl aldehydes with aryl boronic acids 
(Scheme 1.17). Utilizing (S)-SEGPHOS and a variety of allenyl aldehydes with varying 
tether-lengths and heteroatom substitutions, cyclic homoallylic alcohol products are 
formed in good to excellent yields as single syn-diastereomers with high levels of 
enantioselectivity. Carbometalation of the allenyl aldehyde by the arylpalladium species, 
formed from transmetalation of the aryl boronic acid to palladium, leads to the kinetic (Z)-
allylpalladium intermediate, which, due to arising A1,2-strain, does not isomerize. 
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Intramolecular carbonyl addition then occurs by way of a 6-centered transition structure 
where steric interactions with the chiral ligand are minimized. 
Scheme 1.17 Palladium-Catalyzed Arylative Cyclization of Allenyl Aldehydes with 
Arylboronic Acids 
 
In 2009, Lu and coworkers33 described a cationic palladium(II)-catalyzed coupling 
of 2-formylarylboronic acids and allenoates (Scheme 1.18). Palladium catalysts modified 
by the achiral bidentate phosphine ligand 1,3-bis(diphenylphosphino)propane (dppp) and 
non-coordinating tetrafluoroborate ligands were identified to effectively catalyze the 
tandem annulation reaction to yield indenol derivatives in good yields as single 
diastereomers. Efforts toward the asymmetric variant of this reaction identified (R)-Tol-
BINAP and (S)-Tol-SUNPHOS to induce moderate levels of enantioselectivity however, 
levels of chiral induction were highly substrate dependent (not shown). In a subsequent 
report, related reactions conditions allowed the formation of 1-benzoxepine derivatives.34 
Utilizing 5-substituted-2-acylmethoxyarylboronic acids and allenoates, products of the 
tandem annulation could be achieved in good yields as single diastereomers. The catalytic 
mechanism of these transformations is postulated to involve formation of an arylpalladium 
intermediate by way of transmetalation, followed by carbopalladation of the internal alkene 
of the allene due to coordination with the ester carbonyl. Addition to the carbonyl then 
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likely occurs via the O-bound palladium species (Scheme 1.18, bottom right). Protonation 
of the resulting tertiary palladium alkoxide releases the product alcohol and primes the 
cationic palladium center for transmetalation. 
Scheme 1.18 Cationic Palladium(II)-Catalyzed Tandem Annulation of Carbonyl-
Containing Boronic Acids and Allenoates 
 
Han, Lu, and co-workers35 reported another example of arylative cyclization using 
N-tosyl-aniline tethered allenyl aldehydes to synthesize tetrahydroquinoline derivatives 
(Scheme 1.19). Here, cationic palladium(II) complexes modified by (R)-BINAP are 
effective catalysts for the formation of these 3,4-cis-1,2,3,4-tetrahydroquinolines with 
good to excellent levels of syn-diastereo- and enantioselectivity. Again, cationic palladium 
centers are crucial in these transformations as the non-coordinating anionic ligands provide 
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a vacant coordination site in the η1-allylpalladium intermediates, allowing for pre-
coordination and activation of the carbonyl. 
Scheme 1.19 Cationic Palladium(II)-Catalyzed Arylative Cyclization of N-Tosyl-Aniline 
Tethered Allenyl Aldehydes 
 
1.2.3 Rhodium 
Ma, Jia, and co-workers36 reported the rhodium-catalyzed three-component 
coupling of a methyl allenoate with aryl boronic acids and aldehydes (Scheme 1.20). 
Utilizing a rhodium(I) precatalyst and triphenylphosphine as ligand, transmetalation from 
an aryl boronic acid results in the formation of an arylrhodium complex. Subsequent 
carbometalation of the allenoate and carbonyl addition yield a rhodium alkoxide.  




Hydrolysis regenerates the active catalytic species and provides the hydroxyl ester which 
can then cyclize to form a variety of α,β-unsaturated δ-lactones in moderate yields. 
1.2.4 Nickel 
In 2018, Lam and co-workers37 reported the nickel-catalyzed coupling of 2-acetyl-
or 2-formylarylboronoic acids with activated allenes (Scheme 1.21). Exploiting 
[Ni(OAc)2·4H2O], a variety of substituted 3-methyleneindanol products could be isolated 
in moderate to good yields as single syn-diastereomers. In an improvement on prior art, 
allenes with non-carbonyl substituents such as phosphonates, phosphine oxides, and 
sulfones, undergo coupling to yield single syn-diastereomers with moderate yields 
(Scheme 1.21). Preliminary studies directed towards the asymmetric variant of this reaction 
identified a phosphinooxazoline ligand afforded only moderate levels of enantioselectivity 
when combined with [Ni(O2CCF3)2·4H2O] as the nickel precatalyst (not shown). 
Scheme 1.21 Nickel-Catalyzed Allene–2-Acetylarylboronic Acid Annulation 
 
More recently, Lam and co-workers38 described the nickel-catalyzed arylative 
intramolecular allylation of tethered allene–ketones (Scheme 1.22). Utilizing a nickel 
catalyst modified by the chiral bidentate phosphinooxazoline ligand (S)-tBu-PHOX, 
coupling tethered allene–α-ketoamides and aryl boronic acids delivered a variety of chiral 
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pyrrolidine-2-ones with excellent levels of syn-diastero- and enantioselectivity. 
Furthermore, tethered allene–ketones with a variety of tether lengths and heteroatom 
substitutions afforded aza- and carbocycles in moderate to good yields with excellent levels 
of syn-diastero- and enantioselectivity. 




Copper complexes modified by the chiral bidentate phosphine ligand (R)-
DIFLUOROPHOS were identified by Kanai, Shibasaki, and co-workers39 as effective 
catalysts for the coupling of an ethyl allenoate with dialkylzincs and unactivated ketones 
(Scheme 1.23). Utilizing dimethyl or diphenyl sulfoxide as Lewis basic additives and 
molecular sieves, α,β-unsaturated δ-lactone products were formed in good yields with 
moderate to high levels of enantioselectivity. The proposed catalytic mechanism is 
postulated to occur by reduction of Cu(OAc)2 with dialkylzinc to form the active 
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alkylcopper(I) species. Ester-directed carbometalation of the allene results in a copper 
homoenolate, which is in equilibrium with the copper enolate. Ketone addition results in 
formation of an aldolate with either α- or γ-selectivity (Scheme 1.23, bottom). The γ-
aldolate then undergoes lactonization to release the product and give a copper ethoxide. 
Interaction with another equivalent of dialkylzinc and molecular sieves forms the 
alkylcopper(I) species, regenerating the catalytic cycle. The use of Lewis basic additives is 
postulated to facilitate the reverse reaction of the α-selective reaction allowing 
consumption of material via the γ-selective pathway. 
Scheme 1.23 Enantioselective Copper-Catalyzed Three-Component Dialkylzinc–Allene–
Ketone Coupling 
 
1.4 BOROMETALATIVE PROCESSES 
1.4.1 Copper 
In 2016, Hoveyda and coworkers40 reported a copper-catalyzed three-component 
coupling of bis(pinacolato)diboron [B2(pin)2], monosubstituted allenes, and aldehydes or 
ketones (Scheme 1.24). Utilizing either racemic-BINAP or the commercially available  
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Scheme 1.24 Copper-Catalyzed Borylative Aldehyde or Ketone Allylation Followed by 
C–B Oxidation 
 
NHC ligand salt 1,3-bis(1-adamantyl)imidazolium tetrafluoroborate (Ad-NHC), racemic 
β-hydroxyketones are produced with high levels of chemo- and syn-diastereoselectivity, 
following oxidative workup of the 2-B(pin)-substituted homoallylic alkoxides. In the same 
report, efforts towards the enantioselective variant were also described (Scheme 1.23, 
bottom). Utilizing CatASium® T1 for aldehydes and (R)-(+)-Cl-MeO-BIPHEP for 
ketones, moderate to good levels of enantioselectivity could be obtained. In both cases, the 
intermediate homoallylic alkoxides were isolated after oxidative workup as the β-
hydroxyketones. Reaction products could also be isolated as the vinylbromides, following 
exposure of the substituted homoallylic alkoxide to CuBr2 in methanol solvent. 
Mechanistically, generation of a copper-boron complex followed by borometalation of the 
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allene terminus results in a nucleophilic 2-B(pin)-substituted allylcopper intermediate that 
can undergo carbonyl addition via a closed six-centered transition state (Scheme 24, bottom 
right). 
Tao, Tian, and co-workers41 reported a copper(I)-catalyzed borylative cyclization 
of tethered allene cyclohexanediones (Scheme 1.25). Copper complexes modified by 
triphenylphosphine were effective catalysts for the formation of cis-decalinols when 
utilizing [B2(pin)2] as boron source. The resulting 2-B(pin)-substituted homoallylic 
alcohols are subjected to oxidative workup yielding ketone-bearing cis-decalinol products 
as single diastereomers in excellent yields. The complementary copper catalyst modified 
by racemic-BINAP effectively catalyzes this transformation utilizing bis(neopentyl 
glycolato)diboron ([B2(nep)2]) as boron source to form stable hemiboronates as single syn-
diastereomers in excellent yields. The catalytic mechanism is postulated to proceed by way 
of a highly organized 6-centered transition state, accounting for the high levels of 
diastereoselectivity observed (Scheme 1.25, bottom right). 




Gagosz, Riant, and co-workers42 described copper complexes modified by the 
bidentate phosphine ligand 1,1′-ferrocenediyl-bis(diphenylphosphine) (dppf) for the 
catalytic boroacylation of allenes (Scheme 1.26). Utilizing a variety of acyl fluorides, 1,1-
disubstituted allenes, and [B2(pin)2], β-boryl-β,γ-unsaturated ketones are afforded in 
moderate to good yields. The catalytic mechanism is postulated to occur by borometalation 
of the allene terminus by a borylcopper species giving a β-boryl allylcopper intermediate. 
Carbonyl addition then occurs via a 6-centered transition state followed by β-fluoride 
elimination to release the product. 
Scheme 1.26 Copper-Catalyzed Boroacylation of 1,1-Disubstituted Allenes 
 
In 2017 Fujihara, Tsuji, and co-workers43 described a related copper-catalyzed 
boroformylation of allenes (Scheme 1.27). A variety of 1,1-disubstituted allenes were 
reacted with hexyl formate and [B2(pin)2] to form the corresponding β-boryl β,γ-
unsaturated aldehydes in good to excellent yields. A later report by the same group utilized 
similar reaction conditions to effectively generate products of allene boroacylation and 
boroalkoxyoxalylation employing anhydrides and oxalates, respectively, as carbonyl 
electrophiles.44 Mechanistically similar to the previous transformation reported by Gagosz, 
Riant, and co-workers,42 following borometalation carbonyl addition occurs by way of a 6-
center transition state to give a copper carboxylate. β-Elimination releases the acylation 
products and generates a copper alkoxide, which then undergoes σ-bond metathesis with 
[B2(pin)2] to regenerate the catalytic cycle. 
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Scheme 1.27 Copper-Catalyzed Boroforymlation, Boroacylation, and 
Boroalkoxyoxalylation of 1,1-Disubtituted Allenes 
 
An enantioselective variant of these boroacylation reactions employing 1,1-
disubstituted allenes and benzoyl fluorides was later described by Zhang and co-workers 
(Scheme 1.28).45 Through ligand design and synthesis, a novel class of chiral ligands, 
deemed WJ-Phos, were identified to form copper complexes that are effective catalysts for 
the formation of β-boryl-β,γ-unsaturated ketones bearing a quaternary carbon stereocenter 
in good yields with high levels of enantioselectivity. 
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The of use of allenes in hydro-, carbo-, and borometalative processes to generate 
nucleophilic allylmetal intermediates for carbonyl addition provide powerful methods to 
circumvent the use of preformed carbanion equivalents. Although a significant amount of 
progress has been achieved, there are still unmet challenges to be overcome. Primarily, 
several of the described transformations utilize stoichiometric metallic reductants. 
Furthermore, the use of allenes containing directing or activating substituents, such as 
esters, is prevalent. Future advancements in this field will likely focus on utilization of 
organic reductants and unactivated starting materials and the development of more robust 
catalysts and ligands for selective processes. 
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Chapter 2:  Cyclometalated Iridium–PhanePhos Complexes in the 
Enantioselective Formation of Acyclic Quaternary Carbon 
Stereocenters* 
2.1 INTRODUCTION 
The catalytic enantioselective formation of all-carbon quaternary stereocenters 
remains a formidable challenge in chemical synthesis.1−3 Diverse catalytic enantioselective 
methods enabling formation of quaternary carbon stereocenters that reside within cyclic 
frameworks have been reported.1 In contrast, catalytic enantioselective methods that 
deliver acyclic quaternary carbon stereocenters remain relatively uncommon.1d,k,4,5 In the 
course of developing catalytic enantioselective carbonyl reductive couplings via alcohol-
mediated hydrogen transfer or hydrogen auto-transfer,6 the Krische group recently 
developed enantioselective methods for the formation of acyclic quaternary carbon 
stereocenters that operate under non-cryogenic conditions and are completely atom-
efficient, bypassing the use of stoichiometric metals.3 In these processes, vinyl 
epoxides3a,b,d and 1,3-dienes3c as serve as pronucleophiles. 
 
* This chapter is based on the previously published works: 
1)  Holmes, M. T.; Nguyen, K. D.; Schwartz, L. A.; Luong, T.; Krische, M. J. Enantioselective Formation of 
CF3-Bearing All-Carbon Quaternary Stereocenters via C-H Functionalization of Methanol: Iridium 
Catalyzed Allene Hydrohydroxymethylation. J. Am. Chem. Soc. 2017, 139, 8114. 
2)  Schwartz, L. A.; Holmes, M. T.; Brito, G. A.; Goncalves, T. P.; Richardson, J.; Ruble, J. C.; Huang, K. -
W.; Krische, M. J. Cyclometallated Iridium-PhanePhos Complexes Are Active Catalysts in 
Enantioselective Allene-Fluoral Reductive Coupling and Related Alcohol-Mediated Carbonyl Additions 
that Form Acyclic Quaternary Carbon Stereocenters. J. Am. Chem. Soc. 2019, 141. 2087 
L.A.S contributed to reaction discovery and optimization (Table 2.1; Figure 2.2), substrate scope (Tables 
2.2–2.4), kinetic and mechanistic studies (Figures 2.3 – 2.5; Scheme 2.5), and preparation of manuscript 
and supporting information. 
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2.2 IRIDIUM CATALYZED ALLENE HYDROHYDROXYMETHYLATION 
2.2.1 Background 
The enantioselective formation of acyclic CF3-bearing all-carbon quaternary 
centers is an especially daunting challenge.7−10 As established in seminal work by 
Shibata,7a methods capable of delivering this motif are restricted to conjugate additions of 
β,β-disubstituted enones7a,b,e,g,h or nitroolefins7c,d,f,i−k and two isolated reports of 
asymmetric allyl8a and propargyl8b substitution (Scheme 2.1). Attempts to adapt previously 
developed technology from the Krische group to the formation of acyclic CF3-bearing 
stereocenters via ruthenium catalyzed CF3-allene-paraformaldehyde reductive coupling 
mediated by 2-propanol failed to deliver highly enantiomerically enriched adducts.11 The 
unique efficacy of iridium-PhanePhos12 complexes in previously developed methanol 
mediated hydrohydroxymethylations of 2-substituted-1,3-dienes,3c along with the 
availability of improved protocols for the preparation of CF3-allenes,
13 motivated 
continued efforts toward this elusive bond formation. Expanding upon the use of methanol 
as a C1-feedstock in metal catalyzed C−C coupling,14−16 iridium-PhanePhos complexes 




were utilized to promote the methanol-mediated hydrohydroxymethylation of CF3-allenes 
to form highly enantiomerically enriched adducts with complete branched regioselectivity 
(Scheme 2.1). Thus, catalytic enantioselective formation of acyclic CF3-bearing all-carbon 
quaternary stereocenters is achieved in the absence of stoichiometric metals or byproducts. 
2.2.2 Reaction Development and Scope 
Given the singular effectiveness of iridium-PhanePhos in asymmetric diene 
hydrohydroxymethylation,3c these conditions were applied to the coupling of methanol 
with 1,1-disubstituted CF3-allenes 2.1[a−o]. Although the desired coupling products 
2.2[a−o] were generated with complete branched regioselectivity, the reaction was highly 
substrate dependent with significant variation in isolated yield and enantioselectivity. 
Furthermore, all other chiral ligands that were evaluated failed to deliver products of C−C 
coupling. These circumstances led us to explore the influence of alternate reaction 
parameters. As illustrated in the optimization of the methanol-mediated 
hydrohydroxymethylation of CF3-allene 2.1i to form 2.2i, several interesting trends 
emerged (Table 2.1). For CF3-allene 2.1i and other allenes bearing electron deficient aryl 
moieties, changing the precatalyst from [Ir(cod)Cl]2 to Ir(cod)(acac) resulted in higher 
levels of enantiomeric enrichment, but with lower conversion (Table 2.1, entries 2 and 3). 
A modest increase in reaction temperature improved the isolated yield of 2.2i without 
compromising enantioselectivity (Table 2.1, entry 4). The addition of water (500 mol %) 
increased enantioselectivity, but led to competing transfer hydrogenation of 2.1i (Table 1, 
entry 5). Tetrabutylammonium iodide (TBAI) (10 mol %) suppresses competing transfer 
hydrogenation and increases enantioselectivity to a small extent (Table 1, entry 6). Using 
water (500 mol %) and TBAI (10 mol %) in concert, the neopentyl alcohol 2.2i could be 
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obtained in 81% yield and 90% ee (Table 2.1, entry 7). Exchanging acetone for ethyl 
acetate as solvent improved enantioselectivity but diminished yield (Table 2.1, entry 8). 
Table 2.1. Optimization of the Enantioselective Iridium-Catalyzed C–C Coupling of CF3-
Allenes with Methanola 
 
Taking into account the aforesaid influence of the indicated reaction parameters, 
the conversion of 1,1-disubstituted CF3-allenes 2.1[a−o] to neopentyl alcohols 2.2[a−o] 
was explored (Table 2.2). Two general sets of conditions emerged. In the coupling of CF3-
allenes 2.1[a−f] and 2.1k, which incorporate electron rich, electron neutral or slightly 
electron deficient aryl moieties, use of the iridium catalyst derived from [Ir(cod)Cl]2 and 
(R)-PhanePhos in acetone solvent at 70 °C was optimal. For CF3-allenes bearing highly 
electron deficient aryl moieties, the precatalyst Ir(cod)(acac) in ethyl acetate solvent at 80 
°C was preferred. Under both sets of conditions, TBAI and H2O were frequently required 
to enhance enantioselectivity. By tailoring reaction conditions in this manner, alcohols 
2.2[a−o] with CF3-bearing all-carbon quaternary stereocenters could be formed with 
uniformly high levels of enantioselectivity and as single regioisomers. Alkyl substituted 
CF3-allenes engage in efficient methanol-mediated hydrohydroxymethylation, but enantio- 
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Table 2.2. Enantioselective Iridium-Catalyzed Coupling of Methanol with CF3-Allenes 
2.1[a-o] To Form Higher Alcohols 2.2[a-o]a 
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selectivities were lower (<50% ee). The absolute stereochemical assignment of adducts 
2.2[a−o] is based on single crystal X-ray diffraction analysis of 2.2b and 2.2f. Attempted 
use of higher alcohols led to regio- and enantioselective transfer hydrogenation of the 
internal allene π-bond (ca. 40% ee). 
To demonstrate how adducts 2.2[a−o] can be used in chemical synthesis, alcohol 
2.2a was subjected to a series of functional group manipulations. Conversion of alcohol 
2.2a to the corresponding p-toluenesulfonate followed by exposure to sodium cyanide in 
DMSO at 150 °C provided the nitrile 2.3, representing a remarkable example of an SN2 
reaction at a highly congested neopentyl center (Scheme 2.2, eq. 1). Jones oxidation of 
alcohol 2.2a followed by Fischer esterification provides the β,γ-unsaturated methyl ester  
Scheme 2.2 Functional Group Manipulations of Adduct 2.2a 
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2.4 (Scheme 2.2, eq. 2). Finally, conversion of alcohol 2.2a to the benzoate followed by 
oxidative cleavage17 of the vinyl moiety delivers the chiral α-stereogenic carboxylic acid 
2.5 (Scheme 2.2, eq. 3). 
2.2.3 Mechanism and Discussion 
As exemplified in methanol-mediated transfer hydrogenations of C−C π-bonds,18 
the reversible and highly endothermic nature of methanol dehydrogenation (ΔH(MeOH) = 
+20 kcal/mol vs ΔH(EtOH) = +16 kcal/mol)
19 can be overcome by linking dehydrogenation 
to an exothermic process. Methanol dehydrogenation also poses a significant challenge in 
the hydrohydroxymethylation of π-unsaturated reactants and invariably represents the rate-
limiting step.3c,16 However, as the present allene-methanol C−C couplings involve 
formation of a highly congested CF3-bearing all-carbon quaternary stereocenter, it was 
unclear whether methanol dehydrogenation or carbonyl addition would be rate-limiting. 
To gain further insight into the catalytic mechanism, CF3-allene 2.1a was subjected 
to d4-methanol under otherwise standard conditions (Scheme 2.3, eq. 4). The product, 
deuterio-2.2a, completely retains deuterium at the carbinol position (Ha, Hb = >95% 
2H), 
suggesting deuterio-2.2a is kinetically inert with respect to dehydrogenation due to 
coordination of the homoallylic olefin to iridium, blocking the adjacent coordination site 
required for β-hydride elimination. Although deuterium is not incorporated at the vinylic 
terminus of deuterio-2.2a (Hd, He = <5% 
2H), a significant quantity of deuterium appears 
at the internal vinylic position (Hc = 58% 
2H). Unlike related diene methanol C−C 
couplings,3c this data suggests the hydrometallation event is a completely regioselective 
process. Incomplete incorporation of deuterium at the internal vinylic position may be due 
to adventitious water.19,20 In a related competition kinetics experiment, CF3-allene 2.1a was  
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Scheme 2.3 Deuterium Labelling Studies and Catalytic Mechanisma 
 
exposed to equimolar quantities of methanol and d4-methanol under otherwise standard 
conditions (Scheme 2.3, eq. 5). Deuterium incorporation at the carbinol methylene (Ha, Hb 
= 27% 2H) ofthe product deuterio-2.2a constitutes a normal primary kinetic isotope effect 
(kH/kD ≈ 3.0) consistent with turnover-limiting methanol dehydrogenation. The influence 
of the precatalyst and additives (TBAI, H2O) on enantioselectivity suggest the counterion 
(and water) are present during the enantiodetermining carbonyl addition event. To 
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accommodate this observation, we propose that carbonyl addition occurs from an 
allyliridium-(III) intermediate (Scheme 2.3, bottom). 
2.2.4 Conclusion 
In conclusion, CF3-bearing all-carbon quaternary stereocenters are exceptionally 
difficult to prepare in enantiomerically enriched form, with previous protocols for their 
construction largely restricted to conjugate additions to β,β-disubstituted CF3-enones and 
nitroolefins.7 It has been demonstrated that iridium complexes modified by PhanePhos 
catalyze the methanol-mediated hydrohydroxymethylation of CF3-allenes to generate this 
structural motif in a completely regioselective and highly enantioselective fashion in the 
absence of stoichiometric metals or byproducts. 
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2.3 ENANTIOSELECTIVE ALLENE–FLUORAL REDUCTIVE COUPLING AND 
IDENTIFICATION OF CYCLOMETALATED IRIDIUM–PHANEPHOS COMPLEX 
2.3.1 Background 
While the formation of acyclic quaternary carbon stereocenters is a difficult 
challenge in chemical synthesis.1-3 Even more elusive are asymmetric methods that deliver 
(a) acyclic quaternary carbon-containing stereopolyads5 or (b) fluorinated acyclic 
quaternary carbon-containing structural motifs.9h–l,n,p-s,21 As previously discussed, iridium 
complexes modified by the chiral phosphine ligand PhanePhos12 were uniquely effective 
in catalyzing highly regio- and enantioselective methanol-mediated formaldehyde 
additions.3c,14,22 Other chelating phosphine ligands were completely inactive in these 
processes. The singular effectiveness of the iridium−PhanePhos catalyst prompted further 
exploration of its capabilities and investigations into the precise nature of the catalytically 
active species. It was discovered that the iridium complex derived from [Ir(cod)Cl]2 and 
PhanePhos catalyzes highly regio-, diastereo- and enantioselective allene−fluoral reductive 
couplings mediated by 2-propanol to form acyclic quaternary carbon-containing 
stereodiads.11,15,23−26 Of greater significance, these studies led to the identification of a 
cyclometalated iridium−PhanePhos complex that is catalytically competent – not only in 
the present transformation but also in previously reported iridium−PhanePhos-catalyzed 
reactions developed in our laboratory.3c,22 This complex contributes to a growing collection 
of cyclometalated iridium complexes that display diverse catalytic activities (Figure 2.1).27 
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Figure 2.1 Diverse catalytic activities of cyclometalated iridium complexes and the 
identification of a catalytically competent cyclometalated iridium–
PhanePhos complex. 
 
2.3.2 Reaction Development and Scope 
Prior work on enantioselective iridium–PhanePhos-catalyzed C–C coupling 
focused on methanol-mediated formaldehyde additions.3c,22 Steric issues posed by the 
formation of a more highly substituted quaternary carbon C–C bond prohibited reactions 
of higher aldehydes. It was posited that fluoral, a highly reactive carbonyl electrophile like 
formaldehyde, might participate in alcohol-mediated reductive coupling to provide acyclic 
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quaternary carbon stereodiads incorporating a trifluoroethyl carbinol fragment.28 However, 
the feasibility of allene–fluoral reductive coupling was rendered uncertain by two issues. 
First, fluoral is only commercially available as the hydrate or hemiacetal, yet the vast 
majority of enantioselective metal-catalyzed fluoral additions require use of anhydrous 
fluoral.9h–s,21 Second, high levels of stereoselectivity require not only discrimination of 
enantiotopic carbonyl π-faces, but also intervention of a single geometrical isomer of the 
σ-allyliridium nucleophile. The latter issue is further complicated by the fact that 
hydroiridation of 1,1-disubstituted allenes occurs preferentially at the allene π-face 
proximal to the smaller allene substituent (Rs) to furnish the less stable (Z)-σ-allyliridium
 
isomer. Hence, notwithstanding Curtin–Hammett effects,29 in order to form the quaternary 
carbon stereocenter with optimal levels of stereoselectivity, either kinetic stereoselectivity 
favoring formation of the (Z)-σ-allyliridium isomer must be preserved or equilibration 
between the (Z)- and (E)-σ-allyliridium isomers must be achieved prior to carbonyl 
addition with complete conversion to the latter (Figure 2.2, top). The difference in energy 
between (Z)- and (E)-2-phenyl-2-butenes is more than 1 kcal/mol, and greater energetic 
differentiation is anticipated for the corresponding (Z)- and (E)-σ-allyliridium species.30 
With these considerations in mind, the following series of experiments was 
performed (Figure 2.2, bottom). Allene 2.6a (200 mol%), fluoral hydrate 2.7 (100 mol%, 
75 wt% in water), and 2-propanol (200 mol%) were exposed to the iridium catalyst derived 
from [Ir(cod)Cl]2 (2.5 mol%) and (R)-PhanePhos (5 mol%) in tert-butanol (0.5 M) at 100 
°C. In the absence of desiccant, only a trace quantity of the targeted reductive coupling 
product 2.8a was observed. However, upon addition of 4Å molecular sieves, compound 
2.8a was formed in 43% yield as a 5:1 mixture of diastereomers in 96% enantiomeric 
excess. In accord with our stereochemical analysis, it was reasoned that more dilute 
conditions might increase diastereoselectivity by decreasing the rate of carbonyl addition  
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Figure 2.2 Relative and Absolute Stereoselection in 2-Propanol-Mediated Reductive 
Couplings of Allenes with Fluoral Hydrate via Concentration-Dependent 
Diastereoselectivity 
 
with respect to the rate of equilibration between the (Z)- and (E)-σ-allyliridium isomers.29 
Indeed, in the event, diastereoselectivity was found to increase with increasing dilution, 
and at 0.05 M a 13:1 diastereomeric ratio was observed without any erosion of 
enantioselectivity, although under these dilute conditions the isolated yield of 2.8a 
suffered. In the course of our optimization experiments, we also observed that more Lewis 
basic solvents promote higher diastereoselectivities. This fact led us to explore the effect 
of halide additives. To our delight, introduction of Bu4NCl (100 mol%) not only improved 
diastereoselectivity, but also increased the isolated yield of 2.8a. At 0.2 M in the presence 
of Bu4NCl, compound 2.8a was formed in 78% yield as a 17:1 mixture of diastereomers 
with a 96% enantiomeric excess. Diastereoselectivity remained constant at 80, 90 and 100 
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°C, and at lower temperatures conversion decreased precipitously, so diastereoselectivity 
was not calculated. 
These optimized conditions were applied to the reductive coupling of 1,1-
disubstituted allenes 2.6[a−o] bearing aryl and methyl groups with fluoral hydrate 2.7 
(Table 2.3). Allenes 2.6[b−k] bearing aryl moieties with diverse substitution patterns and 
electronic properties are converted to adducts 2.8[b−k] in good yield with uniformly high 
levels of regio-, diastereo- and enantioselectivity. Notably, functional groups that are 
potentially susceptible to reduction, for example nitro groups (2.8j) and ketones (2.8k), 
remain intact. Heteroaryl-substituted allenes 2.6[l−o] are also effective partners for 
reductive coupling, providing adducts 2.8[l−o] with high levels of relative and absolute 
stereocontrol. For N-heterocycles, at least one ortho-substituent adjacent to nitrogen is 
required for high levels of conversion. 
To test the limits of stereoselectivity, 1,1-disubstituted allenes 2.6[p−u] bearing 
higher alkyl substituents were evaluated in reductive couplings to fluoral 2.7 (Table 2.4). 
Remarkably, although increasing size of the alkyl moiety was anticipated to erode 
partitioning of the transient (E)- and (Z)-σ-allyliridium isomers, excellent levels of 
stereocontrol were retained in reactions of allenes 2.6[p−u] that incorporate linear alkyl 
groups. In contrast, attempted reactions of allenes bearing branched alkyl groups, for 
example, cycloalkyl moieties, were low-yielding and non-diastereoselective. The absolute 
stereochemical assignment of all adducts 2.8[a−u] is made in analogy to that established 




Table 2.3 Iridium-Catalyzed Coupling of Allenes 2.6[a-o] with Fluoral Hydrate 2.7 To 
Form Adducts 2.8[a-o] Bearing Acyclic Quaternary Carbon Stereocentersa 
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Table 2.4 Iridium-Catalyzed Coupling of Allenes 2.6[p-u] with Fluoral Hydrate 2.7 To 
Form Adducts 2.8[p-u] Bearing Acyclic Quaternary Carbon Stereocentersa 
 
To briefly illustrate the utility of the reaction products, fluoral adduct 2.8a was 
converted to the CF3-oxetane 2.9a, which bears a quaternary carbon stereocenter (Scheme 
2.4, eq. 4).3d Oxetanes have emerged as useful building blocks in medicinal chemistry due 
to their ability to serve as carbonyl and gem-dimethyl isosteres.31 Recently, CF3-oxetanes 
were shown to function as more polar tert-butyl isosteres.32 To prepare CF3-oxetane 2.9, 
fluoral adduct 2.8a was transformed to the mesylate and subjected to ozonolysis conditions. 
The resulting primary alcohol was exposed to sodium hydride to provide oxetane 2.9 
(Scheme 2.4, eq. 4). As corroborated by the conversion of primary tosylate 2.10 to oxetane 
2.9 (Scheme 2.4, eq. 5), the formation of 2.9 proceeds via secondary to primary 
methanesulfonate transfer. Just as trifluoroethylamines serve as amide bioisosteres,33 CF3-
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azetidines34 may be viewed as β-lactam mimics. To prepare CF3-azetidine 2.11, fluoral 
adduct 2.8a was converted the mesylate and subjected to ozonation conditions to deliver 
the corresponding aldehyde. Reductive amination−cyclization provided CF3-azetidine 2.11 
(Scheme 2.4, eq. 6). 
Scheme 2.4 Preparation of CF3-oxetanes and CF3-azetidines from Adduct 2.8a 
 
2.3.3 Mechanism and Discussion 
Insight into the unusual effectiveness of the iridium–PhanePhos catalyst was 
essential in terms of formulating an accurate interpretation of the catalytic mechanism. 
Products of allene–fluoral reductive coupling were not formed upon use of other chelating 
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phosphine ligands such as BINAP or SEGPHOS under otherwise identical conditions. The 
same is true for previously reported iridium–PhanePhos-catalyzed couplings of methanol 
with 1,3-dienes3c and CF3-allenes.
22 Consequently, the fact that cyclometalated π-
allyliridium C,O-benzoate complexes (Figure 2.1)27c promote C–C coupling in the 
aforesaid processes (albeit with suboptimal levels of stereocontrol) was deemed 
significant. This observation raised the question of whether the unique topology of 
PhanePhos rendered this ligand susceptible to cyclometalation. Although cyclometalated 
complexes of PhanePhos have not been reported, a relatively short contact of 3.56 Å is 
found in the X-ray crystal structure of a palladium–PhanePhos complex35 between metal 
and the ortho-carbon atom of the cyclophane ring. For an iridium center, which has a larger 
atomic radius, one could easily imagine an agostic interaction or C–H oxidative addition 
to form a cyclometalated complex. With these thoughts in mind, an effort was made to 
prepare a cyclometalated iridium–PhanePhos complex and evaluate its catalytic activity. 
In the event, heating a THF solution of [Ir(cod)Cl]2 (100 mol%), (R)-PhanePhos 
(200 mol%) and allyl acetate (400 mol%) at 100 °C for 1 h gave a yellow residue, which 
upon flash silica gel column chromatography delivered the 4-membered metallacycle Ir-
PP-I in up to 60% yield. The structural assignment of Ir-PP-I was corroborated by single-
crystal X-ray diffraction analysis (Figure 2.3). The cyclometalated iridium complex is of 
distorted octahedral geometry, with the two phosphorus atoms of PhanePhos and acetate 
lying in the same plane and with the chloride and aryl moieties apical to the plane. The 
distance between the phosphorus atoms (3.34 Å) is noticeably less than that found in the 
related square planar Pd(rac-PhanePhos)Cl2 complex (3.62 Å).
35 Additionally, the P–Ir–P 
“bite angle” (95.90°) is significantly compressed compared to that found in the palladium 
complex (103.69°).35 The P–Ir–C bond angle of the iridacycle is 67.95°, with an Ir–C bond 
length of 2.04 Å. The bond length of the cyclometalated Ir–P is 2.24 Å, which is slightly 
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shorter than the other Ir–P bond, which has a bond length of 2.26 Å. The differential trans 
influence of these two phosphorus atoms is reflected by the disparity between the two Ir–
O bond lengths of the acetate moiety. The Ir–O bond that is trans to the activated 
phosphorus atom has a bond length of 2.19 Å, which is slightly longer than the Ir–O bond 
trans to the non-cyclometalated phosphorus atom, which has a bond length of 2.15 Å. 
Figure 2.3 Structure of the Cyclometalated Iridium–(R)-PhanePhos Complex Ir-PP-I As 
Determined by Single-Crystal X-Ray Diffraction. 
 
Displacement ellipsoids are scaled to the 50% probability level. 
 
To probe the catalytic competency of the cyclometalated complex, allene 2.6e was 
exposed to fluoral hydrate 2.7 in the presence of Ir-PP-I (5 mol%) under otherwise standard 
conditions. The product of reductive coupling 2.8e was formed in 72% yield in a 14:1 
diastereomeric ratio and 96% enantiomeric excess (Figure 2.4, eq. 7). Similarly, allene 2.6p 
was exposed to fluoral hydrate 2.7 in the presence of Ir-PP-I (5 mol%) under otherwise 
standard conditions to furnish the reductive coupling product 2.8p in 62% yield in a 16:1 
diastereomeric ratio and 93% enantiomeric excess (Figure 2.4, eq. 8). These data are in 
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good alignment with the yields and stereoselectivities observed in reactions in which the 
catalyst is generated in situ from [Ir(cod)Cl]2 (2.5 mol%) and (R)-PhanePhos (5 mol%) 
(Tables 2.3 and 2.4, respectively). The cyclometalated complex Ir-PP-I is also a competent 
catalyst in the previously reported iridium–PhanePhos-catalyzed couplings of methanol 
Figure 2.4 Corroboration of Catalytic Competency of Ir-PP-I for All Iridium–(R)-
PhanePhos-Catalyzed Transfer Hydrogenative Carbonyl Additionsa 
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with 1,3-dienes (Figure 2.4, eq. 9)3c and CF3-allenes (Figure 2.4, eq. 10).
22 These data (eqs 
7–10) corroborate intervention of a cyclometalated catalyst related to Ir-PP-I in the present 
allene–fluoral reductive coupling and the previously reported transfer hydrogenative C–C 
couplings of dienes3c or CF3-allenes.
22 While roughly equivalent stereoselectivities are 
observed using the preformed complex Ir-PP-I, slightly lower yields are evident. This may 
be due to the fact that the catalyst generated in situ incorporates a monodentate chloride 
counterion, whereas Ir-PP-I contains a bidentate acetate counterion, which may inhibit 
catalysis. 
To gain further insight into the catalytic mechanism, a series of deuterium labeling 
experiments were conducted (eqs 11 and 12). Exposure of fluoral hydrate 2.7 to deuterio-
2.6a, which incorporates a fully deuterated methyl group, under standard reaction 
conditions delivers deuterio-2.8a (Scheme 2.5, eq. 11). Deuterium is completely retained 
at the methyl group and is not redistributed to any other position. This experiment 
demonstrates that the reaction does not proceed by way of allene-to-diene isomerization. 
Indeed, the isomeric diene was prepared and subjected to standard reaction conditions and 
was not a competent partner for C–C coupling. The coupling of 2.6a and 2.7 mediated by 
d8-2-propanol under otherwise standard conditions delivers deuterio-2.8a′ (Scheme 2.5, 
eq. 12). Deuterium is incorporated exclusively at the interior vinylic position (15% 2H). 
Exchange between iridium hydrides and the deuterium atoms of D2O is well-documented,
36 
and incomplete deuterium incorporation is likely due to H–D exchange with tert-butanol 
or water associated with aqueous fluoral hydrate. Consistent with this hypothesis, when the 
reaction is conducted in d10-tert-butanol or toluene, enhanced levels of deuterium 
incorporation are observed (Scheme 2.5, eq. 12). 
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Scheme 2.5 Deuterium Labeling Studies 
 
The collective data are consistent with the indicated catalytic mechanism (Scheme 
2.6). Entry into the catalytic cycle is achieved via C–H oxidative addition of the ortho-C–
H bond of PhanePhos to iridium(I). Allene hydrometalation from the resulting iridium(III) 
hydride I delivers the kinetic (Z)-σ-allyliridium isomer IIa. Isomerization to the 
thermodynamically preferred (E)-σ-allyliridium isomer IIb is followed by association of 
fluoral and carbonyl addition to furnish the homoallylic iridium(III) alkoxide IV. Alkoxide 
exchange with 2-propanol releases the product of carbonyl addition 2.8a. β-Hydride 
elimination from the 2-propoxyiridium(III) species V regenerates the iridium(III) hydride 
I to close the catalytic cycle. Knowing that the active catalyst is a cyclometalated halide-
containing iridium(III) complex, one can better understand how halides “tune” the 
environment at the iridium center to influence reactivity and selectivity. In the present 
transformation, the additive Bu4NCl may assist by preserving chloride at the iridium(III) 
center, while in previously discussed couplings of methanol with CF3-allenes,
22 Bu4NI 
likely substitutes the chloride at iridium(III). 
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Scheme 2.6 Proposed Catalytic Mechanism for Iridium–PhanePhos-Catalyzed Allene– 
Fluoral Reductive Coupling Mediated by 2-Propanol 
 
To gain further mechanistic insight, reaction progress kinetic analysis (RPKA) was 
applied to the coupling of allene 2.6a with fluoral hydrate 2.7 to form adduct 2.8a.37,38 Due 
to the volatile nature of the reactants and the complex equilibria between fluoral, fluoral 
hydrate, and hemiacetals that arise upon addition of 2-propanol and tert-butanol, the 
progress of a single reaction could not be monitored. Therefore, a series of reactions were 
conducted in parallel: for each successive time point, an individual reaction was stopped 
and the extent of product formation was determined by GC analysis using an internal 
standard. As each data point derives from a separate experiment, the quality of the data was 
not ideal; nevertheless, several significant conclusions could be drawn. 
 52 
The results of experiments carried out using the “different excess” protocol 
elucidate the order in allene 2.6a and fluoral hydrate 2.7 (Figure 2.5). The observed overlap 
between data sets indicates zero-order kinetics in allene, since the rate of product formation 
is not affected by the change of initial concentration of allene (Figure 2.5, left). In contrast, 
higher concentrations of 2.6a result in faster rates of product formation, which suggests a 
positive order in fluoral (Figure 2.5, right). Evaluation of the effect of increasing catalyst  
Figure 2.5 Reaction Progress Kinetic Analysis of the Reductive Coupling of Allene 2.6a 
and Fluoral 2.7 
 
Product formation as monitored by GC analysis in reactions carried out utilizing “different 
excess” protocol: [cat] = 0.005 M; [TBAC] = 0.1 M; [2-propanol] = 0.2 M; (a) [2.7]0 = 0.1 
M, [2.6a]0 = as noted; (b) [2.6a]0 = 0.2 M, [2.7]0 = as noted. (c) Time adjustment of product 
formation in varying catalyst loading reactions as monitored by GC analysis: [2.6a] = 0.2 
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loading using Burés’s method39 suggests the reaction is first order in catalyst (Figure 2.5, 
bottom). Furthermore, results of a set of experiments performed using the “same excess” 
protocol indicate minimal catalyst deactivation occurs (see Experimental Data). These data 
corroborate a catalytic mechanism involving rapid allene hydrometalation followed by 
turnover-limiting carbonyl addition (Scheme 2.6). These data also implicate the π- 
allyliridium species, which could be detected via high-resolution mass spectrometry as the 
catalyst resting state. 
Initial computational studies, performed by colleagues at King Abdullah University 
of Science and Technology (KAUST),  were aimed at formulating a unified stereochemical 
model accounting for relative and absolute stereochemistry in the present and prior3c,22 
iridium–(R)-PhanePhos-catalyzed transfer hydrogenative carbonyl additions (Figure 4, eqs 
7−10). Accordingly, 48 different conformations based on a Zimmerman–Traxler-type 
transition structure40 were thus computationally analyzed41 to identify the transition state 
with the lowest energy barrier. In the most favored transition state (Figure 2.6), the σ-allyl 
occupies a coordination site that minimizes steric repulsion with the CH2 moiety of the 
cyclophane ethano linkage that resides ortho to iridium. At the same time, nonbonded 
interactions between the terminal aryl moiety of the σ-allyl and the cyclometalated phenyl 
ring are decreased. The carbonyl electrophile, fluoral, can then enter the coordination site 
trans to the PPh2 moiety of the iridacycle and syn to Ir–Cl with the CF3 pointing away from 
the iridium center. The orientation of the fluoral C–H bond suggests possible intervention 
of a formyl C–H bond with the chloride ligand.42 Addition of the σ-allyl to the Si-face of 
the carbonyl through a closed transition structure defines enantiotopic π-facial selectivity. 
This model is also applicable to iridium– (R)-PhanePhos-catalyzed couplings of methanol 
with 1,3-dienes3c and the above described CF3-allenes.
22 
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Figure 2.6 Computationally Determined Stereochemical Model Accounting for Relative 
and Absolute Stereochemistry for All Iridium–(R)-PhanePhos-Catalyzed 
Transfer Hydrogenative Carbonyl Additions 
 
Computational studies were used to further assess the veracity of our interpretation 
of the catalytic mechanism (Scheme 2.6). Allene hydrometalation from intermediate I, an 
iridium(III) hydride−allene complex, delivers the kinetic (Z)- σ-allyliridium isomer IIb, 
which can interconvert with the thermodynamically preferred (E)-σ-allyliridium isomer 
IIa. The Curtin−Hammett situation29 favors the reaction to proceed by association of 
fluoral to IIIa followed by carbonyl addition via TS2-E to furnish the homoallylic 
iridium(III) alkoxide IVa. Alkoxide exchange with 2-propanol releases the product of 
carbonyl addition 2.8a and regenerates the iridium-(III) hydride coordinated with an allene 
after β-hydride elimination to close the catalytic cycle. Consistent with the excellent levels 
of diastereo- and enantioselectivity that are observed, the transition state leading to the 
disfavored enantiomer, TS2-E-2R3S, requires the fluoral carbonyl group to become anti-
periplanar to the Ir–Cl bond, which results in a higher energy barrier due to the increased 
steric interactions with the cyclometalated phenyl ring and the ortho-CH2 group of the 
PhanePhos ligand. Within the same core geometry at iridium, the second lowest transition 
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state, TS2-Z-2S3S, will afford a diastereomer from the (Z)-isomer IIb with the same 
stereoselectivity for the allylation of fluoral. Notably, both computational studies and 
RPKA implicate rapid allene hydrometalation followed by turnover-limiting carbonyl 
addition with the allyliridium species as a potential catalyst resting state. 




In summary, a highly regio- and enantioselective iridium-catalyzed allene−fluoral 
reductive coupling mediated by 2-propanol was achieved. This method enables generation 
of enantiomerically enriched quaternary carbon stereocenters in the context of a CF3-
bearing stereodiad. Of greater significance, a chromatographically stable cyclometalated 
iridium–(R)-PhanePhos complex, Ir-PP-I, was identified that is catalytically competent in 
the present allene–fluoral reductive couplings as well as previously reported 
iridium−PhanePhos-catalyzed C–C couplings of methanol with dienes3c or CF3-allenes.
22 
These findings suggest that cyclometalated iridium–PhanePhos complexes akin to Ir-PP-I 
may constitute a privileged catalyst class. A catalytic mechanism involving rapid allene 
hydrometallation followed by turnover-limiting carbonyl addition was corroborated by 
deuterium labeling studies, reaction progress kinetic analysis (RPKA) and DFT 
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calculations. Computational studies also were used to formulate a unified stereochemical 
model that accounts for the origins of enantioselectivity in the present fluoral–allene 
reductive couplings and previously reported iridium–PhanePhos-catalyzed C–C couplings 
of methanol with dienes3c or CF3-allenes.
22 
2.4 SUMMARY AND OUTLOOK 
In conclusion, it has been demonstrated that iridium complexes modified by 
PhanePhos catalyze the methanol-mediated hydrohydroxymethylation of CF3-allenes and 
the 2-propanol-mediated allene–fluoral reductive coupling with high levels of regio- and 
enantioselectivities. The identification of the cyclometalated iridium–(R)-PhanePhos 
complex, Ir-PP-I, was significant and allowed for greater understanding of catalyst 
topology. Further exploitation of this catalyst system will likely focus on the discovery and 
development of expanded allylative alcohol-mediated carbonyl addition reactions. 
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2.5 EXPERIMENTAL DETAILS 
2.5.1 General Information 
All reactions were run under an atmosphere of argon, unless otherwise indicated. 
Resealable pressure tubes (13x100 mm) were purchased from Fischer Scientific (catalog 
number 14–959–35C) and were flame dried followed by cooling in a desiccator or under a 
stream of argon prior to use. Acetone (HPLC grade), absolute methanol and ethanol were 
used as received from vendors (Fischer and Sigma Aldrich) without further purification. 
[Ir(cod)Cl]2, Ir(cod)(acac) and (R)-PhanePhos ligand were used as received from Strem 
Chemicals Inc. Preparative column chromatography employing Silicycle silica gel (40-63 
μm) was performed according to the method of Still.43 Analytical thin-layer 
chromatography (TLC) was carried out using 0.25 mm commercial silica gel plates 
(Dynamic Absorbents F254). Visualization was accomplished with UV light followed by 
dipping in CAM, p-Anisaldehyde (PAA), or KMnO4 stain solution followed by heating. 
Specific optical rotations were recorded on an Atago AP-300 automatic polarimeter at the 
sodium line (589.3 nm) in CHCl3. Solution concentrations are given in the units of 10
–2 g 
mL–1. 4Å molecular sieves (Sigma Aldrich, powder, 325 mesh particle size) were dried 
prior to each use by heating with a propane torch in vacuo and cooling to room temperature 
under Ar. Trifluoromethylallenes 2.1a, 2.1d, 2.1h, 2.1i and 2.1o were prepared according 
to literature procedure and compared to authentic samples.44,45 Trifluoromethylallenes 
1b,1c, 1e-1g, 1j-1n were prepared were prepared in an analogous manner. NaO2CCBrF2 
was prepared according to literature procedures.46 1,1-Disubstituted allenes 2.6[a–e]47, 
2.6g48, 2.6h48, 2.6i48, 2.6p47, 2.6q49, 2.6s,49 and 2.6u50 were prepared according to literature 
procedures. 1,1-Disubstituted allenes were stable for several months at -20 °C, but some 
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degradation can be observed at higher temperatures.  Racemic reactions were conducted 
using a 1:1 ratio of (R)- and (S)-PhanePhos. 
2.5.2 Spectroscopy and Spectrometry 
Infrared spectra were recorded on a Perkin-Elmer 1600 spectrometer. High-
resolution mass spectra (HRMS) were obtained on a Karatos MS9 and are reported as m/z 
(relative intensity). Accurate masses are reported for the molecular ion (M+H, M+Na), or 
a suitable fragment ion. Proton nuclear magnetic resonance (1H NMR) spectra were 
recorded with a Varian INOVA (500 MHz) spectrometer equipped with a Bruker 
AVANCE III cryoprobe. Chemical shifts are reported in delta (δ) units, parts per million 
(ppm) downfield from tetramethylsilane or ppm relative to the center of the singlet at 7.26 
ppm for deuteriochloroform. Data reported as multiplicity (s = singlet, d = doublet, t = 
triplet, q = quartet, m = multiplet). Integration and coupling constants were reported in 
Hertz (Hz). Carbon-13 nuclear magnetic resonance (13C NMR) spectra were recorded with 
a Varian INOVA (125 MHz) spectrometer and were routinely run with broadband 
decoupling. Chemical shifts are reported in delta (δ) units, ppm relative to the center of the 
triplet at 77.16 ppm for deuteriochloroform. Fluorine-19 nuclear magnetic resonance (19F 
NMR) spectra were recorded with a Varian INOVA (470 MHz) spectrometer. Deuterium 
nuclear magnetic resonance (2H NMR) spectra were recorded in CHCl3 solution with a 
Varian Gemini 500 (77 MHz) spectrometer (relaxation delay 2.00s). 
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2.5.3 Experimental Data for Section 2.2 
2.5.3.1 General Procedures 
General Procedure A 
 
To a round-bottomed flask equipped with a magnetic stir bar under an argon atmosphere 
charged with Pd(PPh3)2Cl2 (1 mol%) and CuI (2 mol%) was added THF (1 M) followed 
by Et3N (1 M). The reaction mixture was allowed to stir for five minutes at 0 °C. Aryl 
iodide (100 mol%) was added followed by propargyl alcohol (110 mol%) and the reaction 
mixture was allowed to stir at room temperature for 16 hours. The solvent was removed in 
vacuo and the residue was subjected to flash column chromatography (SiO2) under the 
conditions noted to afford the propagylic alcohols. For aryl bromides, the reaction mixture 
was allowed to stir at 50 °C for 16 hours.45 
 
General Procedure B 
 
To a round-bottomed flask equipped with a magnetic stir bar under an argon atmosphere 
charged with bromodifluoroacetic acid (140 mol%) in CH2Cl2 (0.4 M) was added 
dimethylformamide (10 mol%) followed by oxalyl chloride (130 mol%). The reaction 
mixture was allowed to stir for 1 hour at room temperature, at which point the reaction 
mixture was added dropwise via syringe to a cooled (0 °C) solution of propargyl alcohol 
(100 mol%) and Et3N (200 mol%) in CH2Cl2 (0.4 M). The reaction mixture was allowed 
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to stir for 14 hours at room temperature. To the reaction mixture was added HCl (1 N). The 
reaction mixture was transferred to a separatory funnel. The organic layer was washed with 
H2O (2x) and the combined aqueous layers were extracted with CH2Cl2 (2x). The combined 
organic layers were washed with brine, dried (MgSO4), filtered and the solvent was 
removed in vacuo. The residue was subjected to flash column chromatography (SiO2) 
under the conditions noted to afford the propargyl bromodifluoroacetates. [Note: some 
propargyl bromodifluoroacetates are prone to hydrolysis on silica gel so a minimum 
amount of silica gel was used].45 
 
General Procedure C 
 
To a dried pressure tube charged with KF (200 mol%), CuI (10 mol%), 1,10-
phenanthroline (10 mol%), and NaO2CCF2Br (25 mol%) was added propargyl 
bromodifluoroacetate (100 mol%) followed by DMF (1 M). The reaction mixture was 
flushed with Ar, sealed and allowed to stir at 50 °C for 14 hours. The reaction mixture was 
cooled to room temperature and diluted with EtOAc. The reaction mixture was transferred 
to a separatory funnel. The organic layer was washed with H2O (2x), brine, dried (MgSO4), 
filtered and the solvent was removed in vacuo. The residue was subjected to flash column 







General Procedure D 
 
To a round-bottomed flask equipped with a magnetic stir bar under an argon atmosphere 
charged with aryl trifluoromethyl ketone (100 mol%) in THF (0.5 M) at 0 °C was added 
ethynyl magnesium bromide (0.5 M solution in THF, 150 mol%). The reaction mixture 
was allowed to stir at room temperature until complete consumption of starting material 
was observed (TLC, 1-2 hours). To the reaction mixture was added saturated NH4Cl (aq). 
The reaction mixture was transferred to a separatory funnel and the aqueous layer was 
extracted with Et2O (3x). The combined organic extracts were washed with brine, dried 
(MgSO4), filtered and the solvent was removed in vacuo. The residue was subjected to 
flash column chromatography (SiO2) under the conditions noted to afford the tertiary 
propargylic alcohols.44 
 
General Procedure E 
 
To a round-bottomed flask equipped with a magnetic stir bar under an argon atmosphere 
charge with tertiary propargylic alcohol (100 mol%) in THF (0.5 M) at 0 °C was added 
NaH (150 mol%, 60% w/w) and the reaction mixture was allowed to stir for 30 minutes. 
Benzyl bromide (100 mol%) and TBAI (5 mol%) were added and the reaction mixture was 
allowed to stir for 14 hours at room temperature. Saturated NH4Cl (aq) and Et2O were 
added to the reaction mixture and the reaction mixture was transferred to a separatory 
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funnel. The organic layer was washed with H2O, brine, dried (MgSO4), filtered and the 
solvent was removed in vacuo. The residue was subjected to flash chromatography (SiO2) 
under the conditions noted to afford the benzyl protected propargylic alcohol. [Note: it is 
essential that any trace of unreacted benzyl bromide be removed during the purification as 
this can interfere with the following reactions].44 
  
General Procedure F 
 
To a round-bottomed flask equipped with a magnetic stir bar under an argon atmosphere 
charged with benzyl protected propargylic alcohol (100 mol%) in CHCl3 (0.2 M) was 
added gold catalyst (see above inset, 0.05 mol%) and the reaction mixture was allowed to 
stir at 60 °C for 1.5 hours. The solvent was removed in vacuo. The residue was subjected 
to flash column chromatography under the conditions noted to afford the 
trifluoromethylallenes.44 
 
General Procedure G 
 
 
To a dried pressure tube under an argon atmosphere charged with iridium precatalyst (5 
mol% Ir), (R)-PhanePhos (5 mol%) was added solvent (EtOAc or Me2CO) (0.1 M) 
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followed by MeOH (1 M) and trifluoromethylallene (100 mol%). The reaction mixture was 
allowed to stir for 18 hours at 70 °C (for Me2CO) or 80 °C (for EtOAc). The solvent was 
removed in vacuo and residue was subjected to flash column chromatography (SiO2) under 
the noted conditions to furnish the product of hydrohydroxymethylation. 
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2.5.3.2 Procedures and Spectral Data for the Synthesis of Trifluoromethylallenes 2.1[b, 




4’-chloro-2,2,2-trifluoroacetophenone (1.67 g, 8 mmol) was subjected to general procedure 





Crude tertiary propargylic alcohol 2.15b was subjected to general procedure E. Upon flash 
column chromatography (SiO2, 2:98 to 1:5 Et2O/hexanes), the title compound 2.16b (1.12 
g, 3.4 mmol) was obtained as a light yellow oil in 43% yield over two steps. 
 
Rf = 0.35 (1:5 Et2O/hexanes). 
1H NMR (500 MHz, CDCl3) δ: 7.71 (d, J = 8.3 Hz, 2H), 7.42 (d, J = 8.3 Hz, 2H), 7.39-
7.30 (m, 5H), 4.83 (d, J = 11.2 Hz, 1H), 4.41 (d, J = 11.2 Hz, 1H), 2.96 (s, 1H). 
13C NMR (125 MHz, CDCl3) δ: 136.9, 136.3, 131.9, 129.8, 128.8, 128.6, 128.1, 127.7, 
122.8 (q, J = 279 Hz), 80.0, 79.0 (q, J = 31 Hz), 76.1, 68.1. 
19F NMR (470 MHz, CDCl3) δ: -78.5. 
HRMS (CI+, m/z) for C17H12OF3Cl: calcd. = 324.0529; found = 324.0530. 
FTIR (neat): 3299, 3036, 2970, 2121, 1595, 1489, 1382, 1185, 1175, 1093, 1-61, 1017, 










Benzyl protected propargylic alcohol 9b (300 mg, 0.93 mmol) was subjected to general 
procedure F. Upon flash column chromatography (SiO2, pentane) title compound 1b (150 
mg, 0.69 mmol) was obtained as a colourless oil in 74% yield.  
 






4’-bromo-2,2,2-trifluoroacetophenone (2.53 g, 10 mmol) was subjected to general 
procedure D. Upon flash column chromatography (SiO2, 1:5 Et2O/hexanes), the title 
compound 8c (1.98 g, 7.1 mmol) was obtained as a light yellow oil in 71% yield. 
 
Rf = 0.25 (1:5 Et2O/hexanes). 
1H NMR (500 MHz, CDCl3) δ: 7.61 (d, J = 8.6 Hz, 2H), 7.53 (d, J = 8.6 Hz, 2H), 3.06 (br 
s, 1H), 2.84 (s, 1H). 
13C NMR (125 MHz, CDCl3) δ: 133.7, 131.6, 129.0, 124.3, 123.0 (q, J = 285 Hz), 77.1, 
77.2, 72.6 (q, J = 32.7 Hz). 
19F NMR (470 MHz, CDCl3) δ: -80.7. 
HRMS (CI+, m/z) for C10H6OF3Br: calcd. = 277.9554; found = 277.9557. 








Tertiary propargylic alcohol 2.15c (1.98 g, 7.1 mmol) was subjected to general procedure 
E. Upon flash column chromatography (SiO2, pentane), the title compound 2.16c (1.55 g, 
4.2 mmol) was obtained as a light yellow oil in 59% yield. 
 
Rf = 0.16 (pentane). 
1H NMR (500 MHz, CDCl3) δ: 7.65 (d, J = 7.5  Hz, 2H), 7.58 (d, J = 7.5 Hz, 2H), 7.39-
7.30 (m, 5H), 4.83 (d, J = 11 Hz, 1H), 4.41 (d, J =  11 Hz, 1H), 2.96 (s, 1H). 
13C NMR (125 MHz, CDCl3) δ: 136.9, 132.5, 131.8, 130.1, 128.6, 128.1, 127.7, 124.6, 
122.7 (q, J = 285 Hz), 80.0, 79.0 (q, J = 35 Hz), 76.0, 68.1. 
19F NMR (470 MHz, CDCl3) δ: -78.5. 
HRMS (CI+, m/z) for C17H12OF3Br: calcd = 368.0024; found = 368.0021. 








Benzyl protected propargylic alcohol 2.16c (304 mg, 0.82 mmol) was subjected to general 
procedure F. Upon flash column chromatography (SiO2, pentane), the title compound 2.1c 
(187 mg, 0.71 mmol) was obtained as a light yellow oil in 87% yield. 
 
Rf = 0.51 (pentane). 
1H NMR (500 MHz, CDCl3) δ: 7.50 (d, J = 8.7 Hz, 2H), 7.30 (d, J = 8.7 Hz, 2H), 5.55 (q, 
J = 3.5 Hz, 2H). 
13C NMR (125 MHz, CDCl3) δ: 208.5 (q, J = 4.1 Hz), 132.1, 128.8, 128.3, 123.3 (q, J = 
269 Hz), 122.6, 101.3 (q, J = 40.4 Hz), 84.2. 
19F NMR (470 MHz, CDCl3) δ: -60.6. 
HRMS (CI+, m/z) for C10H6F3Br: calcd = 261.9605; found = 261.9613. 









3-Iodoanisole (2.34 g, 10 mmol) was subjected to general procedure A. Upon flash column 
chromatography (SiO2, 1:3 EtOAc/hexanes), the title compound 2.13e (1.44 mg, 0.89 
mmol) was obtained as a brown solid in 89% yield. 
 




3-(3-methoxyphenyl)prop-2-yn-1-yl 2-bromo-2,2-difluoroacetate (2.14e) 
 
Propargyl alcohol 2.13e (405 mg, 2.5 mmol) was subjected to general procedure B. Upon 
flash column chromatography (SiO2, 1:20 EtOAc/hexanes), the title compound 2.14e (408 
mg, 1.28 mmol) was obtained as a light yellow oil in 51% yield. 
 
Rf = 0.54 (1:4 EtOAc/hexanes). 
1H NMR (500 MHz, CDCl3) δ: 7.25 (t, J = 8.0 Hz, 1H), 7.07 (d, J = 7.7 Hz, 1H), 6.99 (s, 
1H), 6.93 (dd, J = 2.1, 8.3 Hz, 1H), 5.16 (s, 2H), 3.81 (s, 3H). 
13C NMR (125 MHz, CDCl3) δ: 159.3, 159.0 (t, J = 32.1 Hz), 129.5, 124.5, 122.4, 116.8, 
115.9, 108.4, (t, J = 315.1 Hz), 88.6, 80.0, 56.4, 55.3. 
19F NMR (470 MHz, CDCl3) δ:-60.8. 
HRMS (CI+, m/z) for C12H9BrFO3: calcd = 317.9703; found = 317.9703. 
FTIR (neat): 2940, 2836, 2359, 2241, 1780, 1597, 1576, 1289, 1206, 1167, 1121, 1046, 








Progargyl bromodifluoroacetate 2.14e (363 mg, 1.14 mmol) was subjected to general 
procedure C. Upon flash column chromatography (SiO2, 3:97 CH2Cl2:pentane), the title 
compound 2.1e (190 mg, 0.89 mmol) was obtained as a colourless oil in 78% yield. 
 






5-Iodo-1,3-benzodioxole (1.27 mL, 10 mmol) was subjected to general procedure A. Upon 
flash column chromatography (SiO2, 1:5 to 1:2 EtOAc/hexanes), the title compound 2.13f 
(1.62 g, 9.2 mmol)) was obtained as a brown solid in 92% yield. 
 




3-(benzo[d][1,3]dioxol-5-yl)prop-2-yn-1-yl 2-bromo-2,2-difluoroacetate (2.14f) 
 
Propargyl alcohol 2.13f (441 mg, 2.5 mmol) was subjected to general procedure B. Upon 
flash column chromatography (SiO2, 1:20 EtOAc/hexanes), the title compound 2.14f (636 
mg, 1.91 mmol) was obtained as a light yellow oil in 76% yield. 
 
Rf = 0.71 (1:4 EtOAc/hexanes). 
1H NMR (500 MHz, CDCl3) δ: 7.01 (dd, J = 1.1, 8.1 Hz, 1H), 6.91 (d, J = 1.1 Hz, 1H), 
6.76 (d, J = 8.1 Hz, 1H), 5.99 (s, 2H), 5.13 (s, 2H). 
13C NMR (125 MHz, CDCl3) δ: 159.2 (t, J = 31.9 Hz), 148.9, 147.6, 127.2, 114.7, 112.0, 
108.7, 108.6 (t, J = 315.0 Hz), 101.6, 88.8, 78.7, 56.7. 
19F NMR (470 MHz, CDCl3) δ: -60.9. 
HRMS (CI+, m/z) for C12H7BrF2O4: calcd. = 331.9496; found = 331.9500. 








Progargyl bromodifluoroacetate 2.14f (411 mg, 1.23 mmol) was subjected to general 
procedure C. Upon flash column chromatography (SiO2, 3:97 CH2Cl2:pentane), the title 
compound 2.1f (201 mg, 0.89 mmol)  was obtained as a light yellow oil in 72% yield. 
 
Rf = 0.24 (hexanes). 
1H NMR (500 MHz, CDCl3) δ: 6.93 (d, J = 8.8 Hz, 1H), 6.91 (s, 1H), 6.81 (d, J = 8.8 Hz, 
1H), 5.98 (s, 2H), 5.50 (q, J = 3.3 Hz, 2H). 
13C NMR (125 MHz, CDCl3) δ: 208.4 (q, J = 4.0 Hz), 148.2, 147.8, 123.3 (q, J = 274 Hz), 
122.9, 121.1, 109.6, 107.8, 101.7 (q, J = 34.7 Hz), 101.5, 83.6. 
19F NMR (470 MHz, CDCl3) δ: -60.6. 
HRMS (CI+, m/z) for C11H6O2F3: calcd.  = 227.0320; found = 227.0318. 
FTIR (neat): 2900, 2360, 1970, 1611, 1506, 1490, 1305, 1231, 1110, 1086, 1039, 936, 






Methyl 4-(3-hydroxyprop-1-yn-1-yl)benzoate (2.13g) 
 
Methyl-4-iodobenzoate (2.62 g, 10 mmol) was subjected to general procedure A. Upon 
flash column chromatography (SiO2, 1:5 to 1:2 EtOAc/hexanes), the title compound 2.13g 
(1.49 g, 7.8 mmol) was obtained as a brown solid in 78% yield. 
 




Methyl 4-(3-(2-bromo-2,2-difluoroacetoxy)prop-1-yn-1-yl)benzoate (2.14g) 
 
Propargyl alcohol 2.13g (476 mg, 2.5 mmol) was subjected to general procedure B. Upon 
flash column chromatography (SiO2, 1:15 EtOAc/hexanes), the title compound 2.14g (430 
mg, 1.24 mmol) was obtained as a light yellow oil in 50% yield. 
 
Rf = 0.65 (1:4 EtOAc/hexanes). 
1H NMR (500 MHz, CDCl3) δ: 7.96 (d, J = 8.3 Hz, 2H), 7.48 (d, J = 8.3 Hz, 2H), 5.14 (s, 
2H), 3.88 (s, 3H). 
13C NMR (125 MHz, CDCl3) δ: 166.2, 158.9 (t, J = 32.1 Hz), 131.9, 130.5, 129.5, 125.9, 
108.4 (t, J = 316.1 Hz), 87.7, 83.0, 56.1, 52.3. 
19F NMR (470 MHz, CDCl3) δ: -60.9. 
HRMS (CI+, m/z) for C13H9BrF2O4: calcd.  = 345.9652; found = 345.9655. 







Methyl 4-(1,1,1-trifluorobuta-2,3-dien-2-yl)benzoate (2.1g) 
 
Progargyl bromodifluoroacetate 2.14g (360 mg, 1.03 mmol) was subjected to general 
procedure C. Upon flash column chromatography (SiO2, 10:90 to 1:3 CH2Cl2:pentane), the 
title compound 2.1g (204 mg, 0.84 mmol) was obtained as a colourless solid in 82% yield. 
 
Rf = 0.09 (1:20 CH2Cl2/pentane). 
1H NMR (500 MHz, CDCl3) δ: 8.03 (d, J = 7.1 Hz, 2H), 7.51 (d, J = 7.1 Hz, 2H), 5.62 (q, 
J = 3.1 Hz, 2H), 3.93 (s, 3H). 
13C NMR (125 MHz, CDCl3) δ: 209.1 (q, J = 4 Hz), 166.7, 133.9, 130.1, 129.9, 127.0, 
123.1 (q, J = 274 Hz), 101.7 (q, J = 36.1 Hz), 84.4, 52.4. 
19F NMR (470 MHz, CDCl3) δ: -60.3. 
HRMS (CI+, m/z) for C12H9O2F3: calcd. = 242.0555; found = 242.0556. 
FTIR (neat): 2954, 1970, 1936, 1711, 1613, 1432, 1260, 1119, 1094, 934, 880, 773 cm-1. 








2,2,2,3’,5’-pentafluoroacetophenone (1.05 g, 5.0 mmol) was subjected to general 
procedure D. Upon flash column chromatography (SiO2, 1:5 Et2O/hexanes), the title 
compound 2.15j (0.97 g, 4.1 mmol) was obtained as a light yellow oil in 82% yield. 
 
Rf = 0.43 (4:1 Hexanes:EtOAc). 
1H NMR (500 MHz, CDCl3) δ: 7.29 (br d, J = 6.6 Hz, 2H), 6.88 (tt, J = 2.3, 8.7 Hz, 1H), 
3.36 (br s, 1H), 2.86 (s, 1H). 
13C NMR (125 MHz, CDCl3) δ: 162.7 (dd, J = 12.9, 249.3 Hz), 138.3 (t, J = 9.4 Hz), 122.7 
(q, J = 285.8 Hz), 110.7 (m), 105.2 (t, J = 25.4 Hz), 78.4, 77.3, 72.0 (qt, J = 2.5, 33.1 
Hz). 
19F NMR (470 MHz, CDCl3) δ: -80.6, -108.8. 
HRMS (CI+, m/z) for C10H5F5O: calcd. = 236.0261; found = 236.0260. 
FTIR (neat): 3590, 3307, 2128, 1624, 1608, 1444, 1314, 1262, 1185, 1121, 1038, 984, 











Tertiary propargylic alcohol 2.15j (2.26g, 9.55 mmol) was subjected to general procedure 
E. Upon flash column chromatography (SiO2, pentane), the title compound 2.16j (2.65 g, 
8.12 mmol) was obtained as a light yellow oil in 85% yield. 
 
Rf = 0.8 (4:1 hexanes:EtOAc). 
1H NMR (500 MHz, CDCl3) δ: 7.41–7.32 (m, 8H), 6.92 (tt, J = 8.6, 2.3 Hz, 1H), 4.87 (d, 
J = 11 Hz, 1H), 4.48 (d, J = 11 Hz, 1H), 3.00 (s, 1H). 
13C NMR (125 MHz, CDCl3) δ: 163.9 (d, J = 12.4 Hz), 161.9 (d, J = 12.4 Hz), 137.4 (t, J 
= 8.9 Hz), 136.5, 128.5, 128.2, 127.7, 122.4 (q, J = 285.8 Hz), 111.6 (d, J = 27.6 Hz), 
105.6 (t, J = 25.3 Hz), 80.3, 78.6 (q, J = 32.0 Hz), 68.4. 
19F NMR (470 MHz, CDCl3) δ: -78.3, -108.5. 
HRMS (CI+, m/z) for C17H11F5O: calcd. 326.0730; found = 326.0721. 










Benzyl protected propargylic alcohol 2.16j (326 mg, 1.0 mmol) was subjected to general 
procedure F. Upon flash column chromatography (SiO2, pentane), the title compound 2.1j 
(153 mg, 0.70 mmol) was obtained as a light yellow oil in 70% yield. 
 
Rf = 0.48 (pentane). 
1H NMR (500 MHz, CDCl3) δ: 6.97 (br d, J = 7.2 Hz, 2H), 6.77 (tt, J = 1.9, 8.8 Hz, 1H), 
5.64 (q, J = 3.3 Hz, 2H). 
13C NMR (125 MHz, CDCl3) δ: 208.8 (q, J = 3.3 Hz), 163.2 (dd, J = 13.1, 249 Hz), 132.6 
(t, J = 11.9 Hz), 122.9 (q, J = 271.4 Hz), 110.2 (m), 103.8 (t, J = 26.3 Hz), 101.0 (q, J 
= 34.1 Hz), 84.8. 
19F NMR (470 MHz, CDCl3) δ: -60.6 (t, J = 3.1 Hz), -101.9 (t, J = 8.3 Hz). 
HRMS (CI+, m/z) for C10H5F5: calcd.  = 220.0305; found = 220.0311. 









2-Methoxy-5-bromopyridine (1.88 g, 10 mmol) was subjected to general procedure A. 
Upon flash column chromatography (SiO2, 1:4 to 1:3 EtOAc/hexanes), the title compound 
2.13k (603 mg, 3.7 mmol) was obtained as a brown solid in 37% yield. 
 
Rf = 0.21 (1:4 EtOAc/hexanes). 
1H NMR (500 MHz, CDCl3) δ: 8.29 (d, J = 2.1 Hz, 1H), 7.59 (dd, J = 2.3, 8.6 Hz, 1H), 6.7 
(d, J = 8.6 Hz, 1H), 4.49 (s, 2H), 3.94 (s, 3H). 
13C NMR (125 MHz, CDCl3) δ: 163.6, 150.2, 141.3, 112.4, 110.8, 88.8, 82.6, 53.7, 51.6. 
HRMS (H+, m/z) for C9H9NO2: calcd. = 164.0706; found = 164.0703. 




3-(6-methoxypyridin-3-yl)prop-2-yn-1-yl 2-bromo-2,2-difluoroacetate (2.14k) 
 
Propargyl alcohol 6k (370 mg, 2.27 mmol) was subjected to general procedure B to furnish 
the title compound 2.14k. This compound was unstable to silica gel so was filtered through 





Crude progargyl bromodifluoroacetate 2.14k was subjected to general procedure C. Upon 
flash column chromatography (SiO2, 5:95 CH2Cl2/pentane), the title compound 2.1k (236 
mg, 1.1 mmol) was obtained as a colourless oil in 48% yield over two steps. 
 
Rf = 0.24 (5:95 CH2Cl2/pentane). 
1H NMR (500 MHz, CDCl3) δ: 8.23 (br s, 1H), 7.61 (dd, J = 2.4, 8.7 Hz, 1H), 6.76 (d, J = 
8.7 Hz, 1H), 5.55 (q, J = 3.2 Hz, 2H), 3.95 (s, 3H). 
13C NMR (125 MHz, CDCl3) δ: 207.9, 163.9, 145.5, 137.3, 123.0 (q, J = 273 Hz), 118.4, 
111.0, 98.9 (q, J = 35 Hz), 83.8, 53.6. 
19F NMR (470 MHz, CDCl3) δ: -61.0. 
HRMS (CI+, m/z) for C10H8NOF3: calcd.  = 215.0558; found = 215.0562. 











5-bromo-1-indanone (4.43 g, 21 mmol) was subjected to general procedure A. Upon flash 
column chromatography (SiO2, 1:4 EtOAc/hexanes), the title compound 2.13l (1.66 g, 8.94 
mmol) was obtained as a brown solid in 43% yield. 
 
Rf = 0.13 (1:4 EtOAc/hexanes). 
1H NMR (500 MHz, CDCl3) δ: 7.70 (d, J = 7.9 Hz, 1H), 7.53 (s, 1H), 7.42 (d, J = 7.9 Hz, 
1H), 4.53 (br d, J = 4.2 Hz, 2H), 3.13 (t, J = 5.9 Hz, 2H), 2.71 (t, J = 6.0 Hz, 2H), 1.72 
(br t, J = Hz, 1H, OH). 
13C NMR (125 MHz, CDCl3) δ: 206.1, 154.9, 136.7, 130.8, 129.8, 128.9, 123.6, 90.5, 85.2, 
51.6, 36.3, 25.6. 
HRMS (CI+, m/z) for C12H10O2: calcd.  = 186.0681; found = 186.0683. 







Propargyl alcohol 2.13l (1.66 g, 8.94 mmol) was subjected to general procedure B. Upon 
flash column chromatography (SiO2, 1:3 EtOAc/hexanes), the title compound 2.14l (2.32 
g, 6.76 mmol) was obtained as a light yellow oil in 76% yield. 
 
Rf = 0.60 (1:3 EtOAc/hexanes). 
1H NMR (500 MHz, CDCl3) δ: 7.71 (d, J = 7.9 Hz, 1H), 7.58 (s, 1H), 7.45 (d, J = 7.9 Hz, 
1H), 5.18 (s, 2H), 3.14 (t, J = 6.0 Hz, 2H), 2.72 (t, J = 6.1 Hz, 2H). 
13C NMR (125 MHz, CDCl3) δ: 206.1, 159.0 (t, J = 32.1 Hz), 154.8, 137.4, 131.0, 130.2, 
127.6, 123.7, 108.3 (t, J = 313.3 Hz), 87.9, 83.4, 56.1, 36.3, 25.6. 
19F NMR (470 MHz, CDCl3) δ: -60.9. 
HRMS (CI+, m/z) for C14H9BrF2O3 = 341.9703; found = 341.9683. 









Progargyl bromodifluoroacetate 2.14l (2.32 g, 6.76 mmol) was subjected to general 
procedure C. Upon flash column chromatography (SiO2, 1:4 EtOAc/hexanes), the title 
compound 2.1l (1.08 g, 4.55 mmol) was obtained as a pale yellow solid in 67% yield. 
 
Rf = 0.23 (1:4 EtOAc/hexanes). 
1H NMR (500 MHz, CDCl3) δ: 7.74 (d, J = 8.2 Hz, 1H), 7.55 (s, 1H), 7.45 (d, J = 8.2 Hz, 
1H), 5.64 (q, J = 3.3 Hz, 2H), 3.16 (t, J = 5.8 Hz, 2H), 2.72 (t, J = 6.1 Hz, 2H). 
13C NMR (125 MHz, CDCl3) δ: 209.3 (q, J= 4.1 Hz), 206.2, 155.6, 136.7, 135.6, 126.5, 
124.9, 124.0, 123.1 (q, J = 273.9 Hz), 101.7 (q, J = 34.3 Hz), 84.2, 36.4, 25.8. 
19F NMR (470 MHz, CDCl3) δ: -60.2. 
HRMS (CI+, m/z) for C13H9F3O = 238.0605; found = 238.0605. 
FTIR (neat): 3051, 2963, 1965, 1930, 1698, 1605, 1289, 1124, 1105, 1093, 725 cm-1. 








3-(4-((trifluoromethyl)thio)phenyl)prop-2-yn-1-ol (2.13m)  
 
4-(trifluoromethylthio)bromobenzene (2.57 g, 10 mmol) was subjected to general 
procedure A. Upon flash column chromatography (SiO2, 1:4 EtOAc/hexanes), the title 
compound 2.13m (1.64 g, 7.1 mmol) was obtained as a white solid in 71% yield. 
 
Rf = 0.21 (1:3 EtOAc/hexanes). 
1H NMR (500 MHz, CDCl3) δ: 7.60 (d, J = 8.3 Hz, 2H), 7.47 (d, J = 8.3 Hz, 2H), 4.51 (d, 
J = 6.1 Hz, 2H), 1.67 (t, J = 6.1 Hz, 1H, OH). 
13C NMR (125 MHz, CDCl3) δ: 136.2, 132.7, 129.6 (q, J = 318 Hz), 125.6, 124.8, 90.0, 
84.6, 51.8. 
19F NMR (470 MHz, CDCl3) δ: -42.5. 
HRMS (CI+, m/z) for C10H6OSF3: calcd.  = 231.0091; found = 231.0084. 
FTIR (neat): 3317, 2951, 1591, 1484, 1397, 1262, 1114, 1084, 1017, 833, 755 cm-1. 










Propargyl alcohol 2.13m (1.40 g, 6.5 mmol) was subjected to general procedure B. Upon 
flash column chromatography (SiO2, 1:20 EtOAc/hexanes), the title compound 2.14m 
(1.70 g, 4.4 mmol) was obtained as a light yellow oil in 58% yield. 
 
Rf = 0.67 (1:5 EtOAc/hexanes). 
1H NMR (500 MHz, CDCl3) δ: 7.62 (d, J = 8.5 Hz, 2H), 7.51 (d, J = 8.5 Hz, 2H), 5.16 (s, 
2H). 
13C NMR (125 MHz, CDCl3) δ: 159.1 (t, J = 32.1 Hz), 136.2, 133.0, 129.4 (q, J = 312 Hz), 
125.8 (q, J = 2.2 Hz), 124.3, 108.5 (t, J = 314 Hz), 87.4, 82.9, 56.2. 
19F NMR (470 MHz, CDCl3) δ: -42.3, -60.9. 
HRMS (CI+, m/z) for C12H6BrF5O2S = 387.9192 ; found = 387.9189. 








(4-(1,1,1-trifluorobuta-2,3-dien-2-yl)phenyl)(trifluoromethyl)sulfane (2.1m)  
 
Progargyl bromodifluoroacetate 2.14m (1.70 g, 4.4 mmol) was subjected to general 
procedure C. Upon flash column chromatography (SiO2, hexanes), the title compound 
2.1m (0.72 g, 2.5 mmol) was obtained as a pale yellow solid in 58% yield. 
 
Rf = 0.71 (1:10 CH2Cl2/hexanes). 
1H NMR (500 MHz, CDCl3) δ: 7.68 (d, J = 8.6 Hz, 2H), 7.52 (d, J = 8.6 Hz, 2H), 5.65 (q, 
J = 3.2 Hz, 2H). 
13C NMR (125 MHz, CDCl3) δ: 209.0 (q, J = 5.2 Hz), 136.6, 132.2, 129.5 (q, J = 310 Hz), 
128.0, 124.4, 123.2 (q, J = 272 Hz), 101.3 (q, J= 44.5 Hz), 84.5. 
19F NMR (470 MHz, CDCl3) δ: -42.5, -60.4. 
HRMS (CI+, m/z) for C11H6F6S = 284.0094; found = 384.0101. 






3-(4-methoxy-3-nitrophenyl)prop-2-yn-1-ol (2.13n)  
 
4-iodo-2-nitroanisole (2.79 g, 10 mmol) was subjected to general procedure A. Upon flash 
column chromatography (SiO2, 1:2 EtOAc/hexanes), the title compound 2.13n (1.71 g, 8.3 
mmol) was obtained as a yellow solid in 83% yield. 
 
Rf = 0.09 (1:4 EtOAc/hexanes). 
1H NMR (500 MHz, CDCl3) δ: 7.92 (d, J = 2.0 Hz, 1H), 7.59 (dd, J = 2.0, 8.7 Hz, 1H), 
7.03 (d, J = 8.7 Hz, 1H), 4.49 (d, J = 5.9 Hz, 2H), 3.97 (s, 3H), 1.65 (t, J = 5.9 Hz, 1H, 
OH). 
13C NMR (125 MHz, CDCl3) δ: 153.0, 139.4, 137.3, 129.1, 115.2, 113.7, 88.1, 83.3, 56.8, 
51.7. 
HRMS (CI+, m/z) for C10H9NO4: calcd.  = 207.0532; found = 207.0531. 
FTIR (neat): 3367, 2942, 1618, 1529, 1348, 1273, 1032, 878, 822 cm-1. 





3-(4-methoxy-3-nitrophenyl)prop-2-yn-1-yl 2-bromo-2,2-difluoroacetate (2.14n)  
 
Propargyl alcohol 2.13n (1.24 g, 6.0 mmol) was subjected to general procedure B. Upon 
flash column chromatography (SiO2, 1:10 EtOAc/hexanes), the title compound 2.14n (1.0 
g, 2.75 mmol) was obtained as a light yellow oil in 46% yield. 
 
Rf = 0.20 (1:10 EtOAc/hexanes). 
1H NMR (500 MHz, CDCl3) δ: 7.96 (d, J = 2.1 Hz, 1H), 7.63 (dd, J = 2.1, 8.7 Hz, 1H), 
7.06 (d, J = 8.7 Hz, 1H), 5.14 (s, 2H), 3.99 (s, 3H). 
13C NMR (125 MHz, CDCl3) δ: 159.1 (t, J = 31.6 Hz), 153.6, 139.6, 137.7, 129.4, 114.0, 
113.8, 108.5 (t, J = 313.5 Hz), 86.2, 81.2, 56.9, 56.2. 
19F NMR (470 MHz, CDCl3) δ: -60.9. 
HRMS (CI+, m/z) for C14H9BrF2O3 = product not observed. MS peak for starting material 
6n was observed instead. 






1-methoxy-2-nitro-4-(1,1,1-trifluorobuta-2,3-dien-2-yl)benzene (2.1n)  
 
Progargyl bromodifluoroacetate 2.14n (1.0 g, 2.27 mmol) was subjected to general 
procedure C. Upon flash column chromatography (SiO2, 1:10 EtOAc/hexanes), the title 
compound 2.1n (372 mg, 1.43 mmol) was obtained as a pale yellow solid in 63% yield. 
 
Rf = 0.24 (1:10 EtOAc/hexanes). 
1H NMR (500 MHz, CDCl3) δ: 7.90 (d, J = 2.2 Hz, 1H), 7.60 (dd, J = 2.2, 9.7 Hz, 1H), 
7.10 (d, J = 9.7 Hz, 1H), 5.63 (q, J = 3.3 Hz, 2H), 3.98 (s, 3H). 
13C NMR (125 MHz, CDCl3) δ: 208.3 (q, J = 3.5 Hz), 153.8, 140.0, 132.4, 124.6, 123.1 
(q, J = 272 Hz), 121.9, 114.0, 100.2 (q, J = 32 Hz), 84.9, 56.8. 
19F NMR (470 MHz, CDCl3) δ: -60.8 (t, J = 3.3 Hz). 
HRMS (CI+, m/z) for C11H8F3O3N = 259.0456; found = 259.0461. 
FTIR (neat): 2981, 2844, 1976, 1942, 1621, 1531, 1352, 1274, 1090, 1016, 870, 821 cm-1 












Trifluoromethylallene 2.1a (27.6 mg, 0.15 mmol) was subjected to general procedure G 
using [Ir(cod)Cl]2 in Me2CO at 70 °C. Upon flash column chromatography (SiO2, 15:85 
EtOAc/hexanes), the title compound 2.2a (24.5 mg, 0.11 mmol) was obtained as a light 
yellow oil in 76% yield. The addition of TBAI (10 mol%) afforded the title compound 2.2a 
in 95% yield 
 
Rf = 0.25 (4:1 hexanes : EtOAc) 
1H NMR (500 MHz, CDCl3) δ: δ 7.52 – 7.47 (m, 2H), 7.43 – 7.33 (m, 3H), 6.13 (dd, J = 
11.2, 17.8 Hz 1H), 5.62 (d, J = 11.2 Hz, 1H), 5.40 (d, J = 17.8 Hz, 1H), 4.26 (ddd, J = 
11.9, 6.9, 0.5 Hz, 1H), 4.17 (ddd, J = 11.9, 7.0, 0.5 Hz, 1H). 
13C NMR (125 MHz, CDCl3) δ: 134.8 (s), 134.0 (q, J = 1.9 Hz), 129.1 (q, J = 1.3 Hz), 
128.7, 128.4, 126.8 (q, J = 284.7 Hz), 120.76, 63.6 (q, J = 2.4 Hz), 57.1 (q, J = 22.9 
Hz). 
19F NMR (470 MHz, CDCl3) δ: -68.9. 
HRMS (CI+, m/z) for C11H11F3O: calcd. = C11H11F3O = 216.0762; found = 216.0761. 
FTIR (neat): 3403, 2961, 2363, 1585, 1414, 1252, 1146, 1066, 935, 878, 699 cm-1. 
HPLC: (Chiralcel column AD-H, Hexane:2-PrOH = 97:3, 1.0 mL/min, 210 nm) ee = 89% 
or 90% (10 mol% TBAI). 
[𝜶]𝑫
















Trifluoromethylallene 2.1b (32.7 mg, 0.15 mmol) was subjected to general procedure G 
using [Ir(cod)Cl]2 in Me2CO at 70 °C. Upon flash column chromatography (SiO2, 15:85 
EtOAc/hexanes), the title compound 2.2b (29.0 mg, 0.12 mmol) was obtained as a light 
yellow oil in 77% yield. The addition of H2O (500 mol%) afforded the title compound 2.2b 
in 62% yield. 
 
Rf = 0.29 (15:85 EtOAc/hexanes). 
1H NMR (500 MHz, CDCl3) δ: 7.44 (d, J = 8.6 Hz, 2H), 7.37 (d, J = 8.6 Hz, 2H), 6.10 (dd, 
J = 12.3, 17.3 Hz, 1H), 5.62 (d, J = 12.3 Hz, 1H), 5.36 (d, J = 17.3 Hz, 1H), 4.24 (dd, 
J = 7.5, 11.8 Hz, 1H), 4.12 (dd, J = 7.5, 11.8 Hz, 1H), 1.58 (t, J = 7.5 Hz, 1H, OH). 
13C NMR (125 MHz, CDCl3) δ: 134.6, 133.7, 133.3, 130.8, 128.8, 126.5 (q, J = 283 Hz), 
121.2, 63.4 (q, J = 2.6 Hz), 56.8 (q, J = 24.0 Hz). 
19F NMR (470 MHz, CDCl3) δ: -69.1. 
HRMS (CI+, m/z) for C11H10OF3Cl = 250.0372; found = 250.0374. 
FTIR (neat): 3419, 2970, 2359, 1496, 1366, 1151, 1098, 1014, 936, 822, 747 cm-1. 
HPLC: (Chiralcel column OJ-H, Hexane:2-PrOH = 97:3, 1.0 mL/min, 210 nm) ee = 86% 
or 90% (500 mol% H2O). 
[𝜶]𝑫















Trifluoromethylallene 2.1c (39.5 mg, 0.15 mmol) was subjected to general procedure G 
using [Ir(cod)Cl]2 in Me2CO at 70 °C. Upon flash column chromatography (SiO2, 15:85 
EtOAc/hexanes), the title compound 2.2c (34.8 mg, 0.12 mmol) was obtained as a light 
yellow oil in 79% yield. The addition of H2O (500 mol%) afforded the title compound 2.2c 
in 60% yield. 
 
Rf = 0.27 (15:85 EtOAc/hexanes). 
1H NMR (500 MHz, CDCl3) δ: 7.52 (d, J = 8.4 Hz, 2H), 7.38 (d, J = 8.4 Hz, 2H), 6.10 (dd, 
J = 11.4, 18.0 Hz, 1H), 5.62 (d, J = 11.4 Hz, 1H), 5.36 (d, J= 18.0 Hz, 1H), 4.23 (dd, J 
= 7.1, 11.9 Hz, 1H), 4.12 (dd, J = 7.1, 11.9 Hz, 1H), 1.57 (t, J = 7.1 Hz, 1H, OH). 
13C NMR (125 MHz, CDCl3) δ: 133.9, 133.6, 131.8, 131.0, 126.4 (q, J = 286 Hz), 122.8, 
121.3, 63.3, 56.9 (q, J = 22 Hz). 
19F NMR (470 MHz, CDCl3) δ: -69.1. 
HRMS (CI+, m/z) for C11H10OF3Br = 293.9867; found = 293.9869. 
FTIR (neat): 3409, 2964, 2360, 1493, 1259, 1153, 1079, 1010, 818 cm-1. 
HPLC: (Chiralcel column OJ-H, Hexane:2-PrOH = 97:3, 1.0 mL/min, 210 nm) ee = 87% 
or 91% (500 mol% H2O). 
[𝜶]𝑫















Trifluoromethylallene 2.1d (32.1 mg, 0.15 mmol) was subjected to general procedure G 
using [Ir(cod)Cl]2 in Me2CO at 70 °C. Upon flash column chromatography (SiO2, 15:85 
EtOAc/hexanes), the title compound 2.2d (33.3 mg, 0.14 mmol) was obtained as a light 
yellow oil in 90% yield. The addition of TBAI (10 mol%) afforded the title compound 2.2d 
in 93% yield. 
 
Rf = 0.37 (hexanes:EtOAc = 3:1). 
1H NMR (500 MHz, CDCl3) δ: 7.41 (d, J = 8.9 Hz, 2H), 6.92 (d, J = 8.9 Hz, 2H), 6.11 (dd, 
J = 10.4, 17.4 Hz, 1H), 5.60 (d, J = 10.4 Hz, 1H), 5.39 (d, J = 17.4 Hz, 1H), 4.22 (dd, 
J = 5.5, 10.8 Hz, 1H), 4.13 (dd, J = 5.5, 10.8 Hz, 1H), 3.82 (s, 3H), 1.55 (t, J = 5.5 Hz, 
1H, OH). 
13C NMR (125 MHz, CDCl3) δ: 159.5, 134.2, 130.4, 126.8 (q, J = 282 Hz), 126.5, 120.6, 
114.1, 63.5, 56.5 (q, J = 24 Hz), 55.4. 
19F NMR (470 MHz, CDCl3) δ: -69.3. 
HRMS (CI+, m/z) for C12H13O2F3: calcd. = 246.0868; found = 246.0871. 
FTIR (neat):3485, 2937, 2840, 1612, 1515, 1465, 1524, 1147, 1036, 933, 828, 738 cm-1. 
HPLC: (Chiralcel column OJ-H, Hexane:2-PrOH = 97:3, 1.0 mL/min, 210 nm) ee = 89% 
or 90% (10 mol% TBAI). 
[𝜶]𝑫















Trifluoromethylallene 2.1e (32.1 mg, 0.15 mmol) was subjected to general procedure G 
using [Ir(cod)Cl]2 in Me2CO at 70 °C. Upon flash column chromatography (SiO2, 15:85 
EtOAc/hexanes), the title compound 2.2e (31.0mg, 0.13 mmol) was obtained as a light 
yellow oil in 84% yield.  
 
Rf = 0.39 (3:1 hexanes/EtOAc). 
1H NMR (500 MHz, CDCl3) δ: 7.31 (t, J = 8.1 Hz, 1H), 7.08 (d, J = 8.1 Hz, 1H), 7.05 (br 
s, 1H), 6.90 (dd, J = 2.4, 8.1 Hz, 1H), 6.10 (dd, J = 11.8, 18.0 Hz, 1H), 5.61 (d, J = 11.8 
Hz, 1H), 5.43 (d, J = 18.0 Hz, 1H), 4.24 (dd, J = 6.9, 12.6 Hz, 1H), 4.15 (dd, J = 7.5, 
12.6 Hz, 1H), 3.82 (s, 3H), 1.56 (t, J = 7.3 Hz, 1H, OH). 
13C NMR (125 MHz, CDCl3) δ: 159.8, 136.3, 133.8, 129.7, 126.6 (q, J = 285 Hz), 121.2, 
120.7, 115.9, 113.2, 63.7, 57.0 (q, J = 20.3 Hz), 55.4. 
19F NMR (470 MHz, CDCl3) δ: -68.6. 
HRMS (CI+, m/z) for C12H13O2F3 = 246.0868; found = 246.0871. 
FTIR (neat): 3456, 2923, 2357, 1603, 1584, 1366, 1171, 1144, 1044, 940, 781, 701 cm-1. 
HPLC: (Chiralcel column AS-H, Hexane:2-PrOH = 99:1, 0.5 mL/min, 210 nm) ee = 90%. 
[𝜶]𝑫















Trifluoromethylallene 2.1f (34.2 mg, 0.15 mmol) was subjected to general procedure G 
using [Ir(cod)Cl]2 and TBAI (10 mol%) in Me2CO at 70 °C. Upon flash column 
chromatography (SiO2, 15:85 EtOAc/hexanes), the title compound 2.2f (30.8 mg, 0.12 
mmol) was obtained as a light yellow oil in 79% yield. 
 
Rf = 0.22 (15:85 EtOAc/hexanes). 
1H NMR (500 MHz, CDCl3) δ: 6.98 (m, 1H), 6.97 (m, 1H), 6.82 (dd, J = 0.5, 8.1 Hz, 1H), 
6.08 (dd, J = 11.5, 18.1 Hz, 1H), 5.98 (s, 2H), 5.60 (d, J = 11.5 Hz, 1H), 5.41 (d, J = 
18.1 Hz, 1H), 4.19 (dd, J = 6.7, 12.2 Hz, 1H), 4.10 (dd, J = 7.4, 12.2 Hz, 1H), 1.56 (dd, 
J = 6.7, 7.4 Hz, 1H, OH). 
13C NMR (125 MHz, CDCl3) δ: 148.1, 147.6, 134.0, 128.2, 126.7 (q, J = 288 Hz), 123.3, 
122.9, 109.8, 108.3, 101.5, 63.6, 56.7 (q, J = 25.5 Hz). 
19F NMR (470 MHz, CDCl3) δ: -69.2. 
HRMS (CI+, m/z) for C12H11O3F3 = 260.0660; found = 260.0661. 
FTIR (neat): 3444, 2901, 2358, 1736, 1507, 1491, 1241, 1161, 1040, 935, 814 cm-1. 
HPLC: (Chiralcel column AS-H, Hexane:2-PrOH = 99:1, 1.0 mL/min, 210 nm) ee = 90%. 
[𝜶]𝑫












Methyl (S)-4-(1,1,1-trifluoro-2-(hydroxymethyl)but-3-en-2-yl)benzoate (2.2g) 
 
Trifluoromethylallene 2.1g (36.3 mg, 0.15 mmol) was subjected to general procedure G 
using Ir(cod)(acac), TBAI (10 mol%) and H2O (200 mol%) in EtOAc at 80 °C. Upon flash 
column chromatography (SiO2, 30:70 EtOAc/hexanes), the title compound 2.2g (24.2 mg, 
0.089 mmol) was obtained as a light yellow oil in 59% yield.  
 
Rf = 0.23 (30:70 EtOAc/hexanes). 
1H NMR (500 MHz, CDCl3) δ: 8.05 (d, J = 8.6 Hz, 2H), 7.59 (d, J = 8.6 Hz, 2H), 6.13 (dd, 
J = 10.4, 17.4 Hz, 1H), 5.63 (d, J = 10.4 Hz, 1H), 5.36 (d, J = 17.4 Hz, 1H), 4.29 (dd, 
J = 7.5, 11.8 Hz, 1H), 4.17 (dd, J = 7.5, 11.7 Hz, 1H), 3.92 (s, 3H), 1.63 (t, J = 7.4 Hz, 
1H, OH). 
13C NMR (125 MHz, CDCl3) δ: 166.7, 139.9, 133.6, 130.2, 129.7, 129.4, 126.5 (q, J = 284 
Hz), 121.4, 63.5, 57.3 (q, J = 23 Hz), 52.4. 
19F NMR (470 MHz, CDCl3) δ: -68.7. 
HRMS (CI+, m/z) for C13H14O3F3: calcd. = 275.0895; found = 275.0902. 
FTIR (neat): 3504, 2955, 2359, 2342, 1724, 1438, 1286, 1154, 1117, 1019, 773, 735 cm-
1. 
HPLC: (Chiralcel column OJ-H, Hexane:2-PrOH = 97:3, 1.0 mL/min, 230 nm) ee = 92%. 
[𝜶]𝑫
















Trifluoromethylallene 2.1h (37.8 mg, 0.15 mmol) was subjected to general procedure G 
using Ir(cod)(acac), TBAI (10 mol%) and H2O (200 mol%) in EtOAc at 80 °C. Upon flash 
column chromatography (SiO2, 15:85 EtOAc/hexanes), the title compound 2.2h (27.2 mg, 
0.096 mmol) was obtained as a light yellow oil in 64% yield. The addition of H2O (500 
mol%) afforded the title compound 2.2h in 54% yield. 
 
Rf = 0.31 (20:80 EtOAc/hexanes). 
1H NMR (500 MHz, CDCl3) δ: 7.65 (br s, 4H), 6.13 (dd, J = 11.4, 17.6 Hz, 1H), 5.65 (d, 
J = 11.4 Hz, 1H), 5.36 (d, J = 17.6 Hz, 1H), 4.29 (dd, J = 7.4, 12.2 Hz, 1H), 4.16 (dd, 
J = 7.0, 12.2 Hz, 1H), 1.64 (t, J = 7.0 Hz, 1H, OH). 
13C NMR (125 MHz, CDCl3) δ: 139.0, 133.5, 130.6 (q, J = 32 Hz), 129.9, 126.4 (q, J = 
283 Hz), 125.5 (q, J = 3.9 Hz), 124.0 (q, J = 270 Hz), 120.8, 63.3, 57.2 (q, J = 23 Hz). 
19F NMR (470 MHz, CDCl3) δ: -62.9, -68.9. 
HRMS (CI+, m/z) for C12H10OF6: calcd. = 284.0636; found = 284.0628. 
FTIR (neat): 3398, 2954, 2357, 1622, 1326, 1157, 1123, 1072, 1018, 940, 834, 731 cm-1. 
HPLC: (Chiralcel column OJ-H, Hexane:2-PrOH = 97:3, 1.0 mL/min, 210 nm) ee = 90% 
(200 mol% H2O or 91% (500 mol% H2O). 
[𝜶]𝑫

















Trifluoromethylallene 2.1i (34.4 mg, 0.15 mmol) was subjected to general procedure G 
using Ir(cod)(acac), TBAI (10 mol%) and H2O (500 mol%) in EtOAc at 80 °C. Upon flash 
column chromatography (SiO2, 30:70 EtOAc/hexanes), the title compound 2.2i (28.1 mg, 
0.096 mmol) was obtained as a yellow oil in 72% yield. The addition of H2O (200 mol%) 
afforded the title compound 2.2i in 76% yield. 
 
Rf = 0.29 (30:70 EtOAc/hexanes). 
1H NMR (500 MHz, CDCl3) δ: 8.42 (s, 1H), 8.23 (d, J = 9.5 Hz, 1H), 7.88 (d, J = 9.5 Hz, 
1H), 7.59 (t, J = 9.5 Hz, 1H), 6.16 (dd, J = 11.2, 17.6 Hz, 1H), 5.69 (d, J = 11.2 Hz, 
1H), 5.36 (d, J = 17.6 Hz, 1H), 4.34 (dd, J = 7.0, 11.9 Hz, 1H), 4.18 (dd, J = 6.1, 11.9 
Hz, 1H), 1.60 (br t, J = 7.0 Hz, 1H, OH). 
13C NMR (125 MHz, CDCl3) δ: 148.5, 137.2, 135.7, 133.2, 129.5, 126.3 (q, J = 288 Hz), 
124.8, 123.5, 122.0, 63.1, 57.1 (q, J = 23.6 Hz). 
19F NMR (470 MHz, CDCl3) δ: -69.2. 
HRMS (CI+, m/z) for C11H10NO3F3 = 261.0613; found = 261.0611. 
FTIR (neat): 3481, 2971, 1530, 1351, 1158, 944, 808, 739 cm-1. 
HPLC: (Chiralcel column AD-H, Hexane:2-PrOH = 97:3, 1.0 mL/min, 210 nm) ee = 91% 
(200 mol% H2O or 94% (500 mol% H2O). 
[𝜶]𝑫
















Trifluoromethylallene 2.1j (33.0 mg, 0.15 mmol) was subjected to general procedure G 
using Ir(cod)(acac), TBAI (10 mol%) and H2O (200 mol%) in EtOAc at 80 °C. Upon flash 
column chromatography (SiO2, 30:70 EtOAc/hexanes), the title compound 2.2j (26.1 mg, 
0.10 mmol) was obtained as a yellow oil in 69% yield. The addition of H2O (500 mol%) 
afforded the title compound 2.2j in 52% yield. 
 
Rf = 0.25 (15:85 EtOAc/hexanes). 
1H NMR (500 MHz, CDCl3) δ: 7.07 (br d, J = 7.5 Hz, 2H), 6.82 (tt, J = 2.5, 8.0 Hz, 1H), 
6.07 (dd, J = 11.3, 17.9 Hz, 1H), 5.64 (d, J = 11.3 Hz, 1H), 5.39 (d, J = 17.9 Hz, 1H), 
4.21 (dd, J = 6.5, 11.7 Hz, 1H), 4.11 (dd, J = 6.5, 11.7 Hz, 1H), 1.65 (t, J = 6.5 Hz, 1H, 
OH). 
13C NMR (125 MHz, CDCl3) δ: 163.0 (dd, J = 16.4, 254 Hz), 138.8 (t, J = 8.6 Hz), 133.0, 
126.3 (q, J = 286 Hz), 122.8, 112.7 (m), 104.1 (t, J = 26.7 Hz), 63.4 (q, J = 2.0 Hz), 
57.0 (q, J = 21.1 Hz). 
19F NMR (470 MHz, CDCl3) δ: -68.9, -108.9 (t, J = 8.8 Hz). 
HRMS (CI+, m/z) for C11H9OF5: calcd. = 252.0574; found = 252.0575. 
FTIR (neat): 3409, 2957, 2359, 1626, 1601, 1438, 1172, 1121, 987, 857 cm-1. 
HPLC: (Chiralcel column OJ-H, Hexane:2-PrOH = 97:3, 1.0 mL/min, 210 nm) ee = 91% 
(200 mol% H2O or 93% (500 mol% H2O). 
[𝜶]𝑫















Trifluoromethylallene 2.1k (32.5 mg, 0.15 mmol) was subjected to general procedure G 
using [Ir(cod)Cl]2 in Me2CO at 70 °C. Upon flash column chromatography (SiO2, 25:75 
EtOAc/hexanes), the title compound 2.2k (29.7 mg, 0.12 mmol) was obtained as a yellow 
oil in 80% yield. The addition of H2O (500 mol%) afforded the title compound 2.2k in 71% 
yield. 
 
Rf = 0.23 (1:3 EtOAc/hexanes). 
1H NMR (500 MHz, CDCl3) δ: 8.29 (d, J = 2.7 Hz, 1H), 7.69 (dd, J = 2.7, 8.8 Hz, 1H), 
6.76 (d, J = 8.8 Hz, 1H), 6.11 (dd, J = 11.8. 18.5 Hz, 1H), 5.63 (d, J = d, J = 11.8 Hz, 
1H), 5.35 (d, J = 18.5 Hz, 1H), 4.24 (dd, J = 7.7, 12.3 Hz, 1H), 4.10 (dd, J = 6.9, 12.3 
Hz, 1H), 3.95 (s, 3H), 1.64 (br m, 1H, OH). 
13C NMR (125 MHz, CDCl3) δ: 163.8, 147.9, 139.5, 133.4, 126.4 (q, J = 276 Hz), 123.1, 
121.3, 110.6, 62.8 (q, J = 2.8 Hz), 55.3 (q, J = 23.7 Hz), 53.5. 
19F NMR (470 MHz, CDCl3) δ: -69.8. 
HRMS (H+, m/z) for C11H12F3NO2: 248.0893, found: 248.0893. 
FTIR (neat): 3372, 2952, 2363, 1608, 1571, 1497, 1385, 1295, 1260, 1154, 1076, 1022, 
936, 832 cm-1. 
HPLC: (Chiralcel column OJ-H, Hexane:2-PrOH = 97:3, 1.0 mL/min, 210 nm) ee = 84% 
or 89% (500 mol% H2O). 
[𝜶]𝑫
















Trifluoromethylallene 2.1l (35.7 mg, 0.15 mmol) was subjected to general procedure G 
using Ir(cod)(acac), TBAI (10 mol%) and H2O (200 mol%) in EtOAc at 80 °C. Upon flash 
column chromatography (SiO2, 40:60 EtOAc/hexanes), the title compound 2.2l (32.8 mg, 
0.12 mmol) was obtained as a yellow oil in 81% yield. The addition of H2O (500 mol%) 
afforded the title compound 2.2l in 59% yield. 
 
Rf = 0.24 (40:60 EtOAc/hexanes). 
1H NMR (500 MHz, CDCl3) δ: 7.76 (d, J = 8.4 Hz, 1H), 7.66 (s, 1H), 7.53 (d, J = 8.4 Hz, 
1H), 6.14 (dd, J = 10.1, 16.2 Hz, 1H), 5.65 (d, J = 10.1 Hz, 1H), 5.38 (d, J = 16.2 Hz, 
1H), 4.32 (dd, J = 7.1, 12.0 Hz, 1H), 4.19 (dd, J = 6.9, 12.0 Hz, 1H), 3.17 (m, 2H), 2.71 
(m, 2H), 1.70 (t, J = 6.7 Hz, 1H, OH). 
13C NMR (125 MHz, CDCl3) δ: 206.6, 155.3, 141.9, 136.7, 128.6, 127.8, 126.6 (q, J = 288 
Hz), 123.7, 121.4, 63.5, 57.5 (q, J = 23 Hz), 36.6, 26.1. 
19F NMR (470 MHz, CDCl3) δ: -68.5. 
HRMS (CI+, m/z) for C14H14O2F3: calcd. = 271.0946; found = 271.0940. 
FTIR (neat): 3456, 2965, 2361, 1702, 1611, 1324, 1248, 1168, 1138, 1050 cm-1. 
HPLC: (Chiralcel column AD-H, Hexane:2-PrOH = 95:5, 1.0 mL/min, 210 nm) ee = 89% 
(200 mol% H2O or 92% (500 mol% H2O). 
[𝜶]𝑫
𝟐𝟕= +22.9 (c = 1.0, CHCl3). 














(S)-2-(trifluoromethyl)-2-(4-((trifluoromethyl)thio)phenyl)but-3-en-1-ol (2.2m)  
 
Trifluoromethylallene 2.1m (42.6 mg, 0.15 mmol) was subjected to general procedure G 
using Ir(cod)(acac), TBAI (10 mol%) and H2O (500 mol%) in EtOAc at 80 °C. Upon flash 
column chromatography (SiO2, 10:90 EtOAc/hexanes), the title compound 2.2m (27.4 mg, 
0.087 mmol) was obtained as a yellow oil in 58% yield. 
 
Rf = 0.29 (15:85 EtOAc/hexanes). 
1H NMR (500 MHz, CDCl3) δ: 7.67 (d, J = 7.7 Hz, 2H), 7.57 (d, J = 7.7 Hz, 2H), 6.12 (dd, 
J = 9.7, 18.3 Hz, 1H), 5.64 (d, J = 9.7 Hz, 1H), 5.37 (d, J = 18.3 Hz, 1H), 4.27 (dd, J = 
7.3, 11.8 Hz, 1H), 4.16 (dd, J = 7.3, 11.8 Hz, 1H), 1.61 (t, J = 7.3 Hz, 1H, OH). 
13C NMR (125 MHz, CDCl3) δ: 138.0, 136.2, 133.5, 130.5, 129.5 (q, J = 300 Hz), 126.4 
(q, J = 284 Hz), 124.8, 121.5, 63.4, 57.1 (q, J = 22.1 Hz). 
19F NMR (470 MHz, CDCl3) δ: -42.3, -68.8. 
HRMS (CI+, m/z) for C12H10OSF6 = 316.0357; found = 316.0354 
FTIR (neat): 3402, 2972, 2484, 1498, 1259, 1090, 1054, 1033, 940, 826, 757 cm-1. 
HPLC: (Chiralcel column OJ-H, Hexane:2-PrOH = 99:1, 1.0 mL/min, 210 nm) ee = 91%. 
[𝜶]𝑫














(S)-2-(4-methoxy-3-nitrophenyl)-2-(trifluoromethyl)but-3-en-1-ol (2.2n)  
 
Trifluoromethylallene 2.1n (38.9 mg, 0.15 mmol) was subjected to general procedure G 
using Ir(cod)(acac), TBAI (10 mol%) and H2O (500 mol%) in EtOAc at 80 °C. Upon flash 
column chromatography (SiO2, 30:70 EtOAc/hexanes), the title compound 2.2n (32.1 mg, 
0.11 mmol) was obtained as a yellow oil in 73% yield. 
 
Rf = 0.13 (15:85 EtOAc/hexanes). 
1H NMR (500 MHz, CDCl3) δ: 8.01 (d, J = 2.5 Hz, 1H), 7.70 (dd, J = 2.5, 8.9 Hz, 1H), 
7.11 (d, J = 8.9 Hz, 1H), 6.11 (dd, J = 11.7, 17.0 Hz, 1H), 5.65 (d, J = 11.7 Hz, 1H), 
5.35 (d, J = 17.0 Hz, 1H), 4.26 (dd, J = 7.4, 12.2 Hz, 1H), 4.11 (dd, J = 7.4, 12.2 Hz, 
1H), 3.98 (s, 3H), 1.69 (t, J = 7.4 Hz, 1H, OH). 
13C NMR (125 MHz, CDCl3) δ: 152.8, 139.5, 135.3, 133.3, 127.2, 127.1, 126.4 (q, J = 284 
Hz), 121.8, 113.5, 63.1 (q, J = 2.6 Hz), 56.7, 56.4 (q, J = 22.8 Hz). 
19F NMR (470 MHz, CDCl3) δ: -69.6. 
HRMS (CI+, m/z) for C12H12NO4F3 = 291.0718; found = 291.0717. 
FTIR (neat):  3536, 2950, 1623, 1531, 1353, 1272, 1156, 1055, 1033, 1016, 944, 821 cm-
1. 
HPLC: (Chiralcel column OD-H, Hexane:2-PrOH = 90:10, 1.0 mL/min, 210 nm) ee = 
94%. 
[𝜶]𝑫
















Trifluoromethylallene 2.1o (38.0 mg, 0.15 mmol) was subjected to general procedure G 
using Ir(cod)(acac), TBAI (10 mol%) and H2O (500 mol%) in EtOAc at 80 °C. Upon flash 
column chromatography (SiO2, 10:90 EtOAc/hexanes), the title compound 2.2o (24.4 mg, 
0.085 mmol) was obtained as a light yellow oil in 57% yield.  
 
Rf = 0.25 (20:80 EtOAc/hexanes). 
1H NMR (500 MHz, CDCl3) δ: 7.40 (s, 2H), 7.37 (br s, 1H), 6.07 (dd, J = 11.7, 18.7 Hz, 
1H), 5.66 (d, J = 11.7 Hz, 1H), 5.38 (d, J = 18.7 Hz, 1H), 4.22 (dd, J = 5.6, 11.1 Hz, 
1H), 4.11 (dd, J = 5.6, 11.1 Hz, 1H), 1.62 (t, J = 5.6 Hz, 1H, OH). 
13C NMR (125 MHz, CDCl3) δ: 138.3, 135.1, 132.8, 128.6, 127.9, 126.1 (q, J = 285 Hz), 
121.7, 63.1, 56.8 (q, J = 19.8 Hz). 
19F NMR (470 MHz, CDCl3) δ: -68.8. 
HRMS (CI+, m/z) for C11H9OF3Cl2 = 283.9983; found = 283.9984. 
FTIR (neat): 3421, 2939, 1588, 1464, 1421, 1259, 1160, 1071, 942, 859, 802, 689 cm-1. 
HPLC: (Chiralcel column OJ-H, Hexane:2-PrOH = 97:3, 1.0 mL/min, 210 nm) ee = 90%. 
[𝜶]𝑫
















Acq. Operator   : JULIAN                         Seq. Line :   2
Acq. Instrument : LC 1                            Location : Vial 21
Injection Date  : 6/2/2017 1:55:14 PM                  Inj :   1
                                                Inj Volume : 5.0 µl
Acq. Method     : C:\CHEM32\1\DATA\WANDI\JC_III_153 2017-04-14 20-15-45\MICHAEL\MICHAEL 2017-06-
                  02 13-43-07\KHOA-97-03-10ML.M
Last changed    : 6/2/2017 2:05:47 PM by JULIAN
                  (modified after loading)
Analysis Method : C:\CHEM32\1\METHODS\TAO-9505-1ML-60MIN.M
Last changed    : 6/2/2017 2:10:32 PM by JULIAN
                  (modified after loading)
Sample Info     : Column: OJ-H new
                  Flow: 1.0 mL/min
                  Hex/ipa = 97:3
                  
 




























                         Area Percent Report                         
=====================================================================
 
Sorted By             :      Signal
Multiplier:                   :      1.0000
Dilution:                     :      1.0000
Use Multiplier & Dilution Factor with ISTDs
 
 
Signal 1: DAD1 D, Sig=230,16 Ref=360,100
 
Peak RetTime Type  Width     Area      Height     Area  
  #   [min]        [min]   [mAU*s]     [mAU]        %
----|-------|----|-------|----------|----------|--------|
   1   6.418 MM    0.2235 2698.21338  201.17372  48.6837
   2   8.304 BB    0.2676 2844.11743  166.27774  51.3163
 
Totals :                  5542.33081  367.45146
 
Data File C:\CHEM32\... 2017-04-14 20-15-45\MICHAEL\MICHAEL 2017-06-02 13-43-07\021-0201.D
Sample Name: MTH-3-002rac
LC 1 6/2/2017 2:10:38 PM JULIAN Page 1 of 2
=====================================================================
Acq. Operator   : JULIAN                         Seq. Line :   2
Acq. Instrument : LC 1                            Location : Vial 21
Injection Date  : 6/2/2017 1:55:14 PM                  Inj :   1
                                                Inj Volume : 5.0 µl
Acq. Method     : C:\CHEM32\1\DATA\WANDI\JC_III_153 2017-04-14 20-15-45\MICHAEL\MICHAEL 2017-06-
                  02 13-43-07\KHOA-97-03-10ML.M
Last changed    : 6/2/2017 2:05:47 PM by JULIAN
                  (modified after loading)
Analysis Method : C:\ EM32\1\METHODS\TAO-9505-1ML-6 MIN.M
Last changed    : 6/2/2017 2:10:32 PM by JULIAN
                  (modified after loading)
Sample Info     : Column: OJ-H new
   Flow: 1.0 mL/min
 Hex/ipa = 97:3
              




























                         Area Percent Report                         
=====================================================================
 
Sorted By             :      Signal
Multiplier:                   :      1.0000
Dilution:                     :      1.0000
Use Multiplier & Dilution Factor with ISTDs
 
 
Signal 1: DAD1 D, Sig=230,16 Ref=360,100
 
Peak RetTime Type  Width     Area      Height     Area  
  #   [min]        [min]   [mAU*s]     [mAU]        %
----|-------|----|-------|----------|----------|--------|
   1   6.418 MM    0.2235 2698.21338  201.17372  48.6837
   2   8.304 BB    0.2676 2844.11743  166.27774  51.3163
 
Totals :                  5542.33081  367.45146
 
Data File C:\CHEM32\... 2017-04-14 20-15-45\MICHAEL\MICHAEL 2017-06-02 13-43-07\021-0201.D
Sample Name: MTH-3-002rac
LC 1 6/2/2017 2:10:38 PM JULIAN Page 1 of 2
=====================================================================
Acq. Operator   : KHOA            Seq. Line :   2
Acq. Instrument : LC 2                         L cat on : Vial 14
Injection Date  : 6/1/2017 3:00:42 PM                  Inj :   1
                                                Inj Volume : 5.0 µl
Acq. Method     : C:\CHEM32\2\DATA\KHOA\KHOA 20 7-06-01 14-5 -42\MICHAEL_97_3_1.M
Last changed    : 6/1/2017 3:18:40 PM by KHOA
                  (modified after loading)
Analysis Method : C:\CHEM32\2\METHODS\JACKY_WASH.M
Last changed    : 6/2/2017 1:24:02 PM by JULIAN
                  (modified after loading)
Sample Info     : Column: OJ-H (new)
                  Flow-rate: 1.0 mL/min
                  Hex/iPA = 95:5
                  
 





















                         Area Percent Report                         
=====================================================================
 
Sorted By             :      Signal
Multiplier:                   :      1.0000
Dilution:                     :      1.0000
Use Multiplier & Dilution Factor with ISTDs
 
 
Signal 1: DAD1 C, Sig=210,8 Ref=360,100
 
Peak RetTime Type  Width     Area      Height     Area  
  #   [min]        [min]   [mAU*s]     [mAU]        %
----|-------|----|-------|----------|----------|--------|
   1   6.835 VB    0.2644 2.49147e4  1510.46399  95.1529
   2   9.041 BV    0.2959 1269.16443   66.71927   4.8471
 
Totals :                  2.61839e4  1577.18326
 
 
Data File C:\CHEM32\2\DATA\KHOA\KHOA 2017-06-01 14-50-42\014-0201.D
Sample Name: MTH-2-183-3,5-Cl Ircodacac
LC 2 6/2/2017 1:24:08 PM JULIAN Page 1 of 2
=====================================================================
Acq. Operator   : KHOA                           Seq. Line :   2
Acq. Instrument : LC 2                            Location : Vial 14
Injection Date  : 6/1/2017 3:00:42 PM                  Inj :   1
                                                Inj Volume : 5.0 µl
Acq. Method     : C:\CHEM32\2\DATA\KHOA\KHOA 2017-06-01 14-50-42\MICHAEL_97_3_1.M
Last changed    : 6/1/2017 3:18:40 PM by KHOA
                  (modified after loading)
Analysis Method : C:\CHEM32\2\METHODS\JACKY_WASH.M
Last changed    : 6/2/2017 1:24:02 PM by JULIAN
                 (modified after loading)
Sample Info     : Column: OJ-H (new)
                  Flow-rate: 1.0 mL/min
                  Hex/iPA  95:5
                  
 





















                         Area Percent Report                         
=====================================================================
 
Sorted By             :      Signal
Multiplier:                   :      1.0000
Dilution:                     :      1.0000
Use Multiplier & Dilution Factor with ISTDs
 
 
Signal 1: DAD1 C, Sig=210,8 Ref=360,100
 
Peak RetTime Type  Width     Area      Height     Area  
  #   [min]        [min]   [mAU*s]     [mAU]        %
----|-------|----|-------|----------|----------|--------|
   1   6.835 VB    0.2644 2.49147e4  1510.46399  95.1529
   2   9.041 BV    0.2959 1269.16443   66.71927   4.8471
 
Totals :                  2.61839e4  1577.18326
 
 
Data File C:\CHEM32\2\DATA\KHOA\KHOA 2017-06-01 14-50-42\014-0201.D
Sample Name: MTH-2-183-3,5-Cl Ircodacac
LC 2 6/2/2017 1:24:08 PM JULIAN Page 1 of 2
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2.5.3.4 Procedures and Spectral Data for the Elaboration of Product 2.2a 
(S)-2-phenyl-2-(trifluoromethyl)but-3-en-1-yl 4-methylbenzenesulfonate (pre-2.3) 
 
To an oven-dried pressure tube equipped with a magnetic stir bar charged with TsCl 
(105 mg, 0.55 mmol, 110 mol%) and DMAP (2.0 mg, catalytic) was added alcohol 2.2a 
(108.1 mg, 0.5 mmol, 100 mol%) in CH2Cl2 (2.5 mL) via syringe followed by Et3N (0.18 
mL, 1.25 mmol, 250 mol%). The reaction was allowed to stir at 60 °C for 4 hours. The 
reaction mixture was allowed to cool to room temperature and CH2Cl2 (5 mL) and saturated 
NaHCO3 (aq, 5 mL) were added. The reaction mixture was transferred to a separatory 
funnel. The aqueous layer was extracted with CH2Cl2 (3 x 5 mL). The combined organic 
phases were washed with brine (1 x 10 mL), dried (MgSO4), filtered and the solvent was 
removed in vacuo. The residue was subjected to flash column chromatography (SiO2, 1:8 
EtOAc/hexanes) to furnish the title compound pre-2.3 (168.5 mg, 0.455 mmol) in 91% 
yield as a colorless oil. 
 
[𝜶]𝑫
𝟐𝟒= +11.4 (c = 1.14, CHCl3). 
 






To an oven-dried pressure tube equipped with a magnetic stir bar charged with pre-2.3 
(148 mg, 0.4 mmol, 100 mol%) and sodium cyanide (59.0 mg, 1.2 mmol, 300 mol%) was 
added DMSO (0.8 mL, 0.5 M). The pressure tube was sealed and the reaction mixture was 
allowed to stir for 45 hours at 150 °C. The reaction mixture was allowed to cool to room 
temperature and Et2O (10 mL) and H2O (10 mL) were added. The reaction mixture was 
transferred to a separatory funnel. The aqueous phase was extracted with Et2O (2 × 10 mL). 
The combined organic phases were dried (MgSO4), filtered and the solvent was removed 
in vacuo. The residue was subjected to flash column chromatography (SiO2, 15:85 




𝟐𝟒= -8.85 (c = 1.13, CHCl3). 
 




(S)-2-phenyl-2-(trifluoromethyl)but-3-enoic acid (pre-2.4) 
 
To a flame-dried round bottom flask equipped with magnetic stir bar charged with alcohol 
2.2a (108.1 mg, 0.5 mmol, 100 mol%) was added acetone (5.0 mL, 0.1 M). The reaction 
mixture was cooled to 0 °C and freshly prepared H2CrO4 (0.75 mL, 2.00 M, 300 mol%) 
was added. The reaction mixture was allowed to stir at room temperature for 5 hours. 2-
propanol (5 mL) was slowly added. The reaction mixture was filtered through a pad of 
cotton and the precipitate was washed with CH2Cl2 (10 mL). The filtrate was collected and 
transferred to a separatory funnel. The organic phase was washed with HCl (1N, 2 × 5 mL), 
brine (10 mL), dried (MgSO4), filtered and the solvent was removed in vacuo. The residue 
was subjected to flash column chromatography (SiO2, 2:3 EtOAc/hexane) to afford the title 
compound pre-2.4 (102.4 mg, 0.445 mmol) in 89% yield as a tan solid. 
 
[𝜶]𝑫
𝟐𝟔= +38.4 (c = 1.12, CHCl3). 
 




Methyl (S)-2-phenyl-2-(trifluoromethyl)but-3-enoate (2.4) 
 
To an oven-dried pressure tube equipped with magnetic stir bar charged with carboxylic 
acid pre-2.4 (69.1 mg, 0.3 mmol, 100 mol%) was added methanol (1.2 mL, 0.25 M) and 
concentrated sulfuric acid (6 μL, 35 mol%). The pressure tube was sealed and the reaction 
mixture was allowed to stir at 90°C for 16 hours. The reaction mixture was allowed to cool 
to room temperature and CH2Cl2 (10 mL) and H2O (10 mL) were added. The reaction 
mixture was transferred to a separatory funnel.  The aqueous layer was extracted with 
CH2Cl2 (2 × 10 mL). The combined organic phases were washed with brine (10 mL), dried 
(MgSO4), filtered and the solvent was removed in vacuo. The residue was subjected to 
flash column chromatography (SiO2, 1:8 EtOAc/hexanes) to afford the title compound 2.4 
(61.5 mg, 0.252 mmol) in 84% yield as a yellow viscous oil. 
 
[𝜶]𝑫
𝟑𝟒= +47.5 (c = 1.19, CHCl3). 
 
The spectral data recorded for this compound was in complete agreement with the 
literature.51  
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(S)-2-phenyl-2-(trifluoromethyl)but-3-en-1-yl benzoate (pre-2.5) 
 
To a round bottomed flash equipped with a magnetic stir bar charged with alcohol 2.2a 
(108.1 mg, 0.5 mmol, 100 mol%) in CH2Cl2 (2.5 mL, 0.2 M) was added benzoyl chloride 
(80.8 mg, 0.575 mmol, 115 mol%) and Et3N (105 μL, 0.75 mmol, 150 mol%). The reaction 
mixture was allowed to stir at room temperature for 10 hours. CH2Cl2 (5 mL) and saturated 
NaHCO3 (aq, 5 mL) were added and the reaction mixture was transferred to a separatory 
funnel. The aqueous layer was extracted with CH2Cl2 (3 x 5 mL). The combined organic 
phases were washed with brine (1 x 10 mL), dried (MgSO4), filtered and the solvent was 
removed in vacuo. The residue was subjected to flash column chromatography (SiO2, 1:10 
EtOAc/hexanes) to furnish the title compound pre-2.5 (141 mg, 0.44 mmol) in 88% yield 
as pale yellow oil. 
 
Rf  = 0.65 (4:1 Hexanes: EtOAc). 
1H NMR (400 MHz, CDCl3): δ 7.96 – 7.92 (m, 2H), 7.58 – 7.51 (m, 3H), 7.44 – 7.33 (m, 
5H), 6.17 (dd, J = 17.8, 11.7 Hz, 1H), 5.59 (d, J = 11.7 Hz, 1H), 5.41 (d, J = 17.8 Hz, 
1H), 4.93 – 4.85 (m, 2H). 
13C NMR (100 MHz, CDCl3): δ 166.1, 134.9, 133.6 (d, J = 1.6 Hz), 133.4, 129.8, 129.6, 
128.7 (d, J = 1.2 Hz), 128.6, 128.6, 128.5, 126.6 (d, J = 284.9 Hz), 120.5, 64.6 (d, J = 
2.2 Hz), 55.4 (q, J = 24.2 Hz). 
19F NMR (100 MHz, CDCl3): δ -68.6. 
HRMS (ESI+, m/z) for C18H15F3O2 [M+Na]
+: Calcd. 343.0916, Found 343.0920. 
FTIR (neat): 3063, 2366, 1775, 1723, 1601, 1450, 1269, 1151, 936, 871, 699 cm-1. 
[𝜶]𝑫







(S)-2-((Benzoyloxy)methyl)-3,3,3-trifluoro-2-phenylpropanoic acid (2.5)  
 
To a round bottom flask equipped with a magnetic stir bar charged with NaIO4 (3.2 mmol, 
0.684 g, 800 mol%) in pH 7.0 buffer (20 mL, 0.02 M) was added KMnO4 (0.4 mmol, 63.2 
mg, 100 mol%) and the reaction mixture was allowed to stir for 15 minutes at room 
temperature. Pre-2.5 (0.4 mmol, 128.1 mg, 100 mol%) in t-BuOH (20 mL, 0.02M) was 
added via syringe and the reaction mixture was allowed to stir at room temperature for 15 
hours. Na2S2O3.5H2O (300 mol%, 1.2 mmol, 298 mg) was added and the reaction mixture 
was allowed to stir for 45 minutes. H2O (20 mL) and EtOAc (20 mL) were added and the 
reaction mixture was allowed to stir for a further 30 minutes. The reaction mixture was 
transferred to a separatory funnel. The aqueous phase was extracted with EtOAc (4 x 10 
mL). The combined organic phases were washed with HCl (1N, 3 x 10 mL), brine (1 x 10 
mL), dried (Na2SO4), filtered and the solvent was removed in vacuo. The residue was 
subjected to flash column chromatography (SiO2, 1:19 MeOH/CH2Cl) to furnish the title 
compound 2.5 (83.9 mg, 0.248 mmol) in 62% yield as a white solid. 
 
Rf = 0.25 (CH2Cl2/MeOH = 9:1). 
1H NMR (400 MHz, CDCl3) δ: 8.01 – 7.95 (m, 2H), 7.55 (t, J = 7.4 Hz, 1H), 7.43 – 7.34 
(m, 7H), 6.46 (bs, 1H), 5.13 (d, J = 11.3 Hz, 1H), 5.02 (d, J = 11.4 Hz, 1H). 
13C NMR (100 MHz, CDCl3) δ: 169.6, 165.7, 133.6, 131.2, 129.9, 129.6, 129.3, 129.2, 
128.8, 128.7, 127.7, 64.4, 60.4 (q, J = 25.8 Hz) 
19F NMR (100 MHz, CDCl3) δ: -67.7. 
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HRMS: Compound decomposed in GC due to decarboxylation/elimination of benzoic 
acid. Compound 10 was observed plus benzoic acid  
MP: 131.8 – 132.6 oC 
FTIR (neat): 3139 (b), 2978, 2360, 1754, 1725, 1692, 1601, 1453, 1289, 1173, 1069, 942, 
698 cm-1. 
[𝜶]𝑫









2.5.3.5 Isotopic Labeling Studies 
 
Trifluoromethylallene 2.1a (33.0 mg, 0.15 mmol) was subjected to general procedure G 
using [Ir(cod)Cl]2 in Me2CO at 70 °C with d4-MeOH instead of MeOH. 
 
HRMS (CI+, m/z) for C11H9D2OF3 = 218.0888; found = 218.0893; 






Trifluoromethylallene 2.1a (33.0 mg, 0.15 mmol) was subjected to general procedure G 
using [Ir(cod)Cl]2 in Me2CO at 70 °C with 1:1 d4-MeOH:MeOH added. 
 
HRMS (CI+, m/z) for C11H9D2OF3 = 218.0888; found = 218.0891; 




2.5.3.6 Crystallographic Material for Coupling Product 2.2b and 2.2f (4-
Bromobenzoate Derivative) 
Single Crystal Diffraction Data for Coupling Product 3.2b 
Empirical formula  C18 H13 Br Cl F3 O2 
Formula weight  433.64 
Temperature  123(2) K 
Wavelength  0.71073 Å 
Crystal system  monoclinic 
Space group  P 21 
  Unit cell dimensions a = 11.375(10) Å σ= 90°. 
 b = 7.357(6) Å β= 116.91(4)°. 
 c = 11.576(9) Å γ = 90°. 
Volume 863.8(13) Å3 
Z 2 
Density (calculated) 1.667 Mg/m3 
Absorption coefficient 2.573 mm-1 
F(000) 432 
Crystal size 0.260 x 0.097 x 0.054 mm3 
Theta range for data collection 1.973 to 25.558°. 
Index ranges -13<=h<=13, -8<=k<=8, -13<=l<=13 
Reflections collected 8167 
Independent reflections 3054 [R(int) = 0.1043] 
Completeness to theta = 25.242° 99.1 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 1.00 and 0.739 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3054 / 151 / 226 
Goodness-of-fit on F2 0.945 
Final R indices [I>2sigma(I)] R1 = 0.0597, wR2 = 0.1302 
R indices (all data) R1 = 0.1159, wR2 = 0.1512 
Absolute structure parameter 0.025(15) 
Extinction coefficient n/a 
Largest diff. peak and hole 0.973 and -0.742 e.Å-3 
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Figure 2.7 Crystal Structure of 2.2b 4-Bromobenzoate Derivative 
View of 2.2b 4-Bromobenzoate derivative showing the atom labelling scheme. 
Displacement ellipsoids are scaled to the 50% probability level. 
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Single Crystal Diffraction Data for Coupling Product 2.2f 4-Bromobenzoate 
Empirical formula  C19 H14 Br F3 O4 
Formula weight  443.21 
Temperature  100(2) K 
Wavelength  0.71073 Å 
Crystal system  triclinic 
Space group  P 1 
Unit cell dimensions a = 6.7013(13) Å α= 76.249(5)°. 
 b = 9.3224(18) Å β= 85.028(5)°. 
 c = 14.718(3) Å γ = 81.015(5)°. 
Volume 881.0(3) Å3 
Z 2 
Density (calculated) 1.671 Mg/m3 
Absorption coefficient 2.386 mm-1 
F(000) 444 
Crystal size 0.210 x 0.200 x 0.160 mm3 
Theta range for data collection 3.082 to 27.476°. 
Index ranges -8<=h<=8, -12<=k<=12, -19<=l<=18 
Reflections collected 13880 
Independent reflections 7401 [R(int) = 0.0301] 
Completeness to theta = 25.242° 99.8 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 1.00 and 0.779 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 7401 / 436 / 643 
Goodness-of-fit on F2 1.020 
Final R indices [I>2sigma(I)] R1 = 0.0334, wR2 = 0.0808 
R indices (all data) R1 = 0.0387, wR2 = 0.0838 
Absolute structure parameter 0.014(4) 
Extinction coefficient n/a 
Largest diff. peak and hole 0.529 and -0.258 e.Å-3 
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Figure 2.8 Crystal Structure of 2.2f 4-Bromobenzoate Derivative  
View of 2.2f 4-bromobenzoate derivative showing the atom labeling scheme. 
Displacement ellipsoids are scaled to the 50% probability level.  
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2.5.4 Experimental Data for Section 2.3 
2.5.4.1 General Procedures 
General Procedure H 
 
To a round-bottomed flask equipped with a magnetic stir bar under an argon atmosphere 
charged with methyltriphenylphosphonium bromide (110 mol%) in THF (0.25M) at 0 °C 
was added potassium tert-butoxide (120 mol%). The reaction mixture was allowed to stir 
at room temperature for 1 hour. Acetophenone (100 mol%) was added and the reaction 
mixture was allowed to stir at room temperature for 16 hours. To the reaction mixture was 
added H2O.  The reaction mixture was transferred to a separatory funnel and the aqueous 
layer was extracted with Et2O (3x). The combined organic extracts were washed with brine, 
dried (MgSO4), filtered, and the solvent was removed in vacuo. The residue was subjected 
to flash column chromatography (SiO2) under the conditions noted to afford the styrenes. 
 
General Procedure I 
 
To a round-bottomed flask equipped with a magnetic stir bar under an argon atmosphere 
charged with styrene (100 mol%), bromoform (200 mol%) and tetrabutylammonium 
bromide (10 mol %) in CH2Cl2 (3M) was added dropwise sodium hydroxide (50% in H2O, 
500 mol%). The reaction mixture was allowed to stir for 24 hours at 50 °C. The reaction 
mixture was cooled to room temperature, diluted with EtOAc, and H2O was added. The 
reaction mixture was transferred to a separatory funnel and the aqueous layer was extracted 
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with EtOAc (3x). The combined organic extracts were washed with aqueous HCl (1N), 
H2O and brine. The solution was dried (MgSO4), filtered and the solvent was removed in 
vacuo. The residue was subjected to flash column chromatography (SiO2) under the 
conditions noted to afford the 1,1-dibromo-cyclopropanes. 
 
General Procedure J 
 
To a round-bottomed flask equipped with a magnetic stir bar under an argon atmosphere 
charged with cyclopropane (100 mol%) in THF (0.5 M) was added dropwise 
isopropylmagnesium chloride (2M in THF, 180 mol%). The reaction mixture was allowed 
to stir for 1 hour at room temperature. Aqueous HCl (1N) was added to the reaction mixture 
and the mixture was transferred to a separatory funnel. The aqueous layer was extracted 
with Et2O (3x) and the combined organic extracts were washed with brine.  The solution 
was dried (MgSO4), filtered, and the solvent was removed in vacuo. The residue was 




General Procedure K 
 
To a dried pressure tube under an argon atmosphere charged with [Ir(cod)Cl]2 (2.5 mol%), 
(R)-PhanePhos (5 mol%), tetrabutylammonium chloride (100 mol%) and dried 4 Å 
molecular sieves (300 wt%) was added 1,1-disubstituted allene (200 mol%), isopropanol 
(200 mol%) and tert-butanol (0.2M) followed by fluoral hydrate (100 mol%). The reaction 
mixture was allowed to stir for 16 hours at 100 °C. The solvent was removed in vacuo and 
the residue was subjected to flash column chromatography (SiO2) under the noted 
conditions to furnish the fluoral adducts. 
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2.5.4.2 Procedures and Spectral Data for 1,1-Disubstituted Allenes 2.6[a–u] 
N-(4-(prop-1-en-2-yl)phenyl)acetamide (2.17f) 
 
4’-acetamidoacetophenone (2.51 g, 14.20 mmol) was subjected to general procedure H. 
Upon flash column chromatography (SiO2, 1:2 EtOAc/hexanes), the title compound 2.17f 
(1.99 g, 11.35 mmol) was obtained as a light yellow solid in 80% yield 
 
The spectral data recorded for this compound was in complete agreement with the 




Styrene 2.17f (1.99 g, 11.35 mmol) was subjected to general procedure I. Upon flash 
column chromatography (SiO2, 1:1 EtOAc/hexanes), the title compound 2.18f (2.33 g, 6.72 
mmol) was obtained as a clear oil in 59% yield. 
 
Rf = 0.3 (10:1 CH2Cl2 : MeOH) 
1H NMR (500 MHz, CDCl3) δ: 7.49 (d, J = 8.4 Hz, 2H), 7.25 (d, J = 8.2 Hz, 2H), 7.13 (bs, 
1H), 2.18 (s, 3H), 2.13 (d, J = 7.4 Hz, 1H), 1.76, (d, J = 7.6 Hz, 1H), 1.69 (s, 3H). 
13C NMR (125 MHz, CDCl3) δ: 168.1, 138.3, 136.8, 129.1, 119.7, 35.3, 33.7, 29.7, 27.6, 
24.6. 
HRMS (ESI+H, m/z) for C12H13Br2NO: calcd. = 345.9437; found = 345.9434. 






1,1-disubstituted cyclopropane 2.18f (2.33 g, 6.72 mmol) was subjected to general 
procedure J. Upon flash column chromatography (SiO2, 1:2 EtOAc:hexanes), the title 
compound 2.6f (968.8 mg, 5.17 mmol) was obtained as a light yellow solid in 79% yield. 
 
Rf = 0.3 (1:1 hexanes : EtOAc) 
1H NMR (500 MHz, CDCl3) δ: 7.46 (d, J = 8.7 Hz, 2H), 7.35 (d, J = 8.4 Hz, 2H), 7.18 (bs, 
1H), 5.02 (q, J = 3.1 Hz, 2H), 2.17 (s, 3H), 2.07 (t, J = 3.1 Hz, 3H). 
13C NMR (125 MHz, CDCl3) δ: 208.9, 168.1, 136.3, 132.7, 126.2, 119.7, 99.3, 76.6, 24.7, 
16.7. 
HRMS (ESI+H, m/z) for C12H13NO: calcd. = 188.1070; found = 188.1073. 
FTIR (neat):  3300, 3000, 2350, 1650, 1600, 1550, 1500, 1400, 1350, 1300, 800 cm-1. 








In a dry rounded bottom flask with indium (0.92 g, 8 mmol), was added anhydrous DMF 
(8 mL) and 1-bromo-2-butyne (1.05 mL, 12 mmol, 150 mol %) under nitrogen atmosphere. 
After 1 hour, the resulting homogenous solution was added to a suspension of 3-
nitroiodobenzene (2.00 g, 8.00 mmol, 100 mol %), Pd(PPh3)4 (0.37 g, 0.32 mmol, 4 mol 
%) and lithium iodide (3.21 g, 24 mmol, 300 mol %) in anhydrous DMF (8 mL). This 
mixture was stirred at 100 oC for 1 h, cooled to room temperature and quenched with 
saturated aqueous NaHCO3 (15 mL). The aqueous layer was extracted with diethyl ether 
(3 x 30 mL), and the combined organic solvents were washed with water (20 m L) and 
brine (2 x 20 mL), dried with Na2SO4, filtered, and concentrated under reduced pressure. 
The residue was purified by silica gel column chromatography using hexanes/EtOAc 20:1 
to give the desired allene 2.6j (0.49 g, 2.80 mmol) as a yellow oil in 35 % yield.56 
 
The spectral data recorded for this compound was in complete agreement with the 




In a dry pressure tube with 4-bromoacetophenone (2.0 g, 10 mmol), PdCl2(PPh3)2 (0.14 g, 
0.2 mmol, 2 mol %), copper (I) iodide (0.19 g, 1 mmol, 10 mol %) was purged with argon 
and propargyl alcohol (0.71 mL, 12 mmol, 120 mol %) and triethylamine (20 mL) were 
added. The resulting mixture was heated to 80 oC for 12 h, cooled to room temperature and 
quenched with saturated aqueous NaHCO3 (15 mL). The aqueous layer was extracted with 
dichloromethane (3 x 30 mL), and the combined organic solvents were dried with Na2SO4, 
filtered, and concentrated under reduced pressure. The residue was purified by silica gel 
column chromatography using n-hexane/EtOAc 3:1 to give the desired alcohol (1.74 g, 10 
mmol) as white solid in 99 % yield. 
 




3-(4-acetylphenyl)prop-2-yn-1-yl 4-methylbenzenesulfonate (2.20k) 
 
In a dry rounded bottom flask with 1-(4-(3-hydroxyprop-1-yn-1-yl)phenyl)ethan-1-one 
2.19k (1.0 g, 5.74 mmol) and tosyl chloride (1.20 g, 6.31 mmol, 110 mol %), was added 
diethyl ether (8 mL) and then potassium hydroxide (1.61 g, 28.7 mmol, 500 mol %) at 0 
oC. The mixture was allowed to warm to room temperature and after 1 h was quenched 
with water (30 mL) and extracted with diethyl ether (3 x 30 mL). The combined organic 
solvents were dried with Na2SO4, filtered, and concentrated under reduced pressure. The 
residue was purified by silica gel column chromatography using n-hexane/EtOAc 2:1 to 
give the desired tosylate 2.20k(1.40 g, 4.26 mmol) as white solid in 74 % yield. 
 






In a dry rounded bottom flask with cupper (I) bromide (0.48 g, 3.33 mmol, 100 mol %) 
purged with nitrogen atmosphere in THF (10 mL) was added methylmagnesium bromide 
(1.1 mL, 100 mol %, 3 M) dropwise. After 1 h, a THF (10 mL) solution of 3-(4-
acetylphenyl)prop-2-yn-1-yl 4-methylbenzenesulfonate 2.20k (1.04 g, 3.17 mmol) was 
added dropwise and the solution was allowed to stir at room temperature for 1 h. After 1 
h, reaction was quenched with water (30 mL) and extracted with dichloromethane (3 x 30 
mL). The combined organic solvents were dried with Na2SO4, filtered, and concentrated 
under reduced pressure. The residue was purified by silica gel column chromatography 
using n-hexane/EtOAc 10:1 to give the desired allene 2.6k (0.21 g, 1.21 mmol) as clear oil 
in 38 % yield. 
 
Rf = 0.51 (5:1 hexanes : EtOAc)  
1H NMR (500 MHz, CDCl3) δ: 7.89 (dd, J = 8.5, 1.4 Hz, 2H), 7.46 (d, J = 8.1 Hz, 2H), 
5.07 (q, J = 3.2 Hz, 2H), 2.57 (s, 3H), 2.12 – 2.09 (m, 3H). 
13C NMR (125 MHz, CDCl3) δ: 209.8, 197.6, 141.9, 135.1, 131.6, 128.4, 125.6, 99.5, 26.5, 
16.5. 
HRMS (ESI + H, m/z) for C12H13O: calcd. = 173.0963; found = 173.0961. 





2-Methoxy-5-(prop-1-en-2-yl)pyridine (2.17m)  
 
5-Acetyl-2-methoxypyridine (1.51 g, 10 mmol) was subjected to general procedure H. The 






Styrene 2.17m (10 mmol) was subjected to general procedure I. Upon flash column 
chromatography (SiO2, 3:97 EtOAc:hexanes), the title compound 2.18m (1.63 g, 5.5 
mmol) was obtained as a light yellow solid in 55% yield over two steps. 
 
Rf = 0.32 (95:5 hexanes:EtOAc) 
1H NMR (500 MHz, CDCl3) δ: 8.05 (d, J = 2.5 Hz, 1H), 7.55 (dd, J = 2.5, 8.3 Hz, 1H), 
6.74 (d, J = 8.3 Hz, 1H), 3.94 (s, 3H), 2.13 (d, J = 7.3 Hz, 1H), 1.79 (d, J = 7.3 Hz, 
1H), 1.69 (s, 3H). 
13C NMR (125 MHz, CDCl3) δ: 163.2, 146.5, 139.2, 131.0, 110.6, 53.5, 36.2, 33.5, 33.0, 
27.4. 
HRMS (ESI+H, m/z) for C10H11Br2NO: calcd. = 319.9280; found = 319.9277. 







1,1-Disubstituted cyclopropane 2.18m (1.63 g, 5.5 mmol) was subjected to general 
procedure J. Upon flash column chromatography (SiO2, 3:97 EtOAc:hexanes), the title 
compound 2.6m (640 mg, 4.0  mmol) was obtained as a colorless oil in 73% yield. 
 
Rf = 0.41 (95:5 hexanes:EtOAc) 
1H NMR (500 MHz, CDCl3) δ: 8.13 (s, 1H), 7.62 (d, J = 9.3 Hz, 1H), 6.70 (d, J = 9.3 Hz, 
1H), 5.03 (q, J = 2.8 Hz, 2H), 3.93 (s, 3H), 2.08 (t, J = 2.8 Hz, 3H). 
13C NMR (125 MHz, CDCl3) δ: 208.4, 163.2, 143.4, 136.7, 125.6, 110.7, 97.3, 77.5, 53.6, 
16.6. 
HRMS (CI+, m/z) for C10H11NO: calcd. = 162.0913; found = 162.0916. 






To a stirred solution of 5-bromo-2-methylpyrimidine (2.60 g, 15 mmol) in DMF (15 mL) 
was added triethylamine (4.2 mL, 30 mmol) and propargyl alcohol (0.97 mL, 16.5 mmol). 
The solution was sparged for 10 minutes with Ar. Copper iodide (114 mg, 0.6 mmol) and 
bis(triphenylphosphine)palladium (II) dichloride (211 mg, 0.3 mmol) were added and the 
reaction mixture was stirred at 100 °C for 36 h. H2O (100 mL) and ethyl acetate (100 mL) 
were added and the reaction mixture was filtered. The phases were separated and the 
aqueous layer washed with ethyl acetate (3 x 100 mL). The combined organic phases were 
washed with brine (100 mL), dried (MgSO4), filtered and the solvent removed in vacuo. 
The residue was subjected to flash column chromatography (SiO2, 2:1 hexanes:EtOAc) to 
afford the title compound 2.19n (0.79 g, 5.3 mmol) as a light yellow solid in 36% yield. 
 
Rf = 0.1 (1:1 hexanes:EtOAc) 
1H NMR (500 MHz, CDCl3) δ: 8.71 (s, 2H), 4.52 (d, J = 5.6 Hz, 2H), 2.75 (s, 3H), 2.67 (t, 
J = 5.6 Hz, 1H, OH). 
13C NMR (125 MHz, CDCl3) δ: 167.0, 159.0, 116.0, 94.2, 79.1, 51.4, 26.1. 
HRMS (ESI+H, m/z) for C8H8N2O: calcd. = 149.0709; found = 149.0710. 
FTIR (neat): 3708, 3258, 2938, 2864, 2360, 1589, 1447, 1032, 744 cm-1. 





3-(2-methylpyrimidin-5-yl)prop-2-yn-1-yl 4-methylbenzenesulfonate (2.20n) 
 
To a stirred solution of propargyl alcohol 2.19n (0.74 g, 5.0 mmol) in Et2O (7 mL) at 0 °C 
was added tosyl chloride (1.05 g, 5.5 mmol) followed by crushed potassium hydroxide 
(1.40 g, 25 mmol). The reaction mixture was stirred at 0 °C for 1 hour. The reaction mixture 
was poured onto ice water (30 mL) and diluted with Et2O (30 mL). The phases were 
separated and the organic phase was washed with H2O (2 x 30 mL). The combined aqueous 
phases were washed with Et2O (2 x 30 mL). The combined organic phases were washed 
with brine (20 mL), dried (MgSO4), filtered and the solvent removed in vacuo. The residue 
was subjected to flash column chromatography (SiO2, 1:1 hexanes:EtOAc) to afford the 
title compound 2.20n (1.22 g, 4.1 mmol) as a light yellow solid in 81% yield. 
 
Rf = 0.16 (1:1 hexanes : EtOAc) 
1H NMR (500 MHz, CDCl3) δ: 8.50 (s, 2H), 7.85 (d, J = 8.0 Hz, 2H), 7.34 (d, J = 8.0 Hz, 
2H), 4.96 (s, 2H), 2.73 (s, 3H), 2.42 (s, 3H). 
13C NMR (125 MHz, CDCl3) δ: 167.7, 159.1, 145.5, 133.4, 130.0, 128.4, 114.9, 87.1, 82.6, 
58.0, 26.3, 21.8. 
HRMS (Cl+, m/z) for C15H14N2O3S: calcd. = 303.0798; found = 303.0796. 
FTIR (neat): 3709, 2981, 2362, 1584, 1446, 1369, 1176, 939, 746 cm-1. 







To a stirred solution of propargyl tosylate 2.20n (0.40 g, 1.3 mmol) and copper (I) bromide 
(37 mg, 0.3 mmol) in THF (2 mL) was added MeMgBr (3 M in Et2O, 0.5 mL, 1.6 mmol) 
dropwise over 10 minutes. The reaction mixture was stirred for 1 hour at 25 °C. Saturated 
aqueous NH4Cl solution (2 mL) and EtOAc (3 mL) were added and the phases were 
separated. The aqueous phase was washed with EtOAc (3 x 3 mL) and the combined 
organic phases were washed with brine (5 mL), dried (MgSO4), filtered and the solvent 
removed in vacuo. The residue was subjected to flash column chromatography (SiO2, 2:1 
hexanes:EtOAc) to afford the title compound 2.6n (113 mg, 0.78 mmol) as a light yellow 
solid in 65% yield. 
 
Rf = 0.27 (2:1 hexanes : EtOAc) 
1H NMR (500 MHz, CDCl3) δ: 8.62 (s, 2H), 5.13 (q, J = 3.3 Hz, 2H), 2.71 (s, 3H), 2.09 (t, 
J = 3.3 Hz, 3H). 
13C NMR (125 MHz, CDCl3) δ: 208.3, 165.9, 153.8, 127.2, 94.8, 78.4, 25.6, 15.9. 
HRMS (ESI+, m/z) for C9H10N2: calcd. = 147.0917; found = 147.0917. 
FTIR (neat): 2986, 1944, 1584, 1546, 1412, 1034, 858 cm-1. 








6-Bromoquinoline (1.08 mL, 8.0 mmol) was subjected to general described in 2.6j.56 Upon 
flash column chromatography (SiO2, 1:3 EtOAc/hexanes), the title compound 2.6o (0.65 
g, 3.6 mmol) was obtained as a light yellow oil in 45 % yield. 
 
Rf = 0.29 (3:1 hexanes : EtOAc) 
1H NMR (500 MHz, CDCl3) δ: 8.85 (dd, J = 4.3, 1.7 Hz, 1H), 8.12 (dd, J = 8.3, 1.8 Hz, 
1H), 8.02 (d, J = 8.8 Hz, 1H), 7.88 (dd, J = 8.9, 2.1 Hz, 1H), 7.68 (d, J = 2.0 Hz, 1H), 
7.38 (dd, J = 8.3, 4.3 Hz, 1H), 5.14 (q, J = 3.1 Hz, 2H), 2.22 (t, J = 3.1 Hz, 3H). 
13C NMR (125 MHz, CDCl3) δ: 209.8, 149.9, 147.5, 136.0, 135.1, 129.1, 128.6, 128.4, 
122.9, 121.3, 99.7, 77.6, 16.7. 
HRMS (ESI + H, m/z) for C13H11N: calcd. = 182.0964; found = 182.0968. 








To a stirred solution of propargyl alcohol (2.4 mL, 40 mmol) in CH2Cl2 (130 mL) at 0 °C 
was added imidazole (3.3 g, 48 mmol) followed by triisopropylchloride (9.4 mL, 44 mmol). 
The reaction mixture was stirred for 14 hours. Water (100 mL) was added and the phases 
were separated. The organic phase was washed with water (100 mL), brine (100 mL), dried 
(MgSO4), filtered and the solvent removed in vacuo. The silyl propargyl ether was 
dissolved in THF (40 mL) and cooled to -78 °C. nBuLi (2.5M in hexane, 19.2 mL, 48 
mmol) was added and the reaction mixture was stirred at -78 °C for 10 minutes. The 
reaction mixture was warmed to 0 °C and stirred for 1 hour. The reaction mixture was 
cooled to -78 °C and paraformaldehyde (1.44 g, 48 mmol) was added in a single portion. 
The reaction mixture was allowed to warm to room temperature and stirred for 14 hours. 
Saturated aqueous NH4Cl solution (50 mL) was added followed by EtOAc (100 mL). The 
phases were separated and the organic phase was washed with water (2 x 100 mL). The 
combined aqueous phases were washed with EtOAc (2 x 100 mL). The combined organic 
phases were washed with brine (200 mL), dried (MgSO4), filtered and the solvent removed 
in vacuo. The crude material 2.19q was used in the following step without purification. 
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4-((Triisopropylsilyl)oxy)but-2-yn-1-yl 4-methylbenzenesulfonate (2.20q) 
 
To a stirred solution of propargyl alcohol 2.19q (~40 mmol) in Et2O (40 mL) at 0 °C was 
added tosyl chloride (6.1 g, 32 mmol) followed by crushed potassium hydroxide (11.2 g, 
200 mmol). The reaction mixture was stirred at 0 °C for 1 hour. The reaction mixture was 
poured onto ice water (100 mL) and diluted with Et2O (100 mL). The phases were separated 
and the organic phase was washed with H2O (2 x 100 mL). The combined aqueous phases 
were washed with Et2O (2 x 100 mL). The combined organic phases were washed with 
brine (100 mL), dried (MgSO4), filtered and the solvent removed in vacuo. The residue 
was subjected to flash column chromatography (SiO2, 5:95 ethyl acetate:hexanes) to afford 
the title compound 2.20q (10.3 g, 26 mmol) as a colorless oil in 65% yield over 3 steps. 
 
Rf = 0.41 (9:1 hexanes:EtOAc) 
1H NMR (500 MHz, CDCl3) δ: 7.81 (d, J = 7.9 Hz, 2H), 7.34 (d, J = 7.9 Hz, 2H), 4.74 (s, 
2H), 4.28 (s, 2H), 2.45 (s, 3H), 1.05 (m, 21H). 
13C NMR (125 MHz, CDCl3) δ: 145.1, 133.3, 129.9, 128.3, 88.3, 76.4, 48.2, 51.9, 21.8, 
18.0, 12.1. 
HRMS (ESI+NH4, m/z) for C20H32O4SSi: calcd. = 414.2129; found = 414.2135. 







To a stirred solution of copper (I) bromide (1.43 g, 10 mmol) in THF (20 mL) was added 
PhMgBr (3M in Et2O, 4 mL, 12 mmol) over 5 minutes. The reaction mixture was stirred 
for 5 minutes. In a separate flask propargyl tosylate 2.20q (3.97 g, 10 mmol) was dissolved 
in THF (20 mL). The prepared nucleophile was added to this second flask dropwise over 
10 minutes and the reaction mixture was stirred for 1 hour. Saturated aqueous NH4Cl 
solution (50 mL) was added followed by EtOAc (50 mL). The phases were separated and 
the organic phase was washed with water (2 x 50 mL). The combined aqueous phases were 
washed with EtOAc (2 x 50 mL). The combined organic phases were washed with brine 
(100 mL), dried (MgSO4), filtered and the solvent removed in vacuo. The residue was 
subjected to flash column chromatography (SiO2, hexanes) to afford the title compound 
2.6q (2.36 g, 7.9 mmol) as a colorless oil in 79% yield. Note: The use of stoichiometric 
copper (I) bromide was essential to minimize the formation of the inseparable isomeric 
alkyne through SN2 attack. 
 
Rf = 0.29 (hexanes) 
1H NMR (500 MHz, CDCl3) δ: 7.47 (d, J = 7.8 Hz, 2H), 7.32 (t, J = 7.8 Hz, 2H), 7.20 (t, 
J = 7.8 Hz, 1H), 5.14 (t, J = 2.8 Hz, 2H), 4.68 (t, J = 2.8 Hz, 2H), 1.13 (m, 3H), 1.07 
(d, J = 6.5 Hz, 18H). 
  
 246 
13C NMR (125 MHz, CDCl3) δ: 208.7, 134.9, 128.4, 126.9, 126.6, 105.8, 78.9, 63.0, 18.2, 
12.2. 
HRMS (ESI+H, m/z) for C19H30OSi: calcd. = 303.2139; found = 303.2140. 







Magnesium turnings (108 mg, 4.5 mmol) were placed into a 3-necked flask equipped with 
a reflux condenser. THF (6 mL) was added followed by a single crystal of iodine and the 
reaction mixture was stirred until the solution decolorized. 4-Fluorophenethyl bromide 
(910 mg, 4.5 mmol) was added and the reaction mixture was heated until it began to reflux. 
The heat was removed and the reaction mixture was stirred until the reflux ended. In a 
separate flask, 3-phenyl-2-propyn-1-ol tosylate49 (860 mg, 3 mmol) and copper (I) bromide 
(43 mg, 0.3 mmol) were dissolved in THF (6 mL). The Grignard reagent was transferred 
to this flask through a cannula and the reaction mixture was stirred at room temperature for 
1 hour. Saturated aqueous NH4Cl solution (10 mL) was added followed by EtOAc (10 mL). 
The phases were separated and the organic phase was washed with water (2 x 10 mL). The 
combined aqueous phases were washed with EtOAc (2 x 10 mL). The combined organic 
phases were washed with brine (20 mL), dried (MgSO4), filtered and the solvent removed 
in vacuo. The residue was subjected to flash column chromatography (SiO2, hexanes) to 
afford the title compound 2.6t (0.48 g, 2.0 mmol) as a colorless oil in 67% yield as a 4:1 
mixture of allene:alkyne. 
  
Rf = 0.37 (hexanes) 
1H NMR (500 MHz, CDCl3) δ: 7.40 (d, J = 7.6 Hz, 2H), 7.33 (t, J = 7.6 Hz, 2H), 7.22 (t, 
J = 7.6 Hz, 1H), 7.17 (dd, J = 5.8, 8.5 Hz, 2H), 6.98 (dd, J = 8.5, 8.5 Hz, 2H), 5.07 (t, 
J = 3.2 Hz, 2H), 2.84 (m, 2H), 2.70 (m, 2H). 
 249 
13C NMR (125 MHz, CDCl3) δ: 208.6, 161.4 (d, J = 240 Hz), 137.6 (d, J = 3 Hz), 136.1, 
129.8 (d, J = 8 Hz), 128.5, 126.8, 125.9, 115.0 (d, J = 21 Hz), 104.3, 78.7, 33.4, 31.5. 
19F NMR (470 MHz, CDCl3) δ: -117.7 (tt, J = 5.7, 8.5 Hz). 
HRMS (CI+, m/z) for C17H14F: calcd. = 237.1080; found = 237.1083. 








Acetophenone-β,β,β-d3 (1.17 mL, 10 mmol) was subjected to general procedure H. Upon 
flash column chromatography (SiO2, hexanes), the title compound deuterio-2.17a (0.98 g, 
8.1 mmol) was obtained as a clear oil in 81% yield. Note: Keeping the reaction mixture at 
0 °C throughout this reaction was essential to avoid H-D exchange. 
 






Styrene deuterio-2.17a (0.98 g, 8.1 mmol) was subjected to general procedure I. Upon flash 
column chromatography (SiO2, hexanes), the title compound deuterio-2.18a (1.79 g, 6.1 
mmol) was obtained as a clear oil in 75% yield. 
 
Rf = 0.44 (hexanes) 
1H NMR (500 MHz, CDCl3) δ: 7.36 (m, 2H), 7.30 (m, 3H), 2.16 (d, J = 8.6 Hz, 1H), 1.78 
(d, J = 8.6 Hz, 1H). 
2H NMR (500 MHz, CDCl3) δ: 1.63 
13C NMR (125 MHz, CDCl3) δ: 142.3, 128.5, 128.4, 127.2, 36.7, 35.6, 33.6, 26.8 (m). 
HRMS (Cl+, m/z) for C10H8D3Br2: calcd. = 291.9416; found = 291.9416. 








1,1-disubstituted cyclopropane deuterio-2.18a (1.36 g, 4.6 mmol) was subjected to general 
procedure C. Upon flash column chromatography (SiO2, pentane), the title compound 
deuterio-2.6a (0.53 g, 4.0 mmol) was obtained as a clear oil in 87% yield. 
 
Rf = 0.47 (hexanes) 
1H NMR (500 MHz, CDCl3) δ: 7.42 (d, J = 8.4 Hz, 2H), 7.33 (t, J = 8.4 Hz, 2H), 7.21 (t, 
J = 8.4 Hz, 1H), 5.03 (s, 2H). 
13C NMR (125 MHz, CDCl3) δ: 209.1, 136.8, 128.5, 126.7, 125.8, 99.8, 77.0, 16.1 (m). 
2H NMR (500 MHz, CDCl3) δ: 2.01. 
HRMS (CI+, m/z) for C10H6D3: calcd. = 132.0893; found = 132.888. 








2.5.4.3 Procedures and Spectral Data for Coupling Products of Fluoral and 1,1-
Disubstituted Allenes 2.8[a–u] 
(2S,3R)-1,1,1-trifluoro-3-methyl-3-phenylpent-4-en-2-ol (2.8a) 
 
1,1-Disubstituted allene 2.6a (52 mg, 0.4 mmol) was subjected to general procedure K. 
Upon flash column chromatography (SiO2, 4:96 EtOAc:hexanes), the title compound 2.8a 
(35.7 mg, 0.16 mmol, 17:1 dr) was obtained as a yellow oil in 78% yield. Note: This 
reaction was repeated on 2 mmol scale using [Ir(cod)Cl]2 (1 mol%) and (R)-PhanePhos (2 
mol%) to afford the product 2.8a in 71% yield and 17:1 dr. 
 
Rf = 0.41 (90:10 hexanes : EtOAc) 
1H NMR (500 MHz, CDCl3) δ: 7.40-7.34 (m, 4H), 7.26 (m, 1H), 6.39 (dd, J = 11.1, 17.8 
Hz, 1H), 5.36 (d, J = 11.1 Hz, 1H), 5.20 (d, J = 17.8 Hz, 1H), 4.39 (dq, J = 6.0, 7.9 Hz, 
1H), 2.19 (d, J = 6.0 Hz, 1H, OH), 1.57 (s, 3H). 
13C NMR (125 MHz, CDCl3) δ: 143.8, 140.8, 128.7, 127.1, 127.0, 126.2 (q, J = 285 Hz), 
124.0, 76.0 (q, J = 26.0 Hz), 47.5, 21.1 (q, J = 2.7 Hz). 
19F NMR (470 MHz, CDCl3) δ: -70.7 (d, J = 7.4 Hz). 
HRMS (CI+, m/z) for C12H13OF3: calcd. = 230.0918; found = 230.0922. 
FTIR (neat): 3459, 2993, 2363, 1496, 1446, 1271, 1156, 1122, 926, 762, 701 cm-1. 
HPLC: (Chiralcel column OJ-H, Hexane:2-PrOH = 95:5, 1.0 mL/min, 210 nm) ee = 96%. 
[𝜶]𝑫














1,1-Disubstituted allene 2.6b (59.3 mg, 0.4 mmol) was subjected to general procedure K. 
Upon flash column chromatography (SiO2, 1:10 EtOAc/hexanes), the title compound 2.8b 
(40.2 mg, 0.16 mmol, 19:1 dr) was obtained as a light yellow oil in 81% yield. 
 
Rf = 0.4 (4:1 hexanes : EtOAc) 
1H NMR (500 MHz, CDCl3) δ: 7.36 (m, 2H), 7.03 (m, 2H), 6.35 (dd, J = 10.9, 17.7 Hz, 
1H), 5.35 (d, J = 10.9 Hz, 1H), 5.17 (d, J = 17.6 Hz, 1H), 4.33 (dq, J = 5.3, 1.8 Hz, 
1H), 2.22 (d, J = 5.4 Hz, 1H), 1.56 (q, J = 1.1 Hz, 3H). 
13C NMR (125 MHz, CDCl3) δ: 161.6 (d, J = 246.5 Hz), 140.8, 139.2 (d, J = 3.2 Hz), 128.6 
(d, J = 7.9 Hz), 125.0 (q, J = 283.5 Hz), 115.8, 115.2 (d, J = 21.2 Hz), 75.7 (q, J = 28.1 
Hz), 46.9, 21.0 (q, J = 2.6 Hz). 
19F NMR (470 MHz, CDCl3) δ: -70.8 (d, J = 7.2 Hz), -116.0 (m). 
HRMS (CI+, m/z) for C12H12F4O: calcd. = 248.0824; found = 248.0821. 
FTIR (neat):  3500, 2950, 2900, 1600, 1500, 1200, 1150, 1100, 900, 800, 600 cm-1. 
HPLC: (Chiralcel column OJ-H, Hexane:2-PrOH = 95:5, 1.0 mL/min, 210 nm) ee = 96%. 
[𝜶]𝑫













1,1-Disubstituted allene 2.6c (65.9 mg, 0.4 mmol) was subjected to general procedure K. 
Upon flash column chromatography (SiO2, 5:95 EtOAc/hexanes), the title compound 2.8c 
(38.3 mg, 0.14 mmol, 18:1 dr) was obtained as a light yellow oil in 72% yield. 
 
Rf = 0.4 (4:1 hexanes : EtOAc) 
1H NMR (500 MHz, CDCl3) δ: 7.32 (m, 4H), 6.34 (dd, J = 10.7, 17.7 Hz, 1H), 5.36 (d, J 
= 10.9 Hz, 1H), 5.17 (d, J = 17.6 Hz, 1H), 4.33 (dq, J = 7.2, 5.7 Hz, 1H), 2.25 (d, J = 
5.4 Hz, 1H), 1.55 (q, J = 1.5 Hz, 3H). 
13C NMR (125 MHz, CDCl3) δ: 142.2, 140.5, 132.9, 128.5, 128.4, 125.0 (q, J = 284.0 Hz), 
116.1, 75.6 (q, J = 28.3 Hz), 47.0, 20.9 (q, J = 2.5 Hz). 
19F NMR (470 MHz, CDCl3) δ: -70.8 (d, J = 7.2 Hz). 
HRMS (CI+, m/z) for C12H12ClF3O: calcd. = 264.0529; found = 264.0532. 
FTIR (neat):  3450, 3000, 1500, 1300, 1150, 1100, 1050, 1000, 900, 800, 350, 300 cm-1. 
HPLC: (Chiralcel column OJ-H, Hexane:2-PrOH = 93:7, 1.0 mL/min, 210 nm) ee = 96%. 
[𝜶]𝑫













1,1-Disubstituted allene 2.6d (836.4 mg, 4 mmol) was subjected to general procedure K. 
Upon flash column chromatography (SiO2, 1:9 EtOAc/hexanes), the title compound 2.8d 
(528.5 mg, 1.71 mmol, 19:1 dr) was obtained as a light yellow oil in 85% yield. 
 
Rf = 0.4 (4:1 hexanes : EtOAc) 
1H NMR (500 MHz, CDCl3) δ: 7.49 (d, J = 8.9, 2H), 7.29 (d, J = 8.5 Hz, 2H), 6.36 (dd, J 
= 10.9, 17.7 Hz, 1H), 5.38 (d, J = 10.9 Hz, 1H), 5.19 (d, J = 17.5 Hz, 1H), 4.35 (dq, J 
= 7.2, 5.8 Hz, 1H), 2.29 (d, J = 5.5 Hz, 1H), 1.56 (q, J = 1.3 Hz, 3H). 
13C NMR (125 MHz, CDCl3) δ: 142.8, 140.4, 131.5, 128.8, 125.0 (q, J = 284.8 Hz), 121.0, 
116.1, 75.6 (q, J = 28.3 Hz), 47.0, 20.9 (q, J = 2.4 Hz). 
19F NMR (470 MHz, CDCl3) δ: -70.75 (d, J = 7.2 Hz). 
HRMS (CI+, m/z) for C12H12BrF3O: calcd. = 308.0024; found = 308.0023. 
FTIR (neat):  3500, 2950, 1500, 1300, 1150, 110, 1050, 1000, 900, 800, 700, 600 cm-1. 
HPLC: (Chiralcel column OJ-H, Hexane:2-PrOH = 95:5, 1.0 mL/min, 210 nm) ee = 96%. 
[𝜶]𝑫













1,1-Disubstituted allene 2.6e (64.9 mg, 0.4 mmol) was subjected to general procedure K. 
Upon flash column chromatography (SiO2, 5:95 EtOAc/hexanes), the title compound 2.8e 
(39.6 mg, 0.16 mmol, 14:1 dr) was obtained as a light yellow oil in 79% yield. 
 
Rf = 0.3 (4:1 hexanes : EtOAc) 
1H NMR (500 MHz, CDCl3) δ: 7.3 (m, 2H), 6.88 (m, 2H), 6.37 (dd, J = 10.9, 17.7 Hz, 
1H), 5.34 (d, J = 11.0 Hz, 1H), 5.17 (d, J = 17.7 Hz, 1H), 4.32 (dq, J = 5.4, 1.9 Hz, 
1H), 3.80 (s, 3H), 2.17 (d, J = 5.1 Hz, 1H), 1.54 (q, J = 1.4 Hz, 3H). 
13C NMR (125 MHz, CDCl3) δ: 158.4, 140.9, 135.4, 128.0, 125.1 (q, J = 282.9 Hz), 115.4, 
113.8, 75.9 (q, J = 27.9 Hz), 55.3, 46.7, 21.1 (q, J = 2.4Hz). 
19F NMR (470 MHz, CDCl3) δ:-70.7 (d, J = 7.2 Hz). 
HRMS (APPI, m/z) for C13H15F3O2: calcd. = 261.1097; found = 261.1096. 
FTIR (neat):  3500, 2950, 2800, 1510, 1250, 1150, 1050, 1000, 900, 800 cm-1. 
HPLC: (Chiralcel column OJ-H, Hexane:2-PrOH = 92:8, 1.0 mL/min, 210 nm) ee = 96%. 
[𝜶]𝑫















1,1-Disubstituted allene 2.6f (74.9 mg, 0.4 mmol) was subjected to general procedure K. 
Upon flash column chromatography (SiO2, 1:1 EtOAc/hexanes), the title compound 2.8f 
(36.7 mg, 0.13 mmol, 11:1 dr) was obtained as a light yellow oil in 64% yield. 
 
Rf = 0.2 (10:1 CH2Cl2 : MeOH) 
1H NMR (500 MHz, CDCl3) δ: 7.49 (s, 1H), 7.43 (d, J = 8.6 Hz, 2 H), 7.31 (d, J = 8.6 Hz, 
2H), 6.37 (dd, J = 11.0, 17.6 Hz, 1H), 5.32 (d, J = 10.9 Hz, 1H), 5.16 (d, J = 17.7 Hz, 
1H), 4.32 (dq, J = 5.2, 2.0 Hz, 1H), 3.04 (d, J = 5.6 Hz, 1H), 2.11 (s, 3H), 1.52 (bs, 
3H). 
13C NMR (125 MHz, CDCl3) δ: 168.9, 140.7, 140.1, 136.4, 127.5, 125.2 (q, J = 284.3 Hz), 
119.9, 115.5, 75.6 (q, J = 28.2 Hz), 47.0, 24.4, 21.1 (q, J = 1.9 Hz). 
19F NMR (470 MHz, CDCl3) δ: -70.7 (d, J = 7.1 Hz). 
HRMS (ESI+H, m/z) for C14H16F3NO2: calcd. = 288.1206; found = 288.1211. 
FTIR (neat): 3300, 2300, 1700, 1600, 1500, 1350, 1250, 1150, 1100, 650 cm-1. 
HPLC: (Chiralcel column OJ-H, Hexane:2-PrOH = 90:10, 1.0 mL/min, 210 nm) ee = 90%. 
[𝜶]𝑫













1,1-Disubstituted allene 2.6g (64.1 mg, 0.4 mmol) was subjected to general procedure K. 
Upon flash column chromatography (SiO2, 1:10 EtOAc/hexanes), the title compound 2.8g 
(39.6 mg, 0.15 mmol, 18:1 dr) was obtained as a light yellow oil in 76% yield. 
 
Rf = 0.3 (4:1 hexanes : EtOAc) 
1H NMR (500 MHz, CDCl3) δ: 7.28 (t, J = 8.0 Hz, 1H), 6.98 (m, 1H), 6.94 (m, 1H), 6.80 
(m, 1H), 6.38 (dd, J = 11.1, 17.7 Hz, 1H), 5.36 (d, J = 11.0 Hz, 1H), 5.21 (d, J = 17.7 
Hz, 1H), 4.37 (dq, J = 5.3, 2.0 Hz, 1H), 3.81 (s, 3H), 2.21 (d, J = 5.1 Hz, 1H), 1.55 (q, 
J = 1.4 Hz, 3H). 
13C NMR (125 MHz, CDCl3) δ: 159.7, 145.5, 140.3, 129.5, 125.0 (q, J = 283.8 Hz), 119.0, 
115.8, 113.7, 111.5, 75.9 (q, J = 28.3 Hz), 55.2, 47.4, 21.0 (q, J = 2.6 Hz). 
19F NMR (470 MHz, CDCl3) δ: -70.7 (d, J = 7.2 Hz). 
HRMS (APPI, m/z) for C13H15F3O2: calcd. = 261.1097; found = 261.1091. 
FTIR (neat):  3450, 3000, 2850, 1550, 1450, 1250, 1150, 1100, 1000, 900, 800, 700 cm-1. 
HPLC: (Chiralcel column OJ-H, Hexane:2-PrOH = 95:5, 1.0 mL/min, 210 nm) ee = 96%. 
[𝜶]𝑫













1,1-Disubstituted allene 2.6h (80 mg, 0.4 mmol) was subjected to general procedure K. 
Upon flash column chromatography (SiO2, 4:96 EtOAc/hexanes), the title compound 2.8h 
(42.5 mg, 0.14 mmol, 19:1 dr) was obtained as a yellow oil in 71% yield. 
 
Rf = 0.38 (9:1 hexanes : EtOAc) 
1H NMR (500 MHz, CDCl3) δ: 7.26 (s, 3H), 6.31 (dd, J = 9.7, 15.4 Hz, 1H), 5.41 (d, J = 
9.7 Hz, 1H), 5.20 (d, J = 15.4 Hz, 1H), 4.30 (dq, J = 6.3 Hz, 1H), 2.30 (d, J = 6.3 Hz, 
1H, OH), 1.53 (s, 3H). 
13C NMR (125 MHz, CDCl3) δ: 147.6, 139.4, 135.0, 127.1, 125.8, 124.9 (q, J = 285 Hz), 
116.8, 75.4 (q, J = 30 Hz), 47.2, 21.0. 
19F NMR (470 MHz, CDCl3) δ: -70.9 (d, J = 6.3 Hz). 
HRMS (Cl+, m/z) for C12H11F3Cl2: calcd. = 298.0139; found = 298.0136. 
FTIR (neat): 3442, 2981, 1586, 1564, 1417, 1271, 1165, 1131, 1033, 932, 801, 699 cm-1. 
HPLC: (Chiralcel column OJ-H, Hexane:2-PrOH = 99:1, 1.0 mL/min, 210 nm) ee = 95%. 
[𝜶]𝑫













1,1-Disubstituted allene 2.6i (59.2 mg, 0.4 mmol) was subjected to general procedure K. 
Upon flash column chromatography (SiO2, 4:96 EtOAc/hexanes), the title compound 2.8i 
(28.8 mg, 0.12 mmol, 13:1) was obtained as a yellow oil in 58% yield. 
 
Rf = 0.39 (9:1 hexanes : EtOAc) 
1H NMR (500 MHz, CDCl3) δ: 7.35 (t, J = 10 Hz, 1H), 7.27 (m, 1H), 7.13 (t, J = 8.7 Hz, 
1H), 7.03 (dd, J = 8.7, 10.0 Hz, 1H), 6.45 (dd, J = 9.9, 17.6 Hz, 1H), 5.30 (d, J = 9.9 
Hz, 1H), 5.13 (d, J = 17.6 Hz, 1H), 4.81 (dq, J = 6.6 Hz, 1H), 2.32 (d, J = 6.6 Hz, 1H, 
OH), 1.62 (s, 3H). 
13C NMR (125 MHz, CDCl3) δ: 160.9 (d, J = 242 Hz), 140.3, 130.1 (d, J = 12 Hz), 129.1 
(d, J = 9 Hz), 128.9 (d, J = 5 Hz), 125.1 (q, J = 285 Hz), 124.3 (d, J = 3 Hz), 116.3 (d, 
J = 24 Hz), 115.5, 72.9 (dq, J = 8, 28 Hz), 46.8, 18.4. 
19F NMR (470 MHz, CDCl3) δ: -71.4 (d, J = 6.6 Hz), -108.6 (m). 
HRMS (CI+, m/z) for C12H12OF4: calcd. = 248.0824; found = 248.0827. 
FTIR (neat): 3430, 2931, 2368, 1489, 1451, 1276, 1166, 1103, 929, 810, 757 cm-1. 
HPLC: (Chiralcel column OJ-H, Hexane:2-PrOH = 95:5, 1.0 mL/min, 210 nm) ee = 96%. 
[𝜶]𝑫














1,1-Disubstituted allene 2.6j (70.1 mg, 0.4 mmol) was subjected to general procedure K. 
Upon flash column chromatography (SiO2, 1:9 EtOAc/hexanes), the title compound 2.8j 
(40.7 mg, 0.15 mmol, > 20:1 dr) was obtained as a light yellow oil in 74% yield.  
 
Rf = 0.2 (9:1 Hexanes : EtOAc)  
1H NMR (500 MHz, CDCl3) δ: 8.29 (t, J = 2.1 Hz, 1H), 8.13 (dd, J = 8.3, 2.3 Hz, 1H), 
7.80 – 7.72 (m, 1H), 7.52 (t, J = 8.0 Hz, 1H), 6.40 (dd, J = 17.5, 10.8 Hz, 1H), 5.43 (d, 
J = 10.9 Hz, 1H), 5.21 (d, J = 17.6 Hz, 1H), 4.45 – 4.35 (m, 1H), 2.51 (d, J = 5.5 Hz, 
1H), 1.63 (s, 3H). 
13C NMR (125 MHz, CDCl3) δ: 148.3, 146.2, 139.9, 133.3, 129.2, 124.8 (q, J = 285 Hz), 
122.2, 122.0, 116.9, 75.5 (q, J = 28.5 Hz), 47.3, 29.7, 21.1 (q, J = 2.46 Hz). 
19F NMR (470 MHz, CDCl3) δ: -70.8 (d, J = 7.27 Hz),  
HRMS (CI+H, m/z) for C12H13NO2F3: calcd. = 276.0848; found = 276.0843. 
FTIR (neat): 3473, 2922, 2852, 1528, 1349, 1217, 1156, 1091, 928, 693 cm-1. 
HPLC: (Chiralcel column AD-H, Hexane:2-PrOH = 97:3, 1.0 mL/min, 210 nm) ee = 96%.  
[𝜶]𝑫





















1,1-Disubstituted allene 2.6k (69 mg, 0.4 mmol) was subjected to general procedure K. 
Upon flash column chromatography (SiO2, 1:5 EtOAc/hexanes), the title compound 2.8k 
(46.8 mg, 0.17 mmol, 20:1 dr) was obtained as a light yellow solid in 86% yield.  
 
Rf = 0.14 (5:1 Hexanes : Ethyl acetate)  
1H NMR (500 MHz, CDCl3) δ: 7.95 – 7.91 (m, 2H), 7.51 – 7.48 (m, 2H), 6.38 (dd, J = 
17.6, 10.9 Hz, 1H), 5.39 (d, J = 10.8 Hz, 1H), 5.19 (d, J = 17.5 Hz, 1H), 4.42 (qd, J = 
7.2, 5.5 Hz, 1H), 2.59 (s, 3H), 2.35 (d, J = 5.7 Hz, 1H), 1.59 (d, J = 1.6 Hz, 3H). 
13C NMR (125 MHz, CDCl3) δ: 197.7, 149.2, 140.3, 135.7, 128.5, 127.2, 124.9 (q, J = 282 
Hz), 116.4, 75.5 (q, J = 28 Hz), 47.5, 26.6, 20.7 (q, 2.6 Hz). 
19F NMR (470 MHz, CDCl3) δ: -70.8 (d, J = 7.1 Hz). 
HRMS (ESI + H, m/z) for C14H16F3O2: calcd. = 273.1097; found = 273.100. 
FTIR (neat): 3427, 2922, 2853, 1674, 1605, 1407, 1360, 1271, 1154, 1121, 1095, 1014, 
960, 822, 692 cm-1. 
HPLC: (Chiralcel column OJ-H, Hexane:2-PrOH = 95:5, 1.0 mL/min, 210 nm) ee = 96%.  
[𝜶]𝑫
𝟐𝟒 = -16 (c = 0.5, CHCl3). 
















1,1-Disubstituted allene 2.6l (54.5 mg, 0.4 mmol) was subjected to general procedure K 
using a reaction time of 8 hours. Upon flash column chromatography (SiO2, 5:95 
EtOAc/hexanes), the title compound 2.8l (32.3 mg, 0.14 mmol, 13:1 dr) was obtained as a 
clear oil in 68% yield. Note: the shorter reaction time was required due to the formation of 
overreduced product under standard reaction times. Additionally instability on chiral 
column was observed. 
 
Rf = 0.3 (4:1 hexanes : EtOAc) 
1H NMR (500 MHz, CDCl3) δ: 7.33 (m, 1H), 7.15 (m, 1H), 7.08 (m, 1H), 6.35 (dd, J = 
6.4, 17.6 Hz, 1H), 5.31 (d, J = 10.9 Hz, 1H), 5.15 (d, J = 17.6 Hz, 1H), 4.23 (dq, J = 
7.3, 6.2 Hz, 1H), 2.23 (d, J = 5.8 Hz, 1H), 1.58 (q, J = 1.4 Hz, 3H). 
13C NMR (125 MHz, CDCl3) δ: 144.5, 140.2, 126.5, 126.0, 124.9 (q, J = 283.5 Hz), 121.8, 
115.8, 75.8 (q, J = 28.3 Hz), 45.9, 21.4 (q, J = 2.4 Hz). 
19F NMR (470 MHz, CDCl3) δ: -71.1 (d, J = 7.3 Hz). 
HRMS (CI+, m/z) for C10H11F3OS: calcd. = 236.0483; found = 236.0479. 
FTIR (neat): 3500, 2950, 2900, 1450, 1400, 1300, 1150, 1100, 1000, 900, 800, 700, 650 
cm-1. 
HPLC: (Chiralcel column OJ-H, Hexane:2-PrOH = 95:5, 1.0 mL/min, 210 nm) ee = 94%. 
[𝜶]𝑫














1,1-Disubstituted allene 2.6m (64 mg, 0.4 mmol) was subjected to general procedure K. 
Upon flash column chromatography (SiO2, 1:9 EtOAc/hexanes), the title compound 2.8m 
(35.5 mg, 0.14 mmol, 19:1 dr) was obtained as a yellow oil in 68% yield. 
 
Rf = 0.19 (9:1 hexanes : EtOAc) 
1H NMR (500 MHz, CDCl3) δ: 8.18 (d, J = 2.7 Hz, 1H), 7.60 (dd, J = 2.7, 9.5 Hz, 1H), 
6.72 (d, J = 9.5 Hz, 1H), 6.34 (dd, J = 10.9, 17.7 Hz, 1H), 5.34 (d, J = 10.9 Hz, 1H), 
5.15 (d, J = 17.7 Hz, 1H), 4.27 (dq, J = 6.5 Hz, 1H), 3.92 (s, 3H), 2.41 (d, J = 6.5 Hz, 
1H, OH), 1.56 (s, 3H). 
13C NMR (125 MHz, CDCl3) δ: 163.0, 145.5, 140.5, 137.8, 131.6, 124.9 (q, J = 277 Hz), 
116.0, 110.4, 75.5 (q, J = 30 Hz), 53.5, 45.5, 20.9. 
19F NMR (470 MHz, CDCl3) δ: -70.8 (d, J = 6.8 Hz). 
HRMS (ESI+H, m/z) for C12H14F3NO2: calcd. = 262.1049; found = 262.1051. 
FTIR (neat): 3375, 2981, 2359, 1606, 1498, 1385, 1272, 1158, 1026, 927, 828 cm-1. 
HPLC: (Chiralcel column OJ-H, Hexane:2-PrOH = 95:5, 1.0 mL/min, 210 nm) ee = 97%. 
[𝜶]𝑫














1,1-Disubstituted allene 2.6n (58 mg, 0.4 mmol) was subjected to general procedure K. 
Upon flash column chromatography (SiO2, 2:1 EtOAc:hexanes), the title compound 2.8n 
(33.8 mg, 0.14 mmol, 15:1 dr) was obtained as a yellow solid in 69% yield. 
 
Rf = 0.31 (1:2 hexanes : EtOAc) 
1H NMR (500 MHz, CDCl3) δ: 8.59 (s, 2H), 6.34 (dd, J = 11.8, 17.8 Hz, 1H), 5.35 (d, J = 
11.8 Hz, 1H), 5.13 (d, J = 17.8 Hz, 1H), 4.19 (q, J = 7.6 Hz, 1H), 2.63 (s, 3H), 1.54 (s, 
3H). 
13C NMR (125 MHz, CDCl3) δ: 166.2, 156.0, 138.9, 134.1, 124.9 (q, J = 286.7 Hz), 117.3, 
75.1 (q, J = 29.0 Hz), 44.6, 25.3, 21.2. 
19F NMR (470 MHz, CDCl3) δ: -70.8 (d, J = 7.6 Hz). 
HRMS (CI+, m/z) for C11H13F3N2O: calcd. = 247.1053; found = 247.1052. 
FTIR (neat): 3158, 2937, 2364, 1589, 1451, 1271, 1156, 1127, 931, 753, 698 cm-1. 
HPLC: (Chiralcel column OD-3, Hexane:2-PrOH = 97:3, 1.0 mL/min, 210 nm) ee = 96%. 
[𝜶]𝑫
𝟐𝟒= -41 (c = 0.25, CHCl3). 













1,1-Disubstituted allene 2.6o (72 mg, 0.4 mmol) was subjected to general procedure K. 
Upon flash column chromatography (SiO2, 1:2 EtOAc/hexanes), the title compound 2.8o 
(39.2 mg, 0.14 mmol, >20:1 dr) was obtained as a light yellow solid in 70% yield.  
 
Rf = 0.11 (2:1 Hexanes : Ethyl acetate)  
1H NMR (500 MHz, CDCl3) δ: 8.29 (t, J = 2.1 Hz, 1H), 8.13 (dd, J = 8.3, 2.3 Hz, 1H), 
7.80 – 7.72 (m, 1H), 7.52 (t, J = 8.0 Hz, 1H), 6.40 (dd, J = 17.5, 10.8 Hz, 1H), 5.43 (d, 
J = 10.9 Hz, 1H), 5.21 (d, J = 17.6 Hz, 1H), 4.45 – 4.35 (m, 1H), 2.51 (d, J = 5.5 Hz, 
1H), 1.63 (s, 3H). 
13C NMR (125 MHz, CDCl3) δ: 150.3, 146.8, 142.9, 140.5, 136.6, 129.0, 128.9, 127.9, 
125.8, 124.2 (q, J = 285 Hz), 121.3, 116.2, 75.5 (q, J = 28 Hz), 47.5, 21.3 (q, J = 2.37 
Hz). 
19F NMR (470 MHz, CDCl3) δ: -70.7 (d, J = 6.97 Hz). 
HRMS (ESI + H, m/z) for C15H14F3NO: calcd. = 282.1100; found = 282.1008. 
FTIR (neat): 3161, 2923, 2853, 1500, 1378, 1271, 1152, 1129, 1112, 1098, 937, 834 cm-
1. 
HPLC: (Chiralcel column AD-H, Hexane:2-PrOH = 97:3, 1.0 mL/min, 210 nm) ee = 95%.  
[𝜶]𝑫
𝟐𝟒 = -11.8 (c = 1.0, CHCl3).  














1,1-Disubstituted allene 2.6p (58 mg, 0.4 mmol) was subjected to general procedure K. 
Upon flash column chromatography (SiO2, 4:96 EtOAc/hexanes), the title compound 2.8p 
(37 mg, 0.15 mmol, 12:1 dr) was obtained as a yellow oil in 76% yield. 
 
Rf = 0.41 (9:1 hexanes : EtOAc) 
1H NMR (500 MHz, CDCl3) δ: 7.37 (m, 4H), 7.27 (m, 1H), 6.23 (dd, J = 10.6, 18.0 Hz, 
1H), 5.47 (d, J = 10.6 Hz, 1H), 5.17 (d, J = 18.0 Hz, 1H), 4.49 (dq, J = 7.1, 7.1 Hz, 
1H), 2.20 (d, J = 7.1 Hz, 1H, OH), 2.04 (m, 2H), 0.68 (t, J = 7.5 Hz, 3H). 
13C NMR (125 MHz, CDCl3) δ: 140.6, 138.8, 128.4, 128.2, 126.9, 125.2 (q, J = 279 Hz), 
117.6, 74.2 (q, J = 31 Hz), 51.9, 28.3, 8.6. 
19F NMR (470 MHz, CDCl3) δ: -70.4 (d, J = 7.1 Hz). 
HRMS (CI+, m/z) for C13H15OF3: calcd. = 244.1075; found = 244.1071. 
FTIR (neat): 3473, 2980, 2367, 1497, 1447, 1271, 1155, 1121, 1088, 926, 752, 701 cm-1. 
HPLC: (Chiralcel column OJ-H, Hexane:2-PrOH = 95:5, 1.0 mL/min, 210 nm) ee = 93%. 
[𝜶]𝑫














1,1-Disubstituted allene 2.6q (121 mg, 0.4 mmol) was subjected to general procedure K. 
Upon flash column chromatography (SiO2, 3:97 EtOAc/hexanes), the title compound 2.8q 
(46.3 mg, 0.12 mmol, 20:1 dr) was obtained as a yellow oil in 58% yield. Note: HPLC 
traces were run on the silyl deprotected material. 
 
Rf = 0.44 (9:1 hexanes : EtOAc) 
1H NMR (500 MHz, CDCl3) δ: 7.32 (dd, J = 7.3, 7.3 Hz, 2H), 7.25 (m, 3H), 6.21 (dd, J = 
10.9, 17.0 Hz, 1H), 5.41 (d, J = 10.9 Hz, 1H), 5.27 (d, J = 17.0 Hz, 1H), 4.79 (d, J = 
8.5 Hz, 1H), 4.75 (d, J = 9.5 Hz, 1H), 4.63 (dq, J = 7.8, 8.5 Hz, 1H), 4.23 (d, J = 9.5 
Hz, 1H), 1.14 (m, 3H), 1.06 (d, J = 6.8 Hz, 18H). 
13C NMR (125 MHz, CDCl3) δ: 140.6, 139.5, 128.3, 127.5, 127.3, 125.6 (q, J = 286 Hz), 
117.1, 75.8 (q, J = 23 Hz), 69.2 (q, J = 2 Hz), 50.1, 18.0, 11.9. 
19F NMR (470 MHz, CDCl3) δ: -71.2 (d, J = 8.0 Hz). 
HRMS (ESI+Na, m/z) for C21H33F3O2Si: calcd. = 425.2094; found = 425.2091. 
FTIR (neat): 3421, 2944, 2867, 2361, 1464, 1386, 1262, 1173, 1092, 882, 768 cm-1. 
HPLC: (Chiralcel column AD-H, Hexane:2-PrOH = 92:8, 1.0 mL/min, 210 nm) ee = 99%. 
[𝜶]𝑫













1,1-Disubstituted allene 2.6r (132 mg, 0.4 mmol) was subjected to general procedure K. 
Upon flash column chromatography (SiO2, 3:97 EtOAc/hexanes), the title compound 2.8r 
(72.2 mg, 0.17 mmol, 10:1 dr) was obtained as a yellow oil in 84% yield. Note: HPLC 
traces were run on the silyl deprotected material. 
 
Rf = 0.47 (9:1 hexanes : EtOAc) 
1H NMR (500 MHz, CDCl3) δ: 7.40-7.33 (m, 4H), 7.26 (m, 1H), 6.24 (dd, J = 11.6, 18.3 
Hz, 1H), 5.46 (d, J = 11.6 Hz, 1H), 5.23 (d, J = 18.3 Hz, 1H), 4.47 (dq, J = 7.0, 7.0 Hz, 
1H), 3.59 (m, 2H), 2.34 (d, J = 7.0 Hz, 1H, OH), 2.17-2.02 (m, 2H), 1.32 (m, 1H), 1.23 
(m, 1H), 1.07-1.01 (m, 21H). 
13C NMR (125 MHz, CDCl3) δ: 140.9, 138.7, 128.4, 128.1, 126.9, 125.2 (q, J = 285 Hz), 
117.5, 74.8 (q, J = 29 Hz), 63.4, 51.2, 31.8, 27.6, 18.0, 11.9. 
19F NMR (470 MHz, CDCl3) δ: -70.4 (d, J = 7.0 Hz). 
HRMS (ESI+H, m/z) for C23H37F3O2Si: calcd. = 431.2588; found = 431.2580. 
FTIR (neat): 3438, 2943, 2866, 1497, 1463, 1274, 1163, 1115, 1033, 921, 883, 701 cm-1. 
HPLC: (Chiralcel column AD-H, Hexane:2-PrOH = 92:8, 1.0 mL/min, 210 nm) ee = 95%. 
[𝜶]𝑫














1,1-Disubstituted allene 2.6s (121 mg, 0.4 mmol) was subjected to general procedure K. 
Upon flash column chromatography (SiO2, 15:85 EtOAc/hexanes), the title compound 2.8s 
(65.0 mg, 0.16 mmol, 15:1 dr) was obtained as a white solid in 81% yield. 
 
Rf = 0.37 (75:25 hexanes : EtOAc) 
1H NMR (500 MHz, CDCl3) δ: 7.75 (m, 2H), 7.64 (m, 2H), 7.28-7.16 (m, 5H), 6.16 (dd, 
J = 11.2, 18.2 Hz, 1H), 5.40 (d, J = 11.2 Hz, 1H), 5.09 (d, J = 18.2 Hz, 1H), 4.39 (dq, 
J = 7.2 Hz, 1H), 3.52 (t, J = 7.30 Hz, 2H), 2.33 (d, J = 7.3 Hz, 1H, OH), 1.98 (dd, J = 
8.2, 9.8 Hz, 2H), 1.40 (m, 1H), 1.34 (m, 1H). 
13C NMR (125 MHz, CDCl3) δ: 168.5, 140.4, 138.6, 134.1, 132.1, 128.6, 128.0, 127.2, 
125.2 (q, J = 293 Hz), 123.3, 117.8, 74.5 (q, J = 28 Hz), 51.3, 38.2, 32.8, 23.6. 
19F NMR (470 MHz, CDCl3) δ: -70.5 (d, J = 6.8 Hz). 
HRMS (ESI+Na, m/z) for C22H20F3NO3: calcd. = 426.1287; found = 426.1284. 
FTIR (neat): 3463, 2939, 2363, 1705, 1439, 1398, 1272, 1156, 1122, 757, 721, 702 cm-1. 
HPLC: (Chiralcel column AD-H, Hexane:2-PrOH = 88:12, 1.0 mL/min, 210 nm) ee = 
93%. 
[𝜶]𝑫
𝟐𝟒= -4.5 (c = 1.0, CHCl3). 













1,1-Disubstituted allene 2.6t (95 mg, 0.4 mmol) was subjected to general procedure K. 
Upon flash column chromatography (SiO2, 3:97 EtOAc/hexanes), the title compound 2.8t 
(48.6 mg, 14 mmol, 11:1 dr) was obtained as a yellow oil in 72% yield. 
 
Rf =0.46 (9:1 hexanes : EtOAc) 
1H NMR (500 MHz, CDCl3) δ: 7.44-7.39 (m, 4H), 7.31 (t, J = 8.0 Hz, 1H), 7.00 (dd, J = 
5.8, 8.4 Hz, 2H), 6.92 (dd, J = 8.4, 8.4 Hz, 2H), 6.30 (dd, J = 11.3, 18.3 Hz, 1H), 5.53 
(d, J = 11.3 Hz, 1H), 5.23 (d, J = 18.3 Hz, 1H), 4.56 (dq, J = 7.2, 7.2 Hz, 1H), 2.34-
2.22 (m, 5H). 
13C NMR (125 MHz, CDCl3) δ: 161.3 (d, J = 245 Hz), 140.5, 138.7, 137.6 (d, J = 3 Hz), 
129.5 (d, J = 8 Hz), 128.6, 128.0, 127.2, 125.1 (q, J = 282 Hz), 117.9, 115.1 (d, J = 22 
Hz), 74.3 (q, J = 29 Hz),  51.6, 38.2, 29.7. 
19F NMR (470 MHz, CDCl3) δ: -70.4 (d, J = 7.2 Hz), -117.5 (tt, J = 5.5, 8.2 Hz). 
HRMS (CI+, m/z) for C19H18OF4: calcd. = 338.1294; found = 338.1297. 
FTIR (neat): 3459, 2993, 2363, 1496, 1416, 1271, 1156, 1122, 1018, 926, 762, 701 cm-1. 
HPLC: (Chiralcel column OJ-H, Hexane:2-PrOH = 95:5, 1.0 mL/min, 210 nm) ee = 96%. 
[𝜶]𝑫











Ethyl (R)-5-phenyl-5-((S)-2,2,2-trifluoro-1-hydroxyethyl)hept-6-enoate (2.8u) 
 
1,1-Disubstituted allene 2.6u (92 mg, 0.4 mmol) was subjected to general procedure K. 
Upon flash column chromatography (SiO2, 8:92 EtOAc/hexanes), the title compound 2.8u 
(42.9 mg, 0.13 mmol, 9:1 dr) was obtained as a yellow oil in 65% yield. 
 
Rf = 0.21 (85:15 hexanes : EtOAc) 
1H NMR (500 MHz, CDCl3) δ: 7.36 (m, 4H), 7.27 (m, 1H), 6.23 (dd, J = 11.3, 18.2 Hz, 
1H), 5.48 (d, J = 11.3 Hz, 1H), 5.21 (d, J = 18.2 Hz, 1H), 4.48 (dq, J = 7.3 Hz, 1H), 
4.10 (q, J = 7.1 Hz, 2H), 2.40 (d, J = 7.3 Hz, 1H, OH), 2.23 (m, 2H), 2.00 (m, 2H), 1.41 
(m, 1H), 1.32 (m, 1H), 1.23 (t, J = 7.1 Hz, 3H). 
13C NMR (125 MHz, CDCl3) δ: 173.4, 140.5, 138.6, 128.5, 128.0, 127.1, 125.1 (q, J = 282 
Hz), 117.5, 74.5 (q, J = 29 Hz), 60.4, 51.3, 35.0, 34.3, 19.6, 14.2. 
19F NMR (470 MHz, CDCl3) δ: -70.4 (d, J = 7.3 Hz). 
HRMS (ESI+Na, m/z) for C17H21F3O3: calcd. = 353.1335; found = 353.1336. 
FTIR (neat): 3437, 2981, 2947, 1731, 1600, 1448, 1264, 1156, 1121, 702 cm-1. 
HPLC: (Chiralcel column OJ-H, Hexane:2-PrOH = 97:3, 1.0 mL/min, 210 nm) ee = 96%. 
[𝜶]𝑫












2.5.4.4 Procedures and Spectral Data for the Elaboration of Adduct 2.8a 
(2S,3R)-1,1,1-trifluoro-3-methyl-3-phenylpent-4-en-2-yl methanesulfonate (2.21a) 
 
To a stirred solution of alcohol 2.8a (236 mg, 1.03 mmol) in CH2Cl2 (10 mL) was added 
triethylamine (0.20 mL, 1.55 mmol) followed by methanesulfonyl chloride (0.096 mL, 1.23 
mmol). The reaction mixture was stirred for 14 hours at room temperature. Saturated 
aqueous ammonium chloride (10 mL) was added and the phases were separated. The 
organic phase was washed with water (2 x 10 mL). The combined aqueous phases were 
washed with CH2Cl2 (2 x 10 mL). The combined organic phases were washed with brine, 
dried (MgSO4), filtered and the solvent removed in vacuo. The residue was subjected to 
flash column chromatography (SiO2, 96:4 hexanes:ethyl acetate) to afford the title 
compound 2.21a (276 mg, 0.89 mmol) as a colorless oil in 87% yield. Note: the starting 
material and product have identical Rf values so TLC is not an appropriate method for 
determining reaction completion. 
 
Rf = 0.41 (9:1 hexanes:EtOAc) 
1H NMR (500 MHz, CDCl3) δ: 7.41 (d, J = 8.9 Hz, 2H), 7.37 (dd, J = 8.9, 8.9 Hz, 2H), 
7.28 (t, J = 8.9 Hz, 1H), 6.42 (dd, J = 10.8, 17.4 Hz, 1H), 5.42 (d, J = 10.8 Hz, 1H), 
5.33 (q, J = 6.9 Hz, 1H), 5.25 (d, J = 17.4 Hz, 1H), 2.53 (s, 3H), 1.63 (s, 3H). 
13C NMR (125 MHz, CDCl3) δ: 143.2, 139.1, 128.8, 127.6, 127.0, 123.3 (q, J = 284 Hz), 
116.6, 82.8 (q, J = 30 Hz), 46.7, 38.9, 20.9. 
19F NMR (470 MHz, CDCl3) δ: -68.6 (d, J = 6.9 Hz). 
HRMS (ESI+Na, m/z) for C13H15F3O3S: calcd. = 331.0586; found = 331.0589. 
FTIR (neat): 2982, 1497, 1361, 1275, 1176, 1016, 964, 793 cm-1. 
[𝜶]𝑫








To a stirred flask containing mesylate 2.21a (154 mg, 0.5 mmol) in CH2Cl2 (10 mL) was 
added MeOH (1 mL) and the reaction mixture was cooled to -78 °C. Ozone was bubbled 
through the solution until the solution turned blue (~5 mins). N2 was bubbled through the 
solution to remove the excess ozone. NaBH4 (85 mg, 2.5 mmol) was added and the reaction 
mixture was allowed to warm to room temperature and stirred for 14 hours. Saturated 
aqueous ammonium chloride (5 mL) was added and the phases were separated. The 
aqueous phase was washed with CH2Cl2 (2 x 5 mL). The combined organic phases were 
washed with brine, dried (MgSO4), filtered and the solvent removed in vacuo. The residue 
was subjected to flash column chromatography (SiO2, 75:25 hexanes:ethyl acetate) to 
afford the title compound 2.22a (136 mg, 0.44 mmol) as a colorless oil in 87% yield. 
 
Rf = 0.23 (80:20 hexanes:EtOAc) 
1H NMR (500 MHz, CDCl3) δ: 7.49 (d, J = 7.8 Hz, 2H), 7.39 (dd, J = 7.7, 8.4 Hz, 2H), 
7.32 (t, J = 7.7 Hz, 1H), 5.61 (q, J =7.4 Hz, 1H), 3.95 (dd, J = 6.1, 11.5 Hz, 1H), 3.60 
(dd, J = 7.1. 11.5 Hz, 1H), 3.17 (s, 3H), 1.96 (t, J = 6.5 Hz, 1H, OH), 1.50 (q, J = 1.2 
Hz, 3H). 
13C NMR (125 MHz, CDCl3) δ: 139.5, 128.7, 127.7, 126.7, 123.5 (q, J = 286 Hz), 79.6 (q, 
J = 29 Hz), 68.9, 45.0, 39.2, 15.9. 
19F NMR (470 MHz, CDCl3) δ: -68.1 (d, J = 7.4 Hz). 
  
 347 
HRMS (ESI+Na, m/z) for C12H15F3O4S: calcd. = 335.0535; found = 335.0532 
FTIR (neat): 3539, 2940, 1498, 1357, 1272, 1176, 1051, 1011, 963, 830, 699 cm-1. 
[𝜶]𝑫








To a stirred solution of mesylate 2.22a (130 mg, 0.42 mmol) in THF (4.2 mL) in a pressure 
tube was added NaH (25 mg, 0.63 mmol, 60% w/w in mineral oil). The reaction mixture 
was heated to 70 °C for 14 hrs. Water (2 mL) was added followed by Et2O (3 mL) and the 
phases were separated. The organic phase was washed with water (2 x 2 mL) and the 
combined aqueous phases were washed with Et2O (2 x 3 mL). The combined organic 
phases were washed with brine, dried (MgSO4), filtered and the solvent removed in vacuo. 
The residue was subjected to flash column chromatography (SiO2, 94:6 hexanes:ethyl 
acetate) to afford the title compound 2.9a (69 mg, 0.32 mmol) as a colorless oil in 76% 
yield. 
 
Rf = 0.49 (90:10 hexanes:EtOAc) 
1H NMR (500 MHz, CDCl3) δ: 7.40 (t, J = 8.0 Hz, 2H), 7.29 (t, J = 8.0 Hz, 1H), 7.22 (d, 
J = 8.0 Hz, 2H), 5.08 (q, J = 7.6 Hz, 1H), 5.03 (d, J = 5.3 Hz, 1H), 4.71 (d, J = 5.3 Hz, 
1H), 1.67 (q, J = 1.5 Hz, 3H). 
13C NMR (125 MHz, CDCl3) δ: 145.8, 129.0, 127.0, 124.9, 123.9 (q, J = 282 Hz), 85.4 (q, 
J = 32 Hz), 82.2, 45.6, 23.7 (q, J = 2.3 Hz). 
19F NMR (470 MHz, CDCl3) δ: -74.9 (qd, J = 1.5, 7.6 Hz). 
HRMS (CI+, m/z) for C11H12OF3: calcd. = 217.0840; found = 217.0842. 
FTIR (neat): 2974, 2894, 1498, 1392, 1291, 1153, 1128, 1038, 913, 763, 700 cm-1. 
[𝜶]𝑫







To a stirred flask containing fluoral adduct 2.8a (94 mg, 0.41 mmol) in CH2Cl2 (8 mL) was 
added MeOH (1 mL) and the reaction mixture cooled to -78 °C. Ozone was bubbled 
through the solution until the solution turned blue (~5 mins). N2 was bubbled through the 
solution to remove the excess ozone. NaBH4 (78 mg, 2.04 mmol) was added and the 
reaction mixture was allowed to warm to room temperature and stirred for 3 hours. 
Aqueous 1N HCl (5 mL) and EtOAc (20 mL) were added and the phases were separated. 
The aqueous phase was washed with EtOAc (2 x 5 mL). The combined organic phases 
were washed with brine, dried (MgSO4), filtered and the solvent removed in vacuo. The 
residue was subjected to flash column chromatography (SiO2, 75:25 hexanes:ethyl acetate) 
to afford the title compound 2.23a (79 mg, 0.34 mmol) as a colorless oil in 84% yield. 
 
Rf = 0.23 (70:30 hexanes:EtOAc) 
1H NMR (500 MHz, CDCl3) δ: 7.44 (d, J = 7.7 Hz, 2H), 7.38 (dd, J = 7.7, 7.7 Hz, 2H), 
7.29 (t, J = 7.7 Hz, 1H), 4.61 (q, J = 6.5 Hz, 1H), 3.93 (d, J = 11.1 Hz, 1H), 3.90 (d, J 
=11.1 Hz, 1H), 3.75 (br d, J = 4.0 Hz, 1H, OH), 2.22 (br s, 1H, OH), 1.47 (q, J = 1.4 
Hz, 3H). 
13C NMR (125 MHz, CDCl3) δ: 141.6, 128.7, 127.2, 126.3, 125.2 (q, J = 284 Hz), 75.5 (q, 
J = 28 Hz), 70.5, 44.8, 16.8. 
19F NMR (470 MHz, CDCl3) δ: -71.42 (d, J = 6.7 Hz). 
HRMS (EI+, m/z) for C11H13O2F3: calcd. = 234.0868; found = 234.0872. 
FTIR (neat): 3365, 29991, 1499, 1266, 1166, 1107, 1027, 700 cm-1. 
[𝜶]𝑫








To a stirred solution of diol 2.23a (76 mg, 0.32 mmol) in 2,6-lutidine (0.6 mL, 0.5 M) was 
added TsCl (124 mg, 0.65 mmol) and the reaction mixture was stirred for 14 hours at room 
temperature. EtOAc (10 mL) and aqueous 1N HCl (10 mL) were added and the phases 
separated. The organic phase was washed with aqueous 1N HCl (10 mL). The combined 
aqueous phases were washed with EtOAc (2 x 10 mL). The combined organic phases were 
washed with brine, dried (MgSO4), filtered and the solvent removed in vacuo. The residue 
was subjected to flash column chromatography (SiO2, 80:20 hexanes:EtOAc) to afford the 
title compound 2.10a (93 mg, 0.24 mmol) as a white solid in 75% yield. 
 
Rf = 0.34 (70:30 hexanes:EtOAc) 
1H NMR (500 MHz, CDCl3) δ: 7.64 (d, J = 8.5 Hz, 2H), 7.30-7.22 (m, 7H), 4.52 (dq, J = 
6.9 Hz, 6.9 Hz, 1H), 4.41 (d, J = 9.5 Hz, 1H), 3.88 (d, J = 9.5 Hz, 1H), 2.91 (d, J = 6.9 
Hz, 1H, OH), 2.41 (s, 3H), 1.43 (s, 3H). 
13C NMR (125 MHz, CDCl3) δ: 145.1, 139.6, 132.2, 129.9, 128.4, 127.9, 127.4, 126.6, 
124.9 (q, J = 285 Hz), 74.6 (q, J = 1 Hz), 72.6 (q, J = 29 Hz), 44.2, 21.7, 16.0 (q, J = 2 
Hz). 
19F NMR (470 MHz, CDCl3) δ: -70.6 (d, J = 6.9 Hz). 
HRMS (ESI+Na, m/z) for C18H19F3N4S: calcd. = 411.0848; found = 411.0848 
FTIR (neat): 3504, 3044, 1599, 1355, 1172, 977, 812 cm-1. 
[𝜶]𝑫
𝟐𝟒= -4 (c = 1.0, CHCl3). 







To a stirred solution of tosyl protected alcohol 2.10a (71 mg, 0.18 mmol) in THF (1 mL) 
in a pressure tube was added NaH (11 mg, 0.27 mmol, 60% w/w in mineral oil). The 
reaction mixture was heated to 25 °C for 14 hrs. Water (2 mL) was added followed by Et2O 
(3 mL) and the phases were separated. The organic phase was washed with water (2 x 2 
mL) and the combined aqueous phases were washed with Et2O (2 x 3 mL). The combined 
organic phases were washed with brine, dried (MgSO4), filtered and the solvent removed 
in vacuo. The residue was subjected to flash column chromatography (SiO2, 93:7 
hexanes:ethyl acetate) to afford the title compound 2.9a (27 mg, 0.12 mmol) as a colorless 
oil in 68% yield. 
 
The data collected on this sample was in total agreement with the data collected above 





(2S,3R)-1,1,1-trifluoro-3-methyl-4-oxo-3-phenylbutan-2-yl methanesulfonate (2.24a) 
 
A stirred flask containing mesylate 2.21a (154 mg, 0.5 mmol) in CH2Cl2 (10 mL) was 
cooled to -78 °C. Ozone was bubbled through the solution until the solution turned blue 
(~5 mins). N2 was bubbled through the solution to remove the excess ozone. PPh3 (197 mg, 
0.75 mmol) was added and the reaction mixture was allowed to warm to room temperature 
and stirred for 4 hours. The solvent was removed in vacuo. The residue was subjected to 
flash column chromatography (SiO2, 85:15 hexanes:EtOAc) to afford the title compound 
2.24a (142 mg, 0.46 mmol) as a light yellow solid in 92% yield. 
 
Rf = 0.18 (85:15 hexanes:EtOAc) 
1H NMR (500 MHz, CDCl3) δ: 9.34 (s, 1H), 7.44 (dd, J = 8.1, 8.1 Hz, 2H), 7.39 (t, J = 8.1 
Hz, 1H), 7.32 (d, J = 8.1 Hz, 2H), 5.76 (q, J = 6.5 Hz, 1H), 3.11 (s, 3H), 1.77 (s, 3H). 
13C NMR (125 MHz, CDCl3) δ: 196.4, 132.4, 129.5, 129.2, 128.0, 123.2 (q, J = 282 Hz), 
77.8 (q, J = 29.9 Hz), 55.4, 39.6, 13.9. 
19F NMR (470 MHz, CDCl3) δ: -68.7 (d, J = 6.5 Hz). 
HRMS (ESI+Na, m/z) for C12H13F3O4S: calcd. = 333.0379; found = 333.0378 
FTIR (neat): 3041, 1727, 1497, 1360, 1270, 1179, 1021, 966, 830 cm-1. 
[𝜶]𝑫
𝟐𝟒= +46 (c = 0.3, CHCl3). 









To a stirred solution of aldehyde 2.24a (83 mg, 0.26 mmol) in toluene (0.8 mL) was added 
AcOH (0.015 mL, 0.26 mmol) followed by benzyl amine (0.057 mL, 0.52 mmol) and 4 Å 
molecular sieves (80 mg). The reaction mixture was heated to 60 °C for 1 hour. The 
reaction mixture was cooled to 0 °C and NaBH3CN (25 mg, 0.42 mmol) was added in a 
single portion. The reaction mixture was stirred at 25 °C for 3 hours. Saturated aqueous 
NaHCO3 (2 mL) was added followed by EtOAc (3 mL) and the phases were separated. The 
organic phase was washed with water (2 x 2mL) and the combined aqueous phases were 
washed with EtOAc (2 x 2 mL). The combined organic phases were washed with brine, 
dried (MgSO4), filtered and the solvent removed in vacuo. The residue was subjected to 
flash column chromatography (SiO2, 88:12 hexanes:EtOAc) to afford the title compound  
2.25a (79 mg, 0.20 mmol) as a light yellow oil in 76% yield. 
 
Rf = 0.26 (85:15 hexanes:EtOAc) 
1H NMR (500 MHz, CDCl3) δ: 7.36 (d, J = 8.0 Hz, 2H), 7.35 (dd, J = 8.0, 8.0 Hz, 2H), 
7.27 (m, 3H, 7.22 (m, 3H), 5.59 (q, J = 6.5 Hz, 1H), 3.72 (d, J = 12.2 Hz, 1H), 3.66 (d, 
J = 12.2 Hz, 1H), 3.11 (d, J = 12.2 Hz, 1H), 3.09 (s, 3H), 2.78 (d, J = 12.2 Hz, 1H), 
1.58 (s, 3H). 
13C NMR (125 MHz, CDCl3) δ: 140.2, 140.1, 128.6, 128.3, 128.1, 127.3, 126.9, 126.7, 
123.5 (q, J = 284 Hz), 81.3 (q, J = 29 Hz), 57.0, 54.1, 44.3, 39.3, 17.7. 
19F NMR (470 MHz, CDCl3) δ: -67.8 (d, J = 6.5 Hz). 
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HRMS (ESI+H, m/z) for C19H22F3NO3S: calcd. = 402.1345; found = 402.1343 
FTIR (neat): 3736, 3030, 2924, 1449, 1361, 1179, 963, 832, 699 cm-1. 
[𝜶]𝑫







To a stirred solution of amine 2.25a (40 mg, 0.1 mmol) in m-xylenes (0.5 mL) in a sealable 
tube was added K2CO3 (28 mg, 0.2 mmol). The reaction mixture was heated to 140 °C for 
20 hours in a microwave reactor. The reaction mixture was cooled to 25 °C, filtered and 
the solvent removed in vacuo. The residue was subjected to flash column chromatography 
(SiO2, 95:5 hexanes:EtOAc) to afford the title compound 2.11a (13.5 mg, 0.045 mmol) as 
a colorless oil in 45% yield along with recovered starting material (12.8 mg, 0.032 mmol). 
 
Rf = 0.48 (90:10 hexanes:EtOAc) 
1H NMR (500 MHz, CDCl3) δ: 7.55 (d, J = 7.2 Hz, 2H), 7.39-7.25 (m, 8H), 4.07 (d, J = 
14.0 Hz, 1H), 3.90 (d, J = 7.0 Hz, 1H), 3.68 (q, J = 7.3 Hz, 1H), 3.61 (d, J = 14.0 Hz, 
1H), 2.98 (d, J = 7.0 Hz, 1H), 1.63 (s, 3H). 
13C NMR (125 MHz, CDCl3) δ: 140.6, 136.8, 128.8, 128.4, 127.9, 127.4, 127.3, 126.9, 
124.4 (q, J = 280 Hz), 73.2 (q, J = 29 Hz), 63.3, 61.3, 40.8, 28.1. 
19F NMR (470 MHz, CDCl3) δ: -70.6 (d, J = 7.3 Hz). 
HRMS (ESI+H, m/z) for C18H18F3N: calcd. = 306.1464; found = 306.1465 
FTIR (neat): 3029, 2927, 2851, 1497, 1294, 1127, 1030, 697 cm-1. 
[𝜶]𝑫







2.5.4.5 Isotopic Labeling Studies 
(2S,3R)-1,1,1-trifluoro-3-(methyl-d3)-3-phenylpent-4-en-2-ol (deuterio-2.8a) 
 
1,1-Disubstituted allene Deuterio-1a (52 mg, 0.4 mmol) was subjected to general 
procedure K. Upon flash column chromatography (SiO2, 4:96 EtOAc:hexanes), the title 
compounds 3a (33.2 mg, 0.14 mmol, 17:1 dr) was obtained as a yellow oil in 71% yield.  
 
Rf = 0.41 (90:10 hexanes : EtOAc) 
1H NMR (500 MHz, C6D6) δ: 7.12-6.98 (m, 5H), 6.25 (dd, J = 10.5, 14.5 Hz, 1H), 5.06 (d, 
J = 10.5 Hz, 1H), 4.91 (d, J = 14.5 Hz, 1H), 3.88 (dq, J = 7 Hz, 1H), 1.53 (d, J = 7 Hz, 
1H, OH). 
19F NMR (470 MHz, C6D6) δ: -70.5 (d, J = 7 Hz) 







1,1-Disubstituted allene 2.6a (52 mg, 0.4 mmol) was subjected to general procedure K 
using d8-2-PrOH. Upon flash column chromatography (SiO2, 4:96 EtOAc:hexanes), the 
title compound 2.8a’ (35.0 mg, 0.16 mmol, 17:1 dr) was obtained as a yellow oil in 75% 
yield.  
 
1H NMR (500 MHz, CDCl3) δ: 7.40-7.34 (m, 4H), 7.26 (m, 1H), 6.39 (dd, J = 11.1, 17.8 
Hz, 1H), 5.36 (d, J = 11.1 Hz, 1H), 5.20 (d, J = 17.8 Hz, 1H), 4.39 (dq, J = 6.0, 7.9 Hz, 
1H), 2.19 (d, J = 6.0 Hz, 1H, OH), 1.57 (s, 3H). 
19F NMR (470 MHz, CDCl3) δ: -70.73 (d, J = 7.9 Hz, non-deuterated), -70.75 (d, J = 7.9 
Hz, deuterated). 
HRMS (CI, m/z) for C12H11DOF3: calcd. = 230.0903; found = 230.0933. 
 








2.5.4.6 Crystallographic Material for Coupling Product 2.8d (3,5-Dinitrobenzoate 
Derivative) 
Single Crystal Diffraction Data for Coupling Product 2.8d 
 
Empirical formula  C19 H14 Br F3 N2 O6 
Formula weight  503.23 
Temperature  100(2) K 
Wavelength  0.71073 Å 
Crystal system  monoclinic 
Space group  P 21 
  Unit cell dimensions a = 11.4648(11) Å = 90°. 
 b = 7.4731(7) Å = 94.863(4)°. 
 c = 11.5835(11) Å = 90°. 
Volume 988.87(16) Å3 
Z 2 
Density (calculated) 1.690 Mg/m3 
Absorption coefficient 2.147 mm-1 
F(000) 504 
Crystal size 0.34 x 0.22 x 0.18 mm3 
Theta range for data collection 2.400 to 30.525°. 
Index ranges -16<=h<=16, -10<=k<=10, -16<=l<=16 
Reflections collected 30981 
Independent reflections 5960 [R(int) = 0.0407] 
Completeness to theta = 25.242° 99.8 %  
Absorption correction Numerical 
Max. and min. transmission 0.7386 and 0.6021 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 5960 / 1 / 281 
Goodness-of-fit on F2 0.998 
Final R indices [I>2sigma(I)] R1 = 0.0261, wR2 = 0.0524 
R indices (all data) R1 = 0.0324, wR2 = 0.0537 
Absolute structure parameter 0.034(3) 
Extinction coefficient n/a 
Largest diff. peak and hole 0.340 and -0.382 e.Å-3 
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Figure 2.9 Crystal Structure of 2.8d 3,5-Dinitrobenzoate Derivative 
 
View of 2.8d 3,5-dinitrobenzoate derivative showing the atom labeling scheme.  
Displacement ellipsoids are scaled to the 50% probability level. 
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2.5.4.7 Procedure and Spectral Data for Ir-PP-I 
 
A sealed tube equipped with a magnetic stir bar was charged with [Ir(cod)Cl]2 (10 mg, 
0.015 mmol, 100 mol %) and (R)-PhanePhos (17.3 mg, 0.03 mmol, 200 mol %).  The 
mixture was purged with argon and THF (0.6 mL, 0.025 M) was added followed by allyl 
acetate (6.5 L, 0.06 mmol, 400 mol %).  The resulting mixture was stirred at 100  ̊C for 1 
hour.  The reaction mixture was then allowed to cool to ambient temperature.  Upon flash 
column chromatography (SiO2, 30-50% Et2O:pentane), the title catalyst Ir-PP-I (7.8 mg, 
0.009 mmol,) was obtained as a yellow powder in 60% yield. 
 
Rf = 0.45 (1:1 hexanes : EtOAc) 
31P NMR (162 MHz, C6D6) δ: -64.1, -10.3. 






2.5.4.8 Single Crystal Diffraction Data for Ir-PP-I 
Single Crystal Diffraction Data for Ir-PP-I 
 
Empirical formula  C43 H38 Cl3 Ir O2 P2 
Formula weight  947.22 
Temperature  100(2) K 
Wavelength  0.71073 Å 
Crystal system  orthorhombic 
Space group  P 21 21 21 
  Unit cell dimensions a = 12.012(2) Å = 90°. 
 b = 15.314(2) Å = 90°. 
 c = 20.235(3) Å  = 90°. 
Volume 3722.3(10) Å3 
Z 4 
Density (calculated) 1.690 Mg/m3 
Absorption coefficient 3.926 mm-1 
F(000) 1880 
Crystal size 0.170 x 0.060 x 0.050 mm3 
Theta range for data collection 2.013 to 28.380°. 
Index ranges -16<=h<=16, -20<=k<=20, -26<=l<=27 
Reflections collected 77190 
Independent reflections 9295 [R(int) = 0.0796] 
Completeness to theta = 25.242° 99.9 %  
Absorption correction Numerical 
Max. and min. transmission 0.8476 and 0.5258 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 9295 / 306 / 461 
Goodness-of-fit on F2 1.036 
Final R indices [I>2sigma(I)] R1 = 0.0266, wR2 = 0.0571 
R indices (all data) R1 = 0.0319, wR2 = 0.0584 
Absolute structure parameter -0.008(3) 
Extinction coefficient n/a 
Largest diff. peak and hole 1.390 and -0.734 e.Å-3 
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Figure 2.10 Crystal Structure of Ir-PP-I 
 
View of Ir-PP-I showing the atom labeling scheme. Displacement ellipsoids are scaled to 
the 50% probability level. 
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2.5.4.9 Procedures and Spectral Data for the Coupling Products Utilzing Ir-PP-I 
(2S,3R)-1,1,1-trifluoro-3-(4-methoxyphenyl)-3-methylpent-4-en-2-ol (2.8e) 
 
To a dried pressure tube under an argon atmosphere charged with Ir-PP-I (8.6 mg, 0.01 
mmol, 5 mol%), tetrabutylammonium chloride (56.5 mg, 0.2 mmol, 100 mol%) and dried 
4 Å molecular sieves (90 mg, 300 wt%) was added 1,1-disubstituted allene 2.6e (64.1 mg, 
0.4 mmol, 200 mol%), isopropanol (200 mol%) and tert-butanol (0.2M) followed by fluoral 
hydrate (30.9 mg, 0.2 mmol, 100 mol%). The reaction mixture was allowed to stir for 16 
hours at 100 °C. The solvent was removed in vacuo. Upon flash column chromatography 
(SiO2, 5:95 EtOAc:hexanes), the title compound 2.8e (37.3 mg, 0.14 mmol, 14:1 dr) was 
obtained as a light yellow oil in 72% yield. 
 
The data collected on this sample was in total agreement with the data collected above with 
the use of in situ generated catalyst to form 2.8e. 
 











To a dried pressure tube under an argon atmosphere charged with Ir-PP-I (8.6 mg, 0.01 
mmol, 5 mol%), tetrabutylammonium chloride (56.5 mg, 0.2 mmol, 100 mol%) and dried 
4 Å molecular sieves (90 mg, 300 wt%) was added 1,1-disubstituted allene 2.6p (57.7 mg, 
0.4 mmol, 200 mol%), isopropanol (200 mol%) and tert-butanol (0.2M) followed by fluoral 
hydrate (30.9 mg, 0.2 mmol, 100 mol%). The reaction mixture was allowed to stir for 16 
hours at 100 °C. The solvent was removed in vacuo. Upon flash column chromatography 
(SiO2, 4:96 EtOAc:hexanes), the title compound 2.8p (30.3 mg, 0.12 mmol, 16:1 dr) was 
obtained as a yellow oil in 62% yield. 
 
The data collected on this sample was in total agreement with the data collected above with 
the use of in situ generated catalyst to form 2.8p. 
 












To a dried pressure tube under an argon atmosphere charged with Ir-PP-I (8.6 mg, 0.01 
mmol, 5 mol%) was added diene iso-2.6e (32.0 mg, 0.2 mmol, 100 mol%), methanol (0.2 
mL, 1 M), and acetone (2 mL, 0.1 M). The reaction mixture was allowed to stir for 48 hours 
at 80 °C. The solvent was removed in vacuo. Upon flash column chromatography (SiO2, 
1:5 EtOAc:hexanes), the title compound 2.12 (19.3 mg, 0.10 mmol) was obtained as a clear 
oil in 50% yield. 
 
The data collected on this sample was in total agreement with the literature data collected 
previously with the use of in situ generated catalyst.3c 
 












To a dried pressure tube under an argon atmosphere charged with Ir-PP-I (8.6 mg, 0.01 
mmol, 5 mol%) and tetrabutylammonium iodide (6.4 mg, 0.02 mmol, 10 mol%) was added 
allene 2.1d (42.8 mg, 0.2 mmol, 100 mol%), methanol (0.2 mL, 1 M) and acetone (2 mL, 
0.1 M). The reaction mixture was allowed to stir for 18 hours at 70 °C. The solvent was 
removed in vacuo. Upon flash column chromatography (SiO2, 15:85 EtOAc:hexanes), the 
title compound 2.2d (42.5 mg, 0.17 mmol) was obtained as a clear oil in 86% yield. 
 
The data collected on this sample was in total agreement with the literature data collected 
previously with the use of in situ generated catalyst.22 
 










2.5.4.10 Kinetic Studies 
Standard Conditions: To a dried 10 mL volumetric flask under an argon atmosphere 
charged with [Ir(cod)Cl]2 (16.8 mg, 0.025 mmol, 2.5 mol%), (R)-PhanePhos (28.8 mg, 0.05 
mmol, 5 mol%) and tetrabutylammonium chloride (277.9 mg, 1 mmol, 100 mol%) was 
added 1,1-disubstituted allene (260.4, 2 mmol, 200 mol%), isopropanol (0.15 mL, 2 mmol, 
200 mol%) and fluoral hydrate (154.7 mg, 1 mmol, 100 mol%). The flask was then filled 
to the mark with tert-butanol and sonicated until full dissolution. To a dried pressure tube 
under an argon atmosphere charged with dried 4 Å molecular sieves (46 mg) was added 1 
mL of the reaction mixture and the tube quickly sealed.  Equal number of reaction tubes 
were assembled per time point monitored.  The reaction mixtures were then allowed to stir 
at 100 °C with a tube removed each hour for analysis. 
Reaction progress was monitored by GC analysis. The reaction was cooled to room 
temperature before 20 µL of cyclodecane (internal standard) was added and then the 
mixture diluted with dichloromethane (~4 mL). The mixture was then filtered through a 
small amount of silica gel in a pipette prior to analysis. The concentration of product was 
determined by GC analysis. 
 
Reaction order determined by submitting data to Bures plot analysis.38,39 
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Table 2.5 Further reaction conditions for the kinetic experiments. 
Experiment [cat] (M) [allene] (M) [fluoral] (M) 
[excess] 
[allene]-[fluoral] (M) 
Standard 0.005 0.2 0.1 0.1 
Different excess 1 0.005 0.4 0.1 0.3 
Different excess 2 0.005 0.2 0.2 0.0 
Same excess 0.005 0.3 0.2 0.1 
Increased catalyst 0.01 0.2 0.1 0.1 
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2.5.4.11 HRMS Identification of Catalytic Intermediate 
 




Chapter 3:  Direction Conversion of Primary Alcohols to 1,2-Amino 
Alcohols: Enantioselective Irdium-Catalyzed Carbonyl Reductive 
Coupling of Phthalimido-Allene via Hydrogen Auto-Transfer* 
3.1 INTRODUCTION  
Asymmetric carbonyl addition ranks foremost among methods used for the 
convergent construction of enantiomerically enriched alcohols.1 Data mining of patents 
from the pharmaceutical industry reveals that carbonyl addition (alongside Suzuki 
coupling) remains one of the most frequently utilized methods for C–C bond formation.2 
The vast majority of carbonyl addition reactions rely on the use of preformed carbanions, 
which can be moisture sensitive, unsafe, and often require multi-step preparation and 
cryogenic conditions. Metal-catalyzed carbonyl reductive coupling of π-unsaturated 
pronucleophiles has emerged as an alternative to the use of stoichiometric carbanions.3 
However, many of the terminal reductants utilized in such processes (e.g., Mn, Zn, Et3B, 
Et2Zn) are as problematic as the premetalated reagents they replace. Carbonyl reductive 
coupling via hydrogen auto-transfer does not require an exogenous reductant, as alcohol 
reactants serve dually as reductant and carbonyl proelectrophile.4 
Based on this concept and motivated by the prevalence (>40%) of chiral amines (including 
vicinal amino alcohols) in FDA-approved drugs,5a,b a catalytic enantioselective carbonyl 
(α-amino)allylation was sought.6−8 In 1993, Barrett reported a boron reagent for 
asymmetric carbonyl (α-amino)allylation.7 Remarkably, after more than 25 years, 
corresponding catalytic enantioselective processes have remained elusive, and the only 
 
* This chapter is based on the previously published work: 
Spielmann, K.; Xiang, M.; Schwartz, L. A.; Krische, M. J. Direct Conversion of Primary Alcohols to 1,2-
Amino Alcohols: Enantioselective Iridium-Catalyzed Carbonyl Reductive Coupling of Phthalimido-Allene 
via Hydrogen Auto-Transfer. J. Am. Chem. Soc. 2019, 141, 14136. 
L.A.S. contributed to reaction discovery and optimization (Table 3.1), substrate scope (Tables 3.2A & B), 
kinetic and mechanistic studies (Figures 3.2, 3.2, and 3.7–3.17; Schemes 3.2 and 3.3), and preparation of 
manuscript and supporting information. 
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Figure 3.1 Selected Enantioselective Methods for Convergent Construction of Vicinal 
Amino Alcohols via Classical and Metal-Catalyzed Carbonyl Addition 
 
related catalytic transformation to have appeared is the 2-azadiene-ketone reductive 
coupling reported by Malcolmson.9 Phthalimido-allene 3.1, a tractable crystalline solid 
(mp = 79−81 °C), participates in catalytic enantioselective carbonyl reductive coupling via 
hydrogen autotransfer to deliver vicinal amino alcohols with high levels of regio-, anti-
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diastereo-, and enantiocontrol (Figure 3.1). This represents a rare example of the use of 
allene pronucleophiles in enantioselective carbonyl reductive coupling.10 
 
3.2 REACTION DEVELOPMENT AND SCOPE 
Phthalimido allene 3.1 is readily prepared through base-catalyzed isomerization of 
commercially available N-propargyl phthalimide.11 Guided by seminal findings from the 
Krische laboratory,12 it was posited that hydrogen transfer from primary alcohols to 
allenimide 3.1 would generate transient (phthalimido)allyliridium–aldehyde pairs that 
combine by way of closed six-centered transition structures to furnish anti-vicinal amino 
alcohols. The feasibility of this transformation was rendered uncertain by competing 
conventional transfer hydrogenation of allene 3.1 in response to the steric demand of the 
phthalimide moiety, which may retard the rate of aldehyde addition. An assay of diverse 
chiral ruthenium and iridium complexes was undertaken, and a promising result was 
obtained using the cyclometalated π-allyliridium complex modified by 3-nitrobenzoic acid 
and (R)-SEGPHOS, Ir-I, which delivered the desired amino alcohol 3.3a in 10% yield and 
40% ee with >20:1 anti-diastereoselectivity (Table 3.1). Enantioselectivity improved using 
the more Lewis acidic 4-cyano-3-nitro-C,O-benzoate, Ir-II, but the isolated yield of 3.3a 
remained modest due to low conversion. Similar trends were observed with the 
corresponding catalysts based on (R)-BINAP, Ir-III and Ir-IV, but with a small increase in 
enantioselectivity. A pronounced improvement in both conversion and enantioselectivity 
was observed upon use of Ir-V, which incorporates (R)-H8-BINAP.
13 Use of the (R)-H8-
BINAP iridium complex bound by 3,4-dinitro-C,O-benzoic acid, Ir-VI, provided still 
higher levels of enantioselectivity. Finally, introduction of monobasic potassium phosphate 
led to higher conversion, allowing 3.3a to be formed in 80% yield, 96% ee with complete 
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anti-diastereoselectivity (Table 3.1). As borne out by single-crystal X-ray diffraction 
analysis of Ir-VI, the dihedral angle between the tetralin rings of (R)-H8-BINAP (ca. 86°) 
is significantly larger than the dihedral angle between the naphthalene rings of BINAP (ca. 
75°) or SEGPHOS (ca. 72°),14 which may better accommodate the sterically demanding 
phthalimide moiety to facilitate alkoxide exchange at the metal center. 
Table 3.1 Selected Optimization Experiments in the Enantioselective Iridium-Catalyzed 
(α-Amino)allylation of Phthalimido-Allene 3.1 with Alcohol 3.2aa 
 
Reaction scope was evaluated by applying optimal conditions identified for the (α-
amino)allylation of 2-phenylethanol 3.2a to diverse alcohols 3.2[b−z, a′−c′] (Table 3.2A 
& B). All vicinal amino alcohols 3.3[a−z, a′−c′] were formed in good yield with excellent 
levels of diastereo- and enantioselectivity. The (α-amino)allylations of N-Boc-
ethanolamine 3.2j, N-Boc-propanolamine 3.2k, and trifluorobutanol 3.2m, which are 
commercially available, are significant, as the corresponding aldehydes are not available 
for purchase and are relatively unstable. Modification of the heteroaryl-containing alcohols 
3.2c−i, 3.2t, and 3.2u, which includes perphenazine 3.2g, an FDA approved drug, 
establishes the feasibility of utilizing this method for late-stage functionalization.15 Due to 
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a pronounced kinetic bias for primary alcohol dehydrogenation,16 free secondary hydroxyl 
groups are tolerated, as illustrated in the site-selective formation of (R)-butane diol adducts 
Table 3.2A Diastereo- and Enantioselective Iridium-Catalyzed Hydrohydroxyalkylation 




Table 3.2B Diastereo- and Enantioselective Iridium-Catalyzed Hydrohydroxyalkylation 
of Phthalimido-Allene 3.1 with Alcohols 3.2[q–z, a’–c’] To Form 1,2-
Amino Alcohols 3.3[q–z, a’–c’]a 
 
3.3b′ and 3.3c′, which occur with complete levels of catalyst-directed diastereoselectivity. 
Using this first-generation catalytic system, benzylic alcohols are converted to the amino 
alcohols in high yield but lower enantioselectivities are observed. 
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As demonstrated by the conversion of dehydro-3.2l to amino alcohol 3.3l, the 
reactions can also be conducted from the aldehyde oxidation level using 2-propanol as 
terminal reductant (Scheme 3.1, eq. 1). Given the frequent appearance of morpholines as 
substructures in pharmaceutical ingredients,17 compound 3.3a was converted to the 
morpholine 3.5a (Scheme 3.1, eq. 2).18 To further demonstrate utility of amino alcohols 
3.3[a−z, a′−c′], adduct 3.3m was subjected to alkene oxidative cleavage to provide the 
nonproteinogenic amino acid derivative 3.6m (Scheme 3.1, eq. 3).19 
Scheme 3.1 Reactivity From Aldehyde Oxidation Level and Synthesis of Morpholine 
3.5a and Amino Acid Derivative 3.6m 
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3.3 MECHANISM AND DISCUSSION 
Reaction progress kinetic analysis (RPKA) using the “different excess” protocol 
was used to gain mechanistic insight (Figure 3.2).20 The kinetic order of reactants varied 
over time; therefore, general trends were evaluated. Doubling the initial concentration of 
allene 3.1 slightly decreases the rate of product formation. This data suggests allene 
hydrometalation is rapid, allene 3.1 is not involved in the turnover-limiting step and, at 
higher concentrations, allene 3.1 inhibits the rate of product formation (Figure 3.2, left).  
Figure 3.2 Reaction Progress Kinetic Analysis of the Reductive Coupling of 
Phthalimido-Allene 3.1 and Alcohol 3.2a 
 
Product formation as monitored by 1H NMR analysis in reactions conducted using the 
“different excess” protocol: [Ir] = 0.01 M and [KH2PO4] = 0.2 M, with (left) [3.2a]0 = 0.2 
M, [3.1]0 = as noted and (right) [3.1]0 = 0.3 M, [3.2a]0 = as noted. (Bottom) Product 
formation as monitored by NMR analysis in reactions with varying catalyst loading: [3.1] 
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Doubling the initial concentration of alcohol 3.2a results in a slight increase in the rate of 
product formation, signifying a positive order in alcohol 3.2a (Figure 3.2, right). Increasing 
the loading of iridium catalyst, (R)-Ir-VI, results in a dramatic increase in the rate of 
product formation, demonstrating the reaction is positive order in catalyst (Figure 3.2, 
bottom). Separate experiments using the “same excess” protocol reveal significant catalyst 
deactivation that is contributed to by product inhibition.21 Additionally, introduction of 
aldehyde dehydro-3.2a (10 mol%) inhibits product formation, suggesting carbonyl 
addition may not be turnover limiting.21 
Deuterium labeling studies provide additional information on the reaction 
mechanism (Scheme 3.2, eqs 4−6).22 Exposure of allene 3.1 to deuterio-3.2a under 
standard reaction conditions delivers deuterio-3.3a (Scheme 3.2, eq. 4). Deuterium is 
completely retained at the carbinol position, suggesting deuterio-3.3a is inert with respect 
to dehydrogenation. Incorporation of deuterium at both the internal and terminal vinylic 
positions corroborates reversible allene hydrometalation with incomplete regioselectivity. 
In a competition kinetics experiment, allene 3.1 was exposed to equimolar quantities of 
alcohol 3.2a and deuterio-3.2a (Scheme 3.2, eq. 5). The observed levels of deuterium 
incorporation at the carbinol position of deuterio-3.3a are consistent with a normal primary 
kinetic isotope effect (kH/kD ≈ 2.3). Evaluation of the initial rates for the reaction of both 
3.2a and deuterio-3.2a also reveals a primary kinetic isotope effect (kH/kD ≈ 1.5) (Figure 
3.3). Along with the reaction orders suggested from the RPKA experiments, this kinetic 
isotope effect data was consistent with two scenarios: (1) reversible alcohol 
dehydrogenation followed by rate-determining carbonyl addition, or (2) rate-determining 
alcohol dehydrogenation.22 To determine which of these processes is operative an 
additional experiment was undertaken (Scheme 3.2, eq. 6). When pthalimido-allene 3.1 is 
exposed to equimolar quantities of deuterio-3.2a and dehydro-3.2l under standard 
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conditions, hydrogen–deuterium exchange is not observed at the carbinol position of 
deuterio-3.3a and dehydro-3.3l, suggesting alcohol–aldehyde redox equilibration does not 
occur in advance of carbonyl addition. Hence, the collective data implicate turnover-
limiting alcohol dehydrogenation followed by rapid allene hydrometalation. 
Scheme 3.2 Deuterium Labeling Studies for the Reductive Coupling of Phthalimido-





Figure 3.3 Initial Rates Study for Reductive Coupling of Phthalimido-Allene 3.1 with 
Alcohols 3.2a and deuterio-3.2a 
 
Initial Rates Study: [3.1]0 = 0.3 M; [3.2a]0 or [deuterio-3.2a]0 = 0.2 M; [Ir] = 0.01 M 
 
Based on the kinetic and isotopic labeling studies, the indicated catalytic 
mechanism is proposed (Scheme 3.3). Entry into the catalytic cycle occurs through 
protonolysis of the allyliridium complex (R)-Ir-VI by the reactant alcohol. The resulting 
iridium alkoxide I undergoes irreversible dehydrogenation to form the iridium hydride II, 
which is rapidly consumed by reversible allene hydrometalation. Due to the steric demand 
of the phthalimide moiety, the (Z)-σ-(amino)allyliridium complex IIIa is anticipated to be 
the kinetic product of allene hydrometalation. Isomerization to the thermodynamically 
preferred (E)-σ-allyliridium complex IIIb is followed by aldehyde coordination and 
carbonyl addition through a closed chair-like transition structure to form iridium(III) 
alkoxide IV. Exchange with the primary alcohol reactant releases product and regenerates 
iridium alkoxide I to close the catalytic cycle. 
  
3.2a: y = 0.00021x - 0.00400


































In conclusion, a catalytic method for the direct conversion of primary alcohols to 
vicinal amino alcohols that occurs with high levels of regio-, anti-diastereo-, and 
enantioselectivity has been achieved. This hydrogen auto-transfer process exploits the 
tractable, crystalline phthalimido-allene 3.1 as pronucleophile and represents the first 
protocol for catalytic enantioselective carbonyl (α-amino)allylation. More broadly, this 
work contributes to an evolution from use of traditional carbonyl addition methods that 
exploit preformed carbanions to byproduct-free catalytic carbonyl reductive couplings, 




3.5 EXPERIMENTAL DETAILS 
3.5.1 General Information 
All reactions were run under an atmosphere of argon, unless otherwise indicated. 
Resealable pressure tubes (13x100 mm) were purchased from Fischer Scientific (catalog 
number 14–959–35C) and were flame dried followed by cooling in a desiccator or under a 
stream of argon prior to use. All commercial reagents and anhydrous solvents were used 
as received from vendors (Strem Chemicals, Fischer Scientific, Sigma Aldrich and Combi 
Blocks) without further purification. Preparative column chromatography employing 
Silicycle silica gel (40-63 μm) was performed according to the method of Still.23 Analytical 
thin-layer chromatography (TLC) was carried out using 0.25 mm commercial silica gel 
plates (Dynamic Absorbents F254). Visualization was accomplished with UV light 
followed by dipping in CAM, p-Anisaldehyde (PAA), or KMnO4 stain solution followed 
by heating. Specific optical rotations were recorded on an Atago AP-300 automatic 
polarimeter at the sodium line (589.3 nm) in CHCl3. Solution concentrations are given in 
the units of 10-2 g mL-1. Racemic reactions were conducted using racemic catalyst prepared 
in utilizing racemic BINAP ligand. 
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3.5.2 Spectroscopy, Spectrometry, and Data Collection 
Infrared spectra were recorded on a Perkin-Elmer 1600 spectrometer. High-
resolution mass spectra (HRMS) were obtained on a Karatos MS9 and are reported as m/z 
(relative intensity). Accurate masses are reported for the molecular ion (M+H, M+Na), or 
a suitable fragment ion. Proton nuclear magnetic resonance (1H NMR) spectra were 
recorded with a Varian INOVA (500 MHz) spectrometer equipped with a Bruker 
AVANCE III cryoprobe. Chemical shifts are reported in delta (δ) units, parts per million 
(ppm) downfield from tetramethylsilane or ppm relative to the center of the singlet at 7.26 
ppm for deuteriochloroform. Data reported as multiplicity (s = singlet, d = doublet, t = 
triplet, q = quartet, m = multiplet). Integration and coupling constants were reported in 
Hertz (Hz). Carbon-13 nuclear magnetic resonance (13C NMR) spectra were recorded with 
a Varian INOVA (125 MHz) spectrometer and were routinely run with broadband 
decoupling. Chemical shifts are reported in delta (δ) units, ppm relative to the center of the 
triplet at 77.16 ppm for deuteriochloroform. Fluorine-19 nuclear magnetic resonance (19F 
NMR) spectra were recorded with a Varian INOVA (470 MHz) spectrometer. Deuterium 
nuclear magnetic resonance (2H NMR) spectra were recorded in CHCl3 solution with a 
Varian Gemini 500 (77 MHz) spectrometer (relaxation delay 2.00s). 
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3.5.3 Experimental Details and Spectral Data 
3.5.3.1 Selected Optimization Experiments 
 
 
Entry L* Solvent (M) Temp (C) Yield (%) ee (%) dr 
1 (R)-DTBM-SEGPHOS THF (0.2 M) 100 <10 N/D N/D 
2 (R)-Cl,MeO-BIPHEP THF (0.2 M) 100 42 87 >20:1 
3 (R)-Tol-BINAP THF (0.2 M) 100 31 85 >20:1 
4 (R)-H8-BINAP THF (0.2 M) 100 69 96 >20:1 
5 (R)-H8-BINAP Dioxane (0.2 M) 100 68 94 >20:1 
6 (R)-H8-BINAP PhMe (0.2 M) 100 59 92 >20:1 
7 (R)-H8-BINAP THF (0.5 M) 100 60 94 >20:1 
8 (R)-H8-BINAP THF (0.1 M) 100 37 97 >20:1 
9 (R)-H8-BINAP THF (0.2 M) 90 65 96 >20:1 
10 (R)-H8-BINAP THF (0.2 M) 80 40 96 >20:1 
11a (R)-H8-BINAP THF (0.2 M) 100 71 96 >20:1 
a150 mol% of phthalimido-allene 3.1 and 48 h reaction time 
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3.5.3.2 Synthesis of Ir-V and Ir-VI 
 
To a dried pressure tube with a magnetic stir bar under an argon atmosphere charged with 
Cs2CO3 (586 mg, 1.80 mmol, 225 mol%), the corresponding benzoic acid (1.60 mmol, 200 
mol%), (R)-H8-BINAP (505mg, 0.80 mmol, 100 mol%), and [Ir(cod)Cl]2 (268 mg, 0.40 
mmol, 50 mol%) was added THF (8 mL, 0.1 M) followed by allyl acetate (0.22 mL, 2.0 
mmol, 250 mol%). The resulting mixture was stirred at ambient temperature for 30 min, at 
which point the reaction vessel was transferred to an oil bath at 80 °C. After stirring for 
120 min, the reaction mixture was allowed to cool to ambient temperature. The mixture 
was filtered through a celite plug with the aid of THF. The filtrate was concentrated in 
vacuo and the residue subjected to column chromatography (SiO2, 20:1 DCM:THF). The 
gum-like product was dissolved in a minimum volume of THF and precipitated upon rapid 
addition of hexanes. The product was filtered and washed with hexanes, followed by 
removal of trace amount of solvent in vacuo. 
  
(R)-Ir-V: 4-cyano-3-nitrobenzoic acid (307 mg) was used. The title complex was obtained 
as light yellow powder in 85% yield (716 mg). 
 
(R)-Ir-VI: 3,4-dinitrobenzoic acid (340 mg) was used. The title complex was obtained as 
light yellow powder in 86% yield (736 mg). 
(R)-Ir-V: 
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31P NMR (202 MHz, CDCl3): δ −8.18 (d, J = 20.0 Hz), −11.41 (d, J = 19.9 Hz), −12.40 
(d, J = 21.0 Hz), −12.76 (d, J = 19.7 Hz), −14.37 (d, J = 23.7 Hz), −15.64 (d, J = 23.7 
Hz). 
HRMS (H+, m/z) for C55H47IrN2O4P2: calcd. = 1053.2690; found = 1053.2675. 










31P NMR (202 MHz, CDCl3): δ -8.56 (d, J = 20.7 Hz), -11.87 (d, J = 20.1 Hz), -12.41 (d, 
J = 20.0 Hz), -12.89 (d, J = 19.9 Hz), -14.56 (d, J = 23.7 Hz), -15.61 (d, J = 23.7 Hz). 
HRMS (H+, m/z) for C54H47IrN2O6P2: calcd. = 1073.2588; found = 1073.2579. 





31P NMR (202 MHz, CDCl3) 
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3.5.3.3 Synthesis of Phthalimido-Allene 3.1 
 
Synthesis of N-Propargylphthalimide (3.7) 
 
 
3.7 can also be purchased and used from Combi-Blocks. 
 
To a round-bottomed flask equipped with a magnetic stir bar under an argon atmosphere 
charged with phthalimide (15.2 g, 103 mmol, 100 mol%) and K2CO3 (21.4 g, 155 mmol, 
150 mol%) in CH3CN (250 mL) was added propargyl bromide (80% wt in PhMe, 23.0 g, 
155 mmol, 150 mol%).  The reaction mixture was allowed to stir for 24 hours at reflux.  
The hot reaction mixture was then filtered through a pad of Celite and washed with CH3CN 
(3 x 15 mL).  The mixture was then concentrated under reduced pressure. The residue was 
then solubilized in DCM, resulting in a suspension of starting material which was then 
filtered off through a pad of Celite. The resulting residue was concentrated under reduced 
pressure, dissolved in a minimum volume of DCM, and precipitated upon rapid addition 
of pentane. The product was filtered and washed with pentane, followed by removal of 




1H NMR (500 MHz, CDCl3) : 7.88 (dd, J = 5.4, 3.1 Hz, 2H), 7.74 (dd, J = 5.5, 3.0 Hz, 
2H), 4.45 (d, J = 2.5 Hz, 1H), 2.22 (t, J = 2.5 Hz, 1H). 
13C NMR (125 MHz, CDCl3) : 167.1, 134.4, 132.1, 123.7, 77.3, 71.6, 27.1. 
 










To a round-bottomed flask equipped with a magnetic stir bar under an argon atmosphere 
charged with N-propargylphthalimide 3.7 (9.26 g, 50.0 mmol, 100 mol%) in dried THF 
(50 mL) was added potassium tert-butoxide (1.68 g, 15 mmol, 30 mol%).  The reaction 
mixture was allowed to stir at ambient temperature for 3 hours.  The reaction mixture was 
then filtered through a pad of Celite, washed with THF, and the solvent removed in vacuo.  
The residue was purified by flash column chromatography (SiO2, 0-10% EtOAc in 
hexanes) to give the phthalimido-allene (2.21 g, 11.9 mmol) as a pale green crystalline 
solid in 24% yield. 
 
1H NMR (500 MHz, CDCl3) : 7.85 (dd, J = 5.4, 3.1 Hz, 2H), 7.73 (dd, J = 5.5, 3.0 Hz, 
2H), 6.81 (t, J = 6.7 Hz, 1H), 5.47 (d, J = 6.6 Hz, 1H). 
13C NMR (125 MHz, CDCl3) : 204.5, 165.8, 134.4, 133.1, 123.6, 88.4, 85.6. 
 







3.5.3.4 General Procedure and Spectral Data for the Coupling of Phthalimido-Allene 
and Alcohols 
 
To a dried pressure tube with a magnetic stir bar under an argon atmosphere charged with 
(R)-Ir-VI (10.7 mg, 0.01 mmol) (5 mol%), phthalimido-allene 3.1 (55 mg, 0.3 mmol, 150 
mol%), alcohol (0.2 mmol, 100 mol%), and KH2PO4 (27.2 mg, 0.2 mmol, 100 mol%) was 
added THF (1.0 mL, 0.2 M).  The tube was sealed with a PTFE lined cap and the reaction 
mixture was allowed to stir for 48 hours at 100 C.  After reaching ambient temperature, 
the solvent was removed in vacuo and the residue was subjected to flash column 






Alcohol 3.2a (24.0 µL, 0.2 mmol) was subjected to standard reaction conditions (100 C, 
48 h).  Upon flash column chromatography (SiO2, 20:80 EtOAc:hexanes), the title 
compound 3.3a (48.8 mg, 0.16 mmol, >20:1 dr) was obtained as a light yellow solid in 
80% yield. 
 
TLC (SiO2) Rf = 0.35 (20:80 EtOAc:hexanes) 
1H NMR (500 MHz, CDCl3) : 7.83 (dd, J = 5.4, 3.1 Hz, 2H), 7.73 (dd, J = 5.5, 3.0 Hz, 
2H), 7.28 – 7.15 (m, 5H), 6.34 (ddd, J = 17.1, 10.3, 7.9 Hz, 1H), 5.36 (d, J = 10.7 Hz, 
1H), 5.32 (d, J = 17.1 Hz, 1H), 4.78 – 4.76 (m, 1H), 4.41 (ddd, J = 7.7, 5.8, 4.7 Hz, 
1H), 3.45 (brs, 1H), 2.90 – 2.81 (m, 2H). 
13C NMR (125 MHz, CDCl3) : 168.6, 137.9, 134.4, 131.8, 131.4, 129.4, 128.7, 126.7, 
123.7, 120.4, 73.0, 58.7, 40.9. 
HRMS (Na+, m/z) for C19H17NO3: calcd. = 330.1101; found = 330.1104. 
FTIR (neat): 3549, 1698, 1383, 1334, 1055, 721, 703. 
HPLC: (Chiralcel column OD-H, Hexane:2-PrOH = 95:5, 1.0 mL/min, 230 nm) ee = 96%. 
[𝜶]𝑫
𝟑𝟒 = +56.6° (c = 1.31, CHCl3). 















Alcohol 3.2b (40.2 mg, 0.2 mmol) was subjected to standard reaction conditions (100 C, 
48 h).  Upon flash column chromatography (SiO2, 20:80 EtOAc:hexanes), the title 
compound 3.3b (49.9 mg, 0.13 mmol, >20:1 dr) was obtained as a pale yellow oil in 65% 
yield. 
 
TLC (SiO2) Rf = 0.33 (20:80 EtOAc:hexanes) 
1H NMR (500 MHz, CDCl3) : 7.83 (dd, J = 5.4, 3.1 Hz, 2H), 7.71 (dd, J = 5.5, 3.0 Hz, 
2H), 7.36 (d, J = 8.3 Hz, 2H), 7.08 (d, J = 8.4 Hz, 2H), 6.32 (ddd, J = 17.1, 10.3, 7.9 
Hz, 1H), 5.36 (d, J = 10.7 Hz, 1H), 5.33 (d, J = 17.0 Hz, 1H), 4.75 – 4.72 (m, 1H), 4.39 
– 4.35 (m, 1H), 3.47 (brs, 1H), 2.86 – 2.75 (m, 2H). 
13C NMR (125 MHz, CDCl3) : 168.6, 137.0, 134.5, 131.7, 131.7, 131.3, 131.4, 123.7, 
120.7, 120.6, 72.6, 58.9, 40.3. 
HRMS (H+, m/z) for C19H16BrNO3: calcd. = 386.0386; found = 386.0380. 
FTIR (neat): 3454, 2919, 2359, 1700, 1380, 1070, 717. 
HPLC: (Chiralcel column AS-H, Hexane:2-PrOH = 95:5, 1.0 mL/min, 230 nm) ee = 97%. 
[𝜶]𝑫














Alcohol 3.2c (40.4 mg, 0.2 mmol) was subjected to standard reaction conditions (100 C, 
48 h).  Upon flash column chromatography (SiO2, 20:80 EtOAc:hexanes), the title 
compound 3.3c (47.1 mg, 0.12 mmol, >20:1 dr) was obtained as a light yellow oil in 61% 
yield. 
 
TLC (SiO2) Rf = 0.31 (40:60 EtOAc:hexanes) 
1H NMR (500 MHz, CDCl3) : 7.84 (dd, J = 5.4, 3.1 Hz, 2H), 7.74 (dd, J = 5.5, 3.0 Hz, 
2H), 7.44 (t, J = 7.7 Hz, 1H), 7.31 (d, J = 7.9 Hz, 1H), 7.12 (d, J = 7.5 Hz, 1H), 6.39 
(ddd, J = 17.7, 10.3, 7.7 Hz, 1H), 5.35 – 5.30 (m, 2H), 4.79 (dd, J = 7.9, 5.3 Hz, 1H), 
4.64 (dt, J = 8.1, 4.8 Hz, 1H), 3.01 – 2.93 (m, 2H). 
13C NMR (125 MHz, CDCl3) : 168.5, 160.3, 141.4, 138.9, 134.4, 131.8, 131.7, 126.2, 
123.7, 123.1, 120.2, 71.3, 58.8, 41.4. 
HRMS (H+, m/z) for C18H15BrN2O3: calcd. = 387.0339; found = 387.0334. 
FTIR (neat): 3446, 1704, 1380, 1064, 751, 718. 
HPLC: (Chiralcel column AD-H, Hexane:2-PrOH = 95:5, 1.0 mL/min, 230 nm) ee = 96%. 
[𝜶]𝑫


















Alcohol 3.2d (25.6 mg, 0.2 mmol) was subjected to standard reaction conditions (100 C, 
48 h).  Upon flash column chromatography (SiO2, 20:80 EtOAc:hexanes), the title 
compound 3.3d (42.0 mg, 0.13 mmol, >20:1 dr) was obtained as a white solid in 67% yield. 
 
TLC (SiO2) Rf = 0.28 (20:80 EtOAc:hexanes) 
1H NMR (500 MHz, CDCl3) δ 7.84 (dd, J = 5.3, 3.1 Hz, 2H), 7.74 (dd, J = 5.4, 3.0 Hz, 
2H), 7.15 (d, J = 5.1 Hz, 1H), 6.94 – 6.91 (m, 1H), 6.86 (d, J = 3.1 Hz, 1H), 6.37 – 6.27 
(m, 1H), 5.34 (dd, J = 19.6, 13.7 Hz, 2H), 4.80 (dd, J = 7.8, 4.3 Hz, 1H), 4.43 – 4.32 
(m, 1H), 3.76 (s, 1H), 3.08 (d, J = 6.6 Hz, 2H). 
13C NMR (125 MHz, CDCl3) δ 168.6, 139.8, 134.5, 131.8, 131.0, 127.0, 126.3, 124.5, 
123.7, 120.6, 77.2, 73.1, 58.4, 34.9. 
HRMS (Na+, m/z) for C17H15NO3S: calcd. = 336.0665; found = 336.0667. 
FTIR (neat): 3451, 2360, 2341, 1703, 1381, 1261, 1063, 749. 
HPLC: (Chiralcel column OD-H, Hexane:2-PrOH = 95:5, 1.0 mL/min, 230 nm) ee = 92%. 
[𝜶]𝑫
𝟑𝟒 = +72.3° (c = 0.4, CHCl3). 





















Alcohol 3.2e (40.6 mg, 0.2 mmol) was subjected to standard reaction conditions with 7.5 
mol% catalyst (100 C, 48 h).  Upon flash column chromatography (SiO2, 20:80 
EtOAc:hexanes), the title compound 3.3e (54.9 mg, 0.14 mmol, >20:1 dr) was obtained as 
a white solid in 71% yield. 
 
TLC (SiO2) Rf = 0.4 (40:60 EtOAc:hexanes) 
1H NMR (500 MHz, CDCl3) δ 7.93-7.91 (m, 2H), 7.82-7.81 (m, 2H), 7.70-7.69 (m, 2H), 
7.42-7.39 (m, 3H), 6.41 (ddd, J = 17.1, 10.3, 7.6 Hz, 1H), 5.32 (ddt, J = 7.4, 3.0, 1.2 
Hz, 2H), 4.79 (ddt, J = 7.5, 6.2, 1.1 Hz, 1H), 4.61 (td, J = 6.7, 4.9 Hz, 1H), 2.70 (ddd, 
J = 4.8, 15.0, 37.7 Hz, 2H), 2.23 (s, 3H), 1.64 (bs, 1H). 
13C NMR (125 MHz, CDCl3) δ 168.4, 159.6, 145.0, 134.3, 132.5, 132.3, 131.8, 130.2, 
128.8, 127.4, 126.2, 123.5, 119.7, 70.9, 58.3, 29.8, 10.3. 
HRMS (H+, m/z) for C23H21N2O4: calcd. = 389.1496; found = 389.1499. 
FTIR (neat): 2923, 2853, 1710, 1382, 1334, 1066, 718, 692. 
HPLC: (Chiralcel column OD-H, Hexane:2-PrOH = 90:10, 1.0 mL/min, 230 nm) ee = 
96%. 
[𝜶]𝑫
















Alcohol 3.2f (28.6 mg, 0.2 mmol) was subjected to standard reaction conditions with longer 
reaction time (100 C, 72 h).  Upon flash column chromatography (SiO2, 50:50 
EtOAc:hexanes), the title compound 3.3f (47.0 mg, 0.144 mmol, >20:1 dr) was obtained 
as a white solid in 72% yield. 
 
TLC (SiO2) Rf = 0.29 (60:40 EtOAc:hexanes) 
1H NMR (500 MHz, CDCl3) δ 8.55 (s, 1H), 7.84 (dd, J = 5.4, 3.1 Hz, 2H), 7.74 (dd, J = 
5.4, 3.0 Hz, 2H), 6.37 – 6.24 (m, 1H), 5.41 – 5.23 (m, 2H), 4.75 (dd, J = 7.9, 4.4 Hz, 
1H), 4.31 (dt, J = 7.9, 5.0 Hz, 1H), 4.09 (d, J = 6.8 Hz, 1H), 3.03 – 2.92 (m, 2H), 2.34 
(s, 3H). 
13C NMR (125 MHz, CDCl3) δ 168.6, 150.4, 150.0, 134.6, 131.7, 130.9, 127.0, 123.7, 
120.8, 72.6, 58.7, 31.4, 15.2.  
HRMS (H+, m/z) for C17H17N2O3S: calcd. = 329.0954; found = 329.0957. 
FTIR (neat): 3724, 3004, 2360, 2341, 1706, 1275, 260, 750, 669. 
HPLC: (Chiralcel column OD-H, Hexane:2-PrOH = 95:5, 1.0 mL/min, 230 nm) ee = 94%. 
[𝜶]𝑫
𝟑𝟒 = +15.7 (c = 0.87, CHCl3). 


















Alcohol 3.2g (80.8 mg, 0.2 mmol) was subjected to standard reaction conditions with 7.5 
mol% catalyst (100 C, 48 h).  Upon flash column chromatography (SiO2, 100% EtOAc), 
the title compound 3.3g (68.3 mg, 0.116 mmol, >20:1 dr) was obtained as a pale yellow 
solid in 58% yield. 
 
TLC (SiO2) Rf = 0.3 (100% EtOAc) 
1H NMR (500 MHz, CDCl3) : 7.84 (dd, J = 5.1, 3.1 Hz, 2H), 7.72 (dd, J = 5.2, 3.0 Hz, 
2H), 7.12 (dd, J = 16.8, 8.0 Hz, 2H), 7.00 (d, J = 8.1 Hz, 1H), 6.91 (t, J = 7.5 Hz, 1H), 
6.86 (d, J = 8.1 Hz, 2H), 6.81 (s, 1H), 6.42 – 6.30 (m, 1H), 5.35 – 5.24 (m, 2H), 4.74 
(t, J = 7.3 Hz, 1H), 4.30 (dd, J = 13.4, 7.0 Hz, 1H), 3.86 (t, J = 6.7 Hz, 2H), 2.51 (s, 
2H), 2.48 – 2.27 (m, 10H), 2.00 – 1.79 (m, 2H). 
13C NMR (125 MHz, CDCl3) : 168.4, 146.6, 144.6, 134.3, 133.3, 132.5, 131.9, 128.0, 
127.6, 127.5, 124.9, 123.6, 123.0, 122.4, 119.6, 115.9, 77.2, 66.4, 61.2, 57.9, 55.4, 53.2, 
45.4, 24.1. 
HRMS (H+, m/z) for C32H33ClN4O3S: calcd. = 589.2035; found = 589.2038. 
FTIR (neat): 3452, 2940, 2815, 1769, 1708, 1566, 1458, 1382, 1127, 749. 
HPLC: (Chiralcel column AD-H, Hexane:2-PrOH = 9:1, 1.0 mL/min, 230 nm) ee = 98%. 
[𝜶]𝑫
𝟐𝟒 = +34.0° (c = 0.80, CHCl3). 
















Alcohol 3.2h (55.4 mg, 0.2 mmol) was subjected to standard reaction conditions with 7.5 
mol% catalyst (100 C, 48 h).  Upon flash column chromatography (SiO2, 30:70 
EtOAc:Toluene), the title compound 3.3h (52.7 mg, 0.114 mmol, >20:1 dr) was obtained 
as a pale yellow solid in 57% yield. 
 
TLC (SiO2) Rf = 0.38 (30:70 EtOAc:Toluene) 
1H NMR (500 MHz, CDCl3) : 7.75 – 7.70 (m, 4H), 7.66 (d, J = 8.1 Hz, 1H), 7.57 (d, J = 
8.0 Hz, 1H), 7.31 (t, J = 7.7 Hz, 1H), 7.24 – 7.22 (m, 3H), 7.18 – 7.11 (m, 4H), 6.31 
(ddd, J = 17.4, 10.3, 7.2 Hz, 1H), 5.23 (d, J = 10.3 Hz, 1H), 5.16 (d, J = 17.2 Hz, 1H), 
4.84 – 4.81 (m, 1H), 4.72 (t, J = 7.7 Hz, 1H), 4.23 – 4.12 (m, 1H). 
13C NMR (125 MHz, CDCl3) : 167.9, 134.2, 133.9, 133.2, 131.7, 129.4, 129.1, 128.8, 
127.8, 127.3, 123.5, 123.4, 119.5, 119.2, 118.2, 110.3, 103.5, 70.9, 55.9, 48.6. 
HRMS (Na+, m/z) for C28H22N4O3: calcd. = 485.1584; found = 485.1592. 
FTIR (neat): 2922, 1708, 1635, 1558, 1380, 1239, 1066, 740, 718. 
HPLC: (Chiralcel column OD-H, Hexane:2-PrOH = 90:10, 1.0 mL/min, 230 nm) ee = 
98%. 
[𝜶]𝑫
𝟑𝟒 = +3.4° (c = 1.18, CHCl3). 

















Alcohol 3.2i (35.0 mg, 0.2 mmol) was subjected to standard reaction conditions (100 C, 
48 h) with 7.5 mol% Ir-VI. Upon flash column chromatography (SiO2, 30:80 
EtOAc:hexanes), the title compound 3.3i (53.9 mg, 0.15 mmol, >20:1 dr) was obtained as 
a yellow solid in 75% yield. 
 
TLC (SiO2) Rf = 0.28 (30:80 EtOAc:hexanes) 
1H NMR (500 MHz, CDCl3) : 7.95 (s, 1H), 7.83 (dd, J = 5.4, 3.1 Hz, 2H), 7.72 (dd, J = 
5.5, 3.0 Hz, 2H), 7.59 (d, J = 7.9 Hz, 1H), 7.32 (d, J = 8.1 Hz, 1H), 7.17 – 7.12 (m, 1H), 
7.06 (dd, J = 11.0, 3.9 Hz, 1H), 7.00 (s, 1H), 6.30 (ddd, J = 17.9, 10.3, 7.7 Hz, 1H), 5.34 – 
5.23 (m, 2H), 4.75 (dd, J = 7.7, 3.8 Hz, 1H), 4.17 – 4.12 (m, 1H), 3.01 (td, J = 8.8, 4.3 Hz, 
1H), 2.95 – 2.86 (m, 1H), 2.06 – 1.90 (m, 2H). 
13C NMR (125 MHz, CDCl3) : 168.8, 136.5, 134.4, 131. 8, 131.3, 127.5, 123.7, 122.0, 
121.6, 120.1, 119.3, 119.1, 115.9, 111.2, 77.2, 71.8, 59.6, 34.7, 21.4. 
HRMS (Na+, m/z) for C22H20N2O3: calcd. = 383.1366; found = 383.1376. 
FTIR (neat): 3335, 1708, 1639, 1274, 1263, 764, 734, 703. 
HPLC: (Chiralcel column ADH, Hexane:2-PrOH = 90:10, 1.0 mL/min, 230 nm) ee = 96%. 
[𝜶]𝑫
𝟐𝟒 = 68.0° (c = 0.37, CHCl3). 

















Alcohol 3.2j (32.2 mg, 0.2 mmol) was subjected to standard reaction conditions (100 C, 
48 h).  Upon flash column chromatography (SiO2, 30:70 EtOAc:hexanes), the title 
compound 3.3j (45.1 mg, 0.13 mmol, >20:1 dr) was obtained as a pale yellow oil in 66% 
yield. 
 
TLC (SiO2) Rf = 0.32 (30:70 EtOAc:hexanes) 
1H NMR (500 MHz, CDCl3) : 7.85 (dd, J = 5.4, 3.1 Hz, 2H), 7.74 (dd, J = 5.5, 3.0 Hz, 
2H), 6.27 (ddd, J = 17.1, 10.3, 7.9 Hz, 1H), 5.33 (d, J = 10.7 Hz, 1H), 5.31 (d, J = 17.1 
Hz, 1H), 4.97 (brs, 1H), 4.76 – 4.74 (m, 1H), 4.25 (brs, 1H), 3.86 (brs, 1H), 3.46 – 3.40 
(m, 1H), 3.15 – 3.10 (m, 1H), 1.43 (brs, 9H). 
13C NMR (125 MHz, CDCl3) : 168.5 (2C), 156.7, 134.5 (2C), 131.8 (2C), 131.4, 123.7 
(2C), 120.4, 79.9, 71.3, 56.8, 43.6, 28.5 (3C). 
HRMS (Na+, m/z) for C18H22N2O5: calcd. = 369.1421; found = 369.1427. 
FTIR (neat): 3372, 2978, 1704, 1513, 1381, 1165, 1060 
HPLC: (Chiralcel column AD-H, Hexane:2-PrOH = 95:5, 1.0 mL/min, 230 nm) ee = 97%. 
[𝜶]𝑫




















Alcohol 3.2k (35.0 mg, 0.2 mmol) was subjected to standard reaction conditions (100 C, 
48 h).  Upon flash column chromatography (SiO2, 40:60 EtOAc:hexanes), the title 
compound 3.3k (43.2 mg, 0.12 mmol, >20:1 dr) was obtained as a pale yellow oil in 60% 
yield. 
 
TLC (SiO2) Rf = 0.29 (50:50 EtOAc:hexanes) 
1H NMR (500 MHz, CDCl3) : 7.84 (d, J = 3.2 Hz, 2H), 7.77 – 7.69 (m, 2H), 6.35 – 6.22 
(m, 1H), 5.28 (dd, J = 19.2, 13.9 Hz, 2H), 4.97 (s, 1H), 4.70 – 4.63 (m, 1H), 4.22 – 4.16 
(m, 2H), 3.42 (s, 1H), 3.17 (dd, J = 13.0, 5.1 Hz, 1H), 1.73 – 1.56 (m, 2H), 1.41 (s, 9H). 
13C NMR (125 MHz, CDCl3) : 168.6, 156.7, 134.4, 131.8, 123.7, 120.0, 79.5, 70.0, 59.4, 
37.6, 34.4, 28.5. 
HRMS (H+, m/z) for C19H24N2O5: calcd. = 361.1758; found = 361.1756. 
FTIR (neat): 3363, 2360, 2340, 1635, 1274, 1263, 763, 748. 
HPLC: (Chiralcel column OD-H, Hexane:2-PrOH = 95:5, 1.0 mL/min, 230 nm) ee = 94%. 
[𝜶]𝑫




















Alcohol Oxidation level: Alcohol 3.2l (39.2 mg, 0.2 mmol) was subjected to standard 
reaction conditions (100 C, 48 h).  Upon flash column chromatography (SiO2, 30:70 
EtOAc:hexanes), the title compound 3.3l (54.2 mg, 0.142 mmol, >20:1 dr) was obtained 
as a colorless oil in 71% yield. 
 
Aldehyde Oxidation level: dehydro-3.2l (38.8 mg, 0.2 mmol) was subjected to standard 
reaction conditions (100 C, 48 h) with 7.5% catalyst of Ir-VI and 300 mol% 2-PrOH (36.0 
mg).  Upon flash column chromatography (SiO2, 30:70 EtOAc:hexanes), the title 
compound 3.3l (47.3 mg, 0.124 mmol, >20:1 dr) was obtained as a colorless oil in 62% 
yield. 
 
TLC (SiO2) Rf = 0.28 (30:70 EtOAc:hexanes) 
1H NMR (500 MHz, CDCl3) : 7.84 (dd, J = 5.4, 3.1 Hz, 2H), 7.73 (dd, J = 5.4, 3.0 Hz, 
2H), 7.23 (d, J = 8.5 Hz, 2H), 6.85 (d, J = 8.6 Hz, 2H), 6.38 – 6.28 (m, 1H), 5.32 – 5.23 
(m, 2H), 4.72 (dd, J = 7.0, 6.2 Hz, 1H), 4.46 – 4.39 (m, 2H), 4.35 (dd, J = 12.1, 5.8 Hz, 
1H), 3.92 (s, 1H), 3.78 (s, 3H), 3.71 – 3.65 (m, 1H), 3.64 – 3.58 (m, 1H), 1.85 – 1.77 
(m, 2H). 
13C NMR (125 MHz, CDCl3) : 168.5, 159.3, 134.4, 131.9, 130.2, 129.5, 123.6, 123.6, 
119.8, 113.9, 77.2, 73.1, 70.6, 67.8, 59.2, 55.4, 33.8. 
  
 459 
HRMS (Na+, m/z) for C22H23NO5: calcd. = 404.1468; found = 404.1476. 
FTIR (neat): 3404, 1770, 1709, 1513, 1382, 1265, 1085, 733, 703. 
HPLC: (Chiralcel column AD-H, Hexane:2-PrOH = 96:4, 1.0 mL/min, 230 nm) ee = 96%. 
[𝜶]𝑫























Alcohol 3.2m (25.6 mg, 0.2 mmol) was subjected to standard reaction conditions with 
7.5% mol of (R)-Ir-VI (100 C, 48 h).  Upon flash column chromatography (SiO2, 15:85 
EtOAc:hexanes), the title compound 3.3m (47.0 mg, 0.15 mmol, >20:1 dr) was obtained 
as a white solid in 75% yield. 
 
TLC (SiO2) Rf = 0.28 (15:85 EtOAc:hexanes) 
1H NMR (500 MHz, CDCl3) : 7.86 (dd, J = 5.4, 3.1 Hz, 2H), 7.76 (dd, J = 5.4, 3.0 Hz, 
2H), 6.32 – 6.18 (m, 1H), 5.46 – 5.26 (m, 2H), 4.67 (dd, J = 8.0, 3.8 Hz, 1H), 4.21 – 
4.00 (m, 1H), 3.80 (s, 1H), 2.57 – 2.33 (m, 1H), 2.27 – 2.10 (m, 1H), 1.83 – 1.72 (m, 
2H). 
13C NMR (125 MHz, CDCl3) : 168.7, 134.6, 131.7, 130.6, 123.8, 121.1, 77.2, 70.8, 59.6, 
30.34 (q, J = 29.0 Hz), 26.8, 26.8. 
19F NMR (470 MHz, CDCl3) δ: -66.4 (t, J = 10.9 Hz). 
HRMS (H+, m/z) for C15H14F3NO3: calcd. = 314.0999; found =314.1001. 
FTIR (neat): 3346, 2360, 2341, 1704, 1382, 1275, 1137, 749. 
HPLC: (Chiralcel column AD-H, Hexane:2-PrOH = 97:3, 1.0 mL/min, 230 nm) ee = 94%. 
[𝜶]𝑫
𝟐𝟒 = +40.5° (c = 0.74, CHCl3). 




























Alcohol 3.2n (14.4 mg, 0.2 mmol) was subjected to standard reaction conditions using 5 
mol% of (R)-Ir-V as catalyst (100 C, 48 h).  Upon flash column chromatography (SiO2, 
40:60 EtOAc:hexanes), the title compound 3.3n (29.8 mg, 0.16 mmol, >20:1 dr) was 
obtained as a pale yellow solid in 58% yield. 
 
TLC (SiO2) Rf = 0.28 (20:80 EtOAc:hexanes) 
1H NMR (500 MHz, CDCl3) : 7.85 (dd, J = 5.4, 3.1 Hz, 2H), 7.73 (dd, J = 5.4, 3.1 Hz, 
2H), 6.38 (ddd, J = 17.6, 9.9, 7.9 Hz, 1H), 5.32 (dd, J = 13.7, 2.3 Hz, 2H), 4.93 – 4.79 
(m, 1H), 3.40 (dd, J = 8.7, 5.8 Hz, 1H), 3.09 (s, 1H), 1.09 – 0.91 (m, 1H), 0.61 – 0.48 
(m, 1H), 0.44 – 0.31 (m, 2H), 0.23 – 0.11 (m, 1H). 
13C NMR (125 MHz, CDCl3) : 168.7, 134.4, 132.1, 131.8, 123.6, 120.0, 77.2, 76.3, 59.7, 
15.3, 2.6, 2.4. 
HRMS (Na+, m/z) for C15H15NO3: calcd. = 280.0944; found = 280.0946. 
FTIR (neat): 3363, 2359, 2340, 1711, 1264, 1085, 733, 703. 
HPLC: (Chiralcel column OD-H, Hexane:2-PrOH = 95:5, 1.0 mL/min, 230 nm) ee = 96%. 
[𝜶]𝑫
𝟐𝟒 = +20.4° (c = 1.10, CHCl3). 
















Alcohol 3.2o (24.4 mg, 0.2 mmol) was subjected to standard reaction conditions with 
longer reaction time (100 C, 72 h).  Upon flash column chromatography (SiO2, 20:80 
EtOAc:hexanes), the title compound 3.3o (37.5 mg, 0.122 mmol, >20:1 dr) was obtained 
as a white solid in 61% yield. 
 
TLC (SiO2) Rf = 0.26 (20:80 EtOAc:hexanes) 
1H NMR (500 MHz, CDCl3) : 7.86 (dd, J = 5.4, 3.0 Hz, 2H), 7.76 (dd, J = 5.4, 3.0 Hz, 
2H), 6.26 (ddd, J = 17.2, 10.2, 8.2 Hz, 1H), 5.32 (dd, J = 20.1, 13.7 Hz, 2H), 4.63 (dd, 
J = 8.1, 4.1 Hz, 1H), 4.06 (d, J = 4.2 Hz, 1H), 3.73 (d, J = 2.1 Hz, 1H), 2.72 – 2.38 (m, 
4H), 2.30 (dd, J = 8.0, 3.6 Hz, 1H). 
13C NMR (125 MHz, CDCl3) : 168.8, 134.6, 134.5, 131. 7, 130.8, 123.8, 123.7, 121.0, 
77.2, 73.9, 57.7, 37.3 (m), 36.8 (m), 26.4. 
19F NMR (470 MHz, CDCl3) δ: -82.3 (tt, J = 12.0, 5.9 Hz), -82.7 (ddt, J = 17.6, 11.9, 5.8 
Hz), -96.6 (m), -97.0 (m). 
HRMS (Na+, m/z) for C16H15F2NO3: calcd. = 330.0912; found = 330.0916. 
FTIR (neat): 3469, 2631, 2340, 1705, 1382, 1296, 1265, 1070, 763. 
HPLC: (Chiralcel column OD-H, Hexane:2-PrOH = 95:5, 1.0 mL/min, 230 nm) ee = 94%. 
[𝜶]𝑫
𝟑𝟒 = +14.0° (c = 0.87, CHCl3). 





























Alcohol 3.2p (37.4 mg, 0.2 mmol) was subjected to standard reaction conditions (100 C, 
48 h).  Upon flash column chromatography (SiO2, 30:70 EtOAc:hexanes), the title 
compound 3.3p (49.9 mg, 0.134 mmol, >20:1 dr) was obtained as a light yellow solid in 
67% yield. 
 
TLC (SiO2) Rf = 0.20 (30:70 EtOAc:hexanes). 
1H NMR (500 MHz, CDCl3) : 7.85 (dd, J = 5.4, 3.1 Hz, 2H), 7.75 (dd, J = 5.4, 3.0 Hz, 
2H), 6.30 – 6.21 (m, 1H), 5.29 (dd, J = 26.8, 13.7 Hz, 2H), 4.59 (dd, J = 8.1, 3.8 Hz, 
1H), 4.18 (dd, J = 7.6, 3.8 Hz, 1H), 3.97 – 3.91 (m, 3H), 3.75 (dd, J = 8.5, 5.9 Hz, 1H), 
2.74 – 2.64 (m, 1H), 1.40 (s, 9H). 
 13C NMR (125 MHz, CDCl3) : 168.6, 156.4, 134.5, 131.6, 130.7, 123.7, 120.8, 79.5, 
77.2, 73.7, 57.4, 51.1, 31.8, 28.5. 
HRMS (K+, m/z) for C20H24N2O5: calcd. = 411.1317; found = 411.1323. 
FTIR (neat): 3362, 2360, 2341, 1706, 1275, 1260, 764, 750. 
HPLC: (Chiralcel column OD-H, Hexane:2-PrOH = 95:5, 1.0 mL/min, 230 nm) ee = 97%. 
[𝜶]𝑫
𝟑𝟒 = +27.7° (c = 0.64, CHCl3). 
















Alcohol 3.2q (17.6 mg, 0.2 mmol) was subjected to standard reaction conditions (100 C, 
48 h).  Upon flash column chromatography (SiO2, 30:70 EtOAc:hexanes), the title 
compound 3.3q (43.0 mg, 0.16 mmol, >20:1 dr) was obtained as a pale yellow oil in 79% 
yield. 
 
TLC (SiO2) Rf = 0.28 (30:70 EtOAc:hexanes) 
1H NMR (500 MHz, CDCl3) : 7.86 (dd, J = 5.4, 3.1 Hz, 2H), 7.76 (dd, J = 5.5, 3.0 Hz, 
2H), 6.24 (ddd, J = 17.1, 10.3, 7.9 Hz, 1H), 5.32 (d, J = 10.7 Hz, 1H), 5.26 (d, J = 17.1 
Hz, 1H), 4.75 (d, J = 7.1 Hz, 2H), 4.71 (dd, J = 8.1, 6.1 Hz, 1H), 4.56 – 4.53 (m, 2H), 
4.36 (dd, J = 8.0, 3.5 Hz, 1H), 3.92 (brs, 1H), 3.23 – 3.15 (m, 1H). 
13C NMR (125 MHz, CDCl3) : 168.7, 134.7, 131.7, 130.5, 123.9, 120.9, 74.1, 73.9, 73.4, 
57.5, 38.2. 
HRMS (Na+, m/z) for C15H15NO4: calcd. = 296.0893; found = 296.0901. 
FTIR (neat): 3408, 2959, 2880, 1703, 1380, 973, 718. 
HPLC: (Chiralcel column OD-H, Hexane:2-PrOH = 90:10, 1.0 mL/min, 230 nm) ee = 
96%. 
[𝜶]𝑫



















Alcohol 3.2r (40.3 mg, 0.2 mmol) was subjected to standard reaction conditions (100 C, 
48 h).  Upon flash column chromatography (SiO2, 25:75 EtOAc:hexanes), the title 
compound 3.3r (56.0 mg, 0.14 mmol, >20:1 dr) was obtained as white solid in 70% yield. 
 
TLC (SiO2) Rf = 0.30 (30:70 EtOAc:hexanes) 
1H NMR (500 MHz, CDCl3) : 7.86 (dd, J = 5.4, 3.0 Hz, 2H), 7.75 (dd, J = 5.4, 3.0 Hz, 
2H), 6.33 – 6.23 (m, 1H), 5.34 – 5.23 (m, 2H), 4.89 (dd, J = 7.6, 4.2 Hz, 1H), 4.18 – 
4.08 (m, 2H), 3.85 (dd, J = 6.0, 4.4 Hz, 1H), 3.58 (s, 1H), 2.71 – 2.56 (m, 2H), 1.90 (d, 
J = 13.2 Hz, 1H), 1.67 (d, J = 12.7 Hz, 1H), 1.61 – 1.52 (m, 1H), 1.44 (s, 9H), 1.41 – 
1.28 (m, 2H).. 
13C NMR (125 MHz, CDCl3) : 168.7, 154.9, 134.6, 131.8, 131.5, 123.8, 120.2, 79.5, 77.2, 
75.5, 56.4, 39.0, 29.0, 28.6, 26.9. 
HRMS (K+, m/z) for C22H28N2O5: calcd. = 439.1630; found = 439.1629. 
FTIR (neat): 3725, 2989, 2360, 2341, 1707, 1275, 1260, 764, 749, 668. 
HPLC: (Chiralcel column OD-H, Hexane:2-PrOH = 93:7, 1.0 mL/min, 230 nm) ee = 93%. 
[𝜶]𝑫
𝟑𝟒 = +12.6° (c = 0.85, CHCl3). 


















Alcohol 3.2s (23.2 mg, 0.2 mmol) was subjected to standard reaction conditions with 7.5 
mol% catalyst (100 C, 48 h).  Upon flash column chromatography (SiO2, 30:70 
EtOAc:hexanes), the title compound 3.3s (47.6 mg, 0.158 mmol, >20:1 dr) was obtained 
as colorless oil in 79% yield. 
 
TLC (SiO2) Rf = 0.24 (30:70 EtOAc:hexanes) 
1H NMR (500 MHz, CDCl3) : 7.86 (dd, J = 5.3, 3.1 Hz, 2H), 7.75 (dd, J = 5.3, 3.0 Hz, 
2H), 6.28 (ddd, J = 17.6, 10.2, 7.7 Hz, 1H), 5.29 (dd, J = 26.4, 13.7 Hz, 2H), 4.90 (dd, 
J = 7.4, 3.8 Hz, 1H), 3.99 (d, J = 11.8 Hz, 2H), 3.82 (dd, J = 6.3, 4.0 Hz, 1H), 3.71 (s, 
1H), 3.40 – 3.28 (m, 2H), 1.85 (d, J = 13.3 Hz, 1H), 1.72 – 1.43 (m, 4H). 
13C NMR (125 MHz, CDCl3) : 168.7, 134.6, 131.8, 131.5, 123.8, 120.1, 77.2, 75. 8, 68.1, 
67.7, 56.2, 37.9, 29.7, 28.0. 
HRMS (H+, m/z) for C17H19NO4: calcd. = 302.1387; found = 302.1392. 
FTIR (neat): 2987, 2360, 2341, 1705, 1383, 1266, 1079, 731. 
HPLC: (Chiralcel column AD-H, Hexane:2-PrOH = 95:5, 1.0 mL/min, 230 nm) ee = 94%. 
[𝜶]𝑫



















Alcohol 3.2t (49.7 mg, 0.2 mmol) was subjected to standard reaction conditions (100 C, 
48 h).  Upon flash column chromatography (SiO2, 30:70 EtOAc:hexanes), the title 
compound 3.3t (58.0 mg, 0.134 mmol, >20:1 dr) was obtained as a light yellow solid in 
67% yield. 
 
TLC (SiO2) Rf = 0.30 (30:70 EtOAc:hexanes) 
1H NMR (500 MHz, CDCl3) : 7.87 (dd, J = 5.4, 3.1 Hz, 2H), 7.76 (dd, J = 5.5, 3.0 Hz, 
2H), 7.56 (dd, J = 17.4, 7.9 Hz, 2H), 7.28 (d, J = 7.2 Hz, 1H), 7.05 (t, J = 7.6 Hz, 1H), 
6.30 (ddd, J = 17.8, 10.3, 7.8 Hz, 1H), 5.33 (dd, J = 19.2, 13.7 Hz, 2H), 4.92 (dd, J = 
7.6, 4.2 Hz, 1H), 4.24 (d, J = 12.4 Hz, 1H), 4.14 (dd, J = 9.7, 7.3 Hz, 1H), 3.90 (t, J = 
6.1 Hz, 1H), 3.63 (d, J = 2.4 Hz, 1H), 3.15 – 3.03 (m, 2H), 2.09 (d, J = 13.2 Hz, 1H), 
1.84 (d, J = 12.5 Hz, 1H), 1.74 – 1.51 (m, 4H), 1.26 (t, J = 7.1 Hz, 1H). 
13C NMR (125 MHz, CDCl3) : 168.7, 134.6, 131.7, 131.3, 126.1, 123.9, 121.4, 120.8, 
120.5, 119.0, 77.2, 75.2, 56.5, 49.1, 48.6, 38.8, 28.5, 26.5. 
HRMS (H+, m/z) for C24H23N3O3S: calcd. = 434.1533; found = 434.1534. 
FTIR (neat): 2923, 2360, 2341, 1705, 1356, 1275, 763, 750. 
HPLC: (Chiralcel column AD-H, Hexane:2-PrOH = 95:5, 1.0 mL/min, 230 nm) ee = 94%. 
[𝜶]𝑫
𝟑𝟒 = +52.0° (c = 0.72, CHCl3). 















Alcohol 3.2u (38.6 mg, 0.2 mmol) was subjected to standard reaction conditions (100 C, 
48 h) using 7.5 mol% of (R)-Ir-VI.  Upon flash column chromatography (SiO2, 30:70 
EtOAc:hexanes), the title compound 3.3u (54.5 mg, 0.144 mmol, >20:1 dr) was obtained 
as a pale yellow oil in 72% yield. 
 
TLC (SiO2) Rf = 0.2 (30:70 EtOAc:hexanes) 
1H NMR (500 MHz, CDCl3) : 8.28 (d, J = 4.7 Hz, 2H), 7.86 (dd, J = 5.4, 3.1 Hz, 2H), 
7.75 (dd, J = 5.4, 3.0 Hz, 2H), 6.43 (t, J = 4.7 Hz, 1H), 6.36 – 6.24 (m, 1H), 5.31 (dd, 
J = 20.9, 13.7 Hz, 2H), 4.94 (dd, J = 7.5, 4.1 Hz, 1H), 4.80 (d, J = 12.0 Hz, 2H), 3.90 
– 3.83 (m, 1H), 3.62 (d, J = 2.4 Hz, 1H), 2.82 (dtd, J = 15.5, 13.1, 2.5 Hz, 2H), 2.03 (d, 
J = 13.1 Hz, 1H), 1.79 (d, J = 12.8 Hz, 1H), 1.72 (tt, J = 6.8, 4.2 Hz, 1H), 1.44 (dddd, 
J = 29.0, 25.0, 12.6, 4.3 Hz, 2H).. 
13C NMR (125 MHz, CDCl3) : 168.8, 157.8, 134.5, 131.8, 131.5, 123.8, 120.1, 77.2, 75.6, 
56.5, 44.0, 43.9, 39.3, 28.9, 26.9. 
HRMS (Na+, m/z) for C21H22N4O3: calcd. = 401.1584; found = 401.1594. 
FTIR (neat): 3356, 1707, 1587, 1264, 1073, 976, 733, 703. 
HPLC: (Chiralcel column OD-H, Hexane:2-PrOH = 95:5, 1.0 mL/min, 230 nm) ee = 95%. 
[𝜶]𝑫















Alcohol 3.2v (17.2 mg, 0.2 mmol) was subjected to standard reaction conditions (100 C, 
48 h).  Upon flash column chromatography (SiO2, 20:80 EtOAc:hexanes), the title 
compound 3.3v (38.0 mg, 0.14 mmol, >20:1 dr) was obtained as a light yellow solid in 
70% yield. 
 
TLC (SiO2) Rf = 0.2 (20:80 EtOAc:hexanes) 
1H NMR (500 MHz, CDCl3) : 7.83 (dd, J = 5.4, 3.1 Hz, 2H), 7.72 (dd, J = 5.5, 3.0 Hz, 
2H), 6.38 (ddd, J = 17.2, 10.4, 7.8 Hz, 1H), 5.32 (ddd, J = 15.1, 10.6, 3.6 Hz, 2H), 5.22 
– 5.13 (m, 1H), 4.91 (dd, J = 8.9, 6.8 Hz, 1H), 4.67 (dd, J = 7.7, 6.8 Hz, 1H), 1.61 (dd, 
J = 11.3, 0.9 Hz, 6H). 
13C NMR (125 MHz, CDCl3) : 168.5, 138.5, 134.3, 132.1, 131.8, 124.0, 123.6, 120.4, 
77.2, 68.8, 59.4, 25.9, 18.5. 
HRMS (Na+, m/z) for C16H17NO3: calcd. = 294.1101; found = 294.1108. 
FTIR (neat): 2988, 2358, 2340, 1769, 1703, 764, 733. 
HPLC: (Chiralcel column OD-H, Hexane:2-PrOH = 95:5, 1.0 mL/min, 230 nm) ee = 86%. 
[𝜶]𝑫
𝟑𝟒 = +46.3° (c = 0.62 CHCl3). 


















Alcohol 3.2w (35.6 mg, 0.2 mmol) was subjected to standard reaction conditions (100 C, 
48 h).  Upon flash column chromatography (SiO2, 20:80 EtOAc:hexanes), the title 
compound 3.3w (50 mg, 0.138 mmol, >20:1 dr) was obtained as a light yellow oil in 69% 
yield. 
 
TLC (SiO2) Rf = 0.30 (30:80 EtOAc:hexanes) 
1H NMR (500 MHz, CDCl3) : 7.87 (dd, J = 5.4, 3.1 Hz, 2H), 7.75 (dd, J = 5.5, 3.0 Hz, 
2H), 7.36 – 7.29 (m, 3H), 7.27 – 7.24 (m, 2H), 6.36 (ddd, J = 17.5, 10.3, 7.3 Hz, 1H), 
5.95 (dd, J = 13.3, 7.7 Hz, 1H), 5.81 (dd, J = 15.5, 6.6 Hz, 1H), 5.41 – 5.31 (m, 2H), 
4.79 (dt, J = 23.1, 6.2 Hz, 2H), 4.40 (s, 2H), 4.00 (qd, J = 13.0, 5.6 Hz, 2H), 3.28 (s, 
1H). 
13C NMR (125 MHz, CDCl3) : 168.4, 138.2, 134.4, 131.7, 131.5, 131.4, 130.5, 128.4, 
127.7, 127.7, 123.6, 120.1, 77.2, 72.3, 71.9, 69.8, 59.0. 
HRMS (Na+, m/z) for C22H21NO4: calcd. = 386.1363; found = 386.1361. 
FTIR (neat): 2988, 2358, 2340, 1769, 1703, 1383, 1264, 764. 
HPLC: (Chiralcel column OJ-H, Hexane:2-PrOH = 95:5, 1.0 mL/min, 230 nm) ee = 86%. 
[𝜶]𝑫
















Alcohol 3.2x (25.2 mg, 0.2 mmol) was subjected to standard reaction conditions (100 C, 
48 h) using 7.5 mol% of (R)-Ir-VI.  Upon flash column chromatography (SiO2, 20:80 
EtOAc:hexanes), the title compound 3.3x (38.1 mg, 0.12 mmol, >20:1 dr) was obtained as 
a light yellow solid in 61% yield. 
 
TLC (SiO2) Rf = 0.40 (20:80 EtOAc:hexanes). 
1H NMR (500 MHz, CDCl3) : 7.86 (dd, J = 5.4, 3.1 Hz, 2H), 7.78 (dd, J = 5.5, 3.0 Hz, 
2H), 6.41 (ddq, J = 15.6, 4.3, 2.2 Hz, 1H), 6.17 (ddd, J = 17.0, 10.4, 6.7 Hz, 1H), 6.11 
– 6.04 (m, 1H), 5.35 (d, J = 10.7 Hz, 1H), 5.23 (d, J = 17.0 Hz, 1H), 4.86 – 4.84 (m, 
1H), 4.78 – 4.76 (m, 1H), 4.15 (brs, 1H). 
13C NMR (125 MHz, CDCl3) : 168.7, 138.0 (q, J = 6.3 Hz), 134.8, 131.6, 129.6, 124.0, 
123.0 (q, J = 270 Hz), 120.9 (q, J = 121 Hz), 120.6, 71.2, 58.3. 
19F NMR (470 MHz, CDCl3) δ: -64.4 (dt, J = 6.8, 2.6 Hz). 
HRMS (Na+, m/z) for C15H12F3NO3: calcd. = 334.0665; found = 334.0661. 
FTIR (neat): 3456, 3333, 2359, 1687, 1330, 1077, 712. 
HPLC: (Chiralcel column AS-H, Hexane:2-PrOH = 95:5, 1.0 mL/min, 230 nm) ee = 90%. 
[𝜶]𝑫
𝟑𝟒 = +38.6° (c = 1.18, CHCl3). 


















Alcohol 3.2y (27 mg, 0.2 mmol) was subjected to standard reaction conditions (100 C, 48 
h).  Upon flash column chromatography (SiO2, 20:80 EtOAc:hexanes), the title compound 
3.3y (45 mg, 0.14 mmol, >20:1 dr) was obtained as a light yellow oil in 71% yield. 
 
TLC (SiO2) Rf = 0.35 (20:80 EtOAc:hexanes) 
1H NMR (500 MHz, CDCl3) : 7.84 (dd, J = 5.4, 3.1 Hz, 2H), 7.72 (dd, J = 5.5, 3.0 Hz, 
2H), 7.32 – 7.29 (m, 5H), 6.69 (d, J = 15.8 Hz, 1H), 6.36 (ddd, J = 17.0, 10.4, 6.7 Hz, 
1H), 6.20 (dd, J = 15.9, 6.2 Hz, 1H), 5.35 (d, J = 10.7 Hz, 1H), 5.31 (d, J = 17.0 Hz, 
1H), 4.89 – 4.84 (m, 2H), 3.34 (s, 1H). 
13C NMR (125 MHz, CDCl3) : 168.6, 136.5, 134.5, 133.2, 131.8, 131.3, 128.7, 128.1, 
128.0, 126.8, 123.7, 120.2, 73.1, 59.2. 
HRMS (Na+, m/z) for C20H17NO3: calcd. = 342.1101; found = 342.1106. 
FTIR (neat): 3456, 3333, 2359, 1687, 1330, 1077, 712. 
HPLC: (Chiralcel column OD-H, Hexane:2-PrOH = 95:5, 1.0 mL/min, 230 nm) ee = 86%. 
[𝜶]𝑫

















Alcohol 3.2z (31.2 mg, 0.2 mmol) was subjected to standard reaction conditions (100 C, 
48 h).  Upon flash column chromatography (SiO2, 10:90 EtOAc:hexanes), the title 
compound 3.3z (41.7 mg, 0.12 mmol, 10:1 dr) was obtained as a pale yellow oil in 62% 
yield. 
 
TLC (SiO2) Rf = 0.47 (20:80 EtOAc:hexanes) 
1H NMR (500 MHz, CDCl3) : 7.86 (dd, J = 5.4, 3.1 Hz, 2H), 7.75 (dd, J = 5.5, 3.0 Hz, 
2H), 6.28 (ddd, J = 17.6, 10.4, 7.8 Hz, 1H), 5.32 (d, J = 10.7 Hz, 1H), 5.26 (d, J = 17.3 
Hz, 1H), 5.08 (t, J = 7.0 Hz, 1H), 4.68 (dd, J = 7.8, 3.4 Hz, 1H), 4.15 (ddd, J = 8.6, 5.2, 
3.5 Hz, 1H), 3.67 (brs, 1H), 2.04 – 1.88 (m, 1H), 1.73 – 1.66 (m, 1H), 1.66 (s, 3H), 1.58 
(s, 3H), 1.50 – 1.39 (m, 3H), 1.15 – 1.07 (m, 1H), 0.92 (d, J = 6.7 Hz, 3H). 
13C NMR (125 MHz, CDCl3) : 168.9, 134.5, 131.8, 131.4, 131.1, 124.9, 123.7, 120.1, 
70.6, 59.6, 41.6, 36.4, 29.3, 25.9, 25.5, 20.4, 17.8. 
HRMS (Na+, m/z) for C21H27NO3: calcd. = 364.1883; found = 364.1882. 
FTIR (neat): 3466, 2921, 1704, 1380, 1065, 719. 
[𝜶]𝑫








Alcohol 3.2a’ (31.2 mg, 0.2 mmol) was subjected to standard reaction conditions (100 C, 
48 h) using 5 mol% of (S)-Ir-IV. Upon flash column chromatography (SiO2, 10:90 
EtOAc:hexanes), the title compound 3.3a’ (43.1 mg, 0.13 mmol, 13:1 dr) was obtained as 
a pale yellow oil in 64% yield. 
 
TLC (SiO2) Rf = 0.47 (20:80 EtOAc:hexanes) 
1H NMR (500 MHz, CDCl3) : 7.86 (dd, J = 5.4, 3.1 Hz, 2H), 7.75 (dd, J = 5.5, 3.0 Hz, 
2H), 6.28 (ddd, J = 17.6, 10.4, 7.8 Hz, 1H), 5.32 (d, J = 10.7 Hz, 1H), 5.27 (d, J = 17.3 
Hz, 1H), 5.08 (t, J = 7.1 Hz, 1H), 4.65 (dd, J = 7.8, 3.9 Hz, 1H), 4.18 (ddd, J = 10.3, 
3.7 Hz, 1H), 3.54 (brs, 1H), 2.03 – 1.93 (m, 2H), 1.77 – 1.72 (m, 1H), 1.66 (s, 3H), 1.58 
(brs, 4H), 1.34 – 1.28 (m, 1H), 1.21 – 1.14 (m, 2H), 0.90 (d, J = 6.7 Hz, 3H). 
13C NMR (125 MHz, CDCl3) : 168.8, 134.5, 131.9, 131.4, 131.4, 124.9, 123.7, 120.1, 
70.0, 60.2, 41.7, 38.0, 27.9, 25.9, 25.6, 18.9, 17.8. 
HRMS (Na+, m/z) for C21H27NO3: calcd. = 364.1883; found = 364.1883. 
FTIR (neat): 3454, 2923, 1703, 1381, 1066, 719. 
[𝜶]𝑫







Alcohol 3.2b’ (18.0 mg, 0.2 mmol) was subjected to standard reaction conditions (100 C, 
48 h) using 7.5 mol% of (R)-Ir-VI.  Upon flash column chromatography (SiO2, 50:50 
EtOAc:hexanes), the title compound 3.3b’ (39.6 mg, 0.14 mmol, 20:1 dr) was obtained as 
a white solid in 72% yield. 
 
TLC (SiO2) Rf = 0.38 (50:50 EtOAc:hexanes) 
1H NMR (500 MHz, CDCl3) : 7.86 (dd, J = 5.4, 3.1 Hz, 2H), 7.76 (dd, J = 5.5, 3.0 Hz, 
2H), 6.30 (ddd, J = 17.6, 10.4, 7.7 Hz, 1H), 5.33 (d, J = 10.7 Hz, 1H), 5.29 (d, J = 17.3 
Hz, 1H), 4.71 (dd, J = 7.8, 4.4 Hz, 1H), 4.44 (dt, J = 9.8, 3.4 Hz, 1H), 4.20 – 4.13 (m, 
1H), 1.77 (ddd, J = 14.3, 9.6, 2.9 Hz, 1H), 1.77 (ddd, J = 14.3, 8.4, 3.1 Hz, 1H), 1.23 
(d, J = 6.3 Hz, 3H). 
13C NMR (125 MHz, CDCl3) : 168.7, 134.5, 131.8, 131.3, 123.8, 120.3, 69.6, 65.2, 59.5, 
41.7, 23.7. 
HRMS (Na+, m/z) for C15H17NO4: calcd. = 298.1050; found = 298.1054. 
FTIR (neat): 3457, 3378, 2963, 2359, 1693, 1386, 988, 890, 711. 
[𝜶]𝑫
𝟑𝟒 = +56.9° (c = 1.30, CHCl3). 







Alcohol 3.2c’ (18 mg, 0.2 mmol) was subjected to standard reaction conditions (100 C, 
48 h) using 7.5 mol% of (S)-Ir-IV. Upon flash column chromatography (SiO2, 50:50 
EtOAc:hexanes), the title compound 3.3c’ (36.3 mg, 0.13 mmol, 20:1 dr) was obtained as 
a white solid in 66% yield. 
 
TLC (SiO2) Rf = 0.38 (50:50 EtOAc:hexanes) 
1H NMR (500 MHz, CDCl3) : 7.86 (dd, J = 5.4, 3.1 Hz, 2H), 7.75 (dd, J = 5.5, 3.0 Hz, 
2H), 6.27 (ddd, J = 17.6, 10.4, 7.7 Hz, 1H), 5.34 (d, J = 10.7 Hz, 1H), 5.28 (d, J = 17.3 
Hz, 1H), 4.67 (dd, J = 7.8, 3.8 Hz, 1H), 4.35 (dt, J = 10.9, 3.1 Hz, 1H), 4.10 – 4.03 (m, 
1H), 1.72 (ddd, J = 14.2, 10.8, 9.4 Hz, 1H), 1.77 (dt, J = 14.2, 2.5 Hz, 1H), 1.19 (d, J 
= 6.3 Hz, 3H). 
13C NMR (125 MHz, CDCl3) : 168.8, 134.6, 131.8, 130.9, 123.8, 120.4, 73.4, 68.2, 59.8, 
42.0, 23.8. 
HRMS (Na+, m/z) for C15H17NO4: calcd. = 298.1050; found = 298.1053. 
FTIR (neat): 3197, 2966, 2360, 1699, 1381, 1323, 1073, 713. 
[𝜶]𝑫
𝟑𝟒 = −76.1° (c = 0.90, CHCl3). 




3.5.3.5 Procedures and Spectral Data of Product Elaborations 
2-chloro-N-((3R,4S)-4-hydroxy-5-phenylpent-1-en-3-yl)acetamide (3.4a) 
 
To a round bottom flask charged with coupling product 3.3a (92.2 mg, 0.3 mmol, 100 
mol%) was added a solution of N2H4 • H2O in DCM and MeOH (4:6:2, 12 mL) and the 
reaction mixture was stirred at room temperature for 6 hours. The reaction mixture was 
diluted with water (5 mL) and the mixture was transferred to a separatory funnel.  The 
aqueous layer was extracted with DCM (6 x 10 mL). The combined organic extracts were 
washed with a saturated solution of sodium bicarbonate followed by brine. The solution 
was dried (MgSO4), filtered, and the solvent was removed in vacuo. The residue was then 
dissolved in DCM (2 mL, 0.15 M) and triethylamine added (81 µL, 0.6 mmol, 200 mol%). 
The reaction was stirred at -10 °C for 5 minutes and chloroacetyl chloride added dropwise 
(24 µL, 0.6 mmol, 200 mol%). The reaction mixture was stirred at -10 °C for 30 minutes 
and then quenched by addition of a saturated solution of ammonium chloride. The mixture 
was then diluted with EtOAc and the mixture transferred to a separatory funnel. The phases 
were separated and the organic layer was washed with saturated solutions of ammonium 
chloride and sodium bicarbonate followed by brine. The solution was dried (MgSO4), 
filtered, and the solvent was removed in vacuo. The residue was subjected to flash column 
chromatography (SiO2, 60:40 EtOAC:hexanes) to yield the title compound 3.4a (62.4 mg, 
0.25 mmol, >20:1 dr) as a white solid in 82% yield. 
  
 514 
TLC (SiO2) Rf = 0.28 (60:40 EtOAc:hexanes) 
1H NMR (500 MHz, CDCl3) : 7.34 – 7.31 (m, 2H), 7.26 – 7.20 (m, 3H), 7.10 (d, J = 7.7 
Hz, 1H), 5.97 (ddd, J = 17.3, 10.5, 7.0 Hz, 1H), 5.38 – 5.33 (m, 2H), 4.56 – 4.52 (m, 
2H), 4.06 (brs, 2H), 3.99 (dt, J = 9.4, 3.7 Hz, 1H), 2.82 (dd, J = 13.8, 4.2 Hz, 1H), 2.71 
(dt, J = 13.8, 9.4 Hz, 1H), 1.19 (d, J = 6.3 Hz, 3H). 
13C NMR (125 MHz, CDCl3) : 168.6, 137.5, 132.3, 129.4, 129.0, 127.0, 119.3, 74.4, 56.3, 
42.8, 40.7. 
HRMS (Na+, m/z) for C13H16ClNO2: calcd. = 276.0762; found = 276.0767. 
FTIR (neat): 3289, 2918, 1640, 1533, 1267, 1053, 936, 752, 699. 
[𝜶]𝑫
𝟑𝟒 = +37.1° (c = 0.93, CHCl3). 







To a flame dried round bottomed flask charged with 3.4a (52.7 mg, 0.21 mmol, 100 mol%) 
in THF (0.084 M) was added DMF (0.5 mL). The reaction mixture was stirred at 0 °C for 
5 minutes before addition of NaH (60% w/w, 21 mg, 0.52 mmol, 250 mol%).  The mixture 
was then stirred at 0 °C for 40 minutes. Saturated solution of ammonium chloride and 
EtOAC were then added and the reaction mixture transferred to a separatory funnel. The 
phases were separated and the organic phase washed with saturated solutions of ammonium 
chloride and sodium bicarbonate followed by brine. The solution was dried (MgSO4), 
filtered, and the solvent was removed in vacuo. The residue was subjected to flash column 
chromatography (SiO2, 70:30 EtOAC:hexanes) to yield the title compound 3.8a (33.6 mg, 
0.15 mmol, >20:1 dr) as a pale-yellow oil in 74% yield. 
 
TLC (SiO2) Rf = 0.42 (80:20 EtOAc:hexanes) 
1H NMR (500 MHz, CDCl3) : 7.32 – 7.29 (m, 2H), 7.26 – 7.20 (m, 3H), 6.42 (brs, 1H), 
5.97 (ddd, J = 17.4, 10.1, 7.9 Hz, 1H), 5.39 (d, J = 10.2 Hz, 1H), 5.26 (d, J = 17.1 Hz, 
1H), 4.29 (d, J = 16.9 Hz, 1H), 4.14 (d, J = 16.9 Hz, 1H), 4.05 – 4.01 (m, 1H), 3.78 – 
3.75 (m, 1H), 2.87 (dd, J = 14.3, 8.0 Hz, 1H), 2.68 (dd, J = 14.3, 5.9 Hz, 1H). 
13C NMR (125 MHz, CDCl3) : 168.8, 137.3, 134.1, 129.3, 128.7, 126.9, 119.8, 68.2, 57.8, 
37.8. 
HRMS (H+, m/z) for C13H15NO2: calcd. = 218.1176; found = 218.1175. 
FTIR (neat): 3217, 3028, 2923, 1668, 1420, 1112, 740, 699. 
[𝜶]𝑫







To a flame dried round bottomed flask charged with LiAlH4 (20 mg, 0.30 mmol, 300 
mol%) in THF (0.05 M) was added 3.8a (21.7 mg, 0.1 mmol, 100 mol%) in THF (0.05 M) 
at 0 °C. The reaction mixture was stirred reflux for 6 hours. Water (30 µL), NaOH (10% 
aq. Solution, 30 µL), and MgSO4 added to the reaction mixture. The resulting mixture was 
filtered over a celite plug, washed with MeOH, and the solvent removed in vacuo. The 
residue was subjected to flash column chromatography (SiO2, 95:5 DCM:MeOH) to yield 
the title compound 3.5a (14.6 mg, 0.07 mmol, >20:1 dr) as a pale-yellow oil in 72% yield. 
 
TLC (SiO2) Rf = 0.22 (95:5 DCM:MeOH) 
1H NMR (500 MHz, CDCl3) : 7.29 – 7.26 (m, 2H), 7.21 – 7.19 (m, 3H), 6.43 (dt, J = 
17.1, 9.6 Hz, 1H), 5.33 (d, J = 9.7 Hz, 1H), 5.24 (d, J = 17.3 Hz, 1H), 3.96 (ddd, J = 
8.4, 6.0, 2.6 Hz, 1H), 3.93 (dt, J = 11.5, 3.0 Hz, 1H), 3.69 (td, J = 11.1, 2.8 Hz, 1H), 
3.25 (dd, J = 8.8, 2.7 Hz, 1H), 3.21 (td, J = 11.4, 3.6 Hz, 1H), 2.81 (dd, J = 14.3, 8.0 
Hz, 1H), 2.66 (dt, J = 12.2, 2.8 Hz, 1H), 2.57 (dd, J = 14.2, 6.0 Hz, 1H), 2.09 (brs, 1H). 
13C NMR (125 MHz, CDCl3) : 138.2, 134.2, 129.4, 128.5, 126.4, 119.6, 79.1, 67.1, 58.7, 
40.6, 38.3. 
HRMS (H+, m/z) for C13H17NO: calcd. = 204.1383; found = 204.1387. 
FTIR (neat): 2921, 2854, 1454, 1085, 923, 698. 
[𝜶]𝑫









To a solution of alcohol 3.3m (50.0 mg, 0.117 mmol, 100 mol%) in dried DMF (220 µL) 
was added Et3N (82 µL, 0.585 mmol, 500 mol%), TBSCl (44.0 mg, 0.293 mmol, 250 
mol%) and 4-(dimethylamino)pyridine (2.9 mg, 0.0232 mmol, 20 mol%). The reaction was 
heated to 45 °C for 48 h. The contents were diluted with CH2Cl2 (2 mL) and washed with 
H2O (2 mL). The aqueous layer was extracted with CH2Cl2 (2 x 5 mL), and the combined 
organic phases were washed with brine (2 mL), dried (Na2SO4), filtered and the solvent 
was removed in vacuo. The residue was subjected to flash chromatography on silica 
(EtOAc:hexanes 10:90) to furnish the title compound 3.9m (43.5 mg, 0.102 mmol) in 87% 
yield as a clear oil. 
 
TLC (SiO2) Rf = 0.26 (10:90 EtOAc:hexanes) 
1H NMR (500 MHz, CDCl3) : 7.85 (dd, J = 5.4, 3.1 Hz, 2H), 7.74 (dd, J = 5.4, 3.0 Hz, 
2H), 6.25 (ddd, J = 17.2, 10.1, 7.2 Hz, 1H), 5.25 – 5.22 (m, 2H), 4.62 – 4.55  (m, 2H), 
2.35 – 2.24 (m, 1H), 2.21 – 2.10 (m, 1H), 1.80 – 1.73 (m, 1H), 1.61 – 1.54 (m, 1H), 
0.90 (s, 9H), 0.11 (s, 3H), 0.10 (s, 3H). 
13C NMR (125 MHz, CDCl3) : 168.0, 134.4, 133.4, 131.8, 127.6 (q, J = 275.8 Hz), 123.6, 
120.0, 68.9, 57.1, 27.6 (q, J = 29.0 Hz), 25.9, 18.1, – 4.2, – 4.2. 
19F NMR (470 MHz, CDCl3) δ: -66.5 (t, J = 10.8 Hz). 
HRMS (Na+, m/z) for C21H28F3NO3Si: calcd. = 450.1683; found =450.1686. 
FTIR (neat): 2956, 2931, 2858, 1716, 1379, 1254, 1060, 834, 717. 
[𝜶]𝑫









trifluorohexanoic acid (3.6m) 
 
To a stirred solution of 3.9m (100.0 mg, 0.230 mmol, 100 mol%), in 0.650 mL CCl4, 0.650 
mL CH3CN, and 1.0 mL H2O was added NaIO4 (201.2 mg, 0.940 mmol, 400 mol%). After 
all the NaIO4 had dissolved, RuCl3.H2O (4.8 mg, 0.023 mmol, 10 mol%) was added, and 
the reaction mixture was stirred vigorously for 24 h at 25 °C. The contents were diluted 
with DCM (5 mL) and washed with H2O (5 mL). The aqueous layer was extracted with 
DCM (3 x 5 mL), and the combined organic phases were washed with brine (5 mL), dried 
(Na2SO4), filtered and the solvent was removed in vacuo. The residue was subjected to 
flash chromatography on silica (Hexanes/MeOH 90:10) to furnish the title compound 3.6m 
(59.2 mg, 0.136 mmol) in 59% yield as a white solid. 
 
TLC (SiO2) Rf = 0.22 (10:90 MeOH:DCM) 
1H NMR (500 MHz, MeOD) : 7.89 (dd, J = 5.4, 3.1 Hz, 2H), 7.83 (dd, J = 5.4, 3.0 Hz, 
2H), 4.73 – 4.70 (m, 1H), 2.28 – 2.13  (m, 2H), 2.10 – 2.03 (m, 1H), 1.62 – 1.54 (m, 
1H), 0.85 (s, 9H), 0.23 (s, 3H), 0.14 (s, 3H). 
13C NMR (125 MHz, MeOD) : 170.2, 168.0, 134.4, 131.6, 127.3 (q, J = 275.8 Hz), 122.9, 
78.1, 70.0, 30.0 (q, J = 29.0 Hz), 26.4, 24.9, 17.4, – 5.7, – 6.0. 
19F NMR (470 MHz, MeOD) δ: -68.0 (t, J = 10.8 Hz). 
HRMS (Na+, m/z) for C20H26F3NO5Si: calcd. = 468.1425; found =468.1425. 
FTIR (neat): 2935, 2360, 1720, 1385, 1253, 1066, 835, 777, 721. 
[𝜶]𝑫
𝟐𝟒 = −31.1° (c = 1.83, CHCl3). 








3.5.3.6 Isotopic Labeling Studies 
2-phenylethan-1,1-d2-1-ol (deuterio-3.2a) 
 
The title compound was synthesized over one step from 2-phenylacetic acid following 
literature procedures.25 
 
1H NMR (500 MHz, CDCl3) : 7.34 − 7.30 (m, 2H), 7.26 − 7.22 (m, 3H), 2.86 (brs, 2H) 
2H NMR (92 MHz, CHCl3) : 3.86 (brs, 2D) 






Alcohol deuterio-3.2a (24.0 µL, 0.2 mmol) was subjected to standard reaction conditions 
(100 C, 48 h).  Upon flash column chromatography (SiO2, 20:80 EtOAc:hexanes), the title 
compound deuterio-3.3a (41.8 mg, 0.14 mmol, >20:1 dr) was obtained as a light yellow 
solid in 68% yield. 
 
TLC (SiO2) Rf = 0.35 (20:80 EtOAc:hexanes) 
1H NMR (500 MHz, CDCl3) : 7.83 (dd, J = 5.4, 3.1 Hz, 2H), 7.73 (dd, J = 5.5, 3.0 Hz, 
2H), 7.28 – 7.15 (m, 5H), 6.39 – 6.30 (m, 0.4H), 5.37 – 5.28 (m, 1.75H), 4.78 – 4.76 
(m, 1H), 3.42 (brs, 1H), 2.89 – 2.81 (m, 2H). 
2H NMR (92 MHz, CHCl3) : 6.38 (brs, 0.6D), 5.37 (brs, 0.25D), 4.41 (brs, 1D). 








A mix of alcohol 3.2a (120 µL, 1.0 mmol) and alcohol deuterio-3.2a (120.0 µL, 1.0 mmol) 
was subjected to standard reaction conditions (100 C, 48 h).  Upon flash column 
chromatography (SiO2, 20:80 EtOAc:hexanes), title compounds deuterio-3.3a and 3.3a 
(31.9 mg, 0.10 mmol, >20:1 dr) was obtained as a light yellow solid in 52% yield. 
 
TLC (SiO2) Rf = 0.35 (20:80 EtOAc:hexanes) 
1H NMR (500 MHz, CDCl3) : 7.83 (dd, J = 5.4, 3.1 Hz, 2H), 7.73 (dd, J = 5.5, 3.0 Hz, 
2H), 7.28 – 7.15 (m, 5H), 6.39 – 6.30 (m, 0.85H), 5.37 – 5.28 (m, 1.95H), 4.78 – 4.76 (m, 
1H), 4.41 (ddd, J = 7.8, 5.9, 4.7 Hz, 0.7H), 3.42 (brs, 1H), 2.89 – 2.81 (m, 2H). 
2H NMR (92 MHz, CHCl3) : 6.38 (brs, 1D), 5.37 (brs, 1D), 4.41 (brs, 1D). 
HRMS (Na+, m/z) for C19H17NO3: calcd. = 330.1101; found = 330.1105. 
HRMS (Na+, m/z) for C19H16DNO3: calcd. = 331.1163; found = 331.1164. 







Intermolecular competition experiment: 
 
A mix of dehydro-3.2l (19 mg, 0.1 mmol) and Alcohol deuterio-3.2a (12 µL, 0.1 mmol) 
was subjected to standard reaction conditions (100 C, 48 h).  Upon flash column 
chromatography (SiO2, 20:80 EtOAc:hexanes), title compounds deuterio-3.3a (13.0 mg, 
0.042 mmol, 21% yield) and deuterio-3.3l (21.3 mg, 0.056 mmol, 28% yield) were 
obtained as a light yellow solid and pale yellow oil respectively. 
 
TLC (SiO2) Rf-deutreio-3a = 0.35 (20:80 EtOAc:hexanes) 
TLC (SiO2) Rf-deuterio-3l = 0.28 (30:70 EtOAc:hexanes) 
 
Deuterio-3l: 
1H NMR (500 MHz, CDCl3) : 7.84 (dd, J = 5.4, 3.1 Hz, 2H), 7.73 (dd, J = 5.4, 3.0 Hz, 
2H), 7.23 (d, J = 8.5 Hz, 2H), 6.85 (d, J = 8.6 Hz, 2H), 6.38 – 6.28 (m, 0.4H), 5.32 – 
5.23 (m, 1.90H), 4.74 – 4.69 (m, 1H), 4.46 – 4.39 (m, 2H), 4.35 (dd, J = 12.1, 5.8 Hz, 
1H), 3.92 (s, 1H), 3.78 (s, 3H), 3.71 – 3.65 (m, 1H), 3.64 – 3.58 (m, 1H), 1.85 – 1.77 
(m, 2H). 
2H NMR (92 MHz, CHCl3) : 6.36 (brs, 1D), 5.31 (brs, 1D) 









3.5.3.7 Single Crystal Diffraction Data 
Single Crystal Diffraction Data for Coupling Product 3.3a 
Empirical formula  C19 H17 N O3 
Formula weight  307.33 
Temperature  100(2) K 
Wavelength  1.54184 Å 
Crystal system  triclinic 
Space group  P 1 
  Unit cell dimensions a = 7.6636(2) Å = 86.249(2)°. 
 b = 9.5929(2) Å = 76.166(2)°. 
 c = 10.8499(2) Å  = 79.110(2)°. 
Volume 760.39(3) Å3 
Z 2 
Density (calculated) 1.342 Mg/m3 
Absorption coefficient 0.738 mm-1 
F(000) 324 
Crystal size 0.34 x 0.12 x 0.065 mm3 
Theta range for data collection 4.197 to 75.699°. 
Index ranges -9<=h<=9, -11<=k<=12, -13<=l<=13 
Reflections collected 26510 
Independent reflections 5735 [R(int) = 0.0395] 
Completeness to theta = 67.684° 99.7 %  
Absorption correction Gaussian and multi-scan 
Max. and min. transmission 1.00 and 0.534 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 5735 / 3 / 433 
Goodness-of-fit on F2 1.048 
Final R indices [I>2sigma(I)] R1 = 0.0357, wR2 = 0.0952 
R indices (all data) R1 = 0.0367, wR2 = 0.0961 
Absolute structure parameter 0.04(10) 
Extinction coefficient n/a 
Largest diff. peak and hole 0.175 and -0.218 e.Å-3 
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Figure 3.4 Crystal Structure of 3.3a Dimer 
View of H-bound dimer formed in 3.3a showing the heteroatom labeling scheme.  
Displacement ellipsoids are scaled to the 50% probability level.  Dashed lines are indicative 
of an H-bonding interaction.  
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Single Crystal Diffraction Data for Coupling Product 3.3v 
Empirical formula  C16 H17 N O3 
Formula weight  271.30 
Temperature  100(2) K 
Wavelength  1.54184 Å 
Crystal system  monoclinic 
Space group  P 21 
  Unit cell dimensions a = 8.3815(2) Å = 90°. 
 b = 22.4250(2) Å = 117.675(2)°. 
 c = 8.6781(2) Å  = 90°. 
Volume 1444.49(5) Å3 
Z 4 
Density (calculated) 1.248 Mg/m3 
Absorption coefficient 0.702 mm-1 
F(000) 576 
Crystal size 0.31 x 0.18 x 0.11 mm3 
Theta range for data collection 3.943 to 76.170°. 
Index ranges -10<=h<=10, -28<=k<=28, -10<=l<=10 
Reflections collected 33708 
Independent reflections 5984 [R(int) = 0.0393] 
Completeness to theta = 67.684° 100.0 %  
Absorption correction Gaussian and multi-scan 
Max. and min. transmission 1.00 and 0.713 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 5984 / 1 / 389 
Goodness-of-fit on F2 1.020 
Final R indices [I>2sigma(I)] R1 = 0.0372, wR2 = 0.1006 
R indices (all data) R1 = 0.0378, wR2 = 0.1026 
Absolute structure parameter -0.09(6) 
Extinction coefficient n/a 
Largest diff. peak and hole 0.385 and -0.211 e.Å-3 
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Figure 3.5 Crystal Structure of 3.3v 
View of 3.3v showing the atom labeling scheme.  Displacement ellipsoids are scaled to the 




Single Crystal Diffraction Data for (R)-Ir-VI 
Empirical formula  C58 H55 Ir N2 O7 P2 
Formula weight  1146.18 
Temperature  100(2) K 
Wavelength  0.71073 Å 
Crystal system  orthorhombic 
Space group  P 21 21 21 
  Unit cell dimensions a = 14.339(2) Å = 90°. 
 b = 17.764(2) Å = 90°. 
 c = 18.920(3) Å  = 90°. 
Volume 4819.4(11) Å3 
Z 4 
Density (calculated) 1.580 Mg/m3 
Absorption coefficient 2.896 mm-1 
F(000) 2320 
Crystal size 0.220 x 0.110 x 0.100 mm3 
Theta range for data collection 2.293 to 28.413°. 
Index ranges -19<=h<=19, -23<=k<=23, -25<=l<=25 
Reflections collected 67534 
Independent reflections 12021 [R(int) = 0.0906] 
Completeness to theta = 25.242° 99.9 %  
Absorption correction Numerical 
Max. and min. transmission 1.00 and 0.759 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 12021 / 420 / 631 
Goodness-of-fit on F2 1.024 
Final R indices [I>2sigma(I)] R1 = 0.0377, wR2 = 0.0773 
R indices (all data) R1 = 0.0489, wR2 = 0.0806 
Absolute structure parameter -0.007(4) 
Extinction coefficient n/a 
Largest diff. peak and hole 1.197 and -0.918 e.Å-3 
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Figure 3.6 Crystal Structure of (R)-Ir-IV Complex 
View of the Ir complex showing the heteroatom labeling scheme.  Displacement ellipsoids 




3.5.3.8 Kinetic Studies 
Standard Conditions:  To a dried 5 mL volumetric flask under an argon atmosphere 
charged with with (R)-Ir-VI (53.7mg, 0.05 mmol, 5 mol%), phthalimido-allene (277.8 mg, 
1.5 mmol, 150 mol%), KH2PO4 (136.1 mg, 1 mmol, 100 mol%), and 1,3,5-
trimethoxybenzene (internal standard, 168.2 mg , 1 mmol, 100 mol%) was added 2-
phenylethanol (120 L, 1 mmol, 100 mol%).  The flask was then filled to the mark with 
dioxane and sonicated until full dissolution. The reaction mixture was then transfer via 
syringe to a condenser-tube sealed with a rubber septa under an argon atmosphere.  The 
reaction mixture was then heated to 100 C. 
 
Reaction progress was monitored by sampling followed by NMR analysis.  The reaction 
was sampled by removable of approximately 100 L of the reaction mixture via syringe 
and dilution with CDCl3. 




Figure 3.7 Product Formation Under Standard Conditions 
 
 


















































Figure 3.9 Product Formation Under Standard Conditions for First 2 Hours to Determine 
Initial Rate Utilizing deuterio-3.2a 
 
 


















































Figure 3.11 Product Formation Under Different Excess 2 Conditions 
 
 


















































Figure 3.13 Product Formation Under Same Excess Conditions with Product Addition 
 
 





















































Figure 3.16 Product Formation Under Standard Conditions with 10 mol% Aldehyde 



















































In order to determine if any catalyst deactivation occurred during the reaction the 
same excess protocol was utilized. The collected product concentration data for both the 
standard and same excess data sets were converted to alcohol concentration data ([3.2a]t = 
[3.2a]0 – [3.3a]t). Since the starting concentration of the same excess experiments is 
different than that of the standard experiment, the same excess time data was adjusted 
accordingly. This method is representative of starting the reaction from two different 
starting points. At the point where the standard data set reaches the starting point of the 
same excess data set they then represent a reaction with the same conditions, with the 
exception of the first containing product already present and a catalyst that has completed 
more turnovers.20 The failure of these two curves to overlap indicates that significant 
catalyst deactivation occurs. Additionally, in the case of the same excess conditions with 
product addition, a slight shift towards the standard conditions indicates that the product is 
contributing to the deactivation pathway. This is only a moderate contribution.  


































Chapter 4: Regio- and Enantioselective Iridium-Catalyzed Amination of 
Racemic Branched Alkyl-Substituted Allylic Acetates with Primary and 
Secondary Aromatic and Heteroaromatic Amines* 
4.1 INTRODUCTION  
Cyclometalated π-allyliridium C,O-benzoate complexes have been shown to 
catalyze diverse alcohol-mediated carbonyl allylations using allyl carboxylates as 
pronucleophiles.1 In these umpoled allylations,2 the C,O-benzoate moiety assists in 
maintaining neutrality and, hence, nucleophilicity of the π-allyliridium intermediate. 
Nucleophilic properties are displayed by other neutral π-allyliridium species.3 In contrast, 
as illustrated by enantioselective Tsuji−Trost-type allylic aminations developed by 
Takeuchi,4,5 Helmchen,6,7 Hartwig,8,9 Carreira,10 and You,11,12 cationic π-allyliridium 
species invariably serve as electrophiles. In this latter context, two distinct classes of 
iridium catalysts have emerged. Type I catalysts are used under basic conditions in 
combination with linear allyl pro-electrophiles (as branched allyl proelectrophiles react 
stereospecifically).13 Type II catalysts are used under acidic conditions in combination with 
branched allyl proelectrophiles, which react in a non-stereospecific fashion, perhaps due to 
displacement of the π-bond of (σ+π)-allyl (enyl) iridium intermediates by the tethered 
olefin of the phosphoramidite ligand (Figure 4.1).14 
The Krische group previously discovered that neutral π-allyliridium C,O-benzoate 
complexes, which behave as nucleophilic allyl donors,1 can also act as electrophiles, 
representing the first examples of amphiphilic reactivity in the context of transition metal  
 
* This chapter is based on the previously published work: 
Kim, S. W.; Schwartz, L. A.; Zbieg, J. R.; Stivala, C. E.; Krische, M. J. Regio- and Enantioselective 
Iridium-Catalyzed Amination of Racemic Branched Alkyl-Substituted Allylic Acetates with Primary and 
Secondary Aromatic and Heteroaromatic Amines. J. Am. Chem. Soc. 2019, 141, 671. 
L.A.S. contributed to reaction optimization (Scheme 4.1), substrate scope (Tables 4.1, 4.2, and 4.3; Scheme 
4.2), and preparation of manuscript and supporting information. 
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Figure 4.1 Cationic versus Neutral Chiral Iridium Complex for Regio- and 
Enantioselective Allylic Amination 
 
catalysis.15 In the initial communication of these findings, enantioselective allylic 
aminations of branched allylic acetates bearing linear alkyl groups with primary aliphatic 
amines were disclosed.15 These aminations proceed with complete branched 
regioselectivity, overcoming a significant limitation associated with Type I and II catalysts, 
which display incomplete regioselectivity for π-allyl precursors bearing linear alkyl 
groups.16,17 With regard to the amine nucleophile, the Type III SEGPHOS-modified π-
allyliridium complexes used in the initial study enforced high enantioselectivities in 
reactions of primary aliphatic amines (Figure 4.1). The corresponding tol-BINAP-modified 
iridium catalyst provides a significant expansion in scope, enabling highly enantioselective 
aminations of branched alkyl-substituted allylic acetates with electronically diverse 
 550 
primary and secondary aryl amines, including site-selective reactions of bis(amine) 
nucleophiles. Additionally, deuterium labeling studies corroborate C–N bond formation 
occurs via an outer-sphere mechanism. 
4.2 REACTION DEVELOPMENT AND SCOPE 
To develop highly regio- and enantioselective allylic aminations mediated by aryl 
amines, a series of π-allyliridium C,O-benzoate complexes were evaluated in reactions of 
α-methyl allyl acetate (100 mol%) and aniline (200 mol%) under conditions previously 
optimized for primary aliphatic amines.15 The iridium catalyst modified by tol-BINAP, (S)-
Ir-II, delivered the product of allylic amination 4.4a with significantly higher levels of 
enantioselectivity than the corresponding SEGPHOS-modified catalyst, (S)-Ir-I, but a 
lower isolated yield of 4.4a was observed (Scheme 4.1). Changing the solvent from THF 
to DME improved the isolated yield of 4.4a, and by decreasing the reaction temperature 
from 80 to 70 °C 4.4a could be formed in 82% yield and 89% enantiomeric excess (Scheme 
4.1). 
Scheme 4.1 Selected Optimization Experiments in the Iridium-Catalyzed Amination of 
α-Methyl Allyl Acetate 4.1a with Aniline 4.4a 
 
Deviation from these reaction parameters did not result in further improvement, and 
given the low cost of tol-BINAP these conditions were adopted to explore the scope of 
primary aromatic and heteroaromatic amine nucleophiles 4.2[a−l] in aminations of α-
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methyl allyl acetate (Table 4.1). Amine nucleophiles containing a diverse array of 
functional groups were examined to mirror challenges faced in medicinal chemistry. In 
each case, the targeted products of allylic amination 4.4[a−l] were formed with complete 
Table 4.1 Iridium-Catalyzed Amination of α-Methyl Allyl Acetate 4.1a with Primary 
Aromatic and Heteroaromatic Amine 4.2[a–l] To Form Enantiomerically 
Enriched Allylic Amines 4.4[a–l]a 
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branched regioselectivity and uniformly high levels of enantioselectivity. As illustrated in 
the formation of 4.4d, which incorporates a pinacol boronate moiety, the reaction 
conditions tolerate rather sensitive functional groups. The tolerance of ortho-substituted 
anilines, as demonstrated by the formation of 4.4e, is also noteworthy. Perhaps the most 
striking feature, however, is the compatibility of the catalyst with electronically diverse 
aryl amine partners and the tolerance of Lewis basic N-heterocycles, as illustrated by the 
formation 4.4k and 4.4l. The absolute stereochemical assignment of adducts 4.4[b−l] is 
made in analogy to that determined for compound 4.4a, which has been prepared in 
enantiomerically enriched form in two separate reports.8d,18 
In a further exploration of scope, optimized conditions were applied to the 
amination of α-methyl allyl acetate 4.1a using secondary aromatic and heteroaromatic 
amine nucleophiles 4.3[a−l] (Table 4.2). Indoline 4.3a, 6- and 7-aza-indolines 4.3b and 
4.3c, and the 3,3′-spirocyclic indoline 4.3d each underwent asymmetric allylation with 
complete branched regioselectivity and high levels of enantioselectivity. Pronounced 
match-mismatched effects were observed in the conversion of (S)- and (R)-2-methyl 
indolines 4.3e and 4.3f to adducts 4.5e and 4.5f, respectively, suggesting the potential for 
kinetic resolution. The amination of 4.1a using N-methyl aniline 4.3g and related 
compounds 4.3h and 4.3i bearing electron withdrawing and donating groups at the para-
position proceeded smoothly to form adducts 4.5[g−i], respectively. Among these three N-
methyl aniline derivatives (4.3[g−i]), amination using the more-electron-rich N-methyl-p-
anisidine 4.3i occurred with notably higher levels of enantioselectivity. As illustrated by  
the formation of 4.5j and 4.5k, N-methyl anilines containing bromide (4.3j) and chloride 
(4.3k) functional groups are tolerated. Finally, amination of 4.1a using N-methyl-2-
(methylamino)benzimidazole 4.3l is remarkably efficient, providing adduct 4.5l in 94% 
yield with complete selectivity for allylation of the extranuclear 2-(methylamino) moiety.  
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Table 4.2 Iridium-Catalyzed Amination of α-Methyl Allyl Acetate 4.1a with Secondary 
Aromatic and Heteroaromatic Amines 4.3[a–l] To Form Enantiomerically 
Enriched Allylic Amines 4.5[a–l]a 
 
 
To assess how structural variation of the π-allyliridium intermediate impacts 
reactivity, regio- and stereoselectivity, a set of branched allylic acetates 4.1[a−g] were 
explored in aminations mediated by 2-(methylamino)benzoxazole 4.3m (Table 4.3). In 
addition to α-methyl allyl acetate 4.1a, linear alkyl-substituted allylic acetates 4.1b and4.1c 
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smoothly underwent amination to form adducts 4.6[a−c] as single regioisomers with high 
levels of enantiomeric enrichment. Allylic acetates 4.1[d−f], which incorporate cycloalkyl  
Table 4.3 Iridium-Catalyzed Amination of α-Substituted Allyl Acetates 4.1[a–g] with 
Secondary Heteroaromatic Amine 4.3m To Form Enantiomerically 
Enriched Allylic Amines 4.6[a–g]a 
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substituents, delivered adducts 4.6[d−f] as single regioisomers, although an erosion in 
enantioselectivity is observed using the larger cyclopentyl-substituted allyl acetate 4.1f. 
Finally, using the enantiomeric iridium catalysts (S)-Ir-II and (R)-Ir-II, the (S)-citronellol-
derived allylic acetate 4.1g reacts with 4.3m to form 4.6g and iso-4.6g, respectively, with 
good levels of catalyst-directed diastereoselectivity. Under these conditions, aryl-
substituted allyl acetates gave low yields (<10%) of allylic amination product, and linear 
allylic acetates provided mixtures of allylic amination and hydroamination product in low 
isolated yield.19 
Having established the ability to functionalize both primary and secondary aromatic 
amines, we attempted the site-selective modification of reactants 4.3[n−p], which 
incorporate both primary and secondary aromatic amines, using the branched allylic acetate 
4.1a (Scheme 4.2, eqs 1−3). Upon exposure to standard conditions, 5-aminoindole 4.3n 
undergoes completely chemoselective functionalization at the primary amine to form 
adduct 4.7a as a single constitutional isomer with excellent levels of enantioselectivity 
(Scheme 4.2, eq. 1). Similarly, in the conversion of 4.3o to adduct 4.7b, complete control 
of regio- and site-selectivity is accompanied by high levels of enantioselectivity (Scheme 
4.2, eq. 2). The structure of adduct 4.7b was verified by single crystal X-ray diffraction 
analysis, further corroborating the absolute stereochemical assignment of adducts 4.4[a−l], 
4.5[a−l] and 4.6[a−g]. Finally, N-cyclohexyl-1,2-diaminobenzene 4.3p reacts with 4.1a to 
deliver adduct 4.7c, which is modified exclusively at the primary amine (Scheme 4.2, eq. 
3). The ability to engage diamines in site-selective regio- and enantioselectiveamination 
enhances step economy by avoiding manipulations devoted to N-protection–deprotection. 
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Scheme 4.2 Site-Selective Iridium-Catalyzed Amination of α-Methyl Allyl Acetate 4.1a 
with Amines 4.3[n–p] To Form Enantiomerically Enriched Allylic 
Amines 4.7[a–c] 
 
4.3 MECHANISM AND DISCUSSION 
To better understand the nature of the C–N bond forming event, asymmetric 
amination of the enantiomerically enriched (Z)-deuterated allylic acetate 4.1h was 
conducted under standard conditions using (S)-Ir-II (Scheme 4.3, eq. 4).20 Compound 4.8a 
is formed with complete alkene (Z)-stereoselectivity, as determined by 1H NMR. Assuming 
formation of the π-allyliridium occurs with inversion of stereochemistry, as established in 
analogous iridium-phosphoramidite-catalyzed processes,4−12 the stereochemistry of the 
amination product 4.8a is consistent with outer-sphere addition of the nitrogen nucleophile. 
To corroborate this experiment, the amination of allylic acetate 4.1h was conducted using 
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the enantiomeric iridium catalyst, (R)-Ir-II (Scheme 4.3, eq. 5). The amination product 
4.8b is formed with complete alkene (E)-stereoselectivity, as determined by 1H NMR. The 
stereochemistry of 4.8a is again consistent with outer-sphere C–N bond formation. 
Scheme 4.3 Iridium-Catalyzed Amination of Enantiomerically Enriched Deuterated 
Allylic Acetate 4.1h with the Enantiomeric Catalysts (S)-Ir-II (Eq. 4) 
and (R)-Ir-II (Eq. 5)a 
 
Based on the collective data, a general catalytic mechanism and stereochemical 
model were proposed (Scheme 4.4). The π-allyliridium(I) complex I is subject to outer-
sphere amine addition to form the C–N bond and the zwitterionic iridium(I) olefin complex 
II. Deprotonation of ammonium moiety of complex II mediated by cesium carbonate 
generates the anionic iridium(I) species III. Alkene exchange with the allylic acetate 
releases the product of allylic amination and forms the olefin complex IV. Loss of acetate 
ion regenerates the π-allyliridium(I) complex I to close the catalytic cycle. The indicated 
stereochemical model accounts for the observed sense of absolute stereoinduction for outer 
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sphere addition of a nucleophile to the neutral iridium π-allyl complex I. This model is 
based upon the coordination mode revealed in closely related crystal structures.21 
Orientation of the π-allyl is controlled through alleviation of steric clashes between the 
naphthyl and tolyl substituents of the phosphine ligand with the R-group of the resulting 
π-allyl, as illustrated in the disfavored mode of addition (Scheme 4.4). 
Scheme 4.4 General Catalytic Mechanism and Stereochemical Model for 





Previously reported enantioselective allylic aminations are largely restricted to 
chiral iridium–phosphoramidite catalysts.4−12 In comparison to the initial report from the 
Krische group on iridium-catalyzed allylic amination, the tol-BINAP-modified complex 
described above is a significantly more effective catalyst for allylic amination, which has 
enabled use of primary and secondary aromatic or heteroaromatic amine nucleophiles. 
These π-allyliridium C,O-benzoate catalyzed processes overcome a longstanding 
limitation associated with all known catalytic systems for asymmetric allylic amination – 
the ability to promote enantioselective aminations of racemic branched allylic acetates 
bearing n-alkyl groups with complete levels of regioselectivitity.4−12,16 Another notable 
feature of these catalysts involves the ability to promote site-selective N-allylations of 
reactants that incorporate both primary and secondary aromatic amines. As demonstrated 
by mechanistic studies involving amination of the enantiomerically enriched deuterated 
allylic acetate 4.1h, an outer-sphere mechanism for C–N bond formation is operative. This 
work, along with the Krische group’s prior studies,15 significantly expands the scope of 




4.5 EXPERIMENTAL DETAILS 
4.5.1 General Information 
All reactions were carried out under inert gas atmosphere (nitrogen or argon) unless 
otherwise indicated. Resealable pressure tubes (13x100 mm) were purchased from Fischer 
Scientific (catalog number 14-959-35C) and were flame dried followed by cooling in a 
desiccator or under a stream of inter gas prior to use. All commercial reagents and 
anhydrous solvents were used as received from vendors (Fischer Scientific, Sigma Aldrich 
and Combi Blocks) without further purification. The used Iridium catalyst (S)-Ir-II and 
(R)-Ir-II was prepared according to literature known procedures.21 Cesium carbonate was 
used as received from Rockwell Lithium. Preparative column chromatography employing 
Silicycle silica gel (40-63 μm) was performed according to the method of Still22 or on a 
Teledyne Isco Combiflash Rf utilizing Silicycle HP columns using a mobile phase 
composed of either heptane/isopropyl acetate, heptanes/ethyl acetate or 
dichloromethane/methanol. Reactions were monitored by a Shimadzu LCMS/UV system 
with LC-30AD solvent pump, 2020 MS, Sil-30AC autosampler, SPD-M30A UV detector, 
CTO-20A column oven, using a 2-98% acetonitrile/0.1% formic acid (or 0.001% 
ammonia) gradient over 2.5 minutes. Analytical thin-layer chromatography (TLC) was 
carried out using 0.25 mm commercial silica gel plates (Dynamic Absorbents F). 
Visualization was accomplished with UV light followed by dipping in CAM, p- 
Anisaldehyde (PAA), or KMnO4 stain solution followed by heating.  
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4.5.2 Spectroscopy, Spectrometry, and Data Collection 
Infrared spectra were recorded on a Perkin-Elmer 1600 spectrometer using a 
diamond ATR unit. High-resolution mass spectra (HRMS) were obtained on a Karatos 
MS9 and are reported as m/z (relative intensity). Accurate masses are reported for the 
molecular ion (M+H, M+Na), or a suitable fragment ion. Nuclear magnetic resonance (1H, 
13C, 19F NMR) spectra were recorded with a Bruker BioSpin GmbG, Varian Gemini (400 
MHz) or Varian INOVA (500 MHz) spectrometer equipped with a Bruker cryoprobe. The 
chemical shifts are given as parts per million (ppm) and were referenced to the residual 
solvent signal (CDCl3: δH = 7.26 ppm, δC = 77.16 ppm). Specific optical rotations were 
recorded on an Atago AP-300 automatic polarimeter at the sodium line (589 nm) in CHCl3. 
Solution concentrations are given in the units of 10–2 g mL–1. 
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4.5.3 Experimental Details and Spectral Data 
4.5.3.1 Synthesis of Allylic Acetates 4.1[e–g] 
The allylic acetates 4.1[e–g] were prepared by the Grignard reaction and acetylation 
of the as shown below. The allylic acetates 4.1b,23 4.1c,24 and 4.1d25 were identical in all 
respects to the reported materials. 
 
 
To a round-bottomed flask charged with the corresponding aldehyde under an argon 
atmosphere was added THF (0.2 M). The reaction flask was placed an ice batch. After 10 
minutes, vinyl magnesium bromide solution (120 mol%, 1.0 M in THF) was added slowly 
and the mixture was stirred at room temperature for 1 hour, at which point acetic anhydride 
(150 mol%) and triethylamine (200 mol%) were added and the reaction was stirred 
vigorously overnight. After water was added, the mixture was transferred to a separatory 
funnel. The organic layer was extracted with diethyl ether and the combined organic layers 
were washed with 1N HCl, dried (MgSO4), filtered and concentrated under reduced 
pressure. The resulting oily residue was subjected to flash column chromatography give 
the corresponding allylic acetate over 2 steps. 
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1-cyclobutylallyl acetate (4.1e) 
 
The title compound was prepared by the general procedure. 
 
TLC (SiO2) Rf  = 0.61 (heptanes: isopropyl acetate = 4:1).  
1H NMR (500 MHz, CDCl3): δ = 5.70 (ddd, J = 17.2, 10.5, 6.3 Hz, 1H), 5.25 – 5.13 (m, 
3H), 2.58 – 2.45 (m, 1H), 2.07 (s, 3H), 1.97 (dddd, J = 18.3, 9.9, 8.0, 4.7 Hz, 2H), 1.90 
– 1.74 (m, 4H). 
13C NMR (125 MHz, CDCl3): δ = 170.6, 134.6, 116.9, 77.9, 38.3, 24.3, 24.0, 21.2, 18.0. 
LRMS (CI): Calculated for C7H11 [M–OAc]
+ = 95, Found 95. 













1-cyclopentylallyl acetate (4.1f) 
 
The title compound was prepared by the general procedure. 
 
TLC (SiO2) Rf  = 0.61 (heptanes: isopropyl acetate = 4:1).  
1H NMR (500 MHz, CDCl3): δ = 5.70 (ddd, J = 17.2, 10.5, 6.7 Hz, 1H), 5.16 (dt, J = 17.2, 
1.4 Hz, 1H), 5.09 (dt, J = 10.6, 1.3 Hz, 1H), 5.07 – 5.02 (m, 1H), 2.07 – 1.94 (m, 4H), 1.70 
– 1.41 (m, 6H), 1.30 – 1.14 (m, 2H). 
13C NMR (125 MHz, CDCl3): δ = 170.4, 135.9, 116.9, 78.4, 43.5, 28.8, 28.6, 25.5, 25.3, 
21.3. 
LRMS (CI): Calculated for C8H13 [M–OAc]
+ = 109, Found 109. 




(5S)-5,9-dimethyldeca-1,8-dien-3-yl acetate (4.1g) 
 
The title compound was prepared by the general procedure. 
 
TLC (SiO2) Rf  = 0.46 (heptane: isopropyl acetate = 9:1).  
1H NMR (400 MHz, CDCl3): δ = 5.76 (dddd, J = 17.2, 13.3, 10.5, 6.5 Hz, 1H), 5.38 – 5.27 
(m, 1H), 5.23 (ddt, J = 17.2, 8.7, 1.3 Hz, 1H), 5.14 (tt, J = 10.5, 1.2 Hz, 1H), 5.08 (tdd, 
J = 8.4, 4.9, 3.5 Hz, 1H), 2.05 (d, J = 3.9 Hz, 3H), 2.02-1.87 (m, 2H), 1.67 (s, 3H), 1.60 
(d, J = 3.1 Hz, 3H), 1.55-1.45 (m, 2H), 1.40-1.10(m, 3H), 0.91 (t, J = 6.4 Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ = 170.3 (d, J = 14.9 Hz), 136.9 (d, J = 48.9 Hz), 131.3 (d, 
J = 2.2 Hz), 124.6 (d, J = 5.1 Hz), 116.4 (d, J = 76.0 Hz), 73.2 (d, J = 68.0 Hz), 41.4 
(d, J = 28.2 Hz), 37.0 (d, J = 48.7 Hz), 28.8 (d, J = 18.5 Hz), 25.7, 25.3 (d, J = 8.3 Hz), 
21.3 (d, J = 8.2 Hz), 19.6 (d, J = 29.8 Hz), 17.7. 
HRMS (CI): Calculated for C14H24O2 [M–OAc]
+ = 165.1643, Found 165.1635. 
FTIR (neat): 2965, 2917, 2367, 1741, 1338, 1372, 1237, 1020, 988, 929, 668 cm–1. 
[α]
D











4.5.3.2 General Procedure and Spectral Data for Synthesis of Allylic Amines 4.4[a–l], 
4.5[a–l], 4.6[a–g], and 4.7[a–c] 
 
A pressure tube equipped with a magnetic stir bar was charged with cesium carbonate (200 
mol%), (S)-Ir-II (5 mol%). The tube was purged with argon for 5 minutes. DME (1.0 M) 
was added followed by the allylic acetate (100 mol%) and the amine (200 mol%). The tube 
was sealed with a PTFE lined cap and was placed in an oil bath at the indicated temperature 
and stirred for the indicated period of time. After reaching ambient temperature, the crude 





The allylic acetate (50.2 mg, 0.44 mmol, 100 mol%) and the primary amine (81.6 mg, 0.88 
mmol, 200 mol%) were subject to standard reaction conditions (70 oC, 24 hr). The title 
compound was obtained in 82% yield (53.1 mg, 0.36 mmol) as a light yellow oil after 
purification by flash column chromatography (4g SiO2, Isopropyl Acetate / Heptane = 0% 
- 10% over 20 min). 
 
TLC (SiO2) Rf  = 0.40 (heptanes: isopropyl acetate = 4:1).  
1H NMR (400 MHz, CDCl3): δ = 7.20 – 7.09 (m, 2H), 6.68 (tt, J = 7.4, 1.1 Hz, 1H), 6.63 
– 6.57 (m, 2H), 5.83 (ddd, J = 17.2, 10.3, 5.6 Hz, 1H), 5.21 (dt, J = 17.2, 1.4 Hz, 1H), 
5.08 (dt, J = 10.4, 1.4 Hz, 1H), 3.98 (dddd, J = 9.5, 6.6, 4.8, 3.3 Hz, 1H), 3.59 (s, 1H), 
1.31 (d, J = 6.6 Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ = 147.4, 141.3, 129.1, 117.3, 114.1, 113.4, 51.1, 21.6. 
HRMS (ESI): Calculated for C10H13N [M+H
+] = 148.1126, Found 148.1122. 
FTIR (neat): 3404, 2975, 1601, 1504, 1317, 1254, 992, 919, 748, 692 cm–1. 
[α]
D
𝟐𝟖= –3.9 (c 0.2, CHCl3). 













The allylic acetate (50.2 mg, 0.44 mmol, 100 mol%) and the primary amine (133.0 mg, 
0.88 mmol, 200 mol%) were subject to standard reaction conditions (60 oC, 24 hr). The 
title compound was obtained in 85% yield (76.5 mg, 0.37 mmol) as a light yellow oil after 
purification by flash column chromatography (12g SiO2, Isopropyl Acetate / Heptane = 0% 
- 10% over 20 min). 
 
TLC (SiO2) Rf  = 0.23 (heptanes: isopropyl acetate = 4:1).  
1H NMR (400 MHz, CDCl3): δ = 6.68 (dd, J = 8.5, 0.4 Hz, 1H), 6.17 (d, J = 2.7 Hz, 1H), 
6.14 (dd, J = 8.5, 2.7 Hz, 1H), 5.81 (ddd, J = 17.2, 10.3, 5.7 Hz, 1H), 5.20 (dt, J = 
17.3, 1.4 Hz, 1H), 5.07 (dt, J = 10.3, 1.4 Hz, 1H), 4.34 – 4.18 (m, 2H), 4.21 – 4.13 (m, 
2H), 4.00 – 3.77 (m, 1H), 3.33 (br, 1H), 1.28 (d, J = 6.6 Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ = 143.9, 142.4, 141.5, 135.5, 117.5, 114.1, 107.4, 102.3, 
64.8, 64.2, 51.9, 21.7. 
HRMS (ESI): Calculated for C12H15NO2 [M+H
+] = 206.1176, Found 206.1183. 
FTIR (neat): 3394, 2973, 1507, 1207, 1068, 915, 884, 794, 740 cm–1. 
[α]
D
𝟐𝟖= –0.87 (c 0.2, CHCl3). 















The allylic acetate (50.2 mg, 0.44 mmol, 100 mol%) and the primary amine (97.8 mg, 0.88 
mmol, 200 mol%) were subject to standard reaction conditions (60 oC, 24 hr). The title 
compound was obtained in 83% yield (60.3 mg, 0.37 mmol) as a light yellow oil after 
purification by flash column chromatography (12g SiO2, Isopropyl Acetate / Heptane = 0% 
- 10% over 20 min). 
 
TLC (SiO2) Rf  = 0.36 (heptanes: isopropyl acetate = 4:1). 
1H NMR (400 MHz, CDCl3): δ = 1H NMR (400 MHz, Chloroform-d) δ 6.91 – 6.81 (m, 
2H), 6.58 – 6.49 (m, 2H), 5.81 (ddd, J = 17.2, 10.3, 5.7 Hz, 1H), 5.20 (dt, J = 17.2, 1.4 
Hz, 1H), 5.09 (dt, J = 10.4, 1.3 Hz, 1H), 4.01 – 3.83 (m, 1H), 3.48 (br, 1H), 1.31 (d, J 
= 6.6 Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ = 156.9, 154.5, 143.7, 141.2, 115.6, 115.4, 114.3, 114.2, 
51.8, 21.7. 
19F NMR (376 MHz, CDCl3): δ = –128.3. 
HRMS (ESI): Calculated for C10H12NF [M+H
+] = 166.1027, Found 166.1028. 
FTIR (neat): 2975, 1505, 1309, 1213, 1155, 991, 918, 815, 770, 506 cm–1. 
[α]
D
𝟐𝟖= +1.78 (c 0.2, CHCl3). 

























The allylic acetate (50.2 mg, 0.44 mmol, 100 mol%) and the primary amine (205.1 mg, 
0.88 mmol, 200 mol%) were subject to standard reaction conditions (70 oC, 40 hr). The 
title compound was obtained in 85% yield (98.6 mg, 0.34 mmol) as a light yellow oil after 
purification by flash column chromatography (SiO2, hexanes: ethyl acetate = 20:1–10:1). 
 
TLC (SiO2) Rf  = 0.58 (hexanes: ethyl acetate = 4:1).  
1H NMR (500 MHz, CDCl3): δ = 7.61 (d, J = 8.7 Hz, 1H), 6.40 (d, J = 7.0 Hz, 2H), 5.83 
(ddd, J = 17.2, 10.4, 5.3 Hz, 1H), 5.20 (dt, J = 17.2, 1.4 Hz, 1H), 5.08 (dt, J = 10.4, 
1.3 Hz, 1H), 4.04 (p, J = 6.5 Hz, 1H), 3.74 (br, 1H), 2.47 (s, 3H), 1.33 – 1.29 (m, 15H). 
13C NMR (100 MHz, CDCl3): δ = 149.5, 146.7, 140.8, 137.8, 114.5, 114.1, 109.6, 82.7, 
50.4, 24.9, 24.9, 22.5, 21.5. 
HRMS (ESI): Calculated for C17H26NO2 [M+H
+] = 288.2132, Found 288.2138. 
FTIR (neat): 2978, 2362, 1602, 1349, 1215, 1146, 754 cm–1. 
[α]
D
𝟐𝟖= –1.0 (c 1.0, CHCl3). 










The allylic acetate (50.2 mg, 0.44 mmol, 100 mol%) and the primary amine (124.2 mg, 
0.88 mmol, 200 mol%) were subject to standard reaction conditions (70 oC, 24 hr). The 
title compound was obtained in 78% yield (67.1 mg, 0.34 mmol) as a light yellow oil after 
purification by flash column chromatography (SiO2, hexanes: ethyl acetate = 20:1–10:1). 
 
TLC (SiO2) Rf  = 0.58 (hexanes: ethyl acetate = 4:1).  
1H NMR (400 MHz, CDCl3): δ = 6.69 – 6.60 (m, 2H), 6.56 (dd, J = 8.9, 2.7 Hz, 1H), 5.82 
(ddd, J = 16.7, 10.3, 5.8 Hz, 1H), 5.20 (dd, J = 17.3, 1.4 Hz, 1H), 5.08 (dd, J = 10.4, 
1.4 Hz, 1H), 3.91 (p, J = 6.5 Hz, 1H), 3.73 (s, 3H), 3.52 (br, 1H), 1.33 (d, J = 6.6 Hz, 
3H). 
13C NMR (100 MHz, CDCl3): δ = 153.08, 151.5 (d, J = 9.9 Hz), 150.71, 141.28, 129.7 (d, 
J = 12.1 Hz), 114.4 (d, J = 4.6 Hz), 114.19, 109.1 (d, J = 3.3 Hz), 102.38 (d, J = 22.7 
Hz), 55.8, 51.9, 21.7. 
19F NMR (471 MHz, CDCl3): δ = –133.0 (dd, J = 12.9, 9.8 Hz, 1F). 
HRMS (ESI): Calculated for C11H14FNO [M+H
+] = 196.1132, Found 196.1129. 
FTIR (neat): 2964, 1515, 1279, 1214, 1152, 1035, 923, 755 cm–1. 
[α]
D
𝟐𝟖= +6.3 (c 1.0, CHCl3). 














The allylic acetate (50.2 mg, 0.44 mmol, 100 mol%) and the primary amine (120.0 mg, 
0.88 mmol, 200 mol%) were subject to standard reaction conditions (70 oC, 24 hr). The 
title compound was obtained in 89% yield (74.5 mg, 0.39 mmol) as a light yellow oil after 
purification by flash column chromatography (SiO2, hexanes: ethyl acetate = 10:1–4:1). 
 
TLC (SiO2) Rf  = 0.34 (hexanes: ethyl acetate = 2:1).  
1H NMR (400 MHz, CDCl3): δ = 6.74 – 6.68 (m, 2H), 6.64 – 6.57 (m, 2H), 5.84 (ddd, J = 
17.2, 10.3, 5.7 Hz, 1H), 5.20 (dt, J = 17.2, 1.4 Hz, 1H), 5.06 (dt, J = 10.4, 1.4 Hz, 1H), 
3.90 (ttd, J = 6.6, 5.3, 1.3 Hz, 1H), 3.25 (br, 1H), 2.81 (s, 6H), 1.28 (d, J = 6.6 Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ = 144.1, 142.0, 139.9, 115.7, 115.2, 113.9, 52.2, 42.2, 
21.7. 
HRMS (ESI): Calculated for C12H18N2 [M+H
+] = 191.1543, Found 191.1535. 
FTIR (neat): 2979, 2361, 1515, 1216, 814, 753 cm–1. 
[α]
D
𝟐𝟖= –26.3 (c 0.2, CHCl3). 











The allylic acetate (50.2 mg, 0.44 mmol, 100 mol%) and the primary amine (129.5 mg, 
0.88 mmol, 200 mol%) were subject to standard reaction conditions (70 oC, 30 hr). The 
title compound was obtained in 81% yield (71.7 mg, 0.36 mmol) as a light yellow oil after 
purification by flash column chromatography (4g SiO2, Isopropyl Acetate / Heptane = 0% 
- 30% over 20 min). 
 
TLC (SiO2) Rf  = 0.38 (hexanes: ethyl acetate = 2:1).  
1H NMR (400 MHz, CDCl3): δ = 7.76 (d, J = 1.0 Hz, 1H), 7.43 (dd, J = 8.6, 0.6 Hz, 1H), 
6.49 (dd, J = 8.7, 1.9 Hz, 1H), 6.33 (dt, J = 1.7, 0.8 Hz, 1H), 5.88 (ddd, J = 17.2, 10.3, 
5.5 Hz, 1H), 5.27 (dt, J = 17.2, 1.4 Hz, 1H), 5.13 (dt, J = 10.4, 1.3 Hz, 1H), 4.07 (dtd, 
J = 8.1, 6.7, 5.2 Hz, 1H), 3.93 (s, 3H), 3.91 – 3.82 (m, 1H), 1.37 (d, J = 6.6 Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ = 146.6, 141.8, 140.8, 132.6, 121.5, 117.0, 114.3, 112.4, 
88.6, 51.3, 35.2, 21.6. 
HRMS (ESI): Calculated for C12H15N3 [M+H
+] = 202.1339, Found 202.1339. 
FTIR (neat): 3312, 2973, 1624, 1492, 1254, 1098, 982, 919, 732, 620 cm–1. 
[α]
D
𝟐𝟖= –60.3 (c 0.2, CHCl3). 











The allylic acetate (50.2 mg, 0.44 mmol, 100 mol%) and the primary amine (158.6 mg, 
0.88 mmol, 200 mol%) were subject to standard reaction conditions (70 oC, 24 hr). The 
title compound was obtained in 82% yield (84.5 mg, 0.36 mmol) as a light yellow oil after 
purification by flash column chromatography (12g SiO2, Isopropyl Acetate / Heptane = 0% 
- 80% over 20 min). 
 
TLC (SiO2) Rf  = 0.37 (hexanes: ethyl acetate = 1:1).  
1H NMR (400 MHz, CDCl3): δ = 7.92 (s, 2H), 5.76 (ddd, J = 17.2, 10.3, 6.2 Hz, 1H), 5.18 
(dt, J = 17.2, 1.3 Hz, 1H), 5.11 (dt, J = 10.3, 1.2 Hz, 1H), 3.87 – 3.80 (m, 1H), 3.79 – 
3.76 (m, 4H), 3.63 (dd, J = 5.7, 4.0 Hz, 4H), 1.31 (d, J = 6.6 Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ = 157.2, 145.2, 140.6, 133.4, 115.1, 66.9, 52.8, 45.2, 21.7. 
HRMS (ESI): Calculated for C12H18N4O [M+H
+] = 235.1553, Found 235.1555. 
FTIR (neat): 2968, 1480, 1444, 1264, 1116, 954, 731 cm–1. 
[α]
D
𝟐𝟖= +9.92 (c 1.0, CHCl3). 











The allylic acetate (50.2 mg, 0.44 mmol, 100 mol%) and the primary amine (132.2 mg, 
0.88 mmol, 200 mol%) were subject to standard reaction conditions (70 oC, 30 hr). The 
title compound was obtained in 81% yield (72.8 mg, 0.36 mmol) as a light yellow oil after 
purification by flash column chromatography (4g SiO2, Isopropyl Acetate / Heptane = 0% 
- 30% over 20 min). 
 
TLC (SiO2) Rf  = 0.52 (hexanes: ethyl acetate = 2:1).  
1H NMR (400 MHz, CDCl3): δ = 8.92 (s, 1H), 7.57 (dd, J = 8.1, 0.9 Hz, 1H), 7.38 (t, J = 
8.0 Hz, 1H), 6.67 (d, J = 7.9 Hz, 1H), 5.90 (ddd, J = 17.2, 10.4, 5.6 Hz, 1H), 5.26 (dt, 
J = 17.3, 1.4 Hz, 1H), 5.13 (dt, J = 10.3, 1.3 Hz, 1H), 4.20 (dtd, J = 8.2, 6.7, 1.5 Hz, 
1H), 3.60 (d, J = 6.7 Hz, 1H), 1.42 (d, J = 6.6 Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ = 154.4, 151.9, 142.0, 140.5, 127.3, 120.5, 114.6, 113.3, 
107.1, 51.6, 21.7. 
HRMS (ESI): Calculated for C11H12N2S [M+H
+] = 205.0794, Found 205.0802. 
FTIR (neat): 3292, 2974, 1575, 1472, 1287, 1145, 1049, 920, 774, 717 cm–1. 
[α]
D
𝟐𝟖= +31.68 (c 0.2, CHCl3). 













The allylic acetate (50.2 mg, 0.44 mmol, 100 mol%) and the primary amine (150.7 mg, 
0.88 mmol, 200 mol%) were subject to standard reaction conditions (60 oC, 40 hr). The 
title compound was obtained in 76% yield (75.3 mg, 0.33 mmol) as a light yellow oil after 
purification by flash column chromatography (SiO2, hexanes: ethyl acetate = 10:1–4:1). 
 
TLC (SiO2) Rf  = 0.41 (hexanes: ethyl acetate = 2:1).  
1H NMR (500 MHz, CDCl3): δ = 7.30 (t, J = 7.9 Hz, 1H), 7.18 (ddd, J = 7.7, 1.7, 0.9 Hz, 
1H), 7.10 (t, J = 2.1 Hz, 1H), 6.84 – 6.74 (m, 1H), 5.79 (ddd, J = 17.0, 10.3, 5.4 Hz, 
1H), 5.22 (dd, J = 17.3, 1.3 Hz, 1H), 5.12 (dt, J = 10.3, 1.2 Hz, 1H), 4.13 – 3.90 (m, 
2H), 3.01 (s, 3H), 1.34 (d, J = 6.3 Hz, 3H).k 
13C NMR (125 MHz, CDCl3): δ = 148.0, 141.3, 140.0, 130.1, 118.0, 115.3, 114.8, 111.0, 
51.0, 44.4, 21.5. 
HRMS (ESI): Calculated for C11H15NO2S [M+H
+] = 226.0896, Found 226.0900. 
FTIR (neat): 3379, 1599, 1487, 1296, 1141, 961, 757, 683 cm–1. 
[α]
D
𝟐𝟖= –33.3 (c 1.0, CHCl3). 
HPLC (Two connected chiralcel AD-H column, hexanes:i-PrOH = 95:5, 1.00 mL/min, 










The allylic acetate (50.2 mg, 0.44 mmol, 100 mol%) and the primary amine (82.8 mg, 0.88 
mmol, 200 mol%) were subject to standard reaction conditions (70 oC, 24 hr). The title 
compound was obtained in 74% yield (48.3 mg, 0.33 mmol) as a light yellow oil after 
purification by flash column chromatography (SiO2, hexanes: ethyl acetate = 10:1–4:1). 
 
TLC (SiO2) Rf  = 0.45 (hexanes: ethyl acetate = 2:1).  
1H NMR (500 MHz, CDCl3): δ = 8.07 (ddd, J = 5.0, 2.0, 0.9 Hz, 1H), 7.40 (ddd, J = 8.8, 
7.1, 1.9 Hz, 1H), 6.56 (ddd, J = 7.1, 5.0, 1.0 Hz, 1H), 6.36 (dt, J = 8.4, 1.0 Hz, 1H), 
5.87 (ddd, J = 17.2, 10.4, 5.3 Hz, 1H), 5.21 (dt, J = 17.2, 1.4 Hz, 1H), 5.08 (dt, J = 
10.4, 1.4 Hz, 1H), 4.48 (br, 1H), 4.32 – 4.20 (m, 1H), 1.33 (d, J = 6.7 Hz, 3H). 
13C NMR (125 MHz, CDCl3): δ = 158.1, 148.2, 140.7, 137.4, 113.9, 112.9, 106.9, 49.4, 
21.3. 
HRMS (ESI): Calculated for C9H12N2 [M+H
+] = 149.1073, Found 149.1073. 
FTIR (neat): 3528, 2974, 1599, 1445, 1330, 1154, 987, 920, 751 cm–1. 
[α]
D
𝟐𝟖= +6.3 (c 1.0, CHCl3). 













The allylic acetate (50.2 mg, 0.44 mmol, 100 mol%) and the primary amine (82.8 mg, 0.88 
mmol, 200 mol%) were subject to standard reaction conditions (70 oC, 30 hr). The title 
compound was obtained in 87% yield (56.7 mg, 0.38 mmol) as a light yellow oil after 
purification by flash column chromatography (4g SiO2, Isopropyl Acetate / Heptane = 0% 
- 50% over 20 min). 
 
TLC (SiO2) Rf  = 0.22 (hexanes: ethyl acetate = 1:1).  
1H NMR (400 MHz, CDCl3): δ = 8.02 (dd, J = 2.9, 0.7 Hz, 1H), 7.93 (dd, J = 4.7, 1.4 Hz, 
1H), 7.05 (ddd, J = 8.3, 4.7, 0.7 Hz, 1H), 6.86 (ddd, J = 8.3, 2.9, 1.4 Hz, 1H), 5.80 
(ddd, J = 17.2, 10.3, 5.6 Hz, 1H), 5.21 (dt, J = 17.2, 1.3 Hz, 1H), 5.11 (dt, J = 10.4, 
1.3 Hz, 1H), 3.97 (s, 1H), 3.69 (br, 1H), 1.34 (d, J = 6.7 Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ = 143.3, 140.3, 138.7, 136.6, 123.6, 119.1, 114.7, 51.0, 
21.6. 
HRMS (ESI): Calculated for C9H12N2 [M+H
+] = 149.1073, Found 149.1075. 
FTIR (neat): 3253, 2973, 1578, 1481, 1414, 1241, 991, 917, 791, 706 cm–1. 
[α]
D
𝟐𝟖= –12.7 (c 0.2, CHCl3). 














The allylic acetate (50.2 mg, 0.44 mmol, 100 mol%) and the primary amine (104.9 mg, 
0.88 mmol, 200 mol%) were subject to standard reaction conditions (70 oC, 24 hr). The 
title compound was obtained in 92% yield (70.1 mg, 0.40 mmol) as a light purple oil after 
purification by flash column chromatography (4g SiO2, Isopropyl Acetate / Heptane = 0% 
- 10% over 10 min). 
 
TLC (SiO2) Rf  = 0.49 (heptane: isopropyl acetate = 9:1).  
1H NMR (400 MHz, CDCl3): δ = 7.10-7.02 (m, 2H), 6.63 (t, J = 7.3 Hz, 1H), 6.49 (d, J = 
7.8 Hz, 1H), 5.94 (ddd, J = 17.5, 10.5, 5.3 Hz, 1H), 5.26-5.15 (m, 2H), 4.22 (qd, J = 
6.9, 5.1 Hz, 1H), 3.44-3.30 (m, 2H), 2.96 (t, J =18.5 Hz, 2H), 1.32 (d, J = 6.8 Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ = 151.1, 138.4, 130.3, 127.2, 124.4, 117.2, 115.7, 107.6, 
52.6, 47.1, 28.2, 15.5. 
HRMS (ESI): Calculated for C12H15N [M+H
+] = 174.1277, Found 174.1227. 
FTIR (neat): 3047, 3024, 2973, 2933, 2845, 1606, 1487, 1473, 1458, 1257, 1185, 1023, 
919, 743 cm–1. 
[α]
D
𝟐𝟖= -551.36 (c 0.2, CHCl3). 












The allylic acetate (50.2 mg, 0.44 mmol, 100 mol%) and the primary amine (105.7 mg, 
0.88 mmol, 200 mol%) were subject to standard reaction conditions (70 oC, 24 hr). The 
title compound was obtained in 78% yield (59.8 mg, 0.34 mmol) as a light yellow oil after 
purification by flash column chromatography (4g SiO2, Isopropyl Acetate / Heptane = 0% 
- 20% over 20min). 
 
TLC (SiO2) Rf  = 0.25 (heptane: isopropyl acetate =1:1).  
1H NMR (400 MHz, CDCl3): δ = 7.89 (d, J = 4.6 Hz, 1H), 7.80 (d, J = 0.9 Hz, 1H), 6.97 
(dq, J = 4.6, 1.0 Hz, 1H), 5.88 (ddd, J = 17.4, 10.5, 5.5 Hz, 1H), 5.21 (dt, J = 12.2, 1.4 
Hz, 1H), 5.18 (dt, J = 5.3, 1.4 Hz, 1H), 4.18 (qdt, J =  7.0, 5.5, 1.6 Hz, 1H), 3.45-3.32 
(m, 2H), 2.98-2.91 (m, 2H), 1.31 (d, J = 6.9 Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ = 147.7, 139.4, 139.2, 137.5, 129.5, 119.7, 116.2, 52.8, 
46.9, 28.0, 15.7. 
HRMS (ESI): Calculated for C11H14N2 [M+H
+] =175.1230, Found 175.1226. 




𝟐𝟖= –44.4 (c 0.2, CHCl3). 














The allylic acetate (50.2 mg, 0.44 mmol, 100 mol%) and the primary amine (105.7 mg, 
0.88 mmol, 200 mol%) were subject to standard reaction conditions (70 oC, 24 hr). The 
title compound was obtained in 74% yield (56.8 mg, 0.33 mmol) as a light yellow oil after 
purification by flash column chromatography (4g SiO2, Isopropyl Acetate / Heptane = 0% 
- 10% over 10 min). 
 
TLC (SiO2) Rf  = 0.25 (heptane: isopropyl acetate =9:1).  
1H NMR (400 MHz, CDCl3): δ = 7.85-7.83 (m, 1H), 7.13 (dq, J = 6.9, 1.4 Hz, 1H), 6.37 
(dd, J = 7.0, 5.3 Hz, 1H), 5.91 (ddd, J = 17.4, 10.5, 4.9 Hz, 1H), 5.20-5.14 (m, 2H), 
4.86 (qdt, J = 6.8, 4.9, 1.8 Hz, 1H), 3.46-3.41 (m, 2H), 2.95-2.91 (m, 2H), 1.28 (d, J = 
6.9Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ = 162.5, 145.8, 138.4, 138.4, 130.7, 123.2, 115.4, 111.9, 
49.5, 43.6, 25.7, 15.5. 
HRMS (ESI): Calculated for C11H14N2 [M+H
+] = 175.1230, Found 175.1225. 




𝟐𝟖= –31.7 (c 0.2, CHCl3). 
HPLC (Two connected chiralcel OD-3 & OD-H column, hexanes:i-PrOH = 99:1, 1.00 










The allylic acetate (50.2 mg, 0.44 mmol, 100 mol%) and the primary amine (166.5 mg, 
0.88 mmol, 200 mol%) were subject to standard reaction conditions (70 oC, 24 hr). The 
title compound was obtained in 85% yield (88.9 mg, 0.37 mmol) as a light yellow oil after 
purification by flash column chromatography (4g SiO2, Isopropyl Acetate / Heptane = 
10%). 
 
TLC (SiO2) Rf  = 0.33 (heptane: isopropyl acetate =9:1).  
1H NMR (400 MHz, CDCl3): δ = 7.11-7.03 (m, 2H), 6.67 (td, J = 7.4, 1.0 Hz, 1H), 6.49 
(dd, J = 7.8, 0.9 Hz, 1H), 5.92 (ddd, J = 17.4, 10.5, 5.1 Hz, 1H), 5.22 (dt, J = 10.4, 1.5 
Hz, 1H), 5.18 (dt, J = 3.3, 1.5 Hz, 1H), 4.23 (qdt, J = 6.8, 5.1, 1.7 Hz, 1H), 3.97 (ddd, 
J = 11.8, 4.5, 2.2 Hz, 2H), 3.57 (tdd, J = 12.0, 7.7, 2.3 Hz, 2H), 3.39-3.29 (m, 2H), 
1.97 (dtd, J = 13.9, 12.2, 4.7 Hz, 2H), 1.69-1.59 (m, 2H), 1.32 (d, J = 6.9 Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ = 150.0, 138.3, 137.3, 127.9, 122.4, 117.3, 115.7, 107.5, 
65.2, 56.4, 52.1, 41.7, 36.7, 36.6, 36.5, 15.5. 
HRMS (ESI): Calculated for C16H22NO [M+H
+] = 244.1696, Found 244.1699. 
FTIR (neat): 2936, 2848, 2360, 2341, 1660, 1482, 1462, 1251, 1104, 1027, 837, 750, 668, 
547, 464 cm–1. 
[α]
D
𝟐𝟖= –44.7 (c 0.2, CHCl3). 
HPLC (Two connected chiralcel AD-H column, hexanes:i-PrOH = 99:1, 1.00 mL/min, 










The allylic acetate (50.2 mg, 0.44 mmol, 100 mol%) and the primary amine (117.2 mg, 
0.88 mmol, 200 mol%) were subject to standard reaction conditions (70 oC, 24 hr). The 
title compound was obtained in 80% yield, >20:1 dr (69.2 mg, 0.37 mmol) as a light yellow 
oil after purification by flash column chromatography (4g SiO2, Heptane). 
 
TLC (SiO2) Rf  = 0.50 (heptane: isopropyl acetate = 9:1).  
1H NMR (400 MHz, CDCl3): δ = 7.03-6.96 (m, 2H), 6.63-6.54 (m, 2H), 6.07 (ddd, J = 
17.5, 10.6, 4.2 Hz, 1H), 5.26 (ddd, J = 17.5, 2.1, 1.5 Hz, 1H), 5.20, (ddd, J = 10.6, 2.2, 
1.5 Hz, 1H), 4.01 (qdt, J = 6.8, 4.3, 2.2 Hz, 1H), 3.79 (tq, J = 8.9, 6.1 Hz, 1H), 3.18 
(dd, J = 15.6, 9.1 Hz, 1H), 2.61 (ddt, J = 15.7, 8.8, 1.2 Hz, 1H), 1.33 (d, J = 5.3 Hz, 
3H), 1.31 (d, J = 4.4 Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ = 150.5, 140.5, 129.3, 126.8, 124.2, 117.0, 114.8, 108.9, 
57.7, 53.0, 37.6, 21.6, 14.1. 
HRMS (ESI): Calculated for C13H17N [M+H
+] =188.1434, Found 188.1427. 










The allylic acetate (50.2 mg, 0.44 mmol, 100 mol%) and the primary amine (117.2mg, 0.88 
mmol, 200 mol%) were subject to standard reaction conditions (70 oC, 24 hr). The title 
compound was obtained in 48% yield, 5:1 dr (39.8 mg, 0.21 mmol) as a light orange oil 
after purification by flash column chromatography (4g SiO2, Heptane). 
 
TLC (SiO2) Rf  = 0.50 (heptane: isopropyl acetate = 9:1).  
1H NMR (400 MHz, CDCl3): δ = 7.07-6.98 (m, 2H), 6.66-6.54 (m, 1H), 6.48-6.46 (m, 1H), 
6.05 (ddd, J = 17.3, 10.5, 5.3 Hz, 1H), 5.19 (dt, J = 17.4, 1.7 Hz, 1H), 5.14 (dt, J = 
10.5, 1.6 Hz, 1H), 4.10-4.03 (m, 1H), 3.91-3.84 (m, 1H), 3.18 (ddt, J = 15.6, 9.2, 0.9 
Hz, 1H), 2.60 (ddt, J = 15.6, 7.9, 1.1 Hz, 1H), 1.42 (d, J = 7.0 Hz, 3H), 1.28 (d, J = 
6.1 Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ = 150.8, 140.3, 128.9, 127.1, 124.3, 116.8, 114.7, 107.7, 
57.0, 53.4, 37.6, 22.0, 16.4. 
HRMS (ESI): Calculated for C13H17N [M+H
+] =188.1434, Found 188.1428. 










The allylic acetate (50.2 mg, 0.44 mmol, 100 mol%) and the primary amine (94.3 mg, 0.88 
mmol, 200 mol%) were subject to standard reaction conditions (70 oC, 24 hr). The title 
compound was obtained in 71% yield (50.3 mg, 0.31 mmol) as a light yellow oil after 
purification by flash column chromatography (4g SiO2, Heptane). 
 
TLC (SiO2) Rf  = 0.47 (heptane: isopropyl acetate = 10:1).  
1H NMR (400 MHz, CDCl3): δ = 7.25-7.19 (m, 2H), 6.82-6.77 (m, 2H), 6.70 (tt, J = 7.3, 
1.0 Hz, 1H), 5.91 (ddd, J = 17.2, 10.8, 4.2 Hz, 1H), 5.17 (p, J = 1.4 Hz, 1H), 5.13 (ddd, 
J = 9.3, 2.0, 1.4 Hz, 1H), 4.48 (qdt, J = 6.6, 4.1, 2.0 Hz, 1H), 2.73 (s, 3H), 1.25 (d, J = 
6.8 Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ = 150.0, 139.6, 129.1, 116.7, 115.0, 133.3, 55.1, 31.4, 
15.5. 
HRMS (ESI): Calculated for C11H15N [M+H
+] = 162.1277, Found 162.1278. 




𝟐𝟖= –185.6 (c 0.2, CHCl3). 











The allylic acetate (50.2 mg, 0.44 mmol, 100 mol%) and the primary amine (116.3 mg, 
0.88 mmol, 200 mol%) were subject to standard reaction conditions (70 oC, 24 hr). The 
title compound was obtained in 79% yield (64.7 mg, 0.35 mmol) as a light yellow oil after 
purification by flash column chromatography (4g SiO2, Isopropyl Acetate / Heptane = 0% 
- 10% over 10 min). 
 
TLC (SiO2) Rf  = 0.25 (heptane: isopropyl acetate = 9:1). 
1H NMR (400 MHz, CDCl3): δ = 7.48-7.43 (m, 2H), 6.74-6.69 (m, 2H), 5.86 (ddd, J = 
17.3, 10.6, 4.0 Hz, 1H), 5.21 (ddd, J = 10.6, 2.0, 1.1 Hz, 1H), 5.14 (ddd, J = 17.4, 2.0, 
1.1, 1H), 4.53 (qdt, J = 6.7, 4.1, 2.0 Hz, 1H), 2.81 (s, 3H), 1.32 (d, J = 6.8 Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ = 152.3, 137.9, 133.5, 120.6, 115.8, 112.0, 97.6, 54.5, 
31.5, 16.1. 
HRMS (ESI): Calculated for C12H14N2 [M+H
+] = 187.1230, Found 187.1231. 




𝟐𝟖= –207.8 (c 0.2, CHCl3). 
HPLC (Two connected chiralcel OD-3 & OD-H column, hexanes:i-PrOH = 99:1, 1.00 










The allylic acetate (50.2 mg, 0.44 mmol, 100 mol%) and the secondary amine (120.7 mg, 
0.88 mmol, 200 mol%) were subject to standard reaction conditions (70 oC, 24 hr). The 
title compound was obtained in 89% yield (74.9 mg, 0.39 mmol) as a light yellow oil after 
purification by flash column chromatography (SiO2, hexanes: ethyl acetate = 25:1–10:1). 
 
TLC (SiO2) Rf  = 0.38 (hexanes: ethyl acetate = 10:1).  
1H NMR (500 MHz, CDCl3): δ = 6.86 – 6.77 (m, 4H), 5.92 (ddd, J = 17.2, 10.7, 4.6 Hz, 
1H), 5.18 – 5.09 (m, 2H), 4.28 (dtdd, J = 8.5, 6.6, 3.9, 1.8 Hz, 1H), 3.77 (s, 3H), 2.67 (s, 
3H), 1.21 (d, J = 6.7 Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ = 152.1, 144.7, 139.8, 116.4, 115.0, 114.5, 57.1, 55.7, 
32.5, 15.2. 
HRMS (ESI): Calculated for C12H17NO [M+H
+] = 192.1383, Found 192.1381. 
FTIR (neat): 2975, 1509, 1464, 1242, 1110, 1039, 919, 815, 754 cm–1. 
[α]
D
𝟐𝟖= –112.0 (c 1.0, CHCl3). 











The allylic acetate (50.2 mg, 0.44 mmol, 100 mol%) and the secondary amine (163.7 mg, 
0.88 mmol, 200 mol%) were subject to standard reaction conditions (70 oC, 60 hr). The 
title compound was obtained in 64% yield (67.6 mg, 0.28 mmol) as a light yellow oil after 
purification by flash column chromatography (SiO2, hexanes: ethyl acetate = 40:1–20:1). 
 
TLC (SiO2) Rf  = 0.59 (hexanes: ethyl acetate = 10:1).  
1H NMR (500 MHz, CDCl3): δ = 7.06 (t, J = 8.1 Hz, 1H), 6.89 (t, J = 2.2 Hz, 1H), 6.81 
(dd, J = 7.6, 1.7 Hz, 1H), 6.69 (dd, J = 8.5, 2.5 Hz, 1H), 5.88 (ddd, J = 17.4, 10.6, 4.1 
Hz, 1H), 5.20 – 5.11 (m, 2H), 4.44 (qdt, J = 6.5, 4.0, 2.0 Hz, 1H), 2.72 (s, 3H), 1.27 (d, 
J = 6.8 Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ = 151.1, 138.8, 130.2, 123.4, 119.2, 115.7, 115.3, 111.5, 
54.9, 31.4, 15.7. 
HRMS (ESI): Calculated for C11H14BrN [M+H
+] = 240.0382, Found 240.0382. 
FTIR (neat): 1590, 1554, 1487, 1215, 1114, 981, 925, 752, 681 cm–1. 
[α]
D
𝟐𝟖= –95.8 (c 1.0, CHCl3). 










The allylic acetate (50.2 mg, 0.44 mmol, 100 mol%) and the secondary amine (154.9 mg, 
0.88 mmol, 200 mol%) were subject to standard reaction conditions (70 oC, 60 hr). The 
title compound was obtained in 76% yield (76.9 mg, 0.33 mmol) as a light yellow oil after 
purification by flash column chromatography (SiO2, hexanes: ethyl acetate = 40:1–20:1). 
 
TLC (SiO2) Rf  = 0.59 (hexanes: ethyl acetate = 10:1).  
1H NMR (500 MHz, CDCl3): δ = 7.22 (d, J = 9.0 Hz, 1H), 6.81 (d, J = 2.9 Hz, 1H), 6.60 
(dd, J = 9.0, 3.0 Hz, 1H), 5.86 (ddd, J = 17.4, 10.6, 4.1 Hz, 1H), 5.18 (ddd, J = 10.6, 
2.0, 1.2 Hz, 1H), 5.13 (ddd, J = 17.4, 2.0, 1.2 Hz, 1H), 4.39 (qdt, J = 6.5, 4.1, 2.1 Hz, 
1H), 2.71 (s, 3H), 1.26 (d, J = 6.8 Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ = 149.3, 138.4, 132.7, 130.3, 118.9, 115.5, 114.3, 112.5, 
55.2, 31.5, 15.7. 
HRMS (ESI): Calculated for C11H13Cl2N [M+H
+] = 230.0498, Found 230.0496. 
FTIR (neat): 2976, 1593, 1487, 1371, 1214, 1112, 997, 924 cm–1. 
[α]
D
𝟐𝟖= –100.0 (c 1.0, CHCl3). 
HPLC (Two connected chiralcel OD-3 & OD-H column, hexanes:i-PrOH = 99.5:0.5, 1.00 










The allylic acetate (50.2 mg, 0.44 mmol, 100 mol%) and the primary amine (141.9 mg, 
0.88 mmol, 200 mol%) were subject to standard reaction conditions (70 oC, 24 hr). The 
title compound was obtained in 94% yield (89.1 mg, 0.41 mmol) as a light orange oil after 
purification by flash column chromatography (4g SiO2, Isopropyl Acetate / Heptane = 
20%). 
 
TLC (SiO2) Rf  = 0.25 (heptane: isopropyl acetate = 8:2).  
1H NMR (400 MHz, CDCl3): δ = 7.61-7.58 (m, 1H), 7.20-7.14 (m, 4H), 6.02 (ddd, J = 
17.4, 10.5, 4.9 Hz, 1H), 5.29-5.25 (m, 1H), 5.25-5.23 (m, 1H), 4.16 (qdt, J = 6.8, 4.9, 
1.8 Hz, 1H), 3.61 (d, 3H), 2.84 (s, 3H), 1.32 (d, J = 6.8 Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ = 141.7, 138.6, 135.8, 121.5, 120.8, 117.8, 116.2, 108.3, 
58.6, 33.1, 30.8, 15.7. 
HRMS (ESI): Calculated for C13H17N3 [M+H
+] = 216.1495, Found 216.1498. 




𝟐𝟖= –129.9 (c 0.2, CHCl3). 











The allylic acetate (50.2 mg, 0.44 mmol, 100 mol%) and the secondary amine (130.3 mg, 
0.88 mmol, 200 mol%) were subject to standard reaction conditions (70 oC, 24 hr). The 
title compound was obtained in 94% yield (83.7 mg, 0.41 mmol) as a light yellow oil after 
purification by flash column chromatography (SiO2, heptanes: ethyl acetate = 20:1–10:1). 
 
TLC (SiO2) Rf  = 0.63 (hexanes: ethyl acetate = 4:1).  
1H NMR (500 MHz, CDCl3): δ = 7.35 (d, J = 7.8 Hz, 1H), 7.25 (d, J = 7.7 Hz, 1H), 7.15 
(t, J = 7.7 Hz, 1H), 7.03 – 6.96 (m, 1H), 5.91 (ddd, J = 17.3, 10.7, 4.5 Hz, 1H), 5.28 – 
5.20 (m, 2H), 5.04 (dqd, J = 8.8, 6.4, 5.6, 2.0 Hz, 1H), 3.02 (s, 3H), 1.38 (d, J = 6.9 
Hz, 3H). 
13C NMR (125 MHz, CDCl3): δ = 162.8, 148.8, 143.4, 137.2, 123.9, 120.2, 116.4, 116.0, 
108.6, 54.1, 29.5, 15.9. 
HRMS (ESI): Calculated for C12H14N2O [M+H
+] = 203.1179, Found 203.1180. 
FTIR (neat): 2975, 1632, 1575, 1459, 1424, 1246, 1127, 1001, 925, 793, 740 cm–1. 
[α]
D
𝟐𝟖= –94.5 (c 1.0, CHCl3). 











The allylic acetate (103.1 mg, 0.44 mmol, 100 mol%) and the secondary amine (130.3 mg, 
0.88 mmol, 200 mol%) were subject to standard reaction conditions (70 oC, 24 hr). The 
title compound was obtained in 93% yield (131.9 mg, 0.41 mmol) as a light yellow oil after 
purification by flash column chromatography (SiO2, hexanes: ethyl acetate = 20:1–10:1). 
 
TLC (SiO2) Rf  = 0.44 (hexanes: ethyl acetate = 2:1).  
1H NMR (500 MHz, CDCl3): δ = 7.43 – 7.37 (m, 1H), 7.30 – 7.23 (m, 6H), 7.19 (td, J = 
7.7, 1.1 Hz, 1H), 7.03 (td, J = 7.7, 1.2 Hz, 1H), 5.92 (ddd, J = 17.6, 10.4, 5.2 Hz, 1H), 
5.30 – 5.27 (m, 1H), 5.25 (dt, J = 3.5, 1.3 Hz, 1H), 5.07 (ddd, J = 13.2, 7.0, 3.6 Hz, 
1H), 4.44 (d, J = 2.8 Hz, 2H), 3.58 (dt, J = 9.5, 5.8 Hz, 1H), 3.52 (dt, J = 9.4, 6.7 Hz, 
1H), 3.06 (s, 3H), 2.15 – 2.00 (m, 2H). 
13C NMR (125 MHz, CDCl3): δ = 163.0, 148.8, 143.4, 138.1, 135.8, 128.3, 127.7, 127.6, 
123.9, 120.3, 117.0, 116.1, 108.7, 73.3, 66.9, 56.4, 31.0, 30.4. 
HRMS (ESI): Calculated for C20H22N2O2 [M+H
+] = 323.1754, Found 323.1757. 
FTIR (neat): 2857, 1631, 1575, 1459, 1414, 1284, 1246, 1098, 1002, 907, 736, 697 cm–1. 
[α]
D
𝟐𝟖= –78.3 (c 1.0, CHCl3). 












The allylic acetate (89.8 mg, 0.44 mmol, 100 mol%) and the secondary amine (130.3 mg, 
0.88 mmol, 200 mol%) were subject to standard reaction conditions (70 oC, 24 hr). The 
title compound was obtained in 92% yield (118.3 mg, 0.40 mmol) as a light yellow oil after 
purification by flash column chromatography (SiO2, hexanes: ethyl acetate = 20:1–10:1). 
 
TLC (SiO2) Rf  = 0.44 (hexanes: ethyl acetate = 4:1).  
1H NMR (500 MHz, CDCl3): δ = 7.40 (dd, J = 7.8, 1.2 Hz, 1H), 7.30 – 7.25 (m, 3H), 7.24 
– 7.14 (m, 4H), 7.04 (td, J = 7.8, 1.2 Hz, 1H), 5.91 (ddd, J = 17.6, 10.3, 5.2 Hz, 1H), 
5.29 (t, J = 1.4 Hz, 1H), 5.26 (dt, J = 5.2, 1.3 Hz, 1H), 4.94 – 4.85 (m, 1H), 3.08 (s, 
3H), 2.70 (t, J = 8.0 Hz, 2H), 2.15 – 2.00 (m, 2H). 
13C NMR (125 MHz, CDCl3): δ = 163.1, 148.8, 143.4, 141.2, 135.8, 128.5, 128.3, 126.1, 
123.9, 120.3, 117.1, 116.1, 108.7, 58.7, 32.8, 32.5, 29.8. 
HRMS (ESI): Calculated for C19H20N2O [M+H
+] = 293.1648, Found 293.1656. 
FTIR (neat): 2941, 1630, 1574, 1496, 1458, 1245, 1125, 1000, 926, 738, 698 cm–1. 
[α]
D
𝟐𝟖= –29.5 (c 1.0, CHCl3). 











The allylic acetate (61.7 mg, 0.44 mmol, 100 mol%) and the secondary amine (130.3 mg, 
0.88 mmol, 200 mol%) were subject to standard reaction conditions (60 oC, 48 hr). The 
title compound was obtained in 81% yield (81.3 mg, 0.36 mmol) as a light yellow oil after 
purification by flash column chromatography (SiO2, hexanes: ethyl acetate = 30:1–15:1). 
 
TLC (SiO2) Rf  = 0.56 (hexanes: ethyl acetate = 4:1).  
1H NMR (500 MHz, CDCl3): δ = 7.34 (dd, J = 7.8, 1.3 Hz, 1H), 7.23 (dd, J = 7.9, 1.1 Hz, 
1H), 7.14 (td, J = 7.6, 1.2 Hz, 1H), 6.99 (td, J = 7.8, 1.3 Hz, 1H), 5.93 (ddd, J = 17.4, 
10.5, 4.4 Hz, 1H), 5.36 (dt, J = 17.3, 1.6 Hz, 1H), 5.26 (dt, J = 10.5, 1.6 Hz, 1H), 4.16 
– 4.04 (m, 1H), 3.16 (s, 3H), 1.14 (dtt, J = 9.6, 8.0, 4.9 Hz, 1H), 0.74 (dddd, J = 8.0, 
6.7, 4.7, 3.3 Hz, 1H), 0.54 (tdd, J = 10.2, 4.3, 3.2 Hz, 1H), 0.48 – 0.35 (m, 2H). 
13C NMR (125 MHz, CDCl3): δ = 163.0, 148.7, 143.5, 135.5, 123.9, 120.1, 116.9, 115.9, 
108.6, 64.2, 30.6, 12.2, 5.0, 3.0. 
HRMS (ESI): Calculated for C14H16N2O [M+H
+] = 229.1335, Found 229.1337. 
FTIR (neat): 3007, 1629, 1573, 1458, 1423, 1245, 1124, 992, 908, 815, 738 cm–1. 
[α]
D
𝟐𝟖= –35.3 (c 1.0, CHCl3). 











The allylic acetate (67.9 mg, 0.44 mmol, 100 mol%) and the secondary amine (130.3 mg, 
0.88 mmol, 200 mol%) were subject to standard reaction conditions (70 oC, 48 hr). The 
title compound was obtained in 71% yield (75.7 mg, 0.31 mmol) as a light yellow oil after 
purification by flash column chromatography (SiO2, hexanes: ethyl acetate = 20:1–10:1). 
 
TLC (SiO2) Rf  = 0.44 (hexanes: ethyl acetate = 4:1).  
1H NMR (500 MHz, CDCl3): δ = 7.39 – 7.32 (m, 1H), 7.25 (d, J = 5.9 Hz, 1H), 7.15 (td, 
J = 7.7, 1.2 Hz, 1H), 7.00 (td, J = 7.7, 1.3 Hz, 1H), 5.79 (ddd, J = 17.4, 10.7, 5.2 Hz, 
1H), 5.26 – 5.14 (m, 2H), 4.82 – 4.69 (m, 1H), 2.99 (s, 3H), 2.71 (dq, J = 11.0, 7.7 Hz, 
1H), 2.15 (dt, J = 12.6, 7.7 Hz, 1H), 2.05 – 1.77 (m, 5H). 
13C NMR (125 MHz, CDCl3): δ = 163.3, 148.7, 143.5, 133.6, 123.9, 120.1, 117.0, 116.0, 
108.6, 64.4, 35.9, 30.1, 26.3, 25.2, 17.7. 
HRMS (ESI): Calculated for C15H18N2O [M+H
+] = 243.1492, Found 243.1495. 
FTIR (neat): 2938, 1629, 1573, 1458, 1416, 1245, 1122, 990, 917, 821, 738 cm–1. 
[α]
D
𝟐𝟖= –98.8 (c 1.0, CHCl3). 











The allylic acetate (74.0 mg, 0.44 mmol, 100 mol%) and the secondary amine (130.3 mg, 
0.88 mmol, 200 mol%) were subject to standard reaction conditions (60 oC, 60 hr). The 
title compound was obtained in 81% yield (91.3 mg, 0.36 mmol) as a light yellow oil after 
purification by flash column chromatography (SiO2, hexanes: ethyl acetate = 20:1–10:1). 
 
TLC (SiO2) Rf  = 0.44 (hexanes: ethyl acetate = 4:1).  
1H NMR (500 MHz, CDCl3): δ = 7.35 (dd, J = 7.8, 1.1 Hz, 1H), 7.25 (d, J = 7.7 Hz, 1H), 
7.14 (td, J = 7.7, 1.2 Hz, 1H), 6.99 (td, J = 7.7, 1.2 Hz, 1H), 5.89 (ddd, J = 17.0, 10.5, 
6.0 Hz, 1H), 5.30 – 5.18 (m, 2H), 4.56 – 4.45 (m, 1H), 3.06 (s, 3H), 2.25 (dp, J = 10.9, 
8.0 Hz, 1H), 1.82 (dp, J = 12.5, 4.5, 3.8 Hz, 1H), 1.74 – 1.50 (m, 5H), 1.33 (dddd, J = 
16.2, 10.9, 7.9, 2.4 Hz, 2H). 
13C NMR (125 MHz, CDCl3): δ = 163.2, 148.7, 143.6, 135.1, 123.8, 120.1, 117.3, 116.0, 
108.6, 64.6, 41.0, 30.5, 30.3, 30.0, 25.6, 25.3. 
HRMS (ESI): Calculated for C16H20N2O [M+H
+] = 257.1648, Found 257.1650. 
FTIR (neat): 2951, 1629, 1573, 1458, 1245, 1123, 990, 921, 819, 738 cm–1. 
[α]
D
𝟐𝟖= –92.0 (c 1.0, CHCl3). 











The allylic acetate (98.7 mg, 0.44 mmol, 100 mol%) and the primary amine (130.4 mg, 
0.88 mmol, 200 mol%) were subject to standard reaction conditions (70 oC, 60 hr). The 
title compound was obtained in 80% yield, 10:1 dr (110.2 mg, 0.35 mmol) as a light yellow 
oil after purification by flash column chromatography (4g SiO2, Isopropyl Acetate / 
Heptane = 0% - 10% over 10 min). 
 
TLC (SiO2) Rf  = 0.33 (heptane: isopropyl acetate = 9:1).  
1H NMR (400 MHz, CDCl3): δ = 7.35 (ddd, J = 7.8, 1.3, 0.6 Hz, 1H), 7.24 (ddd, J = 7.9, 
1.2, 0.6 Hz, 1H), 7.14 (td, J = 7.7, 1.1 Hz, 1H), 6.99 (td, J = 7.7, 1.2 Hz, 1H), 5.85 
(ddd, J = 172., 10.6, 5.4 Hz, 1H), 5.24 (dt, J = 7.5, 1.3 Hz, 1H), 5.20 (d, J = 1.5 Hz, 
1H), 4.99 (ddq, J = 8.5, 5.6, 1.4 Hz, 1H), 4.93 (dddt, J = 8.4, 6.9, 5.4, 1.6 Hz, 1H), 3.02 
(s, 3H), 2.03-1.93 (m, 1H), 1.89 (dt, J = 14.7, 7.1 Hz, 1H), 1.65-1.57 (m, 2H), 1.56 (d, 
J = 1.4 Hz, 3H), 1.52 (d, J = 1.3 Hz, 3H), 1.50-1.23 (m, 2H), 1.21-1.11 (m, 1H), 0.96 
(d, J = 6.6 Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ = 163.0, 148.8, 143.6, 136.2, 131.4, 124.4, 123.8, 120.1, 
116.8, 116.1, 108.6, 56.9, 38.5, 36.3, 29.9, 29.0, 25.5, 25.3, 20.0, 17.6. 
HRMS (ESI): Calculated for C20H28N2O [M+H
+] = 313.2274, Found 313.2276. 
FTIR (neat): 3726, 2961, 2914, 2360, 2341, 1632, 1575, 1459, 1246, 1125, 922, 754, 739, 







The allylic acetate (98.7 mg, 0.44 mmol, 100 mol%) and the primary amine (130.4 mg, 
0.88 mmol, 200 mol%) were subject to standard reaction conditions (70 oC, 60 hr) with 
(R)-Ir-II. The title compound was obtained in 76% yield, 20:1 dr (104.4 mg, 0.33 mmol) 
as a light yellow oil after purification by flash column chromatography (4g SiO2, Isopropyl 
Acetate / Heptane = 0% - 10% over 10 min). 
 
TLC (SiO2) Rf  = 0.33 (heptane: isopropyl acetate = 9:1).  
1H NMR (400 MHz, CDCl3): δ = 7.36 (ddd, J = 7.8, 1.3, 0.6 Hz, 1H), 7.26-7.23 (m, 1H), 
7.15 (td, J =7.7, 1.2 Hz, 1H), 7.02-6.96 (m, 1H), 5.85 (ddd, J = 17.5, 10.4, 5.0 Hz, 1H), 
5.22 (ddd, J = 5.3, 1.7, 1.2 Hz, 1H), 5.19 (td, J = 1.8, 1.2 Hz, 1H), 5.07 (ddq, J = 8.5, 
5.7, 1.3 Hz, 1H), 4.97 (dtt, J = 11.1, 4.5, 1.7 Hz, 1H), 3.00 (s, 2H), 1.98 (p, J =7.3 Hz, 
2H), 1.83 (ddd, J = 13.6, 10.9, 2.9 Hz, 1H), 1.66 (d, J = 1.3 Hz, 3H), 1.60-1.56 (m, 
3H), 1.47-1.24(m, 4H), 0.96 (d, J = 6.2 Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ = 163.2, 148.8, 143.6, 136.6, 131.5, 134.5, 123.9, 120.1, 
116.3, 116.0, 108.6, 56.5, 37.9, 37.7, 29.6, 29.0, 25.7, 25.5, 19.4, 17.7. 
HRMS (ESI): Calculated for C20H28N2O [M+H
+] = 313.2274, Found 313.2278. 







The allylic acetate (50.2 mg, 0.44 mmol, 100 mol%) and the amine (116.3 mg, 0.88 mmol, 
200 mol%) were subject to standard reaction conditions (60 oC, 24 hr). The title compound 
was obtained in 91% yield (74.5 mg, 0.40 mmol) as a light yellow oil after purification by 
flash column chromatography (12g SiO2, Isopropyl Acetate / Heptane = 0% - 40% over 20 
min). 
 
TLC (SiO2) Rf  = 0.32 (heptanes: ethyl acetate = 2:1).  
1H NMR (400 MHz, CDCl3): δ = 7.91 (br, 1H), 7.19 (dt, J = 8.6, 0.8 Hz, 1H), 7.12 – 7.08 
(m, 1H), 6.86 (d, J = 2.3 Hz, 1H), 6.63 (ddd, J = 8.7, 2.3, 0.4 Hz, 1H), 6.39 (ddd, J = 
3.1, 2.0, 0.9 Hz, 1H), 5.90 (ddd, J = 17.3, 10.4, 5.7 Hz, 1H), 5.25 (dt, J = 17.2, 1.4 Hz, 
1H), 5.08 (dt, J = 10.3, 1.4 Hz, 1H), 4.07 – 3.97 (m, 1H), 1.34 (d, J = 6.6 Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ = 142.1, 141.4, 130.1, 128.8, 124.4, 113.9, 112.8, 111.5, 
103.7, 101.8, 52.5, 21.7. 
HRMS (ESI): Calculated for C12H15N2 [M+H
+] = 187.1230, Found 187.1230. 
FTIR (neat): 3404, 2975, 1626, 1581, 1469, 1231, 1167, 919, 797, 724, 602 cm–1. 
[α]
D
𝟐𝟖= –5.0 (c 0.2, CHCl3). 











The allylic acetate (50.2 mg, 0.44 mmol, 100 mol%) and the amine (213.9 mg, 0.88 mmol, 
200 mol%) were subject to standard reaction conditions (70 oC, 24 hr). The title compound 
was obtained in 61% yield (79.8 mg, 0.27 mmol) as a light yellow oil after purification by 
flash column chromatography (SiO2, hexanes: ethyl acetate = 10:1–5:1). 
 
TLC (SiO2) Rf  = 0.24 (hexanes: ethyl acetate = 4:1).  
1H NMR (500 MHz, CDCl3): δ = 6.53 (d, J = 2.2 Hz, 1H), 6.46 (d, J = 2.2 Hz, 1H), 5.81 
(ddd, J = 17.2, 10.3, 5.6 Hz, 1H), 5.17 (dt, J = 17.2, 1.3 Hz, 1H), 5.09 (dt, J = 10.3, 
1.3 Hz, 1H), 4.50 (d, J = 6.3 Hz, 1H), 4.13 (t, J = 5.5 Hz, 2H), 3.85 (q, J = 6.3 Hz, 
1H), 3.25 – 3.08 (m, 2H), 2.60 (br, 1H), 2.01 (ddd, J = 10.0, 6.5, 4.8 Hz, 2H), 1.31 (d, 
J = 6.6 Hz, 3H). 
13C NMR (125 MHz, CDCl3): δ = 156.5, 144.5, 140.8, 126.4, 116.5, 114.3, 113.5, 110.6, 
71.9, 51.5, 45.6, 33.5, 21.6. 
HRMS (ESI): Calculated for C13H17BrN2O [M+H
+] = 297.0597, Found 297.0581. 




𝟐𝟖= –1.8 (c 1.0, CHCl3). 











The allylic acetate (50.2 mg, 0.44 mmol, 100 mol%) and the amine (167.4 mg, 0.88 mmol, 
200 mol%) were subject to standard reaction conditions (60 oC, 24 hr). The title compound 
was obtained in 86% yield (92.5 mg, 0.38 mmol) as a light yellow oil after purification by 
flash column chromatography (12g SiO2, Isopropyl Acetate / Heptane = 0% - 5% over 20 
min). 
 
TLC (SiO2) Rf  = 0.46 (hexanes: ethyl acetate = 10:1).  
1H NMR (500 MHz, CDCl3): δ = 6.80 – 6.65 (m, 4H), 6.01 – 5.76 (m, 1H), 5.21 (dd, J = 
17.2, 1.7 Hz, 1H), 5.08 (dd, J = 10.4, 1.6 Hz, 1H), 3.93 (p, J = 6.5 Hz, 1H), 3.38 – 3.11 
(m, 3H), 2.12 – 1.99 (m, 2H), 1.84 – 1.72 (m, 2H), 1.66 (dt, J = 13.1, 3.9 Hz, 1H), 1.39 
(dd, J = 14.7, 11.5 Hz, 2H), 1.34 (d, J = 6.6 Hz, 3H), 1.31 – 1.14 (m, 3H). 
13C NMR (125 MHz, CDCl3): δ = 141.8, 136.7, 136.5, 119.2, 118.8, 114.0, 113.9, 113.4, 
52.1, 51.5, 33.7 (d), 26.10, 25.0 (d), 21.87. 
HRMS (ESI): Calculated for C16H24N2 [M+H
+] = 245.2012, Found 245.2016. 
FTIR (neat): 3330, 2926, 1598, 1508, 1448, 1304, 1252, 1148, 916, 733 cm–1. 
[α]
D
𝟐𝟖= +30.0 (c 0.1, CHCl3). 









4.5.3.3 Procedures and Spectral Data for Deuterium Labelling Experiments 
(S,Z)-oct-1-en-3-yl-1-d acetate (4.1h) 
 
1h synthesized from commercially available (S)-(-)-1-Octyn-3-ol, >98% ee. 
 
To a round-bottomed flask charged with potassium carbonate (380.1 mg, 2.8 mmol, 110 
mol%) was added deuterium oxide (6.8 mL, 0.37 M, 99.9 atom % D), followed by (S)-(-)-
1-Octyn-3-ol (315 mg, 2.5 mmol, 100 mol%). The mixture was stirred at room temperature 
overnight. After anhydrous CH2Cl2 (10 mL) were added to the reaction mixture, the mixture 
was transferred to a separatory funnel. The organic layer was extracted with CH2Cl2 (5 mL 
× 2) and the combined organic layers were washed with H2O (20 mL), dried (MgSO4), 
filtered and concentrated under reduced pressure. The resulting oily residue was subjected 
to the next step without further purification. 
 
To a round-bottomed flask charged with the crude substrate under an argon atmosphere 
was added anhydrous CH2Cl2 (10 mL, 0.25 M with respect to propargylic alcohol). The 
reaction vessel was placed in an ice batch. After 5 minutes DIBAL (3 mL, 3.0 mmol, 1 M 
in hexanes) was added slowly and the solution was stirred at room temperature for 30 
minutes. After the reaction vessel was placed in an ice batch, Schwartz’s reagent (773.6 
mg, 3.0 mmol, 120 mol%) was added to the reaction mixture. The mixture was stirred at 
room temperature for 2 hours, at which point saturated aqueous sodium bicarbonate (5 mL) 
were added and the reaction was stirred vigorously. After 2 hours, the reaction mixture was 
filtered (celite) with the aid of CH2Cl2 (10 mL) and the filtrate was transferred to a 
separatory funnel. The organic layer was extracted with CH2Cl2 (10 mL × 2) and the 
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combined organic layers were washed with H2O (20 mL), dried (MgSO4), filtered and 
concentrated under reduced pressure. The resulting oily residue was subjected to the next 
step without further purification. 
 
To a round-bottomed flask charged with the crude substrate and 4-dimethylaminopyridine 
(15.2 mg, 0.13 mmol, 5 mol%) under an argon atmosphere was added CH2Cl2 (12.5 mL, 
0.25 M with respect to propargylic alcohol), followed by acetic anhydride (0.28 mL, 3.0 
mmol, 120 mol%) and triethylamine (0.41 mL, 3.0 mmol, 120 mol%). After 1 hour, 
saturated aqueous sodium bicarbonate (10 mL) was added and the mixture was transferred 
to a separatory funnel. The organic layer was extracted with CH2Cl2 (10 mL × 2) and the 
combined organic layers were washed with 1 N HCl (10 mL), dried (MgSO4), filtered and 
concentrated under reduced pressure. The resulting oily residue was subjected to flash 
column chromatography (SiO2, hexanes: ethyl acetate = 30:1) to furnish the title compound 
as a light yellow oil (240 mg, 1.40 mmol) in 56% yield over 3 steps. 
 
TLC (SiO2) Rf  = 0.72 (hexanes: ethyl acetate = 4:1).  
1H NMR (500 MHz, CDCl3): δ = 5.76 (ddt, J = 10.4, 6.3, 2.6 Hz, 1H), 5.25 – 5.19 (m, 1H), 
5.14 (dd, J = 10.5, 1.1 Hz, 1H), 2.06 (s, 3H), 1.66 – 1.52 (m, 2H), 1.34 – 1.25 (m, 6H), 
0.91 – 0.84 (m, 3H). 
2H NMR (92 MHz, CHCl3): δ = 5.28 (s, 1D). 
13C NMR (125 MHz, CDCl3): δ = 170.4, 136.6, 116.2 (t), 74.9, 34.2, 31.6, 24.7, 22.5, 21.3, 
14.0. 
LRMS (CI): Calculated for C8H14D [M–OAc]
+ = 112, Found 112. 
FTIR (neat): 2932, 1731, 1372, 1247, 1021, 756, 667 cm–1. 
[α]
D








An pressure tube equipped with a magnetic stir bar was charged with amine 4.3m (59.3 
mg, 0.4 mmol, 200 mol%), cesium carbonate (130.3 mg, 0.4 mmol, 200 mol%) and (S)-Ir-
II (11.1 mg, 0.01 mmol, 5 mol%). The tube was purged with argon for 5 minutes. DME 
(0.2 mL, 1.0 M) was added followed by the deuterated allylic acetate 4.1h (34.3 mg, 0.2 
mmol, 100 mol%). The tube was sealed with a PTFE lined cap and was placed in an oil 
bath at 70 °C for 24 hours. After reaching ambient temperature, the crude reaction mixture 
was directly subjected to flash column chromatography (SiO2, hexanes: ethyl acetate = 
25:1–15:1). The title compound was obtained in 89% yield (46.2 mg, 0.18 mmol) as a 
colorless oil. 
 
TLC (SiO2) Rf  = 0.55 (hexanes: ethyl acetate = 4:1).  
1H NMR (500 MHz, CDCl3): δ = 7.35 (dd, J = 7.8, 1.1 Hz, 1H), 7.25 (d, J = 8.0 Hz, 1H), 
7.15 (td, J = 7.7, 1.1 Hz, 1H), 6.99 (td, J = 7.7, 1.2 Hz, 1H), 5.85 (ddd, J = 10.5, 5.1, 
2.4 Hz, 1H), 5.20 (dd, J = 10.6, 1.6 Hz, 1H), 4.86 – 4.77 (m, 1H), 3.02 (s, 3H), 1.74 – 
1.66 (m, 2H), 1.36 – 1.27 (m, 6H), 0.86 (t, J = 6.9 Hz, 3H). 
2H NMR (92 MHz, CHCl3): δ = 5.28 (s, 1D). 
13C NMR (125 MHz, CDCl3): δ = 163.2, 148.8, 143.5, 136.1, 123.8, 120.1, 116.4 (t), 116.0, 
108.6, 58.9, 31.6, 30.9, 29.7, 25.8, 22.5, 14.0. 
HRMS (ESI): Calculated for C16H21DN2O [M+H
+] = 260.1868, Found 260.1870. 
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FTIR (neat): 2930, 1636, 1577, 1460, 1246, 1216, 748 cm–1. 
[α]
D
𝟐𝟖= –71.3 (c 1.0, CHCl3). 














An pressure tube equipped with a magnetic stir bar was charged with amine 4.3m (59.3 
mg, 0.4 mmol, 200 mol%), cesium carbonate (130.3 mg, 0.4 mmol, 200 mol%) and (R)-Ir-
II (11.1 mg, 0.01 mmol, 5 mol%). The tube was purged with argon for 5 minutes. DME 
(0.2 mL, 1.0 M) was added followed by the deuterated allylic acetate 4.1h (34.3 mg, 0.2 
mmol, 100 mol%). The tube was sealed with a PTFE lined cap and was placed in an oil 
bath at 70 oC for 24 hours. After reaching ambient temperature, the crude reaction mixture 
was directly subjected to flash column chromatography (SiO2, hexanes: ethyl acetate = 
25:1–15:1). The title compound was obtained in 85% yield (44.1 mg, 0.17 mmol) as a 
colorless oil. 
 
TLC (SiO2) Rf  = 0.55 (hexanes: ethyl acetate = 4:1).  
1H NMR (500 MHz, CDCl3): δ = 7.35 (dd, J = 7.8, 1.1 Hz, 1H), 7.26 – 7.22 (m, 1H), 7.15 
(td, J = 7.7, 1.1 Hz, 1H), 6.99 (td, J = 7.8, 1.2 Hz, 1H), 5.86 (dd, J = 17.3, 5.3 Hz, 1H), 
5.21 (dd, J = 17.4, 1.7 Hz, 1H), 4.82 (dddd, J = 8.6, 6.8, 5.3, 1.7 Hz, 1H), 3.02 (s, 3H), 
1.76 – 1.63 (m, 2H), 1.41 – 1.21 (m, 6H), 0.87 (t, J = 7.0 Hz, 3H). 
2H NMR (92 MHz, CHCl3): δ = 5.28 (s, 1D). 
13C NMR (125 MHz, CDCl3): δ = 163.2, 148.8, 143.5, 136.2, 136.0, 123.8, 120.1, 116.6, 
116.4, 116.2, 116.0, 108.6, 58.9, 31.6, 30.9, 29.7, 25.8, 22.5, 14.0. 
HRMS (ESI): Calculated for C16H21DN2O [M+H
+] = 260.1868, Found 260.1872. 
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FTIR (neat): 2930, 1636, 1577, 1460, 1246, 1216, 753 cm–1. 
[α]
D
𝟐𝟖= +70.8 (c 1.0, CHCl3). 












4.5.3.4 Single Crystal Diffraction Data for 4.7b 
 
Empirical formula  C13 H18 Br Cl N2 O 
Formula weight  333.65 
Temperature  100(2) K 
Wavelength  1.54184 Å 
Crystal system  monoclinic 
Space group  P 21 
  Unit cell dimensions a = 7.1967(3) Å = 90°. 
 b = 19.2597(4) Å = 105.491(5)°. 
 c = 10.4450(4) Å  = 90°. 
Volume 1395.15(9) Å3 
Z 4 
Density (calculated) 1.588 Mg/m3 
Absorption coefficient 5.697 mm-1 
F(000) 680 
Crystal size 0.160 x 0.070 x 0.030 mm3 
Theta range for data collection 4.393 to 75.594°. 
Index ranges -8<=h<=8, -23<=k<=23, -12<=l<=12 
Reflections collected 21291 
Independent reflections 5628 [R(int) = 0.0497] 
Completeness to theta = 67.684° 100.0 %  
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 5628 / 2 / 351 
Goodness-of-fit on F2 1.063 
Final R indices [I>2sigma(I)] R1 = 0.0362, wR2 = 0.0947 
R indices (all data) R1 = 0.0369, wR2 = 0.0955 
Absolute structure parameter -0.009(15) 
Extinction coefficient n/a 
Largest diff. peak and hole 0.701 and -0.579 e.Å-3 
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Figure 4.2 Crystal Structure of 4.7b Cation 1 
View of cation 1 in 4.7b showing the atom labeling scheme.  Displacement ellipsoids are 
scaled to the 50% probability level.  
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Figure 4.3 Crystal Structure of 4.7b Cation 2 
View of cation 2 in 4.7b showing the atom labeling scheme.  Displacement ellipsoids are 
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